Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AC008763.3		ENSG00000269711	"Novel protein"		19	7678501-7682854	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	7	"bone marrow: 22.6;intestine: 7.7;lung: 18.3;lymphoid tissue: 12.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.3;Club cells: 3.7;Fibroblasts: 1.3;granulocytes: 2.5;Macrophages: 1.3;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 202.7;neutrophil: 90.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"EFO-21: 12.8;HMC-1: 20.9;NB-4: 12.4;THP-1: 33.2;U-937: 24.6"															NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"																					2.3	0.8	0.3	4.6	0.4	22.6	0.6	0.2	0.5	0.2	0.1	0.5	7.7	1.1	0.0	0.4	1.8	1.5	1.4	0.2	0.3	0.7	1.8	18.3	0.0	1.0	0.7	0.1	0.7	0.0	0.3	1.6	0.5	0.5	0.0	0.0	1.2	0.0	0.7	0.9	1.4	0.1	0.2	12.2	0.9	0.6	0.3	0.0	0.6	0.0	0.0	1.2	0.4	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.5	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	202.7	1.3	0.2	18.1	0.0	0.0	0.5	0.1	42.9	0.0	0.0	1.4	90.1	0.7	1.7	1.8	0.8	112.3	0.3	0.4	0.2	0.5	0.2	0.3	1.0	0.7	0.5	0.2	0.3	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
ADAM8	"CD156, CD156A, MS2"	ENSG00000151651	"ADAM metallopeptidase domain 8"	P78325	10	133262420-133276868	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.6;lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 54.7;Extravillous trophoblasts: 96.4;Langerhans cells: 124.9;monocytes: 81.3;NK-cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 21.2"	"Group enriched"	"Detected in many"	5	"basophil: 107.4;eosinophil: 259.0;neutrophil: 139.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 259.0"	"Cell line enhanced"	"Detected in many"		"A-431: 60.0;BEWO: 81.8;CAPAN-2: 70.4;HaCaT: 69.8;HDLM-2: 45.9;U-87 MG: 34.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064637	Approved				"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA064637: AB_2685306"	"unprognostic (8.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.37e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (3.99e-10)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.32e-2)"	5.6	2.4	2.1	22.1	2.3	68.6	2.7	1.4	21.2	4.2	1.7	3.6	5.8	2.2	2.1	3.5	6.0	5.1	2.5	1.8	1.8	4.7	8.4	21.5	11.6	3.2	1.9	3.0	4.3	0.3	3.6	3.1	4.4	4.5	1.6	1.5	4.2	1.1	1.2	3.2	11.3	2.1	1.6	48.5	11.5	2.6	5.9	4.0	3.8	1.7	8.2	11.9	3.2	3.4	60.0	1.7	0.5	0.9	0.4	0.1	81.8	0.7	1.4	0.3	0.4	4.6	70.4	1.0	1.7	0.1	0.5	69.8	0.2	11.9	0.1	45.9	1.0	0.8	0.5	0.0	0.7	3.6	15.9	0.2	1.1	0.6	1.0	3.7	0.1	0.5	3.2	2.4	0.0	4.8	0.2	20.2	0.3	7.1	1.7	0.4	0.7	6.6	0.8	1.4	0.1	0.8	0.4	0.2	1.0	1.1	1.0	2.0	1.7	0.0	1.5	0.6	1.0	3.4	2.2	0.6	34.5	2.0	0.2	107.4	24.8	259.0	22.2	9.2	15.9	10.2	14.8	21.4	37.2	5.6	5.6	8.2	139.4	24.7	9.4	0.7	16.9	25.2	2.1	2.3	1.4	21.2	1.8	1.8	3.2	1.9	4.4	1.6	5.9	3.4	1.3	3.2	10.5	3.3	23.2	7.8	6.6	14.3	0.0	4.3	2.2	1.8	2.4	2.8	9.5	0.0	8.4	7.7	54.7	0.3	1.9	3.1	1.0	1.5	0.9	1.7	0.0	5.7	3.5	2.7	96.4	2.4	6.1	2.1	12.6	1.1	2.5	2.4	23.3	0.0	3.0	0.6	2.0	8.8	124.9	0.4	0.9	33.9	7.2	0.0	81.3	0.2	82.4	2.0	2.9	39.1	0.1	0.0	20.7	11.0	0.3	0.5	10.0	5.1	0.0	0.8	1.0	1.5	0.8	0.6	6.5	20.0	39.4	0.2	0.5	42.5
ADGRE5	"CD97, TM7LN1"	ENSG00000123146	"Adhesion G protein-coupled receptor E5"	P48960	19	14380501-14408725	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 211.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 245.4;Kupffer cells: 111.1;Macrophages: 131.6;NK-cells: 160.6;Plasma cells: 141.5;T-cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013707	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	Yes	10000000	2400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA013707: AB_1846345"	"unprognostic (3.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.51e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.41e-2)"	45.6	21.4	4.7	79.5	7.6	211.6	21.5	7.8	6.3	60.9	4.0	52.7	43.6	143.6	7.0	15.1	48.9	33.2	30.4	4.8	6.0	28.0	19.9	80.2	58.2	9.6	7.4	14.6	31.4	6.1	7.5	32.7	8.4	17.0	29.7	0.4	22.1	10.4	29.5	14.9	51.0	75.3	6.6	145.0	40.5	3.4	9.0	32.5	21.3	13.5	32.0	42.2	29.3	12.1	118.1	81.9	0.8	77.2	33.3	54.1	12.2	79.6	127.0	56.0	61.0	23.5	115.9	13.5	78.5	103.1	79.6	27.2	21.0	38.8	25.0	73.4	23.7	26.4	113.0	10.4	41.0	57.4	117.3	23.9	1.0	57.1	19.4	18.2	5.6	22.7	35.0	101.9	61.9	26.6	3.7	76.3	2.3	92.7	100.4	7.8	33.7	61.8	18.7	10.4	1.0	2.8	45.4	64.1	57.9	1.8	16.7	52.3	14.0	19.0	31.1	79.5	133.2	0.2	0.4	1.1	67.6	100.4	72.0	371.6	158.5	772.8	187.5	281.4	123.9	28.5	94.2	129.6	102.6	18.5	65.5	91.9	623.2	179.2	352.9	48.4	70.6	242.4	4.7	7.6	7.8	6.3	4.8	6.0	9.6	7.4	8.4	6.6	9.0	12.1	10.0	35.3	93.1	1.3	88.6	0.0	8.5	0.0	2.2	0.5	7.2	6.7	3.7	12.8	17.3	0.0	0.0	4.1	245.4	25.8	0.0	18.1	0.1	16.1	26.9	13.1	4.9	25.7	1.4	22.5	46.3	20.0	49.5	13.3	77.0	1.4	23.9	2.9	50.8	0.0	1.8	25.9	0.0	111.1	0.0	1.4	6.5	131.6	0.0	6.5	55.3	2.6	160.6	2.0	11.2	21.2	30.6	4.9	141.5	12.8	17.8	0.9	27.7	1.5	26.3	34.6	23.1	0.5	5.3	3.2	0.0	7.9	184.3	3.7	29.1	17.6
ADPGK	"ADP-GK, DKFZp434B195"	ENSG00000159322	"ADP dependent glucokinase"	Q9BRR6	15	72751369-72785846	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 140.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045194, HPA058525"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA		66000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Centrosome		"HPA045194: AB_10964638, HPA058525: AB_2683742"	"unprognostic (5.96e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.22e-4)"	"prognostic unfavorable (4.52e-7)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-2)"	10.1	7.5	2.7	15.3	2.8	23.7	8.7	3.3	3.8	7.3	9.7	10.3	8.0	5.4	12.1	7.5	9.5	7.0	5.3	2.9	4.9	11.7	10.8	17.0	13.5	4.4	4.4	5.9	7.8	6.6	3.8	16.5	5.0	12.1	11.8	4.3	9.6	5.3	4.7	7.1	8.6	7.8	3.8	13.6	9.8	7.2	3.9	15.3	9.2	5.3	16.4	13.7	5.9	4.9	18.5	37.8	19.8	23.5	43.8	33.2	26.6	52.7	51.0	54.0	74.4	21.5	47.6	34.7	38.3	33.1	53.6	49.0	56.6	27.7	40.2	34.5	38.8	26.0	9.9	20.3	28.2	60.3	37.3	36.2	15.7	28.6	26.4	26.4	31.8	26.7	27.7	57.6	33.1	11.6	18.8	27.0	29.6	36.7	17.6	21.9	32.3	48.5	27.9	21.3	14.3	14.7	48.2	19.7	26.3	30.8	18.9	71.9	26.4	27.0	22.4	103.2	48.5	57.8	119.3	34.6	47.2	58.4	45.7	56.8	69.2	51.6	22.4	48.4	27.9	30.4	20.6	22.8	72.5	26.7	17.7	20.2	27.2	32.0	41.5	55.4	17.9	59.6	2.7	2.8	3.3	3.8	2.9	4.9	4.4	4.4	5.0	3.8	3.9	4.9	19.3	19.2	34.3	22.5	61.7	15.3	20.9	22.7	17.1	15.6	20.1	14.7	3.9	8.6	23.8	20.2	14.6	38.2	75.6	15.1	7.9	25.8	14.9	18.2	22.6	20.2	7.8	10.5	13.0	17.4	62.0	27.4	23.4	17.5	48.9	31.6	21.4	23.9	80.4	15.2	17.5	17.0	24.4	101.3	51.6	6.4	21.8	68.5	26.6	31.9	140.6	11.7	42.2	13.0	22.1	22.3	16.9	15.4	34.9	34.4	15.6	10.7	24.8	24.4	19.7	19.2	16.4	24.4	31.3	11.8	18.2	41.7	36.0	22.9	20.9	31.2
AGFG1	"HRB, RAB, RIP"	ENSG00000173744	"ArfGAP with FG repeats 1"	P52594	2	227472152-227561217	"Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Transport"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 333.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008741	Approved		Supported	Vesicles		NA	NA		120000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA008741: AB_1850752"	"unprognostic (5.76e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (8.73e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (6.10e-4)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (7.31e-6)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (2.03e-2)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.24e-3)"	69.4	39.4	30.4	48.4	31.6	155.5	51.1	29.3	36.0	25.3	23.8	32.2	43.4	25.7	20.1	47.2	27.3	38.9	36.2	32.4	27.0	36.9	36.2	54.6	47.1	34.6	29.0	26.1	35.0	41.6	17.9	75.8	33.4	21.0	33.0	47.7	27.9	23.4	33.9	36.3	36.2	39.3	33.6	46.5	33.2	92.8	34.5	48.6	34.3	38.6	53.3	65.7	32.2	47.3	60.5	97.9	50.8	49.6	84.8	62.1	191.6	78.4	74.6	92.0	81.2	77.4	67.6	42.7	58.3	86.8	123.8	62.2	87.9	101.7	118.6	72.3	48.9	94.1	80.8	144.3	90.9	64.7	57.0	38.3	106.4	116.7	109.5	70.3	93.7	43.3	100.3	112.0	111.8	85.8	77.8	58.0	79.3	80.4	50.4	70.8	83.6	30.3	91.7	81.5	47.0	36.7	64.1	82.5	74.7	87.6	35.3	72.4	92.7	78.8	63.0	114.7	70.0	64.5	46.9	59.6	85.6	54.4	92.5	4.1	5.3	1.9	1.6	4.3	3.2	2.0	1.8	1.5	3.3	3.5	1.5	2.8	5.6	1.1	4.2	2.3	2.3	1.6	30.4	31.6	29.3	36.0	32.4	27.0	34.6	29.0	33.4	33.6	34.5	47.3	36.6	25.6	23.6	45.7	27.2	33.1	37.5	18.0	18.2	37.7	29.3	22.1	23.3	17.2	19.6	22.0	25.0	31.0	26.5	28.2	15.6	17.5	162.3	32.7	34.9	29.1	34.1	13.3	114.2	21.5	17.5	26.8	39.8	65.8	12.7	30.4	23.6	22.9	24.1	43.7	74.9	20.4	12.2	92.8	33.6	333.2	15.5	67.3	19.6	119.9	48.4	43.3	19.6	109.6	116.0	32.6	18.0	11.7	22.7	39.4	31.3	27.4	15.5	35.4	19.7	83.8	21.7	72.6	18.4	25.0	32.1	39.7	24.0	20.6	22.2	57.9
AGTRAP	ATRAP	ENSG00000177674	"Angiotensin II receptor associated protein"	Q6RW13	1	11736084-11754802	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044120	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Golgi apparatus"	"HPA044120: AB_10960748"	"unprognostic (1.08e-3)"	"unprognostic (2.98e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (6.57e-7)"	"unprognostic (4.44e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.89e-2)"	44.1	50.3	26.6	30.2	28.5	132.3	44.3	27.1	32.4	34.6	44.0	29.3	11.2	24.7	47.7	53.6	48.3	25.2	37.0	24.5	30.5	65.8	29.5	62.3	23.4	37.3	28.8	26.9	67.3	25.7	31.2	22.0	31.3	79.1	9.3	3.4	39.0	21.0	54.3	38.8	25.7	20.3	28.4	83.4	33.7	24.7	31.8	11.3	40.8	12.4	13.3	43.9	43.3	31.1	55.9	66.7	16.7	36.9	27.5	34.9	30.5	28.6	49.0	34.8	30.2	42.0	129.7	5.4	126.7	35.4	87.3	45.8	27.9	135.3	10.7	3.1	61.5	1.6	38.4	51.8	84.9	27.6	64.3	34.6	105.4	112.9	59.2	42.4	46.9	17.3	73.8	52.8	19.8	44.6	13.7	80.9	29.7	24.0	67.3	4.6	15.0	27.5	56.7	5.2	14.6	22.0	52.5	26.4	48.4	22.3	59.8	57.4	26.0	44.1	30.8	70.3	30.9	19.6	24.2	33.3	111.7	196.1	20.7	483.4	844.2	694.6	185.7	442.7	90.4	47.0	66.9	109.8	312.2	38.2	72.0	93.5	756.8	73.0	385.2	25.5	90.8	577.4	26.6	28.5	27.1	32.4	24.5	30.5	37.3	28.8	31.3	28.4	31.8	31.1	46.2	22.4	27.4	3.9	12.1	11.6	30.7	112.4	16.5	1.0	54.8	56.0	12.0	32.9	41.6	36.8	6.2	15.7	60.1	6.9	9.8	95.5	20.6	75.3	30.8	36.1	7.2	21.0	0.2	446.7	92.4	45.3	11.2	41.1	88.0	19.1	42.1	7.7	118.3	3.3	0.2	12.3	20.3	143.5	18.9	23.4	37.9	97.8	28.4	1.9	107.4	19.4	122.6	0.5	7.0	96.9	22.5	27.1	8.6	66.5	8.6	55.3	78.5	5.6	13.1	13.0	23.8	3.5	36.1	34.4	13.5	13.1	45.0	50.4	18.2	25.2
AL049634.2		ENSG00000260861	"Novel protein, SIRPB1-SIRPD readthrough"		20	1540144-1620009	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 2.7;lymphoid tissue: 2.6;testis: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 78.3;neutrophil: 127.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 127.7;monocytes: 43.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.5;HMC-1: 6.7;NB-4: 2.6;THP-1: 4.0;U-937: 2.1"															NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"																					0.4	0.8	0.1	2.6	0.1	2.7	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.4	0.3	0.2	0.1	0.2	0.0	0.1	0.3	0.1	0.5	0.7	0.8	0.1	0.2	0.1	0.3	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.6	0.6	0.2	0.8	0.1	3.3	0.5	0.2	0.0	0.0	0.4	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.7	0.0	0.1	0.2	0.0	1.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.0	1.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	2.1	0.1	0.6	35.3	78.3	0.6	27.5	0.3	0.1	0.0	0.4	12.9	0.0	0.1	0.1	127.7	0.2	43.6	10.4	0.2	26.0	0.1	0.1	0.0	0.3	0.1	0.3	0.1	0.2	0.2	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH3B1	ALDH7	ENSG00000006534	"Aldehyde dehydrogenase 3 family member B1"	P43353	11	68008578-68029282	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 46.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 115.4;Alveolar cells type 2: 58.4;Endometrial ciliated cells: 54.5;Kupffer cells: 59.0;Respiratory ciliated cells: 211.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 163.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 67.5;granulocytes: 163.2;monocytes: 125.8"	"Cell line enhanced"	"Detected in many"		"A549: 154.4;CAPAN-2: 154.9;RPMI-8226: 85.9;U-87 MG: 89.1"	"Low region specificity"	"Detected in all"							HPA038525	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA038525: AB_2676062"	"unprognostic (3.50e-1)"	"unprognostic (4.22e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.56e-2)"	"unprognostic (9.66e-3)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (8.27e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.06e-1)"	12.7	26.7	2.9	10.6	4.5	46.5	5.5	5.1	4.2	11.4	8.9	9.8	23.4	6.4	0.9	13.9	39.6	8.8	4.0	2.5	3.8	16.3	4.1	44.4	5.6	6.0	5.6	3.6	8.0	0.6	7.7	11.7	4.9	4.7	6.5	0.5	11.1	4.1	2.0	5.7	18.0	5.6	4.5	20.0	20.7	2.1	5.4	1.3	2.5	1.7	2.6	10.8	8.9	6.2	11.4	154.4	1.1	3.3	9.9	31.0	26.8	15.1	24.8	10.9	5.3	5.7	154.9	0.7	26.9	35.9	15.3	12.9	0.3	2.1	2.7	0.4	0.9	1.6	64.3	13.4	61.0	9.1	0.5	22.5	6.8	5.4	14.6	24.6	0.6	0.8	0.4	27.3	17.8	9.5	0.9	9.0	1.2	76.1	9.2	3.7	5.9	85.9	17.9	1.5	1.8	0.8	35.7	29.7	15.2	0.8	34.3	19.7	16.2	15.7	21.3	76.2	5.3	0.4	3.0	0.2	89.1	24.5	7.4	47.6	91.0	163.2	0.2	125.8	0.3	0.4	0.2	0.2	67.5	0.5	0.2	0.1	26.6	11.8	118.1	7.0	0.1	47.7	2.9	4.5	5.1	4.2	2.5	3.8	6.0	5.6	4.9	4.5	5.4	6.2	0.4	115.4	58.4	1.0	1.4	2.2	2.7	8.4	1.2	0.5	1.7	1.3	3.1	20.0	53.6	5.5	0.0	0.8	2.9	6.6	0.0	7.4	21.6	54.5	9.2	1.8	2.4	7.8	0.2	2.5	8.2	6.5	12.8	5.1	25.2	2.0	1.4	2.3	34.0	3.3	0.1	9.0	12.2	59.0	10.6	10.0	1.8	33.1	3.6	1.9	30.9	2.1	1.0	0.5	5.7	19.3	7.5	1.5	1.3	3.1	36.2	30.1	211.6	0.4	0.0	6.9	6.5	0.4	0.4	1.0	1.0	0.7	2.2	0.0	9.8	6.2
ALOX5AP	FLAP	ENSG00000132965	"Arachidonate 5-lipoxygenase activating protein"	P20292	13	30713478-30764426	"Disease related genes, Predicted membrane proteins"	"Leukotriene biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 487.2;lung: 183.3;lymphoid tissue: 138.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 691.3;granulocytes: 609.1;Hofbauer cells: 492.2;Langerhans cells: 335.4;Macrophages: 637.0;NK-cells: 280.2;T-cells: 368.6"	"Cancer enhanced"	"Detected in all"		"glioma: 49.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 9703.9;eosinophil: 4033.4;neutrophil: 4968.7;plasmacytoid DC: 3555.3"	"Group enriched"	"Detected in all"	8	"dendritic cells: 3555.3;granulocytes: 9703.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 658.4;HL-60: 352.3;HMC-1: 1072.9;THP-1: 434.2;U-937: 321.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026592	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA026592: AB_10601115"	"unprognostic (1.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.83e-2)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	51.6	36.1	10.8	100.6	11.6	487.2	25.7	12.5	18.1	18.8	13.4	22.8	21.6	17.4	7.1	21.8	24.5	40.0	12.4	10.2	15.7	13.3	19.7	183.3	77.2	21.0	15.6	10.6	14.1	9.6	6.1	37.2	21.1	13.2	21.4	3.7	19.9	15.5	3.8	7.4	28.3	42.6	16.6	138.5	20.0	4.3	17.7	93.2	9.1	24.7	108.2	65.6	11.9	31.3	0.6	0.8	1.2	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	1.3	7.1	156.3	2.2	0.0	5.2	1.2	0.0	4.6	0.1	658.4	0.0	18.7	0.3	1.0	0.7	352.3	1072.9	0.8	0.2	0.1	37.9	8.1	1.4	33.3	0.1	3.2	1.9	0.1	19.8	12.7	0.0	0.0	0.2	3.2	3.9	12.4	1.4	0.3	10.2	0.1	0.2	0.3	0.9	2.3	0.0	434.2	1.1	0.0	3.2	0.3	2.6	66.2	0.5	103.8	1.0	321.1	1.4	9703.9	322.4	4033.4	546.0	17.2	808.3	477.9	536.4	449.0	198.5	489.2	271.6	260.7	4968.7	98.0	12.4	3555.3	843.9	775.2	10.8	11.6	12.5	18.1	10.2	15.7	21.0	15.6	21.1	16.6	17.7	31.3	3.5	41.7	102.0	0.0	117.6	23.7	2.6	1.8	1.2	0.0	3.3	9.1	4.1	10.0	23.7	0.0	0.0	3.1	691.3	4.0	15.6	2.3	5.6	14.3	0.7	17.2	26.4	27.1	0.4	1.0	4.0	11.2	21.4	0.7	609.1	1.9	7.1	1.8	492.2	0.0	0.4	2.0	4.1	144.3	335.4	4.5	4.7	637.0	42.7	13.1	217.1	0.1	280.2	0.5	0.3	6.4	3.1	4.1	31.1	1.5	7.3	2.0	11.1	0.1	32.9	4.4	4.0	0.4	1.1	1.7	24.7	4.9	368.6	0.0	2.0	1.4
ALPK1	"FLJ22670, KIAA1527, Lak"	ENSG00000073331	"Alpha kinase 1"	Q96QP1	4	112285509-112442621	"Enzymes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA027435, HPA027443"	Approved		Approved	Centrosome		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Centrosome		"HPA027435: AB_10599614, HPA027443: AB_10599421"	"unprognostic (6.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.17e-4)"	4.8	5.3	1.7	4.4	2.0	10.7	5.1	1.9	2.7	5.4	3.2	4.3	2.4	3.7	3.7	4.4	5.3	4.2	3.1	4.5	1.6	7.2	4.5	5.1	5.4	1.4	1.1	5.4	3.5	4.2	2.5	3.6	1.8	4.9	4.2	2.1	5.4	3.1	1.8	6.9	5.0	4.2	0.5	8.7	4.0	2.1	1.8	5.2	4.2	2.3	6.1	6.0	4.4	2.5	1.6	5.0	1.5	0.3	6.4	10.1	2.1	1.7	3.6	2.6	3.3	0.5	7.8	5.3	3.3	3.3	5.2	1.0	1.7	3.2	3.7	6.7	1.9	3.6	2.0	0.4	10.1	2.2	2.0	12.8	8.3	3.7	7.8	5.7	0.9	2.7	0.9	9.1	5.0	3.1	1.3	2.0	0.3	3.7	1.2	0.6	1.1	1.6	3.9	1.8	0.5	0.8	1.7	6.4	2.8	0.2	2.9	4.1	1.8	2.3	2.0	3.8	1.3	2.2	0.7	4.5	5.8	5.3	2.1	1.6	3.7	1.7	0.2	4.7	0.6	0.9	0.6	0.1	3.7	0.9	0.8	0.6	18.7	0.4	2.2	0.5	0.0	1.4	1.7	2.0	1.9	2.7	4.5	1.6	1.4	1.1	1.8	0.5	1.8	2.5	10.8	12.8	26.8	11.4	7.3	2.9	10.9	11.5	12.5	0.5	8.7	10.7	4.0	4.3	15.5	5.5	0.0	4.9	2.9	10.0	0.0	8.0	11.1	12.0	13.7	8.2	1.2	5.0	5.9	6.7	3.0	9.6	16.3	10.9	6.3	10.9	7.1	7.4	10.1	0.0	1.2	8.6	8.2	13.5	4.6	2.6	3.7	18.7	7.2	73.1	16.1	10.7	1.0	0.5	0.7	7.1	9.0	7.5	2.4	8.8	8.0	5.3	25.7	0.2	6.6	8.4	10.8	0.9	0.7	10.3	4.5	7.3	4.0	7.0	6.4	12.4
AP000295.1		ENSG00000249624	"Novel protein"		21	33229901-33297160	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.1;Club cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.9;monocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"HEL: 3.9;hTERT-RPE1: 3.3;MOLT-4: 4.0;RH-30: 3.9"															NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (2.39e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.00e-1)"		"unprognostic (6.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.33e-2)"	0.5	0.1	0.0	0.2	0.0	1.1	0.1	0.0	0.2	0.3	0.0	0.3	0.0	0.2	0.0	0.3	0.2	0.5	0.1	0.1	0.0	0.5	1.1	0.7	0.3	0.1	0.1	0.4	0.1	0.5	0.0	0.7	0.1	0.2	0.2	0.6	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.4	0.2	0.0	0.3	0.1	0.0	0.6	1.1	0.0	0.1	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.4	0.0	0.9	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.6	0.0	0.4	0.0	3.9	0.0	0.0	0.0	1.9	2.6	2.3	0.1	0.0	1.9	3.3	0.6	1.5	0.4	1.0	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	3.9	1.1	0.2	0.0	1.7	0.0	2.5	0.0	0.0	0.8	0.0	0.0	1.9	0.0	0.3	0.0	0.0	1.5	2.6	0.2	0.6	0.0	0.0	0.0	0.8	3.0	0.1	1.8	0.5	0.1	0.5	0.4	0.5	0.0	0.4	0.3	5.9	0.7	2.8	0.4	0.6	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645290-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.0"	"Cell type enhanced"	"Detected in many"		"monocytes: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 71.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	4.5	2.8	2.4	8.9	2.8	32.0	5.0	2.5	2.7	5.5	1.2	8.5	5.1	5.5	3.5	3.2	4.0	7.3	2.6	2.8	1.3	3.7	4.7	6.7	9.4	2.3	1.2	7.7	4.0	2.8	3.1	7.6	2.2	3.9	9.6	5.8	4.6	3.4	3.4	5.7	7.1	5.0	1.9	9.7	6.6	3.1	2.2	7.7	4.7	3.1	8.8	5.8	3.9	4.3	6.8	8.7	30.3	11.6	9.4	18.2	8.3	17.3	12.1	11.7	11.6	6.3	4.8	9.8	4.5	12.7	4.4	11.3	20.2	11.4	13.9	7.3	8.0	18.5	9.6	7.7	3.5	18.6	22.7	7.5	3.5	12.1	5.5	14.1	19.6	7.3	9.1	5.2	18.7	1.8	9.4	19.0	8.1	7.5	5.8	11.9	22.8	3.1	7.1	11.5	4.1	7.4	13.5	5.3	4.6	18.6	9.2	25.7	17.7	7.5	6.6	9.0	5.4	3.5	7.1	11.5	3.3	25.4	11.5	16.8	18.1	17.0	4.0	8.0	3.1	5.5	2.8	2.3	14.3	6.2	2.9	1.9	71.1	2.9	8.5	10.4	2.1	3.9	2.4	2.8	2.5	2.7	2.8	1.3	2.3	1.2	2.2	1.9	2.2	4.3	11.7	12.8	8.2	10.4	13.8	3.8	5.7	8.7	8.6	5.8	6.4	6.5	1.5	1.5	7.8	7.3	14.6	3.8	21.4	22.3	0.0	9.4	0.7	5.9	11.6	11.1	12.0	7.6	12.8	8.0	8.0	9.1	14.8	8.7	6.3	18.6	13.2	6.7	12.3	5.0	13.8	18.9	4.1	34.7	25.3	1.3	5.9	34.1	10.6	30.9	54.6	2.7	20.6	14.1	11.2	19.7	20.3	5.3	8.9	8.7	9.2	2.7	8.9	9.8	0.0	6.9	8.1	6.9	10.0	8.7	3.3	1.9	14.6	4.3	13.3	15.0
APOBEC3A	"ARP3, PHRBN"	ENSG00000128383	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3A"	P31941	22	38952741-38992778	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 93.9;lymphoid tissue: 48.3;urinary bladder: 24.4"	"Cell type enriched"	"Detected in many"	4	"Urothelial cells: 426.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 11.3;head and neck cancer: 15.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 1014.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 1014.5"	"Not detected"	"Not detected"											"HPA043237, HPA056980, HPA066719"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (6.45e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-3)"	"unprognostic (9.01e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.91e-1)"	7.9	0.4	0.5	20.9	0.5	93.9	0.8	0.7	1.1	2.2	0.8	1.5	1.4	0.4	0.3	12.2	4.2	6.3	1.4	0.9	0.5	0.7	2.0	13.4	1.1	0.6	0.4	0.2	1.5	0.4	0.3	3.5	0.7	0.4	0.6	0.2	6.7	0.3	0.5	0.6	0.8	1.7	0.3	48.3	1.1	0.2	0.5	2.4	1.0	3.7	21.1	24.4	10.3	1.0	0.1	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.6	0.3	34.7	223.9	8.4	0.7	1014.5	1.5	3.1	0.6	0.7	10.4	0.8	0.7	0.7	121.7	0.9	298.5	1.3	1.0	149.1	0.5	0.5	0.7	1.1	0.9	0.5	0.6	0.4	0.7	0.3	0.5	1.0	0.7	28.9	33.6	0.0	0.5	1.3	16.0	1.8	0.0	0.6	0.7	0.3	0.1	0.0	24.1	1.8	4.2	0.3	0.2	17.5	0.0	0.1	0.6	0.5	0.2	1.4	0.0	8.0	0.0	0.2	0.3	6.3	0.0	0.6	25.9	0.3	0.7	0.4	14.9	0.0	0.0	0.0	2.0	18.8	41.4	0.1	0.3	91.3	16.0	0.0	17.9	0.8	2.1	0.0	0.0	1.3	27.4	0.4	15.6	6.7	4.5	0.2	10.7	0.8	0.0	1.0	1.2	0.1	0.4	48.7	6.8	0.3	3.1	0.2	1.7	426.0
ARHGAP26	"GRAF, KIAA0621, OPHN1L, OPHN1L1"	ENSG00000145819	"Rho GTPase activating protein 26"	Q9UNA1	5	142770377-143229011	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 237.3;Excitatory neurons: 611.6;Inhibitory neurons: 261.5;Late spermatids: 153.3;Microglial cells: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"neutrophil: 24.7;NK-cell: 9.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 24.7;NK-cells: 9.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 85.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035106, HPA035107"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA035106: AB_2674465, HPA035107: AB_10669855"	"prognostic favorable (2.05e-4)"	"prognostic favorable (1.36e-4)"	"prognostic favorable (6.95e-4)"	"prognostic favorable (5.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-2)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (9.43e-3)"	"unprognostic (7.19e-3)"	"unprognostic (8.65e-2)"	"unprognostic (3.21e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.88e-6)"	11.0	4.5	10.9	17.7	6.5	36.4	11.3	19.3	17.0	11.9	0.6	12.9	12.0	7.7	9.1	6.4	15.5	14.2	15.0	10.8	3.4	8.9	6.8	19.0	6.4	0.5	2.7	3.0	4.9	3.9	12.2	20.9	0.3	7.4	12.7	17.2	12.8	4.2	12.6	7.4	11.3	9.7	2.3	16.7	15.2	15.4	10.1	13.8	8.3	10.5	12.2	12.2	5.8	9.9	16.4	29.1	8.0	7.6	12.3	12.7	12.4	2.2	2.4	7.6	12.1	44.9	33.0	2.0	16.1	4.9	21.5	7.5	4.1	15.3	8.7	33.8	4.6	0.1	5.3	26.9	7.8	22.6	2.9	4.7	23.0	12.8	31.0	5.6	10.2	9.9	0.6	85.4	2.4	2.3	12.9	9.2	4.3	23.2	7.7	5.2	12.5	36.5	20.4	25.6	3.4	4.7	3.8	4.4	7.1	6.5	2.4	6.2	21.0	4.1	5.8	0.4	8.1	4.0	14.0	0.4	10.7	21.3	5.6	4.0	3.9	2.3	3.8	2.5	1.7	0.5	0.8	2.4	3.0	0.4	0.3	1.1	24.7	9.8	1.6	0.7	0.3	1.8	10.9	6.5	19.3	17.0	10.8	3.4	0.5	2.7	0.3	2.3	10.1	9.9	39.4	16.0	22.5	237.3	5.8	6.9	13.8	13.2	5.7	15.9	20.7	17.0	37.6	21.5	14.1	0.0	8.4	1.3	41.6	38.7	0.0	17.9	77.2	17.9	4.0	32.5	3.6	11.8	611.6	21.1	0.6	13.6	39.8	55.6	26.6	6.4	40.0	6.5	26.4	75.7	261.5	26.4	0.0	48.0	44.9	153.3	6.5	51.6	10.6	326.0	47.3	7.5	40.2	30.7	29.8	21.1	27.8	14.3	14.5	29.3	27.9	5.8	16.1	52.6	46.0	27.6	17.7	2.6	8.7	7.5	5.5	1.9	29.3	50.5	26.8	36.2
ARPC4-TTLL3		ENSG00000250151	"ARPC4-TTLL3 readthrough"		3	9793082-9835401	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.4;B-cells: 1.8;Basal squamous epithelial cells: 1.8;Erythroid cells: 3.0;Gastric mucus-secreting cells: 2.0;Macrophages: 1.5;Plasma cells: 1.7;T-cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"				"unprognostic (9.59e-3)"	"unprognostic (7.61e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.31e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.42e-4)"	"unprognostic (5.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.37e-4)"	2.0	1.6	1.4	2.9	1.4	6.7	1.5	1.4	3.2	2.0	1.4	1.5	2.2	1.2	0.6	2.0	1.4	1.3	1.5	1.4	1.6	1.6	1.0	1.9	2.2	1.7	1.5	1.5	0.8	1.0	1.6	1.1	1.5	1.3	0.9	0.6	1.3	0.7	1.6	2.0	2.0	1.5	1.4	3.2	1.3	1.6	1.9	2.3	1.3	0.5	2.1	1.6	1.6	1.7	2.9	0.4	3.0	1.2	3.1	4.6	8.0	3.1	3.3	2.1	2.3	1.4	1.0	3.8	1.4	9.6	4.2	1.5	3.1	2.5	2.6	6.8	1.5	6.1	1.5	0.9	4.3	6.1	9.4	5.6	3.5	5.5	2.4	2.8	3.1	5.8	4.7	4.1	3.1	0.0	3.8	4.9	3.3	1.7	2.1	5.6	2.5	0.1	4.0	3.1	1.6	2.6	2.1	4.3	3.1	1.7	0.8	13.4	4.0	1.8	2.1	3.7	4.5	4.6	6.7	9.6	3.9	5.7	3.9	0.8	2.9	3.0	2.7	2.8	1.7	1.3	1.8	1.4	3.0	1.3	1.4	1.5	3.2	1.3	3.3	2.7	1.4	3.8	1.4	1.4	1.4	3.2	1.4	1.6	1.7	1.5	1.5	1.4	1.9	1.7	0.1	0.0	2.4	0.0	1.8	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.3	0.0	3.0	0.2	0.0	0.1	1.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.0	0.1
ARRB2	"ARR2, BARR2, DKFZp686L0365"	ENSG00000141480	"Arrestin beta 2"	P32121	17	4710596-4721499	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 263.6;lymphoid tissue: 168.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 262.0;Kupffer cells: 242.5;Langerhans cells: 164.2;Macrophages: 226.4;monocytes: 311.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 195.8;HMC-1: 315.9;NB-4: 199.2;U-937: 279.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075177			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA075177: "	"unprognostic (1.12e-1)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.32e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.88e-1)"	48.6	39.7	54.4	110.0	53.8	263.6	26.1	48.2	62.2	19.3	49.1	29.5	50.5	17.4	10.8	15.1	29.0	31.4	25.0	63.8	67.7	25.2	35.6	94.8	59.4	61.6	58.3	17.5	19.4	16.4	24.9	35.5	59.5	19.5	27.6	16.9	20.9	11.7	12.7	14.6	51.1	29.6	55.4	168.3	35.0	7.2	59.5	45.2	15.8	18.1	38.0	41.6	17.6	66.5	17.3	88.7	34.7	32.9	6.8	9.5	18.6	13.7	18.0	38.4	48.0	31.0	14.2	49.1	12.2	10.3	18.3	28.5	58.0	18.4	39.4	116.6	85.0	195.8	46.8	55.6	10.2	89.2	315.9	8.8	23.5	47.9	18.7	24.9	29.6	89.1	13.5	46.4	8.9	30.5	87.9	199.2	18.9	44.9	18.4	104.3	31.0	53.8	13.2	9.2	36.0	49.2	30.8	50.8	23.6	14.2	24.6	40.0	26.1	14.3	29.1	25.1	51.5	19.8	28.6	27.6	37.9	279.4	21.6	116.2	145.5	269.7	49.1	151.1	35.1	10.1	31.1	51.3	84.9	9.0	29.3	38.7	250.6	29.9	168.6	20.7	28.8	93.5	54.4	53.8	48.2	62.2	63.8	67.7	61.6	58.3	59.5	55.4	59.5	66.5	7.7	22.4	32.3	5.5	26.4	11.5	7.7	16.6	3.4	20.5	9.6	12.3	8.3	14.3	47.9	3.7	2.1	7.5	83.8	7.4	15.6	11.2	0.6	1.5	3.6	10.1	8.4	33.9	20.4	7.3	12.0	8.7	19.4	1.8	94.9	7.8	19.2	12.4	262.0	21.9	18.2	17.0	50.8	242.5	164.2	3.5	5.0	226.4	10.6	42.2	311.3	5.8	89.6	7.1	8.4	6.3	22.0	4.9	23.4	4.4	35.5	17.5	24.4	8.7	19.7	10.9	8.5	1.1	13.1	6.8	8.4	6.0	77.2	3.5	11.4	11.7
ASAP1	"CENTB4, DDEF1, KIAA1249, PAP, ZG14P"	ENSG00000153317	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1"	Q9ULH1	8	130052104-130443674	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 345.8;Late spermatids: 460.2;Oligodendrocyte precursor cells: 622.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 11.6;monocytes: 6.7"	"Cell line enhanced"	"Detected in all"		"TIME: 167.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011136, CAB037292, HPA048565"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		31000	"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Centrosome, Cytosol"		"CAB037292: AB_476723, HPA011136: AB_2668438, HPA048565: AB_2680445"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.63e-8)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.50e-7)"	"unprognostic (3.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.22e-3)"	35.1	22.2	13.5	12.2	15.1	47.8	24.0	7.6	22.0	17.6	3.9	13.4	5.5	19.0	12.2	10.7	17.2	14.6	24.7	14.7	10.5	11.9	9.3	30.1	18.0	14.2	20.9	18.2	7.8	18.1	10.5	27.8	16.5	12.7	8.9	8.6	8.5	11.4	13.4	17.3	12.2	17.9	9.4	30.0	10.6	28.5	29.1	16.3	16.4	10.4	19.0	15.9	15.6	17.1	48.9	31.5	41.1	27.4	46.7	61.9	37.1	44.2	83.8	57.2	62.3	17.5	18.2	14.4	31.8	67.7	38.6	13.2	24.7	41.4	86.3	20.6	15.9	22.6	20.7	23.6	119.9	10.4	6.7	61.7	15.3	33.6	50.3	66.9	60.2	7.7	13.0	45.7	54.0	15.1	13.3	9.8	13.1	24.1	30.5	13.6	9.6	7.0	18.1	25.2	14.6	44.4	32.4	20.5	26.5	42.5	17.0	22.4	167.5	45.9	28.9	20.6	69.8	42.2	12.0	9.7	34.6	14.6	50.3	0.0	2.2	1.5	0.5	2.1	0.3	1.3	1.0	0.9	3.7	1.0	1.3	0.8	11.6	0.6	6.7	0.4	0.8	1.1	13.5	15.1	7.6	22.0	14.7	10.5	14.2	20.9	16.5	9.4	29.1	17.1	97.2	3.2	6.3	206.6	22.7	47.7	21.9	12.0	29.6	25.0	12.4	14.7	33.7	27.1	11.5	3.7	16.7	42.2	14.6	3.6	3.9	10.5	159.7	14.3	34.2	109.1	13.1	98.9	345.8	8.7	37.6	43.7	4.6	27.7	9.5	30.1	103.9	8.2	64.0	62.2	225.8	4.3	8.2	56.1	168.8	460.2	39.1	73.1	44.4	181.8	71.4	9.5	15.5	622.3	245.9	12.5	4.7	54.9	13.7	37.9	5.8	4.3	4.2	7.8	78.9	28.5	90.1	61.4	95.5	25.2	44.9	46.7	23.1	58.9	4.8	22.0
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Excitatory neurons: 178.7;Inhibitory neurons: 176.4;Late spermatids: 119.1;Microglial cells: 132.1;Oligodendrocytes: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 60.1;classical monocyte: 136.6;eosinophil: 88.4;intermediate monocyte: 79.4;myeloid DC: 82.4;neutrophil: 107.4;non-classical monocyte: 60.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 82.4;granulocytes: 107.4;monocytes: 136.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		33000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	16.8	13.5	11.2	25.0	13.1	47.6	18.0	7.3	21.8	14.5	17.0	17.3	13.0	14.9	16.7	16.7	18.7	16.6	10.8	12.4	9.5	13.7	13.2	20.9	23.9	15.0	15.0	12.2	10.9	21.2	7.5	21.0	13.1	11.6	19.2	10.3	12.2	11.9	13.0	18.0	13.8	20.0	12.4	16.4	14.4	22.5	15.4	13.1	13.0	13.5	25.0	20.3	12.0	21.3	48.5	37.1	16.7	9.2	28.0	36.7	80.4	44.5	56.8	43.1	49.9	16.0	42.5	22.1	26.5	39.2	45.1	14.5	18.3	62.0	73.8	19.8	23.5	16.0	33.6	19.6	36.9	46.8	50.8	38.0	28.2	83.6	52.0	45.4	60.5	14.0	24.1	17.9	60.6	31.3	13.7	21.3	13.0	22.2	47.9	17.1	19.6	19.9	32.5	34.2	14.6	14.5	31.6	26.4	17.5	20.1	28.8	44.7	42.5	36.0	25.7	23.6	63.2	11.1	31.8	38.1	57.8	43.1	49.9	60.1	136.6	88.4	15.9	79.4	12.3	13.0	12.9	15.1	82.4	12.3	11.7	13.7	107.4	21.3	60.8	14.7	12.4	56.8	11.2	13.1	7.3	21.8	12.4	9.5	15.0	15.0	13.1	12.4	15.4	21.3	6.4	0.0	9.8	160.0	11.4	11.1	7.3	21.6	9.6	18.1	7.4	3.6	4.2	4.3	12.5	7.3	18.8	16.5	7.9	8.3	7.9	12.3	44.2	10.6	9.5	14.6	11.4	9.5	178.7	12.9	16.8	11.0	10.7	13.2	14.7	12.4	19.6	9.0	57.6	20.2	176.4	7.6	22.4	25.8	12.1	119.1	10.2	28.8	3.6	132.1	30.6	8.1	13.4	99.0	137.2	17.4	7.3	9.8	10.8	6.4	8.4	6.8	16.5	12.5	6.6	11.7	10.6	22.4	11.9	9.8	7.7	19.2	10.1	9.9	7.6	7.4
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196115-62224731	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 115.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles		NA	NA		99000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	17.3	20.8	6.6	13.3	13.6	72.7	26.1	5.9	9.8	25.9	9.0	19.4	27.7	24.6	6.2	25.1	12.7	27.4	19.0	6.8	8.6	33.4	21.8	34.2	24.1	6.9	8.3	5.9	39.7	7.6	13.2	30.6	9.7	10.8	24.3	5.2	15.5	8.2	3.2	11.0	14.4	24.1	6.1	14.9	18.2	7.6	8.5	25.5	19.5	9.0	18.3	20.1	12.8	6.7	20.7	14.0	20.9	9.3	22.5	10.0	60.0	19.8	21.8	15.4	20.5	29.2	32.5	22.3	17.8	18.5	21.6	19.4	13.3	16.6	26.5	46.8	10.8	55.1	6.4	17.2	16.8	33.2	23.8	12.3	30.7	29.6	10.5	11.0	23.4	15.3	30.4	13.7	18.9	15.7	63.7	49.6	20.0	37.4	5.8	115.0	14.4	12.3	29.2	20.1	20.1	14.9	14.1	29.9	23.5	33.4	8.6	38.7	26.7	18.6	16.4	31.7	19.9	38.2	14.4	96.2	14.6	56.5	18.4	14.9	9.0	56.2	20.0	8.6	28.0	14.8	14.7	34.6	10.6	16.6	17.3	26.0	21.3	41.0	11.7	13.3	26.2	17.6	6.6	13.6	5.9	9.8	6.8	8.6	6.9	8.3	9.7	6.1	8.5	6.7	40.3	64.1	9.8	2.0	31.4	71.5	30.9	20.8	92.2	15.6	40.0	20.7	9.2	18.6	21.9	18.4	0.0	40.9	43.8	42.7	23.5	24.0	0.1	51.1	30.3	31.8	9.5	61.6	11.2	57.2	38.3	19.5	36.7	97.3	3.8	9.7	37.5	21.3	60.4	0.0	3.4	22.7	87.5	20.5	58.5	0.7	2.5	34.4	35.6	14.0	19.7	8.6	18.6	2.5	7.2	36.3	24.8	2.2	25.8	25.5	14.2	19.0	19.1	2.1	65.7	8.1	68.2	0.3	1.6	77.4	64.8	65.3	45.9	10.6	13.9	41.1
B3GNTL1	B3GNT8	ENSG00000175711	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1"	Q67FW5	17	82942155-83051810	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 19.9;Respiratory ciliated cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.1;HL-60: 27.0;THP-1: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023585, HPA024547"	Supported		Approved	"Nucleoli,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli, Nucleoli fibrillar center"	Vesicles	"HPA023585: AB_2061075, HPA024547: AB_1845240"	"unprognostic (1.51e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.61e-7)"	"unprognostic (9.95e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (4.17e-9)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.39e-3)"	2.9	2.8	1.8	2.9	2.1	7.8	2.4	1.4	2.3	3.5	3.9	2.0	1.7	3.7	1.2	2.4	3.7	1.3	3.0	1.9	1.4	1.9	2.4	3.0	2.3	1.3	1.5	3.9	2.3	0.8	2.6	1.4	1.6	2.6	0.9	0.5	2.1	1.5	3.8	2.3	2.1	1.8	1.3	4.2	2.0	3.0	2.1	2.3	2.4	1.4	1.1	3.1	2.5	1.6	11.9	7.8	0.2	3.7	2.1	6.6	4.7	4.2	3.7	4.8	3.7	4.7	25.1	5.8	8.1	5.2	11.7	2.2	1.9	0.0	4.1	8.9	5.1	12.2	12.6	16.0	7.5	27.0	0.5	2.4	2.1	2.9	4.8	2.4	5.9	8.9	5.4	5.5	3.9	2.7	7.6	10.3	1.8	8.1	5.6	9.8	0.9	0.4	2.7	2.5	2.4	0.9	3.6	2.7	3.7	3.4	0.0	25.5	9.7	9.2	6.2	1.4	7.6	1.1	2.9	4.4	10.3	3.6	1.3	3.0	6.0	1.0	2.8	5.9	4.4	3.0	4.4	3.3	10.4	5.5	3.9	4.7	19.0	3.2	3.2	4.1	13.5	4.0	1.8	2.1	1.4	2.3	1.9	1.4	1.3	1.5	1.6	1.3	2.1	1.6	2.6	3.2	4.5	4.6	2.9	1.0	2.0	4.4	3.4	3.5	3.0	3.0	2.8	1.5	6.4	5.5	4.2	5.7	3.6	1.3	1.9	1.9	15.3	6.8	4.2	2.3	1.2	7.6	11.3	1.0	3.1	4.0	3.1	1.9	7.0	7.6	1.4	2.0	7.7	3.3	9.2	1.5	6.1	7.3	2.8	19.9	3.1	8.9	1.8	6.5	5.5	1.3	8.2	5.0	4.7	2.1	2.7	4.9	5.2	2.8	0.2	2.4	20.7	3.5	0.0	2.5	2.3	0.9	5.0	5.6	1.7	1.9	6.8	4.8	3.5	2.1
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 164.4;Late spermatids: 422.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 150.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 150.2;monocytes: 51.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA034949: AB_2674376"	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	15.8	12.1	12.3	27.8	13.3	89.4	13.3	27.6	16.0	18.1	9.9	13.4	17.4	19.8	9.7	23.0	9.1	26.1	13.2	10.5	19.5	16.0	30.5	21.4	16.9	23.0	28.4	11.6	17.2	8.3	3.3	50.6	31.0	13.3	13.2	12.0	17.4	8.6	26.3	23.3	17.4	15.9	14.2	20.7	13.5	27.3	16.6	14.2	12.6	12.8	14.8	29.8	13.1	12.3	21.5	8.6	26.1	6.8	20.2	57.7	16.3	23.0	55.0	21.8	24.3	18.1	28.9	25.5	18.0	21.1	22.7	11.1	15.7	30.9	38.6	21.3	13.3	78.7	18.9	18.6	26.8	22.8	28.1	30.3	46.4	42.8	63.4	25.7	11.7	13.9	40.6	129.7	30.2	7.6	19.5	13.0	40.3	8.4	8.9	19.8	61.8	33.1	11.5	16.8	10.8	12.2	12.6	23.5	29.0	26.0	17.1	27.1	29.6	21.3	29.4	23.1	11.8	74.9	51.9	26.9	17.3	27.8	64.9	72.4	51.1	38.6	5.0	40.1	4.1	10.3	8.3	4.3	24.9	13.7	11.9	6.0	150.2	7.1	46.0	6.0	14.8	15.3	12.3	13.3	27.6	16.0	10.5	19.5	23.0	28.4	31.0	14.2	16.6	12.3	31.9	28.9	15.3	12.1	90.6	59.0	53.2	17.9	19.4	16.6	18.3	15.1	20.7	15.7	23.1	14.7	18.8	13.7	33.0	30.7	7.9	19.8	164.4	32.2	45.9	26.0	30.9	33.0	5.1	16.6	15.7	31.3	30.5	64.1	48.6	13.6	22.1	20.9	22.0	13.5	36.9	24.7	12.2	57.1	113.8	422.4	13.4	113.8	21.4	68.4	109.1	10.2	24.7	33.7	25.0	28.2	38.2	14.3	87.8	50.7	25.5	12.8	15.7	12.6	32.9	54.7	36.6	31.5	28.4	34.7	58.1	39.7	31.3	17.4	11.7	48.4
BIN2	BRAP-1	ENSG00000110934	"Bridging integrator 2"	Q9UBW5	12	51281038-51324668	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 101.3;lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 213.6;Extravillous trophoblasts: 172.1;NK-cells: 598.3;Syncytiotrophoblasts: 158.6;T-cells: 165.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 82.6;HMC-1: 134.9;Karpas-707: 59.1;NB-4: 140.8;RPMI-8226: 55.4;THP-1: 117.4;U-937: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038666, HPA038667"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA038666: AB_2676139, HPA038667: AB_2676140"	"unprognostic (8.44e-3)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.48e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (4.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.03e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-1)"	7.1	3.7	3.6	32.5	3.5	101.3	3.3	3.6	4.8	3.6	4.2	8.9	6.2	2.1	1.0	3.2	3.1	9.2	2.3	3.2	3.8	3.0	7.3	16.4	41.9	5.9	4.7	1.7	1.3	1.0	1.1	19.5	5.1	2.1	9.2	0.4	3.4	2.0	1.5	1.3	10.7	6.4	4.4	48.7	7.4	7.9	6.4	48.6	2.2	4.3	36.4	10.1	2.0	6.2	0.1	0.1	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	38.3	0.1	82.6	0.0	0.0	0.0	34.7	134.9	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.1	59.1	0.0	0.5	24.2	140.8	0.1	0.1	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.2	117.4	0.1	0.0	0.1	0.1	0.1	31.5	0.1	8.0	0.1	76.8	0.0	663.7	199.8	245.9	281.0	311.8	227.7	49.2	188.9	237.2	107.2	74.0	145.4	193.5	380.1	235.6	411.7	39.7	267.1	479.5	3.6	3.5	3.6	4.8	3.2	3.8	5.9	4.7	5.1	4.4	6.4	6.2	1.5	3.2	17.6	1.3	54.0	0.6	0.1	0.0	0.0	0.1	1.3	1.5	0.6	1.5	2.6	1.8	0.0	103.9	213.6	4.5	17.6	0.1	26.5	0.1	0.2	3.5	1.2	16.2	0.7	0.0	172.1	2.7	3.1	0.2	56.3	0.1	8.2	1.2	56.9	0.0	0.6	8.5	0.0	73.0	22.3	25.7	0.6	111.2	1.8	44.0	77.6	0.0	598.3	2.0	0.6	0.0	4.6	0.4	51.3	0.1	0.1	1.6	3.7	0.1	0.0	1.0	0.9	39.6	11.3	0.4	0.6	158.6	165.7	0.1	5.4	0.1
C15orf39	"DKFZP434H132, FLJ46337"	ENSG00000167173	"Chromosome 15 open reading frame 39"	Q6ZRI6	15	75195643-75212169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.9;testis: 73.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.9;Late spermatids: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.0;granulocytes: 23.5;monocytes: 16.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039961, HPA041907"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA039961: AB_10673024, HPA041907: AB_2677736"	"unprognostic (3.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.46e-2)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.14e-1)"	14.9	15.5	4.4	12.7	4.6	61.9	13.7	2.4	8.3	13.7	4.6	10.8	11.5	14.4	1.9	20.4	16.1	7.9	14.4	3.3	5.7	8.6	4.3	15.3	10.9	6.3	5.4	18.2	14.5	15.7	8.9	15.2	4.6	8.8	5.3	1.8	14.4	6.8	4.1	15.3	10.2	7.2	5.0	25.5	9.6	73.7	7.7	8.7	11.1	3.8	6.7	15.0	14.4	4.2	20.5	41.2	8.8	10.3	11.7	7.6	26.4	5.8	11.7	6.7	7.2	51.2	27.8	45.9	19.1	8.6	24.0	27.0	37.6	17.5	1.9	45.0	42.7	91.0	19.6	35.4	13.3	26.4	90.1	10.0	13.7	14.2	6.6	8.3	17.2	17.1	39.7	66.4	2.2	12.3	25.5	32.2	27.4	13.6	16.3	23.0	6.6	49.3	4.1	15.9	25.4	8.1	13.4	30.6	21.2	8.8	10.5	33.2	14.7	11.6	17.3	20.6	17.0	47.8	32.9	26.3	11.4	50.3	11.5	8.5	6.4	18.6	1.7	11.7	1.3	1.1	1.0	1.2	3.9	0.7	0.7	1.1	23.5	3.4	16.2	8.0	1.4	4.1	4.4	4.6	2.4	8.3	3.3	5.7	6.3	5.4	4.6	5.0	7.7	4.2	13.0	25.6	5.5	0.7	7.8	14.9	7.0	5.5	19.9	0.3	8.1	5.8	2.3	7.2	9.6	3.7	0.0	12.6	17.7	13.5	0.0	15.8	50.9	17.2	10.0	10.4	7.7	5.9	0.4	14.6	16.8	7.8	8.6	30.0	17.7	14.3	10.8	2.8	12.4	0.0	1.0	6.1	6.1	23.6	10.5	68.8	11.8	24.0	7.2	1.9	31.6	0.7	12.3	1.0	0.1	18.1	26.1	10.9	19.9	5.2	3.4	1.6	8.1	2.2	13.1	6.5	10.0	37.2	5.6	15.5	14.2	20.9	7.3	3.7	8.6	17.8
C16orf54	FLJ35681	ENSG00000185905	"Chromosome 16 open reading frame 54"	Q6UWD8	16	29742463-29745990	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 41.4;lymphoid tissue: 21.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 36.6;dendritic cells: 60.4;granulocytes: 33.6;monocytes: 22.0;NK-cells: 55.6;Plasma cells: 37.1;T-cells: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 18.6;HL-60: 18.9;HMC-1: 11.7;MOLT-4: 15.7;NB-4: 12.8;REH: 8.8;THP-1: 22.1;U-937: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060546	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA060546: AB_2684317"	"unprognostic (2.09e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.92e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-1)"	3.8	0.7	0.7	15.2	1.0	41.4	2.3	1.1	1.1	4.1	0.8	3.5	3.0	0.8	0.7	2.1	0.9	2.9	0.6	0.8	0.9	0.7	1.3	5.6	21.1	1.4	1.0	0.6	1.2	0.2	0.1	0.7	1.3	1.5	3.6	0.3	2.2	0.5	2.3	0.9	6.3	1.7	0.9	14.9	5.7	0.5	1.1	13.2	0.5	1.0	20.4	4.4	0.3	1.8	5.4	0.0	0.3	0.2	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.2	2.9	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	18.6	0.4	0.1	0.0	18.9	11.7	0.4	0.0	0.0	0.0	0.1	0.0	6.5	0.1	5.1	0.0	0.2	15.7	12.8	1.1	0.0	0.0	8.8	0.1	0.1	0.1	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.2	22.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.8	0.2	10.3	0.1	294.4	101.8	380.2	224.8	100.4	212.8	142.8	219.8	196.0	77.4	116.6	178.2	187.4	557.0	224.5	128.3	87.5	129.3	188.0	0.7	1.0	1.1	1.1	0.8	0.9	1.4	1.0	1.3	0.9	1.1	1.8	0.3	3.2	4.7	0.0	36.6	0.5	0.1	0.2	0.0	0.0	0.4	0.1	0.3	0.0	0.1	0.0	0.0	0.2	60.4	0.2	0.0	0.0	0.0	0.1	0.0	0.5	10.8	5.0	0.0	0.0	0.1	0.7	1.5	0.1	33.6	0.1	1.8	0.6	6.2	0.0	0.0	0.8	0.0	18.7	8.7	0.0	0.0	12.5	5.4	2.8	22.0	0.0	55.6	0.5	0.0	0.0	0.0	0.0	37.1	0.0	0.1	0.5	5.5	0.0	0.0	0.5	0.3	0.1	0.2	0.0	0.9	1.4	52.3	0.0	0.6	0.1
C3AR1	"AZ3B, C3AR"	ENSG00000171860	"Complement C3a receptor 1"	Q16581	12	8056844-8066359	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.1"	"Cell type enhanced"	"Detected in some"		"granulocytes: 36.8;Hofbauer cells: 161.5;Kupffer cells: 139.7;Macrophages: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 898.6;eosinophil: 450.8;intermediate monocyte: 273.6;non-classical monocyte: 371.3"	"Group enriched"	"Detected in many"	20	"granulocytes: 898.6;monocytes: 371.3"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 148.0"	"Low region specificity"	"Detected in many"							CAB009405	Enhanced					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009405: AB_2066739"	"unprognostic (1.11e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.16e-2)"	18.0	10.6	3.8	40.1	4.0	22.9	6.7	4.7	5.7	6.8	4.4	7.4	6.6	3.8	1.5	3.9	5.9	16.2	4.4	3.9	6.9	3.1	10.8	18.6	12.4	10.1	6.3	3.7	6.0	3.3	2.5	22.0	9.0	3.3	6.8	0.8	5.6	4.3	1.4	2.0	9.7	15.6	8.3	21.4	5.3	2.1	7.8	4.9	2.4	2.6	5.1	15.2	2.7	15.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.9	0.5	3.8	0.0	0.0	1.6	0.0	0.0	2.2	0.1	0.0	0.0	0.1	0.0	0.0	12.0	0.0	0.0	1.4	15.6	148.0	0.7	0.0	0.2	0.4	0.3	0.7	1.2	4.0	8.2	0.7	0.0	0.7	5.2	0.1	0.0	0.0	0.1	3.1	15.1	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	6.6	0.6	0.5	0.4	0.1	0.3	0.3	0.0	0.4	8.5	6.4	0.4	898.6	105.0	450.8	21.8	273.6	26.9	0.2	10.6	14.5	31.1	0.3	2.0	7.8	14.0	4.1	371.3	2.8	11.0	76.0	3.8	4.0	4.7	5.7	3.9	6.9	10.1	6.3	9.0	8.3	7.8	15.6	0.7	0.0	3.0	0.3	1.1	0.5	0.1	0.1	0.0	0.1	0.3	0.9	0.6	1.5	2.5	0.0	2.1	0.7	5.9	0.0	0.0	0.0	3.0	0.0	0.1	6.6	0.0	0.8	0.4	0.2	1.0	0.6	0.0	0.0	36.8	0.0	1.8	0.8	161.5	0.0	0.3	0.0	0.0	139.7	19.8	4.2	1.2	105.7	0.0	8.4	16.2	0.0	8.2	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.7	0.4	19.7	0.7	1.0	0.0	0.2	0.0	0.6	1.5	8.6	0.1	0.0	0.0
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.5;lymphoid tissue: 84.8"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 394.0"	"Group enriched"	"Detected in many"	42	"granulocytes: 394.0;monocytes: 115.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	72.7	18.2	3.3	84.8	3.1	125.5	8.5	2.4	9.0	11.8	21.6	9.8	2.5	7.5	1.4	8.3	23.9	38.8	11.7	3.9	8.2	9.7	18.0	43.1	11.5	8.9	6.9	5.0	8.9	4.8	51.8	31.8	8.4	5.3	4.2	4.4	5.1	2.5	1.9	2.3	5.8	28.1	5.7	38.2	7.2	2.6	10.5	7.1	3.6	5.8	4.3	37.1	4.6	11.6	1.0	3.9	0.1	0.1	0.7	0.2	0.6	0.7	0.5	0.2	0.1	0.2	4.1	0.3	0.7	0.9	0.4	1.4	0.2	0.5	0.2	0.7	0.5	0.1	3.8	0.6	0.4	1.5	4.7	0.3	2.2	0.4	0.3	0.6	0.0	0.2	0.2	1.7	0.1	1.1	0.2	2.5	1.2	0.2	0.3	0.2	0.1	0.3	1.3	0.9	0.0	0.0	0.3	0.3	0.6	0.5	0.2	2.2	0.0	0.1	2.1	0.3	0.1	0.2	0.3	0.3	6.2	6.5	0.2	41.6	53.8	38.8	0.4	80.4	0.3	0.4	0.3	0.2	6.1	0.6	0.3	0.3	394.0	0.5	115.9	1.1	0.3	19.3	3.3	3.1	2.4	9.0	3.9	8.2	8.9	6.9	8.4	5.7	10.5	11.6	4.4	3.2	20.8	0.0	5.1	5.1	1.0	3.4	2.8	1.0	2.1	4.4	2.9	1.5	15.3	1.8	2.1	0.8	1.5	1.6	3.9	0.0	1.3	17.3	1.8	6.3	0.0	0.4	1.5	0.0	1.5	5.3	1.1	4.6	25.2	0.1	2.9	8.3	130.9	0.0	0.6	0.8	4.1	228.3	122.4	1.3	0.6	446.7	5.4	5.6	56.3	0.2	0.0	1.0	0.3	0.1	0.1	0.0	4.9	0.5	0.7	1.3	40.7	4.3	13.1	4.1	2.8	0.5	0.9	1.4	3.0	1.5	3.3	0.0	1.3	0.5
CARD9		ENSG00000187796	"Caspase recruitment domain family member 9"	Q9H257	9	136361903-136373681	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 14.1;Hofbauer cells: 21.2;Horizontal cells: 15.2;Kupffer cells: 18.8;Langerhans cells: 12.9;Macrophages: 22.3;monocytes: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 57.6;non-classical monocyte: 50.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 22.5;HMC-1: 69.7;NB-4: 50.0;THP-1: 63.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059502	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA059502: AB_2684042"	"unprognostic (7.03e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.62e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.68e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.02e-6)"	"unprognostic (2.52e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-1)"	1.2	1.3	0.5	4.7	0.5	13.0	1.2	2.5	1.0	2.0	0.3	1.0	1.3	0.8	0.4	1.0	1.8	1.0	0.5	0.5	0.7	1.0	0.9	3.4	1.2	1.9	0.9	0.3	0.5	0.1	0.8	0.9	1.3	1.8	0.4	0.2	1.1	1.0	0.2	2.7	1.8	1.1	1.4	9.9	0.6	0.4	1.1	0.4	0.4	0.0	1.5	1.2	1.1	1.7	0.1	0.0	0.3	0.0	0.0	0.0	4.6	9.5	0.3	0.2	0.0	0.7	0.0	0.0	0.1	3.5	0.0	0.0	0.3	0.0	0.1	0.0	0.2	22.5	0.1	6.8	4.9	12.2	69.7	0.0	0.1	0.2	0.2	0.0	0.1	0.0	5.3	0.0	0.0	0.2	0.0	50.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	12.3	0.0	16.0	0.1	0.0	4.1	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	16.0	0.0	6.9	34.5	11.5	0.0	57.6	0.9	0.0	0.0	0.0	26.0	0.0	0.0	0.0	2.3	0.7	50.5	0.1	0.5	14.1	0.5	0.5	2.5	1.0	0.5	0.7	1.9	0.9	1.3	1.4	1.1	1.7	0.8	0.0	4.6	4.6	1.1	1.8	0.6	0.3	3.4	0.2	4.2	4.3	2.6	0.0	4.9	3.7	0.0	0.4	2.2	0.4	1.9	0.1	1.0	1.2	14.1	1.1	0.0	2.5	2.1	0.0	0.4	2.1	1.5	1.4	10.8	0.4	0.7	0.1	21.2	15.2	1.1	0.0	0.0	18.8	12.9	6.9	0.3	22.3	1.8	6.5	16.3	4.6	3.1	0.0	0.2	0.0	0.1	0.0	1.4	0.1	0.0	0.3	0.6	0.9	0.0	0.3	1.5	1.0	1.5	0.9	1.7	0.4	1.4	0.2	0.2	0.6
CCL3	"G0S19-1, LD78ALPHA, MIP-1-alpha, SCYA3"	ENSG00000277632	"C-C motif chemokine ligand 3"	P10147	17	36088256-36090169	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 76.7;lung: 35.8;lymphoid tissue: 49.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 441.4;Hofbauer cells: 2084.4;Kupffer cells: 723.2;Langerhans cells: 710.0;Macrophages: 1534.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 23.6"	"Group enriched"	"Detected in many"	4	"B-cells: 10.4;granulocytes: 10.8;T-cells: 23.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 443.8;U-266/70: 602.5;U-266/84: 2043.3"														"Secreted to blood"	NA	NA	138000		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.54e-1)"	"unprognostic (8.90e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.00e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.23e-2)"	17.6	16.0	0.0	8.1	0.7	76.7	5.6	0.0	1.4	1.5	0.0	2.5	0.0	1.1	0.0	0.5	2.9	10.3	3.7	0.0	0.0	4.6	12.9	35.8	1.8	0.7	0.0	1.2	1.3	0.0	1.7	2.4	0.0	2.2	0.0	0.0	5.6	0.0	0.8	0.8	3.1	0.0	0.0	49.4	3.0	0.7	0.5	0.0	2.0	0.0	0.0	3.0	1.4	1.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	443.8	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	55.6	0.0	0.0	1.3	602.5	2043.3	0.0	0.0	0.0	0.0	0.0	2.1	10.8	23.6	1.3	0.0	5.1	0.0	6.1	0.4	10.4	0.1	6.8	10.5	3.5	1.3	0.0	0.0	11.6	0.0	0.7	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	0.5	1.4	33.0	0.0	28.6	0.0	45.3	27.9	2.0	0.2	1.2	1.8	23.1	50.0	2.2	4.3	4.4	0.0	0.0	19.0	441.4	0.7	0.0	0.6	1.5	1.6	2.5	115.9	0.0	61.9	0.0	0.2	22.6	14.5	2.0	2.8	23.5	0.1	27.1	9.1	2084.4	0.0	0.0	0.5	0.0	723.2	710.0	1.9	1.8	1534.2	94.3	2.8	23.5	2.1	106.1	0.0	0.0	0.4	0.0	0.0	344.8	1.2	0.0	0.9	2.2	3.7	6.6	2.3	9.2	0.5	0.6	0.6	28.8	54.3	248.0	0.1	0.2	1.3
CCL3L3	"CCL3L1, D17S1718, G0S19-2, LD78BETA, MGC12815, SCYA3L, SCYA3L1"	ENSG00000276085	"C-C motif chemokine ligand 3 like 3"	P16619	17	36194869-36196758	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.0;lung: 5.0;lymphoid tissue: 4.0"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 335.4;Kupffer cells: 227.5;Macrophages: 321.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"eosinophil: 4.2;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.2"	"Group enriched"	"Detected in some"	41	"U-266/70: 49.4;U-266/84: 107.3"														"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.58e-2)"	1.6	0.9	0.0	0.3	0.0	11.0	0.7	0.0	0.3	0.1	0.0	0.5	0.1	0.2	0.2	0.1	0.7	0.9	0.4	0.0	0.0	1.1	1.2	5.0	0.5	0.0	0.0	0.2	0.2	0.0	0.3	0.3	0.0	0.5	0.0	0.0	1.3	0.1	0.1	0.1	0.8	0.1	0.0	4.0	0.5	0.5	0.0	0.1	0.3	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.1	49.4	107.3	1.2	0.0	0.0	0.0	0.1	0.0	4.2	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.3	0.5	0.0	2.2	0.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.9	0.0	0.7	0.0	0.0	0.1	0.0	0.0	48.8	0.0	16.0	0.0	0.0	4.4	1.3	0.5	0.0	0.0	0.0	8.6	1.0	335.4	0.0	0.0	0.5	0.0	227.5	2.9	0.9	0.6	321.7	1.8	1.9	1.6	0.7	10.3	0.0	0.0	0.0	1.2	0.0	0.8	0.7	0.0	0.0	0.0	2.3	0.0	0.4	0.3	0.4	3.8	0.7	0.1	13.1	31.4	0.0	0.0	0.4
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103827-36105621	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 3753.7;Hofbauer cells: 849.7;Macrophages: 1168.2;NK-cells: 1232.8;Plasma cells: 974.5;T-cells: 1948.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 414.7"	"Group enriched"	"Detected in all"	6	"granulocytes: 135.0;T-cells: 414.7"	"Group enriched"	"Detected in some"	6	"U-266/70: 51.6;U-266/84: 13.3"									CAB007805	Approved				"Secreted to blood"	NA	NA	144000		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.54e-4)"	"prognostic favorable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"	38.9	28.0	2.0	32.0	2.0	192.9	10.5	3.4	5.5	16.0	4.1	9.9	7.6	10.3	6.4	15.0	8.2	45.1	4.4	2.0	1.9	6.8	84.2	33.9	34.3	3.2	2.9	5.0	15.6	12.0	2.5	17.8	2.8	7.6	11.1	0.1	5.1	3.4	1.0	0.9	11.4	18.0	2.5	65.3	10.3	2.7	2.1	24.1	5.9	4.5	15.4	56.4	4.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	51.6	13.3	0.2	0.2	0.1	0.0	14.4	3.4	135.0	414.7	4.8	101.6	8.4	46.0	240.6	2.3	17.7	13.8	181.7	55.8	42.8	11.1	2.6	0.5	138.9	2.0	2.0	3.4	5.5	2.0	1.9	3.2	2.9	2.8	2.5	2.1	3.3	52.3	0.0	54.5	0.0	135.9	15.6	1.9	0.3	24.5	1.5	26.3	49.3	11.2	14.3	7.2	0.0	0.0	9.7	3753.7	1.2	0.0	0.4	20.8	3.7	4.7	77.6	1.2	60.9	0.0	0.4	11.3	18.9	118.3	5.5	60.8	0.2	21.4	10.5	849.7	1.7	0.0	1.5	0.0	429.4	428.0	32.6	0.9	1168.2	51.6	3.7	10.5	1.1	1232.8	0.0	0.0	0.2	0.1	0.4	974.5	0.8	0.4	2.8	5.8	5.2	0.0	3.9	20.9	0.4	0.4	11.0	14.5	25.9	1948.3	0.0	0.9	1.6
CCL4L2		ENSG00000276070	"C-C motif chemokine ligand 4 like 2"	Q8NHW4	17	36210924-36212878	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.2;lymphoid tissue: 20.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 488.0;Hofbauer cells: 358.5;Kupffer cells: 163.4;Macrophages: 585.2;NK-cells: 249.3;T-cells: 303.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 122.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 122.0"	"Group enriched"	"Detected in some"	4	"Daudi: 4.1;HMC-1: 5.6;U-266/70: 8.8"														"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.99e-3)"	5.5	3.8	0.3	4.4	0.3	32.2	1.5	0.5	1.1	0.9	0.4	1.7	1.5	1.1	0.5	0.7	2.6	6.8	1.3	0.4	0.3	3.1	7.6	12.6	3.2	0.3	0.3	1.9	0.9	2.0	1.1	2.2	0.3	1.9	1.8	0.0	2.0	0.7	0.2	0.4	3.8	1.5	0.3	20.5	1.8	0.2	0.3	1.6	1.4	1.7	0.8	4.8	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.8	1.5	0.7	0.0	0.0	0.0	0.6	0.3	122.0	15.2	0.3	3.6	0.0	0.6	8.9	0.1	0.1	0.1	8.4	18.2	1.2	0.2	0.0	0.0	5.5	0.3	0.3	0.5	1.1	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.4	18.1	0.0	7.7	0.7	13.9	0.4	0.4	0.0	5.7	0.4	13.8	22.9	8.6	4.3	0.0	0.0	0.0	4.2	488.0	0.2	0.0	0.1	0.2	0.4	1.0	38.1	0.0	14.3	1.1	0.0	6.1	3.9	3.1	0.8	5.1	8.2	7.1	1.3	358.5	1.7	0.4	0.1	0.0	163.4	59.1	1.2	0.0	585.2	1.8	6.5	3.3	1.3	249.3	0.0	0.1	0.1	0.1	0.0	50.6	0.4	0.0	0.2	0.0	2.3	13.1	1.1	6.6	0.1	0.1	1.4	0.4	9.6	303.6	0.1	0.0	1.8
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811991-29824312	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8;placenta: 30.8"	"Cell type enriched"	"Detected in many"	14	"Extravillous trophoblasts: 1756.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"BEWO: 293.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.2	5.7	1.9	4.3	2.1	35.8	0.8	2.8	2.7	1.0	0.9	3.9	3.0	1.4	0.6	4.4	0.9	1.0	2.3	2.0	2.5	1.0	0.7	1.1	6.1	2.0	2.1	0.8	1.8	2.8	0.9	30.8	2.0	1.0	4.7	2.0	1.5	1.4	2.1	4.1	2.5	2.2	1.7	4.2	2.1	12.1	2.5	4.5	1.6	1.8	7.8	3.0	1.8	2.3	15.6	31.8	24.3	34.0	5.2	6.0	293.1	24.7	5.3	10.8	13.2	33.0	31.2	13.3	55.9	11.1	14.0	4.9	28.8	12.8	15.2	41.9	17.7	11.2	30.0	34.5	4.1	44.0	28.7	6.2	7.1	14.8	1.9	3.4	13.3	13.2	45.6	5.8	16.8	24.4	24.5	13.0	40.1	36.2	7.2	36.2	28.6	10.1	8.4	24.6	20.5	17.4	35.4	42.7	3.9	35.4	9.5	32.7	8.0	25.0	92.8	14.9	16.9	24.1	18.2	91.6	13.8	5.6	13.7	0.0	0.0	0.0	0.1	0.5	0.3	0.6	0.1	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.3	0.1	1.9	2.1	2.8	2.7	2.0	2.5	2.0	2.1	2.0	1.7	2.5	2.3	3.1	0.0	0.6	0.7	4.8	4.8	1.5	0.3	2.2	2.9	8.2	11.3	3.1	0.0	1.4	0.0	0.0	122.4	3.7	3.5	0.0	0.4	14.6	7.5	4.1	1.9	3.0	30.7	2.9	0.7	1756.5	6.0	5.6	20.1	0.0	4.6	1.4	0.2	43.4	3.3	5.1	3.3	0.0	1.0	2.5	3.6	1.2	4.2	1.8	0.0	0.2	1.7	0.0	2.5	1.3	1.4	2.2	2.2	18.4	2.2	1.0	0.4	0.1	1.1	6.6	4.1	3.4	25.0	17.6	8.5	6.0	115.7	4.5	6.9	4.9	3.5
CCR1	"CD191, CKR-1, CMKBR1, MIP1aR, SCYAR1"	ENSG00000163823	"C-C motif chemokine receptor 1"	P32246	3	46201711-46208313	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.5"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 81.2;Hofbauer cells: 117.4;Kupffer cells: 171.9;Macrophages: 74.2;monocytes: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 330.3;RPMI-8226: 158.5;U-266/70: 57.7;U-266/84: 183.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.95e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	21.0	4.7	2.1	42.5	2.3	24.8	4.0	2.4	3.1	2.5	2.6	5.6	7.3	2.5	1.6	3.4	2.8	11.7	2.4	1.9	2.6	4.9	17.2	18.7	10.9	5.2	3.2	2.1	3.1	1.9	0.9	26.4	4.5	1.6	7.3	0.3	2.1	2.6	1.3	0.6	6.6	15.5	4.7	30.8	4.9	1.7	4.9	5.7	1.0	3.3	10.2	16.7	0.7	7.4	0.3	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.2	0.0	0.3	0.7	1.5	0.1	0.4	0.0	3.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	6.1	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.0	330.3	0.0	0.2	0.2	13.0	0.0	0.0	0.0	0.1	0.0	158.5	0.0	5.6	0.0	0.0	0.0	0.4	1.3	0.9	0.2	35.5	0.0	0.8	0.0	0.0	0.2	57.7	183.7	0.1	29.1	26.5	0.4	82.5	125.1	25.8	10.5	76.2	50.1	2.9	0.1	8.5	53.9	0.2	0.1	1.4	113.4	84.5	51.3	18.9	0.1	50.6	2.1	2.3	2.4	3.1	1.9	2.6	5.2	3.2	4.5	4.7	4.9	7.4	0.3	3.2	3.0	0.0	2.0	0.9	0.0	0.0	0.6	0.0	0.1	0.5	0.6	0.0	1.3	0.0	0.0	1.3	15.9	0.0	1.9	0.0	0.4	0.1	0.6	1.6	0.0	1.7	0.0	0.0	81.2	2.4	0.0	0.0	3.8	0.0	1.4	1.2	117.4	0.0	0.0	0.0	0.0	171.9	23.5	0.1	0.0	74.2	5.4	9.4	51.5	0.2	7.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	3.2	1.5	0.2	0.0	0.4	0.5	0.0	0.2	0.2	1.7	2.9	6.0	0.0	0.0	0.0
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541073-74546115	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.7;lung: 8.4;lymphoid tissue: 7.3"	"Group enriched"	"Detected in some"	5	"granulocytes: 15.2;Hofbauer cells: 32.1;Kupffer cells: 26.3;Langerhans cells: 15.3;Macrophages: 36.1;monocytes: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 228.3;non-classical monocyte: 242.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.1;HMC-1: 33.1;THP-1: 6.5;U-937: 16.2"					"Low region specificity"	"Detected in some"			"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (1.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	4.0	1.3	0.7	6.8	1.1	9.7	0.8	0.8	5.5	0.6	1.1	1.3	1.1	0.6	0.1	0.6	0.7	2.0	0.9	0.7	1.4	0.7	1.5	8.4	2.1	1.7	1.8	0.3	0.6	0.4	0.4	2.9	2.1	0.5	1.3	0.0	0.7	0.5	0.3	0.4	1.2	3.1	1.4	7.3	0.7	0.3	2.7	1.0	1.0	0.2	1.1	3.8	0.4	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	3.3	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	16.2	0.0	51.8	142.1	7.0	0.7	228.3	0.4	2.7	0.3	0.3	158.8	2.4	0.2	0.2	5.2	43.9	242.7	10.5	0.2	64.6	0.7	1.1	0.8	5.5	0.7	1.4	1.7	1.8	2.1	1.4	2.7	2.2	0.1	0.0	1.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.3	0.1	0.0	0.0	15.2	0.0	0.0	0.2	32.1	0.0	0.0	0.0	0.0	26.3	15.3	0.1	0.0	36.1	1.8	1.0	19.6	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	1.3	0.0	0.0	0.0
CD300E	"CD300LE, CLM2, IREM2"	ENSG00000186407	"CD300e molecule"	Q496F6	17	74609885-74623738	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.1;lymphoid tissue: 37.5"	"Group enriched"	"Detected in some"	5	"Kupffer cells: 71.8;Macrophages: 112.4;monocytes: 100.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"thalamus: 3.7"	"Group enriched"	"Detected in some"	6	"classical monocyte: 88.0;intermediate monocyte: 135.1;non-classical monocyte: 148.5"	"Lineage enriched"	"Detected in many"	7	"monocytes: 148.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA015570	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA015570: AB_1846294"	"unprognostic (1.70e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.80e-3)"	"unprognostic (4.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.19e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-4)"	"unprognostic (7.38e-3)"	"unprognostic (1.19e-1)"	14.1	0.8	0.5	37.5	0.2	48.1	0.8	1.3	1.7	0.5	2.5	1.2	0.5	0.6	0.1	0.5	3.2	3.7	1.9	0.3	0.4	1.7	2.5	16.8	1.1	0.4	0.6	0.4	0.9	0.2	0.3	3.1	0.7	0.6	0.9	0.5	0.6	0.2	1.3	0.7	0.6	10.2	0.1	11.0	1.0	0.5	3.7	0.7	0.5	0.3	0.7	18.1	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	88.0	0.6	0.2	135.1	0.1	0.1	0.1	0.1	21.8	0.1	0.1	0.0	1.9	0.1	148.5	0.6	0.1	53.9	0.5	0.2	1.3	1.7	0.3	0.4	0.4	0.6	0.7	0.1	3.7	0.4	0.3	6.4	15.9	0.0	2.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	8.6	1.8	0.0	0.1	2.9	0.0	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	4.0	0.5	0.0	3.8	0.0	0.4	0.4	4.1	0.0	0.2	0.0	0.0	71.8	13.0	0.1	0.0	112.4	1.8	0.0	100.1	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.5	1.5	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.6	0.4	2.3	0.0	0.0	0.0
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.4;lymphoid tissue: 23.9"	"Group enriched"	"Detected in some"	6	"granulocytes: 76.0;Hofbauer cells: 78.8;Kupffer cells: 131.2;Langerhans cells: 41.4;Macrophages: 53.5;monocytes: 65.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 166.5;intermediate monocyte: 122.0;myeloid DC: 213.5;non-classical monocyte: 57.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 213.5;monocytes: 166.5"	"Cell line enhanced"	"Detected in some"		"HEL: 86.1;HL-60: 115.6;HMC-1: 82.4;NB-4: 55.2;RPMI-8226: 62.5;THP-1: 67.0;U-937: 84.1"									"CAB011442, HPA035832, HPA064807, CAB079996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		3400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane"		"CAB011442: , CAB079996: , HPA035832: AB_2674808, HPA064807: AB_2685356"	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	7.9	3.4	1.1	11.2	1.2	32.4	2.5	1.5	1.6	3.0	2.5	3.2	3.3	1.7	1.3	2.0	2.5	6.6	2.0	1.1	1.8	1.4	5.5	12.6	10.1	2.5	1.6	1.4	1.4	1.2	0.9	6.9	2.4	1.4	4.2	0.2	1.8	2.6	0.9	2.7	4.4	7.1	1.9	23.9	2.3	1.0	2.3	3.5	0.9	0.8	3.5	6.2	1.3	3.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	5.5	0.4	0.0	1.3	0.3	0.0	0.2	0.0	0.1	0.1	86.1	0.3	0.0	0.0	115.6	82.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	16.2	21.2	0.2	0.0	0.0	55.2	0.2	0.0	25.9	0.0	4.4	62.5	0.4	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	67.0	0.7	14.0	1.1	1.8	0.1	0.3	7.6	0.2	9.6	84.1	0.4	17.9	166.5	11.0	0.3	122.0	0.4	0.1	0.2	0.5	213.5	0.4	0.3	0.2	20.5	15.5	57.8	6.3	1.1	77.8	1.1	1.2	1.5	1.6	1.1	1.8	2.5	1.6	2.4	1.9	2.3	3.6	0.7	0.0	6.7	0.0	1.0	1.8	0.5	0.0	0.0	0.2	1.4	0.4	0.8	0.0	0.6	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.7	0.1	0.1	3.0	0.0	4.2	0.0	0.0	0.5	1.1	0.0	0.1	76.0	0.1	5.3	0.7	78.8	0.0	0.0	0.0	0.0	131.2	41.4	1.7	0.3	53.5	1.8	11.2	65.0	0.2	1.0	0.5	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.2	0.7	0.6	0.0	1.1	0.3	0.7	0.5	0.0	1.0	0.8	2.5	0.1	0.0	0.4
CD55	"CR, CROM, DAF, TC"	ENSG00000196352	"CD55 molecule (Cromer blood group)"	P08174	1	207321532-207386804	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 2227.6;Syncytiotrophoblasts: 847.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 662.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 472.3;HMC-1: 665.7;PC-3: 395.0;U-2197: 405.3"					"Low region specificity"	"Detected in many"			"HPA002190, CAB010454, HPA024386"	Enhanced				"Secreted to blood"	NA	No	32300000	360000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"			"CAB010454: AB_2075970, HPA002190: AB_1078472, HPA024386: AB_1846319"	"unprognostic (4.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (9.36e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.33e-2)"	64.9	161.5	13.8	99.6	23.3	134.0	59.0	15.8	28.3	103.3	19.0	47.7	47.7	58.3	17.3	58.3	28.0	49.4	48.4	15.7	29.4	20.5	28.0	224.1	26.7	21.1	20.0	67.7	24.5	28.9	26.3	92.5	26.2	16.1	42.9	9.2	126.1	18.1	108.9	85.9	50.7	46.6	15.2	43.1	44.0	36.0	20.8	15.8	47.6	59.5	41.3	183.2	41.8	34.4	33.2	43.6	0.1	14.6	54.2	55.1	220.7	62.5	100.1	31.3	33.1	139.5	44.3	60.8	50.3	35.8	123.3	17.4	65.2	12.9	29.1	29.0	26.4	79.9	472.3	23.3	162.3	50.5	665.7	25.9	150.5	40.8	171.8	133.8	169.7	9.6	89.6	29.3	19.4	35.6	5.3	37.8	43.2	78.9	395.0	7.4	42.3	50.7	54.3	30.7	17.7	0.4	321.2	64.3	53.9	95.1	54.4	41.5	80.4	17.6	33.2	405.3	23.8	24.7	31.4	42.7	44.8	19.6	78.9	317.7	181.2	247.6	35.0	174.4	51.8	108.2	46.0	36.4	121.7	115.2	102.6	101.9	662.2	134.5	223.7	64.8	34.6	159.3	13.8	23.3	15.8	28.3	15.7	29.4	21.1	20.0	26.2	15.2	20.8	34.4	95.9	2227.6	405.3	2.3	529.8	705.1	214.1	143.6	59.2	3.1	69.9	53.8	72.7	7.2	542.6	23.9	0.0	217.5	201.7	196.1	3.9	98.6	324.6	345.6	101.9	143.4	17.3	79.8	7.6	180.2	411.7	244.7	387.9	709.3	146.9	88.9	46.8	9.1	70.0	1.7	10.7	155.7	77.3	177.5	449.2	66.3	32.6	377.3	160.1	7.5	122.6	4.8	69.0	6.0	54.3	388.9	241.2	9.1	305.4	334.9	138.4	3.2	259.5	3.3	6.6	56.1	98.0	8.9	13.7	273.4	765.9	847.7	215.4	281.5	145.1	578.6
CD69	CLEC2C	ENSG00000110848	"CD69 molecule"	Q07108	12	9752486-9760901	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 169.1;lymphoid tissue: 94.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 1017.1;dendritic cells: 694.0;granulocytes: 1455.3;Plasma cells: 308.8;T-cells: 1185.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 26.7;T-cells: 30.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 30.0;JURKAT: 19.5;K-562: 58.4;MOLT-4: 20.9;U-266/70: 22.5;U-698: 25.6;U-937: 97.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002503, HPA050525"	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB002503: AB_563625, HPA050525: AB_2681157"	"prognostic favorable (3.31e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.10e-3)"	"unprognostic (4.76e-3)"	"unprognostic (9.53e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"	14.0	6.2	0.9	48.1	0.7	169.1	18.9	1.2	1.0	9.3	2.2	8.9	8.2	6.0	2.9	11.9	7.7	27.3	3.5	0.7	1.7	4.9	12.9	22.6	94.4	1.7	1.1	2.6	1.7	2.0	4.0	2.6	1.6	10.4	21.3	0.2	5.1	2.9	0.7	4.3	19.5	14.3	2.2	43.6	11.8	1.3	1.0	57.0	6.9	4.6	60.1	18.0	7.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	1.1	0.0	1.5	0.0	0.0	0.0	0.0	12.1	0.0	0.0	1.5	30.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	19.5	58.4	0.0	0.0	0.0	20.9	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.9	8.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	22.5	2.7	25.6	0.0	97.8	0.0	1.3	0.1	5.9	22.9	0.1	30.8	6.0	14.5	16.9	0.1	6.2	20.6	15.6	0.3	26.7	0.0	0.0	7.9	7.3	0.9	0.7	1.2	1.0	0.7	1.7	1.7	1.1	1.6	2.2	1.0	2.4	13.5	41.7	116.7	0.0	1017.1	18.5	3.8	0.0	10.8	0.1	11.8	14.7	2.0	7.2	5.0	1.8	0.0	0.9	694.0	1.1	0.0	1.1	0.4	5.7	3.6	14.3	0.0	33.7	0.0	0.0	0.3	15.4	63.7	16.7	1455.3	0.0	14.6	2.4	16.6	0.0	0.0	0.2	0.0	15.4	77.1	0.3	0.0	80.1	33.8	10.3	3.2	0.1	57.7	0.0	0.1	0.0	0.1	0.0	308.8	2.2	0.4	2.1	1.5	0.6	0.0	4.3	9.2	0.1	0.3	4.2	18.2	1.9	1185.9	0.0	0.9	3.3
CEACAM21	"FLJ13540, R29124_1"	ENSG00000007129	"CEA cell adhesion molecule 21"	Q3KPI0	19	41549518-41586844	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.5;lymphoid tissue: 10.2"	"Cell type enriched"	"Detected in some"	10	"Granulosa cells: 150.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 8.6;Karpas-707: 6.1;THP-1: 3.3;U-266/70: 5.8;U-937: 5.8"									HPA043411	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA043411: AB_10794886"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.57e-1)"	"unprognostic (8.02e-4)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.37e-6)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.37e-1)"	1.3	0.7	1.4	2.2	0.8	17.5	0.8	0.8	1.3	2.2	0.6	0.8	0.6	2.6	0.3	0.4	0.7	0.5	0.5	0.8	2.8	0.7	1.2	3.8	5.3	1.9	2.7	0.4	0.2	0.1	0.4	1.5	2.2	0.6	0.6	0.0	0.5	3.6	0.1	0.2	2.6	0.5	1.8	10.2	0.9	1.1	3.9	2.2	0.6	0.1	3.5	0.8	0.3	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.8	1.0	1.0	0.0	5.8	0.0	0.1	6.0	27.3	29.7	11.7	20.1	10.8	25.6	20.8	6.9	15.1	21.3	21.0	30.2	19.2	7.0	12.4	26.6	17.9	1.4	0.8	0.8	1.3	0.8	2.8	1.9	2.7	2.2	1.8	3.9	1.2	1.5	0.0	0.0	0.3	5.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.6	1.8	0.0	0.1	7.2	0.0	0.0	0.0	5.4	7.3	0.1	2.0	0.0	5.7	0.1	0.0	0.1	0.3	0.0	2.2	4.5	150.8	10.0	0.3	9.4	0.0	0.7	0.0	0.0	9.0	0.6	10.3	0.0	6.2	1.8	15.0	1.0	0.0	9.2	0.0	0.1	0.0	0.0	0.4	10.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.6	0.0	0.0	0.3	8.8	0.0	0.0	0.0
CFLAR	"c-FLIP, CASH, CASP8AP1, Casper, cFLIP, CLARP, FLAME, FLIP, I-FLICE, MRIT"	ENSG00000003402	"CASP8 and FADD like apoptosis regulator"	O15519	2	201116154-201176687	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 609.9;Urothelial cells: 521.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 392.6"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 392.6"	"Cell line enhanced"	"Detected in all"		"U-266/70: 214.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019044, CAB022157, CAB025216"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB022157: , CAB025216: , HPA019044: AB_10696204"	"unprognostic (4.61e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.46e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.83e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-2)"	122.4	50.6	38.8	103.9	40.9	247.6	83.1	54.1	47.4	57.0	75.6	86.0	59.2	57.9	60.6	68.0	66.6	71.6	184.8	39.4	32.7	57.5	59.2	174.6	91.1	46.5	40.5	38.3	40.7	31.8	29.4	94.0	42.1	65.6	56.4	12.4	58.0	63.2	222.8	51.0	64.8	58.8	36.6	98.1	56.5	25.3	51.9	54.1	78.8	89.2	107.3	78.7	61.7	46.1	21.5	42.9	30.0	17.9	92.3	71.0	37.5	53.6	92.1	34.3	41.6	50.4	78.4	5.8	49.6	62.5	41.6	15.5	9.8	40.3	53.9	160.7	29.9	32.3	38.4	82.2	63.6	24.2	102.2	76.8	39.6	58.2	50.3	41.7	176.7	7.3	110.8	131.2	63.1	17.9	11.3	96.3	10.2	17.2	32.7	11.7	7.2	46.5	42.5	44.0	6.6	11.8	35.7	31.2	43.2	19.6	22.1	44.8	193.6	71.0	29.5	26.7	26.1	214.6	76.2	35.9	50.6	19.5	36.3	91.8	60.3	70.3	54.4	61.8	48.4	25.6	46.5	52.1	33.4	20.9	29.5	38.3	392.6	45.2	68.5	23.0	60.7	42.0	38.8	40.9	54.1	47.4	39.4	32.7	46.5	40.5	42.1	36.6	51.9	46.1	191.3	451.9	234.9	30.3	126.4	54.8	229.6	164.9	29.0	10.9	38.9	30.0	205.8	102.9	206.7	69.9	31.3	77.2	166.2	132.5	74.3	148.8	83.3	202.8	75.0	261.0	95.1	59.1	6.9	72.5	34.8	89.5	73.4	219.2	81.6	93.4	201.0	97.5	68.6	13.5	16.8	76.8	40.7	123.2	609.9	44.8	51.9	278.0	97.8	146.1	247.0	23.4	276.0	29.7	56.8	166.4	155.6	49.7	317.8	386.0	116.7	101.5	276.1	30.7	39.5	113.2	77.9	14.4	12.2	33.2	86.1	70.1	168.3	56.1	50.9	521.3
CFP	PFC	ENSG00000126759	"Complement factor properdin"	P27918	X	47623172-47630305	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 83.9;lymphoid tissue: 58.4"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 108.1;Kupffer cells: 356.7;Langerhans cells: 164.1;Macrophages: 177.3;monocytes: 473.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	8	"classical monocyte: 1167.5;intermediate monocyte: 1273.6;myeloid DC: 994.5;neutrophil: 730.3;non-classical monocyte: 868.9"	"Group enriched"	"Detected in all"	46	"dendritic cells: 994.5;granulocytes: 730.3;monocytes: 1273.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.7;HEL: 5.0;HMC-1: 5.5;NB-4: 10.7;U-937: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072644			Approved	Vesicles	"Secreted to blood"	NA	NA		6200000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA072644: "	"unprognostic (2.77e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.66e-5)"	"unprognostic (9.90e-3)"	"unprognostic (1.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.17e-1)"	6.0	1.9	0.3	20.5	0.3	83.9	2.1	0.3	0.6	0.6	0.2	2.1	1.2	0.9	0.2	1.6	3.4	2.1	2.6	0.4	0.1	0.8	12.0	9.3	11.7	0.1	0.0	0.7	0.8	0.1	0.8	0.9	0.0	0.7	0.9	0.2	1.0	0.2	1.0	1.5	3.7	5.2	0.0	58.4	1.5	0.6	0.0	5.1	0.9	0.7	4.4	4.9	0.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	20.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	5.0	0.2	0.0	0.1	1.1	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.2	0.0	10.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.2	1.0	0.0	0.1	0.5	0.1	0.4	0.4	0.1	0.1	7.2	0.0	131.5	1167.5	39.9	3.0	1273.6	2.3	6.7	15.1	1.8	994.5	2.6	21.8	8.1	730.3	12.3	868.9	30.9	14.1	1071.9	0.3	0.3	0.3	0.6	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	9.1	1.0	5.8	4.0	0.1	0.3	1.2	3.4	0.7	0.4	0.9	1.5	2.8	0.0	0.0	0.3	1.7	0.3	0.0	0.2	0.2	0.4	0.4	7.4	0.0	2.5	1.4	0.7	0.5	2.0	1.1	0.6	1.3	4.0	108.1	2.0	17.3	1.7	1.1	0.0	0.0	356.7	164.1	0.3	0.9	177.3	5.4	0.0	473.7	0.3	4.1	2.0	0.3	0.3	0.1	1.2	1.2	0.3	0.1	0.5	7.5	1.9	0.0	1.5	1.2	0.0	0.2	0.5	3.0	0.4	4.8	3.1	0.6	0.0
CGAS	"C6orf150, MB21D1"	ENSG00000164430	"Cyclic GMP-AMP synthase"	Q8N884	6	73413515-73452297	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.2;dendritic cells: 12.0;Glandular and luminal cells: 12.5;Hofbauer cells: 12.4;Macrophages: 10.0;monocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.1;RH-30: 43.8;RPMI-8226: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031700, HPA031702"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031700: AB_10601693, HPA031702: AB_2673999"	"unprognostic (2.49e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.27e-7)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-1)"	2.9	1.1	1.7	6.4	2.1	14.0	1.7	2.2	3.0	2.4	1.7	1.9	2.7	1.9	0.6	2.3	1.8	2.6	1.5	1.9	2.0	1.1	0.8	3.5	7.4	2.6	2.2	1.2	1.2	0.6	0.6	3.1	2.6	1.9	1.8	0.2	1.8	1.8	0.5	1.1	2.5	2.0	2.4	5.2	2.3	1.0	3.0	2.3	1.6	0.9	4.7	4.3	2.1	3.4	19.9	5.8	0.1	0.2	1.2	2.7	0.1	10.1	3.7	11.3	12.6	20.7	14.2	0.2	20.9	4.3	6.3	10.1	9.8	0.2	12.0	31.9	0.0	16.9	8.2	0.1	4.0	12.3	11.5	1.6	3.2	11.8	0.1	0.0	3.5	0.1	0.0	37.1	8.7	8.0	0.0	27.1	6.2	2.4	11.2	23.4	43.8	45.2	0.0	7.3	0.3	0.1	17.3	0.4	10.2	0.2	0.0	33.9	5.0	0.0	9.1	8.5	0.2	8.1	19.8	0.2	0.1	17.5	11.4	26.3	12.7	19.0	6.0	17.5	4.7	8.4	7.9	5.9	7.5	6.7	1.8	3.4	8.5	4.2	11.6	17.6	8.0	6.0	1.7	2.1	2.2	3.0	1.9	2.0	2.6	2.2	2.6	2.4	3.0	3.4	10.2	3.2	4.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	0.6	0.0	0.0	0.2	12.0	0.0	0.0	2.0	0.0	8.4	8.5	6.0	0.0	0.0	0.0	3.9	0.7	2.3	0.0	12.5	5.1	1.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	3.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.3	8.0	0.7	0.0	0.0
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.8;lung: 36.4;lymphoid tissue: 21.7"	"Cell type enriched"	"Detected in some"	10	"Hofbauer cells: 40.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Region enriched"	"Detected in some"	6	"cerebral cortex: 12.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	NA	NA	26400000	57000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 4: Macrophages - Innate immune response"			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	13.6	0.3	0.2	0.4	0.2	49.8	8.3	0.0	12.4	8.1	0.0	1.2	0.0	3.6	0.1	0.0	0.1	0.4	0.2	0.2	0.0	0.1	0.7	36.4	21.7	0.4	0.2	0.5	2.1	0.0	0.0	0.7	1.3	1.0	1.0	0.0	0.4	0.0	0.2	0.4	0.8	0.0	0.4	5.7	0.5	0.0	0.3	3.4	1.3	0.0	1.1	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.0	12.4	0.2	0.0	0.4	0.2	1.3	0.4	0.3	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0
CLEC12A	"CD371, CLL-1, DCAL-2, MICL"	ENSG00000172322	"C-type lectin domain family 12 member A"	Q5QGZ9	12	9951316-9995694	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 79.9;lymphoid tissue: 22.1"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 121.9;Macrophages: 141.6;monocytes: 154.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 202.6"	"Group enriched"	"Detected in many"	37	"dendritic cells: 72.6;granulocytes: 202.6;monocytes: 136.6"	"Group enriched"	"Detected in some"	6	"HL-60: 21.8;U-937: 66.5"	"Region enriched"	"Detected in single"	7	"basal ganglia: 6.2"	"Not detected"	"Not detected"			HPA048515	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA048515: AB_2680425"	"unprognostic (4.74e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.67e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.78e-2)"	"prognostic favorable (9.33e-4)"	6.4	2.6	0.3	13.9	0.2	79.9	1.1	0.3	1.0	2.0	1.3	2.8	1.0	1.0	1.2	1.2	1.0	5.1	1.9	0.2	0.2	0.7	6.4	16.6	6.6	0.6	0.2	0.4	0.7	0.6	0.4	2.4	0.3	0.9	3.0	0.3	1.3	0.4	1.3	1.4	4.5	7.7	0.2	22.1	1.8	0.6	0.3	2.5	1.1	0.7	2.1	4.9	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	21.8	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.5	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	66.5	0.0	23.9	136.6	202.6	0.2	114.6	0.5	0.2	0.1	0.1	72.6	0.1	0.4	0.5	47.2	3.7	130.2	6.4	0.2	61.6	0.3	0.2	0.3	1.0	0.2	0.2	0.6	0.2	0.3	0.2	0.3	0.3	0.7	3.2	5.0	0.0	2.8	0.4	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	3.1	0.0	0.0	0.2	6.9	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	7.2	0.3	0.0	1.0	1.5	0.5	0.1	30.3	0.0	0.7	0.8	19.2	0.0	0.3	0.0	0.0	121.9	16.9	0.0	0.0	141.6	0.0	0.0	154.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.9	0.9	0.2	0.6	1.4	4.2	0.0	0.0	0.0
CLEC4A	"CD367, CLECSF6, DCIR, DDB27"	ENSG00000111729	"C-type lectin domain family 4 member A"	Q9UMR7	12	8123617-8138607	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 21.6;lymphoid tissue: 26.9"	"Group enriched"	"Detected in many"	4	"Kupffer cells: 79.9;Langerhans cells: 119.3;Macrophages: 88.5;monocytes: 98.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 226.8;classical monocyte: 331.7;intermediate monocyte: 198.1;myeloid DC: 327.4;neutrophil: 298.3;non-classical monocyte: 130.0"	"Group enriched"	"Detected in all"	13	"dendritic cells: 327.4;granulocytes: 298.3;monocytes: 331.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007842	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA007842: AB_1078534"	"unprognostic (9.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.34e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.79e-2)"	4.1	2.4	3.0	26.9	3.0	21.6	4.6	3.1	5.9	3.2	2.9	4.6	5.1	3.9	4.3	2.6	2.6	7.4	1.9	3.0	3.0	1.7	4.2	11.1	9.4	4.0	3.1	4.3	1.8	1.0	2.0	4.9	3.1	2.3	6.0	3.5	2.8	3.0	1.6	5.4	4.7	4.6	3.1	15.4	2.4	2.4	2.6	6.2	1.7	2.6	8.9	7.7	1.8	3.3	0.2	0.0	0.3	0.9	1.7	4.2	0.5	1.2	0.5	0.9	1.3	1.6	0.7	0.7	0.1	0.6	0.3	0.2	0.9	0.2	0.6	1.2	1.2	0.7	0.7	0.4	2.1	2.3	2.9	2.1	0.9	0.4	1.2	2.7	0.2	1.6	0.4	0.6	1.2	0.6	0.6	1.7	0.6	0.6	0.4	0.4	0.7	1.1	0.6	1.1	0.2	0.4	0.2	0.8	0.0	1.4	0.1	0.1	0.2	1.6	1.0	0.6	0.8	0.7	0.1	0.9	0.2	0.8	0.0	226.8	331.7	1.1	0.5	198.1	0.6	14.1	0.9	1.3	327.4	25.0	0.6	0.6	298.3	3.3	130.0	44.4	0.6	168.9	3.0	3.0	3.1	5.9	3.0	3.0	4.0	3.1	3.1	3.1	2.6	3.3	1.1	0.0	4.6	3.9	8.6	4.2	0.8	0.6	0.0	0.6	0.7	2.0	0.8	0.0	2.0	0.0	4.2	0.3	8.9	0.4	1.9	0.1	5.5	0.2	0.6	1.5	1.8	2.7	2.2	0.5	0.2	1.4	0.5	0.3	2.5	1.5	0.7	1.3	23.8	0.0	2.4	0.3	0.0	79.9	119.3	1.5	2.5	88.5	7.2	3.7	98.8	1.0	6.2	4.5	2.9	0.6	1.2	1.5	0.7	0.8	0.0	0.3	2.3	1.1	0.0	1.1	1.1	0.6	0.4	0.3	3.3	0.3	2.1	0.7	0.2	0.9
CLEC4E	"CLECSF9, mincle"	ENSG00000166523	"C-type lectin domain family 4 member E"	Q9ULY5	12	8533305-8540905	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 75.7;lymphoid tissue: 52.3"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 31.9;Kupffer cells: 158.0;Macrophages: 115.2;monocytes: 109.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"classical monocyte: 128.8;neutrophil: 448.8"	"Group enriched"	"Detected in many"	17	"granulocytes: 448.8;monocytes: 128.8"	"Group enriched"	"Detected in some"	4	"NB-4: 4.3;RPTEC TERT1: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004935	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA004935: AB_2667299"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.29e-1)"	13.3	5.4	2.3	37.5	2.1	75.7	4.5	1.8	4.4	5.8	2.2	2.2	0.4	2.3	0.4	3.2	5.5	11.8	2.5	2.3	2.9	3.6	6.6	22.4	7.6	1.3	1.3	1.7	6.2	1.7	1.9	2.1	1.2	2.3	1.0	1.3	1.4	1.2	0.7	0.9	3.1	5.7	0.7	52.3	2.5	1.1	2.0	2.2	10.5	5.0	2.3	9.6	1.7	2.9	0.1	0.4	0.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.1	0.1	2.0	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.5	0.1	0.0	1.5	0.0	0.5	0.2	0.2	0.2	0.2	0.0	0.1	0.0	4.3	0.3	0.0	0.0	0.0	0.2	0.1	12.4	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.4	1.0	0.5	0.1	1.0	0.1	0.2	0.1	0.1	1.3	0.4	0.1	0.2	128.8	0.5	0.1	18.1	0.3	0.1	0.1	0.1	16.9	0.1	0.0	0.1	448.8	0.0	0.7	0.7	0.0	30.3	2.3	2.1	1.8	4.4	2.3	2.9	1.3	1.3	1.2	0.7	2.0	2.9	6.2	0.0	4.7	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	5.7	1.8	1.8	0.0	0.0	0.3	0.0	0.0	9.0	0.3	2.1	4.4	3.5	0.0	0.0	0.0	0.0	0.1	1.4	0.0	31.9	0.0	0.0	7.1	2.1	5.6	0.0	0.0	0.0	0.0	158.0	9.0	2.9	0.9	115.2	0.0	0.0	109.5	0.0	4.1	0.0	0.0	0.4	0.0	0.4	1.3	0.0	0.0	0.2	0.7	0.0	13.1	0.2	0.4	0.2	0.5	0.1	0.0	0.1	1.1	0.0	0.0	0.1
CLEC7A	"CD369, CLECSF12, dectin-1, hDectin-1, SCARE2"	ENSG00000172243	"C-type lectin domain containing 7A"	Q9BXN2	12	10116777-10130258	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 84.0;lung: 30.9;lymphoid tissue: 44.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 87.2;Kupffer cells: 415.2;Langerhans cells: 291.5;Macrophages: 255.5;monocytes: 186.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 249.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"Karpas-707: 192.2;U-266/84: 168.1"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.79e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.83e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.14e-1)"	9.9	5.9	2.2	44.5	2.0	84.0	4.5	2.6	3.7	3.5	3.3	7.5	5.6	3.2	3.7	9.7	5.8	11.1	5.7	1.9	3.3	3.5	11.0	30.9	14.4	5.0	2.7	2.4	2.9	2.0	2.7	7.3	4.0	3.3	7.3	1.7	7.3	3.2	1.3	3.8	8.6	8.7	3.6	34.2	4.6	1.5	3.8	10.0	2.6	2.0	11.9	9.1	4.8	6.1	0.3	0.4	0.1	0.2	0.0	0.0	1.1	0.0	0.5	0.2	0.1	0.1	0.4	0.1	0.1	0.0	1.1	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.9	0.7	0.1	0.8	0.1	0.0	0.2	0.1	0.2	0.0	192.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	4.3	0.0	5.2	0.3	0.2	0.3	0.6	0.0	1.4	0.4	0.1	0.3	0.1	0.2	0.2	0.2	11.4	168.1	0.1	0.3	1.0	0.2	1.4	122.9	2.2	0.3	137.2	0.5	0.3	0.3	0.2	60.6	0.3	0.3	0.2	249.6	0.4	148.1	1.0	0.4	40.4	2.2	2.0	2.6	3.7	1.9	3.3	5.0	2.7	4.0	3.6	3.8	6.1	2.0	12.8	15.1	0.3	5.9	3.7	0.2	0.9	8.6	0.0	3.1	2.8	0.9	0.0	9.7	0.0	0.0	1.5	2.1	0.2	0.0	0.1	1.7	0.2	0.1	9.3	0.0	0.0	0.1	0.0	14.1	2.4	0.0	0.1	6.3	0.0	6.1	2.1	87.2	0.0	0.1	0.0	4.1	415.2	291.5	2.2	0.3	255.5	3.6	27.2	186.1	0.0	8.2	0.0	0.0	0.0	1.1	0.0	1.1	0.1	0.0	1.3	2.4	0.4	13.1	1.1	1.0	0.1	0.5	13.2	3.0	5.3	4.1	0.0	0.0	0.5
CRLF2	"CRL2, TSLPR"	ENSG00000205755	"Cytokine receptor like factor 2"	Q9HC73	X	1187549-1212723	"Cancer-related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.8;gallbladder: 1.3;lymphoid tissue: 1.5"	"Cell type enriched"	"Detected in some"	4	"monocytes: 100.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"				"unprognostic (7.84e-2)"	"unprognostic (7.99e-4)"	"unprognostic (6.02e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.31e-6)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.88e-5)"	"unprognostic (7.09e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.62e-1)"	0.2	0.0	0.0	1.5	0.0	1.8	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.5	0.6	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.5	0.8	0.1	0.3	2.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.9	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.3	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	1.8	0.0	1.0	100.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 379.7;lung: 136.7;lymphoid tissue: 375.6;placenta: 105.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 230.8;Cytotrophoblasts: 423.8;Kupffer cells: 177.7;monocytes: 197.6;Syncytiotrophoblasts: 1194.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 1962.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 1962.3"	"Group enriched"	"Detected in some"	18	"BEWO: 70.8;NB-4: 20.3;THP-1: 50.3;U-937: 47.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"	NA	NA		150000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB017116: , HPA048086: AB_2680257"	"unprognostic (5.57e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.31e-2)"	36.2	7.1	5.8	148.2	5.6	379.7	13.0	6.7	19.0	5.2	6.3	6.4	2.6	3.1	0.4	5.6	31.5	15.8	14.6	5.5	7.3	9.7	22.9	136.7	7.3	10.3	7.8	3.2	4.9	1.6	5.5	105.1	11.4	7.5	1.8	0.1	7.4	1.8	3.6	1.6	9.8	12.2	9.6	375.6	9.9	1.2	10.7	5.7	5.8	21.7	2.7	22.2	6.2	11.9	0.0	0.0	0.0	0.0	0.0	0.0	70.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	1.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.5	0.0	50.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	47.8	0.0	1.1	280.8	8.7	0.2	56.8	0.6	0.1	0.4	0.2	97.2	0.4	0.1	0.3	1962.3	3.4	24.1	3.3	0.6	158.4	5.8	5.6	6.7	19.0	5.5	7.3	10.3	7.8	11.4	9.6	10.7	11.9	0.7	25.6	230.8	0.0	3.3	1.0	0.5	0.0	0.0	0.0	5.9	4.7	1.8	0.0	10.0	0.0	0.0	423.8	2.9	0.0	0.0	0.0	0.4	0.3	6.4	4.8	0.0	4.6	0.2	0.0	47.3	8.0	1.5	0.2	18.9	1.1	3.9	1.2	64.1	0.0	0.2	0.0	0.0	177.7	39.2	0.7	0.3	111.5	0.0	77.8	197.6	0.2	6.2	0.5	0.3	0.1	0.0	0.0	0.7	0.3	0.0	0.5	6.6	0.2	0.0	0.3	1.0	0.0	0.4	0.2	0.1	1194.8	4.0	0.0	0.0	3.0
CSGALNACT2	"GALNACT-2, GALNACT2, MGC40204, PRO0082"	ENSG00000169826	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2"	Q8N6G5	10	43138445-43185302	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 133.9"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 121.6;Macrophages: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031540	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"HPA031540: AB_10599943"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.85e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.43e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.05e-3)"	19.7	10.6	8.8	24.1	10.8	133.9	12.9	15.1	13.3	15.1	12.6	15.1	9.2	19.5	8.4	10.5	15.5	25.4	12.8	8.5	10.8	8.8	13.9	26.8	22.5	10.7	9.7	17.0	7.8	8.0	11.6	26.4	11.1	13.4	11.6	9.8	7.9	10.9	14.6	11.0	11.5	20.8	9.4	26.5	10.1	9.2	9.9	27.9	9.9	17.2	17.4	24.0	12.1	13.5	12.6	8.2	15.1	14.4	23.0	38.5	3.7	44.7	59.8	19.3	30.0	2.9	12.7	20.8	10.8	40.6	9.2	11.4	12.6	16.8	31.3	24.9	9.3	10.8	7.9	8.6	50.0	25.3	21.8	38.6	18.1	43.1	89.3	24.3	25.0	30.7	4.6	60.1	39.9	6.5	19.3	15.1	6.5	4.2	10.7	11.9	15.0	8.8	17.1	6.6	13.6	26.8	11.6	11.9	28.8	13.0	15.7	20.5	37.3	16.5	26.2	52.3	30.4	15.4	23.2	10.9	35.1	60.8	7.9	14.7	11.9	19.4	7.3	14.2	6.4	3.0	5.5	5.7	14.4	3.0	6.4	5.4	11.2	11.3	21.8	4.1	7.1	6.9	8.8	10.8	15.1	13.3	8.5	10.8	10.7	9.7	11.1	9.4	9.9	13.5	16.3	16.0	18.7	23.8	20.5	17.7	13.3	7.0	6.2	13.1	10.7	8.5	10.9	5.7	9.6	11.0	10.4	2.1	47.8	1.7	0.0	5.9	2.1	12.0	22.0	16.8	9.0	18.5	42.5	6.9	6.1	31.4	4.6	11.3	48.1	23.5	11.4	11.9	16.4	8.4	41.1	1.6	4.1	68.6	121.6	1.4	17.1	82.6	8.8	16.9	41.5	4.1	35.0	45.2	54.5	13.7	3.1	12.4	33.8	12.7	1.5	4.4	5.8	8.5	26.3	27.7	25.3	17.8	18.3	3.6	12.1	1.5	37.4	7.2	1.6	7.0
CTSW		ENSG00000172543	"Cathepsin W"	P56202	11	65879809-65883741	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.3;lymphoid tissue: 42.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 717.8;NK-cells: 867.2;T-cells: 352.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	8	"gdT-cell: 1376.3;MAIT T-cell: 869.4;memory CD8 T-cell: 892.8;naive CD8 T-cell: 636.3;NK-cell: 2276.1"	"Group enriched"	"Detected in all"	39	"NK-cells: 2276.1;T-cells: 1376.3"	"Group enriched"	"Detected in some"	22	"HEL: 156.7;NB-4: 363.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB016345, HPA066903"	Enhanced				"Intracellular and membrane"	NA	NA		270000	"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB016345: AB_626813, HPA066903: "	"prognostic favorable (3.06e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.36e-6)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (3.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.01e-3)"	5.1	2.9	0.8	12.9	0.9	116.3	3.7	1.8	1.6	2.6	0.6	5.6	6.1	6.7	2.8	3.1	4.0	6.2	2.9	0.8	0.9	2.1	6.5	24.0	29.5	1.6	0.7	2.4	1.8	0.5	1.1	3.3	1.2	2.1	6.3	0.0	9.1	3.9	1.3	2.7	6.1	2.7	1.2	42.4	8.3	1.2	1.1	7.8	3.2	0.4	13.9	8.6	2.5	1.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	156.7	0.3	0.0	0.0	11.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.0	0.0	9.1	0.2	0.2	1.9	363.4	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	5.6	0.1	0.0	0.1	0.4	0.1	0.3	0.5	0.0	0.2	9.9	0.3	46.4	3.4	4.8	1376.3	4.0	869.4	5.1	145.3	892.8	37.6	3.7	86.0	636.3	25.7	2276.1	5.4	23.3	23.7	809.3	0.8	0.9	1.8	1.6	0.8	0.9	1.6	0.7	1.2	1.2	1.1	1.1	5.1	0.0	4.2	0.0	9.7	4.6	0.4	0.0	1.8	0.0	2.3	2.2	0.4	2.8	1.4	0.0	0.0	0.4	717.8	0.3	0.0	0.3	2.0	0.9	0.9	1.9	0.0	44.1	0.0	0.0	0.2	4.0	12.8	1.1	71.7	0.1	5.7	1.6	1.9	0.0	0.0	0.2	0.0	5.6	34.1	11.1	0.0	9.9	17.8	0.0	6.1	0.0	867.2	0.0	0.2	0.0	0.0	0.0	57.7	0.3	0.0	1.1	0.8	0.0	0.0	1.6	1.9	0.3	1.2	0.8	6.3	0.3	352.6	0.1	0.3	0.3
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780059-37813461	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"	"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 160.9;lymphoid tissue: 158.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.2;Kupffer cells: 456.0;Macrophages: 469.3;monocytes: 396.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 276.3;intermediate monocyte: 261.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 90.9;granulocytes: 110.5;monocytes: 276.3"	"Group enriched"	"Detected in some"	5	"Daudi: 52.8;NB-4: 64.2;REH: 54.6;RPMI-8226: 210.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051227	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA051227: AB_2681395"	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	40.5	28.4	5.5	158.9	5.3	160.9	15.2	6.5	5.5	12.3	12.4	22.3	19.3	9.3	4.3	8.9	9.9	26.2	8.0	4.7	9.1	8.0	27.5	91.5	97.1	15.1	9.6	6.9	4.0	4.4	2.5	54.6	13.3	6.7	30.6	1.7	7.0	9.7	3.7	2.2	22.3	55.5	12.5	89.0	17.2	4.7	11.1	18.3	5.3	5.5	73.2	46.8	2.3	24.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	52.8	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.4	3.6	0.6	0.0	0.0	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.1	64.2	0.2	0.0	0.3	54.6	0.0	210.4	0.0	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.1	20.0	0.0	0.0	0.1	0.1	0.2	0.6	1.6	3.4	0.0	8.9	0.0	2.2	276.3	110.5	0.4	261.6	0.5	39.6	0.3	0.4	62.8	32.8	0.3	0.2	19.2	0.6	237.1	90.9	0.9	162.5	5.5	5.3	6.5	5.5	4.7	9.1	15.1	9.6	13.3	12.5	11.1	24.0	2.4	25.6	25.4	0.7	99.9	1.0	0.1	0.0	0.6	0.1	1.0	3.0	11.0	2.8	13.0	1.8	0.0	0.9	82.7	2.0	0.0	0.0	0.6	0.2	0.1	8.1	0.0	5.2	1.6	0.4	1.1	4.4	4.1	0.1	7.6	0.1	5.0	3.2	157.2	1.7	1.6	0.7	0.0	456.0	25.0	0.7	0.6	469.3	1.8	76.8	396.6	0.1	14.4	0.0	0.1	0.1	0.5	0.0	13.6	0.0	0.6	0.5	7.3	0.7	13.1	1.6	1.2	0.0	0.6	1.9	1.3	1.8	7.5	0.0	1.3	0.1
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 94.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 136.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	14.3	22.0	23.9	38.8	23.5	94.3	13.6	17.9	18.2	13.0	22.3	16.3	16.1	15.1	12.1	23.3	11.0	20.5	20.1	17.3	23.3	14.2	21.0	21.5	53.4	21.3	27.8	15.4	15.2	23.0	15.4	15.4	23.6	16.3	19.3	22.0	18.9	16.0	34.3	15.2	16.2	16.8	21.6	39.0	19.9	38.3	32.7	35.6	24.9	20.5	48.4	24.1	12.9	24.2	26.9	8.3	9.4	10.6	14.3	21.0	8.7	39.1	56.7	39.9	23.4	6.9	12.5	30.7	13.7	38.3	43.4	10.3	11.3	23.7	58.7	136.6	16.6	15.5	15.3	5.8	29.1	15.4	69.5	23.0	18.6	48.1	50.1	37.7	16.3	21.3	6.6	26.1	56.4	4.0	14.4	22.3	10.1	8.5	13.3	13.4	18.8	29.4	12.9	9.1	12.0	9.2	33.1	11.2	9.8	14.3	11.0	18.9	18.6	67.2	15.4	23.4	15.9	68.0	68.4	33.2	49.3	16.7	14.7	64.6	15.2	38.3	18.1	17.7	21.8	17.2	27.1	24.5	18.3	11.1	24.4	19.4	32.3	25.7	18.8	11.0	37.3	19.5	23.9	23.5	17.9	18.2	17.3	23.3	21.3	27.8	23.6	21.6	32.7	24.2	28.8	44.8	31.8	31.6	87.7	120.1	59.5	32.2	40.9	89.2	35.5	26.0	34.4	21.5	32.9	18.4	93.8	6.8	84.1	28.3	5.9	20.0	48.2	22.5	24.9	36.0	31.1	26.1	51.9	19.1	4.4	37.3	22.4	47.1	80.5	21.4	27.8	25.5	21.5	67.3	54.7	10.7	30.5	40.0	127.6	31.3	25.4	66.4	74.7	57.1	63.7	23.3	70.0	51.8	119.2	18.0	22.4	21.1	79.7	66.4	15.4	13.9	23.3	48.3	6.6	54.2	30.5	59.2	15.2	64.3	155.6	4.1	119.5	21.3	14.8	66.7
CYRIB	"BM-009, CYRI, CYRI-B, FAM49B"	ENSG00000153310	"CYFIP related Rac1 interactor B"	Q9NUQ9	8	129839593-130017129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 198.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 117.7;dendritic cells: 66.2;Extravillous trophoblasts: 158.5;Hofbauer cells: 239.7;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009076	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1100000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA009076: AB_1848402"	"unprognostic (4.35e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.80e-2)"	"unprognostic (9.61e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.09e-10)"	"unprognostic (3.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-1)"	41.3	26.3	24.8	97.4	37.9	198.6	25.9	29.9	46.1	13.5	23.1	31.1	30.3	15.9	21.1	29.4	15.3	30.7	18.4	28.3	32.2	22.9	26.5	39.0	119.7	35.9	33.1	11.4	15.9	17.8	17.6	42.0	34.9	14.8	35.8	28.5	18.2	13.1	25.8	19.0	42.3	28.8	35.7	83.6	28.6	29.9	33.6	79.2	28.5	24.3	105.1	50.6	14.1	49.9	167.5	87.7	93.6	52.9	8.2	12.1	124.2	49.4	47.8	67.2	71.4	50.9	111.8	165.5	105.9	32.6	53.3	81.2	78.2	130.6	100.3	349.1	54.5	166.4	44.6	57.7	31.9	109.2	137.1	19.3	60.1	45.3	93.9	54.9	60.2	132.0	121.2	186.3	74.5	74.5	372.0	80.3	79.8	130.4	119.7	160.1	63.3	278.3	138.4	67.4	62.1	81.2	99.2	61.9	152.5	84.1	72.4	139.0	37.5	24.7	158.5	52.8	106.8	61.5	195.7	275.1	38.8	233.5	65.3	350.7	212.5	404.4	161.6	256.2	124.7	122.7	91.2	134.0	280.9	98.7	80.1	132.3	553.9	189.6	232.8	179.8	136.7	306.0	24.8	37.9	29.9	46.1	28.3	32.2	35.9	33.1	34.9	35.7	33.6	49.9	8.4	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	117.7	66.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	158.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	239.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	60.5	8.4	0.0	0.0	0.0
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956170-68985068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 589.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		40000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	55.9	27.9	7.9	52.7	8.8	103.5	36.2	8.9	9.3	22.0	7.7	26.5	25.5	25.2	13.4	40.3	24.0	32.4	21.9	7.4	9.7	30.0	42.1	31.5	50.0	10.8	10.1	20.1	45.7	24.5	12.9	38.0	11.0	19.0	32.0	8.1	20.5	17.5	47.9	30.1	21.8	28.4	10.7	30.2	26.4	22.5	8.8	33.6	25.1	26.9	51.0	81.7	23.5	11.3	194.4	112.5	64.5	199.7	56.7	74.4	135.6	129.8	104.3	163.8	138.3	366.7	128.8	289.5	77.8	108.2	77.2	168.1	250.4	161.8	217.5	90.7	176.1	203.2	76.9	153.3	121.2	488.9	184.7	76.8	205.2	196.2	324.5	76.1	121.3	106.8	393.8	140.5	116.8	88.1	192.9	106.1	176.3	91.8	236.8	170.1	105.3	143.0	108.2	102.7	132.5	141.6	116.6	254.8	155.5	76.8	144.9	101.1	125.6	95.5	136.0	129.8	230.7	160.4	228.2	418.2	79.3	362.4	66.5	7.6	10.9	20.4	8.7	17.1	15.9	14.0	11.4	11.8	13.0	12.3	10.6	11.8	4.9	9.4	21.2	12.1	9.2	7.5	7.9	8.8	8.9	9.3	7.4	9.7	10.8	10.1	11.0	10.7	8.8	11.3	199.4	102.5	141.6	8.1	243.7	550.2	346.2	103.8	174.2	25.9	159.9	113.7	74.2	94.4	144.1	71.7	41.7	80.8	139.5	134.0	72.4	141.2	50.8	116.7	260.7	196.7	86.7	98.6	18.5	187.8	151.8	162.2	120.8	201.8	168.5	57.1	104.2	215.3	112.4	25.2	16.0	202.7	67.1	154.5	266.8	19.7	89.5	199.1	124.5	12.2	138.1	25.8	64.9	13.6	18.2	222.9	77.7	77.1	148.9	465.3	59.9	128.2	72.8	29.8	26.3	302.6	174.9	105.5	114.8	224.8	589.7	137.5	159.6	99.4	210.7	375.5
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3 Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 275.5;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 31.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 153.7;HEL: 156.8;U-266/84: 133.1;U-698: 112.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favorable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	29.0	26.1	2.8	15.2	2.9	96.0	20.7	5.5	31.8	0.0	6.6	25.8	12.0	0.0	26.8	18.5	0.0	18.7	19.1	2.7	5.5	23.7	22.0	27.4	9.6	2.8	3.3	0.1	14.8	12.4	25.1	22.1	3.2	33.6	24.0	23.6	18.5	31.3	19.9	20.2	25.9	0.0	2.3	26.5	19.8	70.1	3.8	0.0	22.0	28.1	23.6	22.0	0.0	4.6	0.7	28.3	0.0	0.0	0.0	0.0	20.0	69.3	49.9	35.9	44.0	0.2	0.0	153.7	0.1	69.5	0.0	0.0	0.0	0.0	63.2	38.8	0.0	156.8	0.0	46.5	34.2	0.1	0.1	37.4	43.4	0.0	0.0	0.0	0.0	15.2	0.2	0.1	43.1	0.2	61.8	0.2	27.1	0.0	0.0	0.0	18.0	28.2	38.2	41.5	44.5	0.1	0.1	0.2	51.4	43.5	0.0	36.5	49.1	55.0	0.3	0.1	45.8	78.7	133.1	112.8	6.9	0.1	0.0	1.5	3.8	3.2	4.4	3.9	4.0	3.2	3.3	3.7	4.9	2.7	3.9	3.5	3.5	3.4	2.4	1.4	3.0	3.2	2.8	2.9	5.5	31.8	2.7	5.5	2.8	3.3	3.2	2.3	3.8	4.6	0.1	48.1	75.8	10.1	58.0	94.1	92.7	37.5	89.4	53.8	0.0	0.0	26.0	10.0	41.2	9.2	41.7	38.3	13.3	5.6	5.9	13.9	275.5	0.0	0.0	56.5	16.0	24.6	19.7	0.2	18.9	63.4	56.1	0.0	92.9	0.0	42.1	9.1	20.1	42.1	15.7	9.3	10.2	64.1	127.5	575.3	38.8	58.2	26.6	5.6	27.8	53.7	26.8	4.0	5.7	5.0	8.8	39.5	54.7	70.8	10.5	13.9	101.2	49.3	19.7	56.2	39.2	67.2	70.1	43.8	80.4	37.8	66.2	0.0	8.1	75.0
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.8"	"Group enriched"	"Detected in all"	4	"granulocytes: 32.8;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 44.0"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: AB_2682838"	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	6.9	2.8	2.9	15.8	3.1	51.1	5.8	2.4	4.4	6.6	3.5	9.1	8.7	6.7	2.1	3.2	5.4	9.2	3.5	2.4	5.0	2.2	8.2	10.1	9.6	9.6	3.9	5.3	3.1	3.0	0.4	20.7	5.5	3.8	9.0	6.3	9.0	3.2	1.0	3.0	11.0	7.4	9.3	12.8	13.5	2.2	7.8	15.5	3.5	3.6	7.3	5.9	0.7	5.7	12.3	7.1	2.7	1.1	6.9	19.9	13.3	12.0	25.3	44.0	30.4	0.1	28.0	0.2	0.6	12.2	23.9	4.7	1.2	7.3	12.8	7.0	1.0	27.0	8.1	0.7	8.4	11.1	6.5	5.6	2.1	15.9	1.4	9.2	31.5	6.0	0.5	0.3	28.6	0.3	10.0	7.0	0.6	1.1	5.9	5.4	6.1	0.0	4.2	7.1	0.5	3.6	21.4	2.6	12.2	0.5	1.9	15.3	34.1	2.4	15.6	5.6	4.2	11.2	1.9	0.1	7.8	32.2	3.4	2.4	5.9	5.4	3.7	9.1	5.1	1.2	3.7	3.8	3.6	2.0	2.9	3.3	32.8	2.7	13.1	0.0	5.5	2.5	2.9	3.1	2.4	4.4	2.4	5.0	9.6	3.9	5.5	9.3	7.8	5.7	29.0	9.6	6.7	11.4	14.7	1.0	2.6	3.9	3.4	1.7	11.2	3.3	8.3	2.8	5.1	3.7	22.9	6.1	16.0	24.0	0.0	7.6	15.7	8.5	15.6	18.9	0.0	5.9	1.5	10.1	39.4	13.0	44.4	7.1	8.8	20.3	6.1	6.6	26.1	0.0	5.5	14.1	10.2	23.8	6.0	4.4	3.4	46.2	0.0	33.7	35.6	2.9	24.7	28.6	2.4	26.4	31.5	4.1	6.0	2.1	13.2	3.7	11.5	19.4	6.6	7.1	5.7	0.7	1.4	4.3	2.4	7.1	24.1	12.2	4.5	2.0
DENND1A	"FAM31A, FLJ21129, KIAA1608"	ENSG00000119522	"DENN domain containing 1A"	Q8TEH3	9	123379654-123930152	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 258.9;Excitatory neurons: 188.2;Inhibitory neurons: 175.8;Late spermatids: 88.5;Microglial cells: 178.0;Oligodendrocyte precursor cells: 165.4;Oligodendrocytes: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 12.1;granulocytes: 20.4;monocytes: 21.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020481			Approved	Vesicles,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA020481: AB_2092106"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.63e-2)"	"prognostic favorable (4.11e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.31e-2)"	8.5	8.3	8.2	10.3	8.3	27.0	7.1	2.7	10.3	7.9	6.8	10.6	11.3	8.3	4.6	7.7	8.7	7.2	7.3	8.1	6.2	11.4	10.8	6.9	9.0	5.6	6.0	7.9	6.2	11.9	10.2	11.3	4.9	7.7	9.6	10.3	6.1	7.6	8.4	6.9	12.6	9.9	4.8	14.2	6.9	9.5	6.4	7.1	10.8	4.8	6.2	7.6	6.5	5.7	29.0	16.7	14.7	28.0	9.8	15.3	68.3	27.4	41.0	22.9	19.6	23.0	12.5	23.1	5.5	22.3	30.1	15.9	12.6	19.9	22.2	9.8	9.7	10.9	39.1	17.1	13.2	13.2	7.0	14.2	17.6	18.9	32.2	8.0	20.6	21.8	30.3	17.2	18.7	16.5	15.8	19.1	29.4	33.1	25.2	24.3	14.4	19.5	11.4	10.1	31.1	25.3	22.1	14.4	16.9	9.6	19.8	32.8	9.7	24.5	9.4	28.9	14.6	26.0	21.7	16.0	20.6	25.9	16.5	20.4	21.1	4.3	1.8	14.6	0.9	1.7	1.3	0.8	12.1	1.8	0.8	1.0	12.8	0.8	12.8	1.9	0.6	5.3	8.2	8.3	2.7	10.3	8.1	6.2	5.6	6.0	4.9	4.8	6.4	5.7	6.4	0.0	1.5	258.9	10.0	5.1	2.6	2.5	1.8	16.1	4.8	4.3	7.7	7.2	1.7	16.5	16.7	10.0	6.8	25.3	5.9	4.3	35.1	5.0	8.2	10.5	12.0	20.2	188.2	5.1	32.2	7.6	20.9	3.9	4.5	8.8	7.5	14.5	18.0	32.0	175.8	7.6	2.0	21.4	8.2	88.5	14.6	18.7	3.6	178.0	18.7	11.6	5.2	165.4	145.2	6.1	9.5	11.3	13.1	5.3	18.3	16.0	2.9	13.1	0.0	6.7	5.9	3.8	1.4	3.8	2.8	8.8	5.3	4.5	7.8	3.9
DENND3	KIAA0870	ENSG00000105339	"DENN domain containing 3"	A2RUS2	8	141117278-141195808	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 106.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 157.0;Microglial cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 34.6;neutrophil: 39.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 39.8;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 64.6;HeLa: 89.5;U-937: 58.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024491, HPA041668"		Approved	Approved	Vesicles,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"		"HPA024491: AB_2671581, HPA041668: "	"unprognostic (2.27e-1)"	"unprognostic (9.62e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.42e-2)"	42.8	8.9	21.7	27.2	18.8	106.4	28.2	12.2	28.4	22.9	14.7	36.2	5.7	17.8	2.1	7.5	19.1	13.6	24.9	19.9	17.7	21.5	6.5	57.9	28.6	33.6	24.7	15.1	7.6	4.1	10.0	15.1	25.7	16.9	7.8	3.7	18.2	8.5	13.8	15.6	23.7	8.3	22.7	43.9	15.8	6.1	21.2	7.1	20.6	11.7	25.1	12.4	17.6	31.4	16.4	14.8	1.0	3.1	4.4	6.4	2.4	8.5	27.4	3.8	3.0	4.6	15.3	4.2	22.8	17.5	7.5	7.8	4.2	10.0	2.7	64.6	3.6	17.3	89.5	1.4	3.9	17.2	2.4	0.5	5.1	4.2	5.3	9.2	21.1	7.8	0.2	40.7	2.9	5.2	2.6	24.1	1.1	3.2	16.6	2.9	0.8	16.6	14.8	5.6	4.7	3.0	1.8	1.3	1.1	7.3	6.8	27.6	16.7	0.7	6.8	10.6	0.3	8.0	37.0	1.3	2.6	58.6	1.0	24.3	5.4	34.6	0.8	8.0	0.8	5.0	0.6	0.3	4.1	4.3	0.1	0.2	39.8	2.7	10.0	0.1	0.2	3.5	21.7	18.8	12.2	28.4	19.9	17.7	33.6	24.7	25.7	22.7	21.2	31.4	49.0	157.0	35.2	2.6	39.7	15.7	7.6	11.7	7.4	4.5	6.3	2.0	10.1	10.0	18.8	22.0	4.2	0.7	29.5	18.3	1.9	3.5	6.1	15.1	8.1	31.7	4.8	5.7	53.9	3.5	0.6	4.8	16.8	14.5	10.8	1.9	16.4	0.3	24.4	1.7	5.2	7.9	4.1	55.6	22.2	2.8	1.5	39.7	8.8	79.6	33.0	0.7	21.6	1.5	1.1	11.0	9.9	0.7	38.8	20.3	1.5	2.7	15.1	0.5	39.5	2.1	21.5	8.7	8.5	2.9	9.1	0.5	12.5	0.6	4.1	6.3
DNAH1	"DNAHC1, HDHC7, HL-11, HL11, XLHSRF-1"	ENSG00000114841	"Dynein axonemal heavy chain 1"	Q9P2D7	3	52316319-52400491	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 21.5;Respiratory ciliated cells: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"midbrain: 3.4"	"HPA036805, HPA036806"	Uncertain					NA	NA				"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036805: AB_10670924, HPA036806: AB_10670849"	"unprognostic (8.34e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.60e-4)"	"unprognostic (1.54e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.59e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.84e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.80e-5)"	2.1	1.4	0.2	2.1	0.7	6.2	1.7	0.0	1.1	1.4	2.1	1.4	1.3	1.5	1.3	1.3	4.0	1.6	1.0	0.3	0.5	1.5	2.4	2.4	3.1	1.3	1.7	1.9	1.5	1.4	1.8	1.0	0.8	1.6	1.3	2.5	1.5	0.7	1.1	1.7	2.9	1.7	0.3	2.9	1.6	4.1	0.6	1.9	1.5	0.5	2.4	1.1	1.1	1.8	0.1	0.7	1.0	1.0	1.2	4.6	0.5	0.6	1.0	0.2	0.2	0.0	0.6	0.3	0.6	0.8	0.1	0.1	0.0	0.2	0.4	0.8	1.4	2.0	0.1	0.2	0.6	1.5	1.3	2.0	0.3	0.8	1.0	2.1	0.8	0.8	0.2	1.7	0.8	0.2	0.4	1.4	0.5	0.1	0.9	0.7	0.0	0.6	0.3	0.8	0.1	0.5	1.0	0.1	0.7	0.3	0.2	2.4	1.0	0.3	0.2	0.9	0.2	1.8	1.8	0.5	0.3	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	1.1	0.3	0.5	1.3	1.7	0.8	0.3	0.6	1.8	2.2	6.4	3.7	9.1	3.2	0.5	0.4	2.0	0.6	1.8	1.7	1.8	4.4	0.0	2.7	0.0	4.2	0.6	3.1	2.3	0.0	0.3	9.7	6.9	1.6	2.1	5.4	2.7	13.8	0.6	0.2	1.2	8.2	3.8	3.8	3.2	2.2	3.9	1.2	5.0	10.0	2.6	8.2	3.5	1.6	21.5	1.2	3.2	1.8	3.7	3.4	0.9	4.1	2.5	10.7	0.3	2.1	0.4	2.4	0.9	4.8	0.9	35.5	5.2	0.0	1.4	1.9	6.9	1.5	1.1	0.3	0.8	3.3	1.7	2.2	0.6
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 112.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 5.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA014764	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA014764: AB_1856587"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	27.8	10.7	3.6	26.8	4.5	18.4	18.3	3.9	4.4	13.8	10.4	7.7	6.4	10.5	8.3	13.7	14.6	14.9	12.4	3.2	4.3	8.6	11.3	15.3	16.4	7.0	5.8	13.8	3.8	11.1	6.0	23.1	5.6	8.5	8.0	3.5	6.9	10.2	6.9	13.8	9.0	15.0	4.6	18.6	6.4	6.1	8.5	10.3	6.6	10.7	9.7	19.7	14.3	5.9	32.7	7.0	23.6	22.2	62.0	40.7	26.5	37.6	88.2	46.4	67.4	0.2	8.9	0.9	3.3	66.3	46.4	60.8	3.3	88.7	60.1	33.9	14.6	2.2	9.8	0.3	69.0	1.5	1.7	86.8	37.4	51.5	50.0	24.0	27.7	8.3	0.8	14.4	22.4	1.0	4.4	1.8	12.7	0.2	1.8	5.6	21.6	15.6	30.4	2.2	7.8	5.9	36.4	0.1	0.8	16.2	0.3	3.9	10.5	46.4	13.4	11.8	30.6	3.1	1.1	1.6	24.6	4.0	5.5	0.4	2.0	0.1	0.6	2.5	0.3	2.0	0.5	0.3	5.9	2.1	0.6	0.3	1.6	0.1	1.6	2.7	0.1	0.8	3.6	4.5	3.9	4.4	3.2	4.3	7.0	5.8	5.6	4.6	8.5	5.9	9.4	16.0	4.1	64.9	15.4	52.0	26.4	42.2	78.6	6.3	7.4	10.7	8.3	2.8	20.7	3.7	0.0	2.9	16.5	0.3	7.9	4.8	52.2	11.0	21.9	15.4	1.2	11.4	46.8	8.5	7.0	73.7	3.6	3.1	22.8	100.9	56.4	5.7	39.8	1.7	48.9	0.6	8.2	83.6	77.1	24.9	55.0	112.2	10.6	51.5	79.4	3.4	5.2	73.4	86.4	13.6	0.4	30.1	8.9	32.0	0.4	7.7	30.3	3.0	32.9	16.4	33.4	6.1	5.5	76.6	39.9	4.9	14.0	17.2	1.0	51.0
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347235-89352501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 226.2"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 246.8;granulocytes: 456.9;Kupffer cells: 266.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 97.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1636.7"	"Group enriched"	"Detected in all"	13	"granulocytes: 1636.7;monocytes: 842.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 427.6;NB-4: 325.8;SK-MEL-30: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	113.9	24.7	12.0	63.7	12.9	178.7	50.8	10.0	28.5	39.4	29.8	47.3	24.8	26.2	14.2	34.8	36.6	75.5	30.9	19.8	11.6	58.9	143.3	88.2	42.3	12.6	12.1	14.2	17.9	34.6	17.8	74.1	12.4	18.8	56.1	6.8	226.2	22.9	8.5	17.4	52.1	43.2	12.7	71.0	28.7	6.9	16.0	47.7	77.4	40.2	27.2	76.4	13.8	13.6	6.4	6.2	127.0	427.6	108.1	89.9	0.2	47.5	58.3	9.5	6.8	38.7	6.8	0.0	11.2	20.5	17.9	51.4	0.5	118.4	13.0	0.5	0.8	20.0	1.4	61.4	75.7	86.3	210.9	18.4	40.4	81.5	75.5	94.9	214.4	2.6	0.0	20.4	29.3	3.1	2.9	325.8	78.7	149.5	102.7	216.6	15.5	8.3	129.3	129.7	2.4	88.7	1.1	0.6	253.0	43.3	6.4	46.8	59.0	30.6	0.8	5.8	22.8	3.7	18.5	0.5	126.5	60.0	200.3	1636.7	558.9	247.2	9.8	842.3	4.5	2.7	2.7	3.5	97.0	11.6	1.6	3.2	230.5	14.8	841.0	12.2	6.7	455.2	12.0	12.9	10.0	28.5	19.8	11.6	12.6	12.1	12.4	12.7	16.0	13.6	182.9	102.5	246.8	12.4	18.0	90.9	79.4	97.4	38.7	2.1	30.3	85.5	11.1	81.5	80.5	180.3	33.3	72.6	36.1	58.3	17.6	12.6	1.6	67.4	14.1	159.8	19.2	6.6	19.6	14.0	4.2	54.5	19.4	134.2	456.9	24.2	177.8	130.2	49.6	1.7	3.8	13.2	46.8	266.7	61.2	1.7	1.5	193.2	12.4	33.7	198.9	8.7	20.6	24.6	2.4	17.1	45.7	3.4	16.2	26.1	17.0	27.5	21.2	2.4	26.3	21.4	29.7	2.6	7.0	14.7	24.7	49.3	42.3	3.5	22.0	61.4
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401879-20493714	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: AB_2732448, HPA065012: AB_2685403"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	6.5	4.9	4.8	9.8	5.2	19.8	4.1	2.8	5.7	3.3	3.0	5.4	5.2	3.6	3.9	4.9	2.5	6.4	5.1	6.4	4.6	5.8	4.4	4.9	11.0	3.7	4.6	1.4	2.1	3.1	1.8	5.6	4.2	3.3	6.3	6.1	2.7	3.1	10.0	2.6	5.7	6.0	3.7	8.4	3.6	3.4	5.5	8.6	8.5	9.3	9.5	8.5	2.7	3.8	14.3	11.6	32.2	35.1	10.9	11.9	22.0	18.9	16.8	18.2	19.9	14.3	8.8	32.3	35.2	18.2	16.9	14.6	37.8	17.4	30.3	12.2	25.3	58.1	20.4	16.3	11.6	38.6	33.0	9.7	12.6	17.7	21.6	18.8	12.7	29.8	65.3	19.4	20.9	15.0	43.6	43.2	24.2	11.0	11.9	46.5	27.8	36.5	21.8	25.1	22.9	42.2	17.3	24.1	26.3	20.0	12.4	23.4	17.2	28.6	17.4	14.2	30.5	12.1	40.1	38.3	7.1	23.2	41.3	5.6	2.3	1.1	1.6	1.6	2.0	0.4	1.0	2.4	2.6	0.4	0.8	1.8	7.2	3.5	1.1	1.1	1.6	1.1	4.8	5.2	2.8	5.7	6.4	4.6	3.7	4.6	4.2	3.7	5.5	3.8	4.8	0.0	2.6	53.8	10.6	9.2	12.3	7.0	7.4	34.1	11.9	7.2	10.6	4.3	10.6	7.3	22.9	8.3	15.0	12.0	9.8	7.6	12.2	3.9	14.1	8.5	12.0	17.2	67.7	6.9	13.8	9.2	12.8	10.6	20.3	32.3	14.6	4.7	17.1	32.0	31.9	11.7	4.1	47.2	17.7	5.7	2.8	28.7	5.4	27.2	23.8	2.9	15.5	37.7	2.9	14.8	10.3	3.0	19.1	22.1	4.5	25.1	2.2	9.0	0.0	9.0	11.5	3.0	4.7	16.5	8.9	3.1	15.3	5.7	13.8	18.4
E2F4	E2F-4	ENSG00000205250	"E2F transcription factor 4"	Q16254	16	67192155-67198918	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054128			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA054128: AB_2682392"	"unprognostic (1.74e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.05e-3)"	"unprognostic (7.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-1)"	43.5	39.6	27.9	39.7	27.2	98.2	38.3	26.5	31.0	35.3	27.1	43.8	32.1	41.2	22.2	47.4	36.7	23.5	39.6	27.4	29.2	38.2	32.0	38.0	48.5	28.7	27.7	33.1	36.1	29.1	39.2	44.0	28.2	36.5	32.0	9.9	29.8	27.6	50.5	34.0	44.3	31.8	27.9	54.7	40.6	32.9	28.2	42.5	33.6	30.0	43.4	42.0	34.1	27.9	67.3	53.2	44.4	54.3	63.5	54.6	158.6	49.1	72.7	88.5	84.8	94.6	71.5	82.7	58.1	52.3	60.7	95.8	69.2	69.2	57.4	35.2	73.4	55.9	31.9	97.5	76.7	110.9	113.0	64.8	53.9	70.4	77.9	33.2	77.8	62.9	107.1	26.8	47.2	115.0	127.9	90.8	109.1	71.7	47.4	152.7	92.8	109.7	41.8	50.9	53.6	63.9	134.2	49.6	58.2	35.2	50.6	109.7	56.0	62.4	58.9	46.1	78.2	65.6	62.0	215.0	73.3	75.5	60.7	1.2	11.8	10.9	8.4	10.7	7.0	6.1	7.7	9.9	14.6	6.6	6.1	5.5	7.5	8.7	8.1	6.3	3.9	7.7	27.9	27.2	26.5	31.0	27.4	29.2	28.7	27.7	28.2	27.9	28.2	27.9	36.2	12.8	16.5	14.7	31.2	41.6	33.9	18.0	10.8	22.3	20.9	16.3	15.1	22.8	13.4	12.9	4.2	116.1	35.1	26.7	19.6	30.2	50.5	16.0	24.4	36.2	22.8	174.7	13.9	37.2	82.8	25.5	36.7	19.4	27.3	25.4	30.0	10.2	44.7	21.9	12.3	23.6	22.4	23.8	29.0	84.9	27.1	30.1	14.2	11.2	41.5	14.3	55.6	10.6	12.2	35.8	19.3	23.7	39.7	56.8	21.4	13.4	9.5	19.2	46.0	20.0	26.9	37.9	45.3	25.8	45.9	79.8	36.7	31.4	30.2	37.9
EHD1	"FLJ42622, FLJ44618, H-PAST, HPAST1, PAST1"	ENSG00000110047	"EH domain containing 1"	Q9H4M9	11	64851642-64888296	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 151.6;testis: 159.9"	"Group enriched"	"Detected in all"	10	"Early spermatids: 1033.0;Late spermatids: 1950.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751, HPA067747"	Approved		Supported	"Plasma membrane"		NA	NA		10000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713, HPA067747: AB_2685896"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (1.46e-3)"	"unprognostic (9.10e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.37e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.59e-2)"	39.7	25.4	21.5	59.7	26.6	151.6	21.8	38.6	32.6	26.2	18.2	32.3	33.8	28.1	8.4	26.0	27.0	25.0	39.3	24.9	26.8	31.2	22.0	44.7	65.6	32.7	28.2	13.6	11.1	8.9	7.0	35.4	29.9	18.8	14.5	3.0	16.6	20.9	32.1	34.4	38.5	28.3	31.0	74.4	29.3	159.9	30.5	28.9	19.3	31.5	50.3	55.3	23.0	33.4	109.4	74.1	26.2	28.9	31.2	50.2	15.4	108.2	97.4	89.5	51.8	96.5	66.2	142.0	37.8	129.9	76.5	86.6	27.3	108.9	34.5	89.5	15.2	94.8	37.1	49.1	36.8	30.9	24.6	22.8	22.9	138.7	43.2	40.6	89.8	27.6	39.6	243.8	68.7	57.8	62.5	51.4	17.5	27.5	95.9	24.8	83.5	49.9	84.5	35.7	18.6	16.6	60.8	109.3	48.6	29.5	149.2	21.8	127.9	39.6	35.4	106.0	52.6	100.2	48.5	112.1	103.3	40.1	22.0	18.0	13.9	99.6	39.0	16.1	39.2	24.0	27.3	33.8	7.2	18.2	16.2	23.1	57.1	25.4	33.7	8.7	31.8	30.7	21.5	26.6	38.6	32.6	24.9	26.8	32.7	28.2	29.9	31.0	30.5	33.4	31.2	76.9	30.3	4.2	46.0	67.3	52.8	39.4	17.6	3.8	28.8	24.8	29.2	18.6	22.9	14.7	2.1	88.6	76.5	75.9	7.9	29.4	1033.0	41.9	24.4	29.3	6.6	19.8	1.7	40.8	24.5	32.4	25.5	54.9	93.8	37.2	10.4	10.9	32.2	5.0	3.5	27.7	12.2	37.4	61.0	1950.6	30.1	79.6	26.6	1.9	34.3	5.9	78.2	2.5	12.2	101.5	47.7	27.1	50.8	28.2	38.9	41.9	16.5	2.8	78.9	47.9	53.5	55.0	27.4	19.9	49.2	137.0	71.7	19.8	22.1	42.7
EIF2AK2	"EIF2AK1, PKR, PPP1R83, PRKR"	ENSG00000055332	"Eukaryotic translation initiation factor 2 alpha kinase 2"	P19525	2	37099210-37157522	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003845, HPA019795, HPA063893"	Approved		Enhanced	Cytosol		NA	NA		44000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: AB_2685144"	"unprognostic (1.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-3)"	"unprognostic (8.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.65e-2)"	"unprognostic (5.32e-2)"	11.1	9.0	7.2	10.5	8.1	30.1	8.6	7.4	9.5	9.8	8.6	8.8	7.6	10.5	8.0	6.3	8.3	9.5	6.3	7.8	11.1	8.5	7.7	8.9	8.0	10.9	8.1	10.8	7.4	11.1	6.6	11.2	10.9	10.1	8.6	6.6	17.7	8.4	4.5	4.6	9.9	11.1	15.6	11.9	9.5	3.3	13.0	11.7	10.0	5.8	7.1	8.0	5.9	8.7	38.4	22.1	16.7	17.4	21.5	28.3	20.1	21.2	29.1	56.3	41.1	23.0	23.2	27.4	27.0	29.8	66.2	27.4	24.2	27.1	29.5	45.7	12.0	33.8	19.2	18.7	17.9	32.2	0.2	22.5	13.1	23.7	19.3	17.7	18.0	10.7	19.1	23.6	20.3	13.4	35.5	17.0	15.8	8.4	10.8	27.6	40.9	12.1	15.3	18.7	14.1	20.4	32.0	24.0	50.7	12.7	9.2	9.0	31.4	25.7	24.9	15.1	36.2	19.0	30.8	0.3	15.9	20.0	23.1	10.7	5.3	6.3	5.4	7.9	5.2	5.3	4.5	5.2	4.8	4.2	3.0	4.3	15.7	6.5	8.0	3.1	6.5	2.1	7.2	8.1	7.4	9.5	7.8	11.1	10.9	8.1	10.9	15.6	13.0	8.7	94.5	67.3	34.0	25.1	35.9	19.5	42.3	33.0	31.3	38.8	26.6	26.0	29.9	32.9	46.0	22.0	14.6	47.8	44.8	32.2	21.5	40.2	2.4	55.8	68.7	76.3	15.0	36.0	39.6	48.5	89.2	52.6	22.4	41.7	41.1	93.5	33.5	21.9	38.2	47.1	42.9	24.0	16.2	29.9	20.8	4.2	57.2	50.7	21.4	48.7	47.1	50.9	45.3	51.3	16.8	54.7	21.8	84.2	46.0	39.5	33.6	33.0	48.9	24.8	39.5	60.5	45.9	2.4	5.5	22.5	10.1	40.8	40.0	61.3	28.6	40.5
ELF4	"ELFR, MEF"	ENSG00000102034	"E74 like ETS transcription factor 4"	Q99607	X	130063955-130110716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 34.3;Granulosa cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058595, HPA060277"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	Nucleoplasm	"HPA058595: AB_2683768, HPA060277: AB_2684239"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.43e-3)"	"unprognostic (7.86e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (1.43e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.42e-4)"	12.2	3.7	1.8	14.6	1.6	53.1	9.6	2.8	2.0	9.4	2.6	18.1	14.2	10.6	2.0	11.7	12.1	9.3	5.6	1.8	2.4	6.0	2.8	15.9	18.3	2.8	2.4	17.5	2.6	4.8	4.2	23.7	2.4	6.1	17.7	0.6	5.5	4.1	2.0	10.9	17.0	10.6	1.5	18.1	20.3	2.6	2.9	19.6	3.9	3.6	18.0	18.8	9.1	3.1	56.0	20.7	3.7	0.4	9.1	19.3	52.6	25.3	32.1	30.4	33.4	28.7	38.9	28.6	49.5	34.8	42.3	35.2	20.5	30.0	29.9	31.0	16.8	56.7	27.3	13.6	20.2	49.7	69.3	20.4	32.6	49.1	48.0	19.0	30.0	6.5	22.0	7.7	16.5	32.8	8.2	28.2	2.4	28.4	19.4	17.6	6.5	12.2	18.3	63.9	13.6	6.0	22.8	21.9	6.9	19.1	11.0	46.9	27.6	21.2	16.6	39.5	47.7	4.2	1.8	22.6	24.6	44.8	5.0	1.6	4.0	5.8	7.1	7.6	5.6	2.6	4.2	6.1	4.5	2.7	4.2	4.8	6.9	6.5	5.5	2.7	4.8	4.2	1.8	1.6	2.8	2.0	1.8	2.4	2.8	2.4	2.4	1.5	2.9	3.1	10.7	9.6	4.4	0.0	8.0	13.6	8.2	2.9	9.1	0.0	2.1	1.5	0.8	0.0	4.4	0.0	0.0	10.6	12.2	24.1	0.0	2.3	0.1	8.9	3.8	8.4	9.0	7.4	0.2	4.0	34.3	6.4	17.9	17.1	1.3	27.5	6.4	1.0	9.7	0.0	0.3	8.3	2.0	12.2	9.2	0.6	1.8	14.8	3.6	5.6	13.1	0.0	16.5	0.0	1.2	9.1	17.4	1.2	2.0	7.5	11.6	0.3	5.4	0.0	6.6	2.6	2.5	0.0	4.0	6.5	10.4	11.2	9.5	5.2	7.1	18.9
EMP3	YMP	ENSG00000142227	"Epithelial membrane protein 3"	P54852	19	48321509-48330553	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 2037.4;Macrophages: 699.2;Melanocytes: 1117.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 195.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 1472.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062030			Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Plasma membrane"		"HPA062030: "	"unprognostic (5.06e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.31e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.31e-7)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-3)"	107.7	85.6	37.6	115.8	37.4	325.1	68.8	37.9	41.0	149.6	36.9	166.7	36.9	143.9	60.7	37.1	96.2	72.5	100.9	38.6	53.8	51.8	29.1	141.0	86.1	52.1	43.9	110.8	18.4	17.1	21.4	67.1	46.9	61.3	65.5	9.2	41.8	90.1	21.7	61.6	81.6	202.9	44.2	91.8	65.3	33.5	43.7	45.2	43.2	43.7	94.7	132.8	106.9	48.4	73.8	739.3	44.9	127.1	691.3	1081.5	1.2	490.7	898.0	627.6	560.7	73.5	265.0	6.9	107.5	1101.0	296.4	12.1	45.5	54.6	390.4	241.3	20.5	335.0	192.0	43.3	572.4	160.2	338.9	586.1	12.2	635.3	436.3	455.5	277.9	66.1	237.4	616.1	1019.5	10.1	25.1	1472.4	55.4	12.1	196.9	22.1	150.1	355.7	554.6	0.4	1.8	2.0	225.2	1.2	131.2	77.2	2.7	253.1	456.6	574.7	236.5	435.8	388.1	287.6	426.6	20.1	339.2	232.5	402.5	2401.3	980.4	1402.3	1324.0	1173.0	1117.1	570.1	1425.3	1327.0	688.7	467.9	818.8	948.4	1094.0	854.5	1148.4	516.9	1631.4	1971.4	37.6	37.4	37.9	41.0	38.6	53.8	52.1	43.9	46.9	44.2	43.7	48.4	66.5	0.0	4.5	5.5	338.0	278.0	75.4	161.0	48.3	2.3	14.7	22.9	5.4	21.5	21.8	33.1	0.0	14.9	375.9	1.5	5.9	72.0	6.5	18.9	255.1	118.6	6.0	94.8	0.2	11.2	26.0	371.3	23.0	15.1	257.0	8.5	128.2	7.2	589.0	0.0	0.3	4.1	42.7	458.8	2037.4	21.3	335.5	699.2	1117.1	6.5	444.5	64.6	565.4	0.0	0.7	114.3	28.2	217.0	334.9	285.5	1.7	9.3	14.6	5.0	105.2	193.0	278.7	16.2	6.7	10.6	189.9	20.2	441.4	29.1	4.9	44.4
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.9;Langerhans cells: 43.2;Microglial cells: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	9.1	3.9	8.1	10.5	9.7	21.2	10.7	5.1	9.2	7.4	0.1	13.3	11.0	6.5	4.2	6.0	5.1	14.7	6.6	9.4	8.6	3.2	4.9	7.8	9.0	4.1	6.8	5.3	3.8	7.5	3.8	5.9	8.1	6.3	14.6	3.6	13.7	7.8	1.3	3.7	11.2	8.8	3.0	8.8	7.6	8.6	5.6	8.7	3.5	6.0	8.2	16.4	4.4	5.0	6.9	4.9	9.7	5.2	17.0	10.2	6.4	4.0	5.4	6.1	10.3	1.8	6.8	7.6	3.6	10.4	6.3	13.1	33.2	1.4	7.8	5.1	4.8	10.6	35.8	0.8	4.3	14.0	19.8	5.5	1.4	9.0	0.5	12.3	4.0	12.5	26.3	41.2	14.4	28.4	9.0	10.0	7.6	16.2	24.6	20.8	24.5	1.6	1.7	7.9	31.4	9.3	15.9	27.4	8.3	6.8	5.8	22.5	0.7	9.8	18.4	8.6	15.5	7.6	1.9	7.1	14.4	10.8	5.3	2.9	0.4	0.4	0.3	0.9	0.2	0.3	0.3	0.4	1.0	0.3	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.1	8.1	9.7	5.1	9.2	9.4	8.6	4.1	6.8	8.1	3.0	5.6	5.0	5.9	0.0	2.2	12.1	6.1	6.1	2.3	1.0	4.6	3.9	10.1	7.2	1.9	10.0	2.2	1.8	0.0	2.4	17.2	15.6	1.9	2.7	15.3	2.1	7.8	5.5	7.2	3.8	54.9	6.1	2.7	16.3	6.6	5.2	7.6	3.6	8.2	1.2	9.7	0.0	27.9	8.1	0.0	25.1	43.2	6.9	14.3	27.5	5.4	52.5	15.2	1.2	11.3	25.1	7.2	4.5	10.5	20.7	11.9	1.9	4.5	1.0	1.8	1.1	0.0	3.2	6.5	4.4	6.4	6.5	3.7	3.4	16.4	36.2	13.8	4.6
FAM160B1	"bA106M7.3, KIAA1600"	ENSG00000151553	"Family with sequence similarity 160 member B1"	Q5W0V3	10	114821744-114899832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043624	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA043624: AB_10797145"	"unprognostic (2.61e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.45e-3)"	"unprognostic (6.43e-2)"	"unprognostic (9.87e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (3.41e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.25e-2)"	15.0	11.7	8.7	10.0	8.4	53.3	11.9	6.1	8.4	12.1	6.1	10.7	12.7	16.0	10.0	7.3	12.3	10.5	14.2	7.8	6.5	7.9	19.0	11.6	12.6	5.6	6.5	14.3	9.8	11.9	7.4	14.9	6.1	10.5	8.1	11.5	8.5	11.3	20.3	8.6	13.2	16.9	5.3	11.4	10.1	18.8	6.9	11.2	11.7	12.3	9.6	11.9	10.0	5.2	16.7	8.9	9.6	14.3	22.9	26.0	11.2	29.7	28.8	16.8	13.4	3.1	6.3	9.9	9.1	27.2	4.3	11.0	4.7	11.9	19.8	36.2	10.2	3.9	16.5	7.2	16.7	10.6	12.8	20.4	11.3	12.5	20.2	36.0	22.9	20.0	5.6	24.4	31.7	7.7	19.0	10.5	6.3	4.8	6.6	16.3	16.3	6.6	11.3	9.9	2.1	8.6	13.2	13.6	15.5	11.3	5.4	6.0	23.1	10.4	6.6	30.7	10.4	10.0	3.0	11.2	13.4	26.0	10.0	19.9	3.2	4.7	5.4	2.4	4.0	3.7	7.4	9.2	3.6	3.6	4.0	5.5	15.2	4.9	2.8	3.7	10.5	2.7	8.7	8.4	6.1	8.4	7.8	6.5	5.6	6.5	6.1	5.3	6.9	5.2	25.9	16.0	8.1	20.5	10.9	7.0	7.9	8.0	14.8	13.9	9.4	6.7	19.5	4.3	8.4	3.7	12.5	12.7	14.1	9.0	1.9	10.2	26.7	12.0	26.2	19.8	7.8	9.9	26.5	9.6	10.2	19.2	23.0	16.8	2.5	29.6	23.9	31.3	6.3	10.1	27.4	9.2	4.1	15.6	6.8	36.0	28.6	11.3	3.6	25.3	11.4	8.3	25.7	28.1	13.8	15.1	3.7	22.2	20.1	19.5	20.8	6.6	8.7	16.9	6.6	13.2	14.4	14.9	6.4	8.9	4.8	12.6	17.5	15.0	5.8	14.8
FCAR	CD89	ENSG00000186431	"Fc fragment of IgA receptor"	P24071	19	54874235-54891420	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"IgA-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 26.1;lung: 10.5;lymphoid tissue: 13.5"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 12.8;Macrophages: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.2;neutrophil: 4.0"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.0;monocytes: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA014050	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA014050: AB_1846338"	"unprognostic (1.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.19e-6)"	"unprognostic (9.23e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.04e-3)"	"unprognostic (9.81e-2)"	4.5	0.3	0.0	1.0	0.0	26.1	0.7	0.0	0.3	0.2	0.0	0.6	0.0	0.2	0.0	0.3	3.4	0.0	1.5	0.0	0.0	0.5	1.7	10.5	0.0	0.1	0.0	0.3	0.2	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.4	0.1	0.4	0.1	0.0	13.5	0.8	0.1	0.0	0.0	0.5	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.1	0.3	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	12.8	0.3	0.0	0.0	18.0	0.0	1.0	2.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.7	0.5	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.1
FCER1G		ENSG00000158869	"Fc fragment of IgE receptor Ig"	P30273	1	161215234-161220699	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 441.6;lymphoid tissue: 470.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 726.6;granulocytes: 705.6;Hofbauer cells: 2318.6;Kupffer cells: 1950.8;Langerhans cells: 1526.3;Macrophages: 1971.3;monocytes: 808.9;NK-cells: 1037.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	11	"basophil: 1987.3;classical monocyte: 3240.2;intermediate monocyte: 5333.6;myeloid DC: 2386.3;neutrophil: 1831.0;NK-cell: 1750.9;non-classical monocyte: 6984.5;plasmacytoid DC: 3315.6"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HEL: 77.8;HMC-1: 301.7;THP-1: 276.1;U-266/84: 90.1;U-937: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022108, HPA026872"	Supported					NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB022108: , HPA026872: AB_1848473"	"unprognostic (3.71e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.87e-2)"	251.7	86.5	34.0	275.6	33.8	441.6	62.9	35.5	66.0	52.5	47.5	82.7	44.9	30.7	38.7	30.6	72.0	101.5	53.1	33.7	42.0	40.3	177.3	286.6	160.9	53.4	48.7	19.9	22.3	26.8	26.9	211.0	50.1	31.0	113.2	8.3	42.9	38.8	11.9	21.0	60.6	160.3	41.5	470.1	39.4	14.5	49.9	62.7	25.5	34.6	82.5	254.6	21.7	65.4	0.2	0.0	0.7	1.3	1.8	0.7	0.4	0.5	0.2	0.5	0.8	2.2	0.1	0.5	0.7	0.0	0.3	0.2	0.5	0.0	0.4	0.3	1.5	77.8	0.6	14.0	0.3	16.1	301.7	6.0	3.3	2.3	0.2	0.7	0.4	1.8	0.1	7.3	2.4	0.5	1.4	37.9	1.6	0.0	0.0	0.1	6.7	0.2	0.5	0.4	0.3	1.0	0.6	0.1	2.7	1.4	0.2	276.1	0.4	1.8	0.4	0.9	1.1	3.0	90.1	0.9	1.7	87.1	0.5	1987.3	3240.2	307.3	13.6	5333.6	15.9	28.2	10.6	10.6	2386.3	9.0	17.3	45.0	1831.0	1750.9	6984.5	3315.6	21.8	4265.5	34.0	33.8	35.5	66.0	33.7	42.0	53.4	48.7	50.1	41.5	49.9	65.4	12.8	86.6	147.7	0.7	35.9	39.6	1.5	0.2	1.8	0.1	5.2	22.1	6.8	15.7	27.3	18.4	0.0	14.5	726.6	1.0	0.0	1.9	3.0	1.0	0.9	38.6	1.8	79.3	0.1	1.0	18.8	18.3	1.1	1.0	705.6	0.5	41.0	13.6	2318.6	0.0	0.2	0.5	0.0	1950.8	1526.3	9.4	5.3	1971.3	80.0	12.2	808.9	0.2	1037.1	0.0	0.1	1.0	1.4	1.2	10.1	1.3	0.4	5.4	15.3	2.3	72.3	3.8	11.2	1.0	2.5	1.4	35.9	23.7	133.3	0.4	0.6	1.8
FCN1	FCNM	ENSG00000085265	"Ficolin 1"	O00602	9	134903232-134917912	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 158.9;lung: 46.2;lymphoid tissue: 96.3"	"Group enriched"	"Detected in many"	10	"Kupffer cells: 504.4;Macrophages: 542.4;monocytes: 1017.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1699.8;intermediate monocyte: 1195.1"	"Lineage enhanced"	"Detected in all"		"monocytes: 1699.8"	"Group enriched"	"Detected in some"	5	"NB-4: 4.7;U-937: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000685, HPA001295, CAB016760"	Enhanced				"Secreted to blood"	NA	NA	1060000000	36000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842"	"unprognostic (1.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.66e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.73e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.28e-1)"	15.9	1.4	0.6	47.7	0.5	158.9	5.1	0.8	0.7	2.0	0.5	3.2	0.5	1.5	0.0	1.6	6.4	3.9	5.1	0.5	0.3	4.1	7.2	46.2	3.2	0.5	0.5	1.0	2.5	0.1	1.0	2.4	0.6	2.3	1.6	0.1	2.8	0.5	1.6	1.2	2.8	12.1	0.2	96.3	3.7	0.7	0.7	2.4	2.2	1.1	1.3	10.1	2.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.1	0.0	7.2	0.1	9.3	1699.8	18.0	2.9	1195.1	3.5	5.9	1.4	1.6	492.6	1.5	1.7	1.6	277.1	2.8	582.2	13.0	2.1	1796.8	0.6	0.5	0.8	0.7	0.5	0.3	0.5	0.5	0.6	0.2	0.7	0.5	2.1	6.4	17.1	0.0	6.6	1.9	0.2	0.0	0.0	0.0	0.3	0.0	2.6	1.5	5.0	1.8	0.0	0.8	6.0	0.1	0.0	0.0	0.1	0.2	0.2	2.7	0.0	5.2	0.0	0.0	1.5	3.6	1.5	0.1	12.6	0.1	3.9	2.6	68.4	0.0	0.0	0.0	0.0	504.4	68.3	0.0	0.0	542.4	0.0	0.0	1017.8	0.0	27.8	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	2.1	0.7	0.0	0.0	1.0	0.5	0.0	0.1	0.2	0.4	1.1	6.1	0.3	0.0	0.2
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 207.8;lung: 86.5;lymphoid tissue: 141.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 182.2;Langerhans cells: 63.8;Macrophages: 155.9;monocytes: 159.7;NK-cells: 259.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Daudi: 86.0;U-266/70: 153.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	25.0	6.8	12.8	62.2	11.9	207.8	16.0	11.9	19.1	7.6	11.5	6.0	3.9	8.1	1.7	5.2	15.6	12.7	8.7	11.4	12.3	7.5	10.8	86.5	27.5	13.6	12.7	2.9	5.8	1.6	2.7	7.9	14.5	7.2	4.0	0.7	6.6	2.4	3.2	4.5	10.1	16.3	12.5	141.1	5.9	2.5	17.2	8.4	7.4	6.5	20.0	17.8	7.3	12.6	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1.7	29.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	3.8	5.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	153.1	2.1	6.5	0.0	19.5	0.0	30.8	381.4	229.4	189.5	469.1	11.3	54.0	15.8	89.1	196.1	84.0	8.0	78.4	272.9	264.5	405.2	9.0	1.2	494.1	12.8	11.9	11.9	19.1	11.4	12.3	13.6	12.7	14.5	12.5	17.2	12.6	8.6	6.4	20.0	0.0	24.9	2.8	0.6	0.2	0.0	0.0	0.4	0.6	1.6	1.5	5.7	1.8	0.0	0.5	55.2	0.0	0.0	0.0	0.3	0.1	0.2	14.9	0.0	7.4	0.2	0.2	0.7	2.7	1.5	0.1	13.3	0.1	6.8	1.9	56.8	0.0	0.1	0.0	0.0	182.2	63.8	0.7	0.3	155.9	1.8	6.5	159.7	0.1	259.5	1.0	0.4	0.0	1.2	0.0	4.2	0.4	0.0	0.7	1.5	0.0	0.0	0.7	0.6	0.2	0.5	0.5	1.1	1.0	28.0	0.0	0.0	2.5
FLOT2	"ECS-1, ECS1, ESA, ESA1, M17S1"	ENSG00000132589	"Flotillin 2"	Q14254	17	28879335-28897733	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001396, CAB004395, HPA071038"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		170000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: "	"unprognostic (6.04e-2)"	"unprognostic (8.76e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.15e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.20e-2)"	60.2	46.4	38.4	56.8	38.6	97.1	56.2	28.1	47.6	42.8	45.2	58.9	21.0	39.1	21.2	69.3	46.8	27.0	63.5	41.1	42.5	71.4	98.4	59.5	68.2	45.9	37.1	37.7	38.8	30.0	22.3	58.4	41.3	67.8	27.2	20.3	61.7	51.6	51.6	38.2	53.0	35.3	37.5	122.7	44.6	10.4	47.1	47.8	39.6	44.1	63.6	78.8	49.6	36.1	55.5	90.8	69.6	60.2	33.6	44.2	76.6	42.5	57.9	60.9	71.3	96.0	45.7	76.9	79.3	47.6	42.0	63.3	76.5	69.7	25.9	245.5	91.4	92.7	80.5	70.3	43.6	76.8	15.2	53.3	53.6	49.3	66.9	64.1	97.4	21.8	89.0	65.6	28.9	83.5	21.2	54.0	61.4	48.6	24.6	32.6	70.6	189.3	92.0	166.9	61.9	103.3	99.8	69.6	77.5	66.7	72.3	136.3	81.5	21.4	38.2	35.2	65.0	36.5	68.2	39.5	59.9	72.3	40.7	171.9	106.0	213.2	98.8	96.6	72.6	98.5	74.6	84.5	144.3	118.1	55.3	69.0	415.2	78.5	110.2	38.8	97.6	143.2	38.4	38.6	28.1	47.6	41.1	42.5	45.9	37.1	41.3	37.5	47.1	36.1	34.2	22.4	21.9	12.7	46.8	12.6	27.1	20.6	29.6	6.9	24.9	30.1	32.9	22.8	16.5	20.2	10.4	96.6	20.5	29.0	15.6	39.3	13.0	25.8	13.2	37.0	25.8	49.2	17.0	31.1	68.9	14.8	23.0	27.6	6.3	15.6	48.9	45.1	44.4	5.0	19.2	25.9	10.2	43.3	22.6	42.3	10.8	31.1	8.8	22.5	75.2	10.7	35.0	16.1	11.0	32.2	16.5	8.6	27.8	14.8	14.8	26.7	19.1	12.4	19.7	7.1	13.4	1.6	6.9	42.4	9.2	37.1	32.5	4.2	32.0	26.7
FMNL1	"C17orf1, C17orf1B, FMNL"	ENSG00000184922	"Formin like 1"	O95466	17	45221444-45247319	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 277.6;lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.1;dendritic cells: 160.0;Kupffer cells: 77.4;Langerhans cells: 141.6;Macrophages: 115.5;monocytes: 132.8;NK-cells: 152.4;Plasma cells: 109.8;T-cells: 134.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 190.8;MOLT-4: 138.4;U-266/70: 158.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008129, HPA028288"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA008129: AB_1848963, HPA028288: AB_10612110"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"prognostic unfavorable (4.23e-8)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.16e-1)"	22.9	7.4	14.2	68.5	11.3	277.6	13.4	10.1	21.5	10.4	9.0	12.5	11.5	5.6	2.3	8.9	14.1	18.5	12.7	20.8	9.0	8.4	8.5	54.6	69.4	16.2	11.2	3.4	6.5	6.8	16.3	12.2	15.5	10.4	7.3	1.3	16.2	3.3	4.7	9.5	36.7	8.2	11.1	104.9	13.7	4.2	17.2	49.7	9.0	6.2	38.7	21.4	10.5	16.3	16.9	32.2	0.3	1.7	0.3	7.0	1.7	2.0	4.3	11.8	8.8	1.5	7.2	51.4	16.2	0.6	12.4	2.7	0.0	0.4	3.9	91.1	4.4	29.8	51.0	2.7	32.6	78.6	100.6	5.4	1.4	15.6	6.7	16.4	0.3	55.8	2.7	190.8	8.8	10.9	138.4	80.7	1.6	2.1	1.0	86.2	11.3	92.7	3.3	2.1	10.0	4.8	9.9	1.7	4.0	2.6	9.2	62.7	4.0	0.7	11.1	1.9	73.3	158.9	75.7	52.2	1.4	62.8	2.5	11.1	6.5	11.3	8.6	7.4	5.7	4.5	6.6	9.4	5.6	5.1	4.4	5.8	28.4	7.2	5.9	3.3	8.1	5.3	14.2	11.3	10.1	21.5	20.8	9.0	16.2	11.2	15.5	11.1	17.2	16.3	7.2	3.2	3.0	0.0	108.1	6.1	2.9	0.9	2.2	4.9	3.3	4.7	2.5	1.5	1.1	1.8	0.0	0.6	160.0	0.7	0.0	1.5	2.5	0.7	4.3	5.7	1.2	34.9	12.8	0.9	1.2	12.9	4.6	1.2	22.9	0.2	6.1	1.5	45.3	3.3	10.3	0.4	0.0	77.4	141.6	0.7	5.3	115.5	44.4	9.4	132.8	0.9	152.4	0.5	1.0	0.5	0.1	0.0	109.8	1.9	0.2	0.8	1.0	1.6	6.6	9.3	2.4	0.8	3.5	0.6	6.1	2.5	134.6	0.2	0.5	1.4
FOXP1	"12CC4, hFKH1B, HSPC215, QRF1"	ENSG00000114861	"Forkhead box P1"	Q9H334	3	70954708-71583989	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 41.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTEC/SVTERT24-B: 95.0"					"Low region specificity"	"Detected in all"			"HPA003876, CAB011501"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB011501: AB_732428, HPA003876: AB_1078907"	"unprognostic (2.31e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.38e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	16.5	3.8	5.0	20.3	41.1	38.5	14.5	0.3	12.5	11.2	9.9	28.7	12.2	15.3	6.5	23.0	14.3	21.0	12.7	7.8	0.0	7.0	13.0	22.9	22.2	3.1	6.7	32.4	16.8	6.5	9.1	13.7	0.9	21.2	23.4	2.6	29.7	9.6	8.2	10.9	15.3	22.7	0.1	17.8	20.6	14.4	6.6	26.3	14.5	11.1	25.4	21.6	14.2	8.1	9.6	8.0	16.8	13.2	8.4	21.3	8.2	26.3	30.9	22.0	17.4	51.9	11.2	31.1	4.3	12.9	17.6	6.9	31.0	22.8	40.3	7.8	11.7	13.0	17.0	52.7	20.5	25.7	31.6	21.7	10.3	95.0	42.1	18.3	36.6	15.4	13.6	36.7	10.8	42.6	11.9	9.3	19.7	7.2	39.9	38.0	30.7	4.7	18.8	30.1	14.5	27.6	32.6	7.7	1.9	15.9	5.6	21.9	47.7	34.9	14.3	48.9	42.2	9.0	7.1	41.8	22.5	35.7	7.5	46.9	15.3	15.2	18.3	13.1	19.4	58.1	38.7	22.6	13.0	62.2	60.8	40.0	27.0	22.2	25.3	21.7	35.9	28.8	5.0	41.1	0.3	12.5	7.8	0.0	3.1	6.7	0.9	0.1	6.6	8.1	158.8	73.7	121.3	130.9	266.5	183.0	170.6	58.2	176.4	30.3	98.5	115.1	42.1	148.7	72.0	33.1	18.8	47.2	122.9	118.1	31.3	79.0	156.0	116.3	48.2	184.9	271.6	111.5	391.0	95.1	12.6	90.4	95.8	128.0	219.8	117.7	184.9	72.3	49.5	6.7	139.9	231.2	154.6	117.6	209.0	89.6	42.0	101.3	37.4	414.1	120.3	15.5	116.4	184.5	286.4	124.8	102.8	24.8	66.0	178.8	91.7	19.4	83.7	42.8	92.1	102.9	119.4	13.7	33.6	111.5	101.4	52.4	168.1	33.1	157.2	146.3
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 195.3;lymphoid tissue: 166.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 119.6;Kupffer cells: 215.3;Macrophages: 178.5;monocytes: 89.7"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 4199.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 4199.5"	"Group enriched"	"Detected in some"	5	"LHCN-M2: 17.2;U-87 MG: 67.1"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: AB_2679694, HPA061744: AB_2684600"	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	69.6	10.0	3.8	166.0	4.4	195.3	5.3	4.1	8.7	8.2	5.7	4.6	3.1	3.7	0.5	8.9	15.4	28.6	7.5	3.6	8.1	4.5	21.4	50.8	12.7	15.2	8.2	2.4	11.2	5.1	3.5	45.1	11.9	3.1	3.3	2.6	4.1	2.3	1.8	1.3	5.2	42.9	8.6	129.2	5.4	2.2	9.9	8.4	3.1	22.8	10.3	66.9	2.7	18.2	0.5	0.8	0.3	0.4	1.0	2.1	0.5	0.2	0.0	0.5	2.0	0.3	0.7	1.2	0.6	0.0	3.9	0.4	0.0	0.0	0.1	0.1	0.0	0.7	0.9	1.0	6.0	0.3	0.5	4.8	0.2	1.8	1.8	9.2	0.0	0.3	0.1	0.6	17.2	0.9	0.1	0.3	0.4	0.3	0.7	0.3	0.7	0.0	1.5	0.5	0.2	0.3	0.6	0.1	0.5	0.2	1.0	1.1	1.0	2.0	0.4	0.1	3.5	0.2	0.0	0.5	67.1	1.7	0.1	317.1	759.9	204.9	1.6	319.7	1.5	0.7	1.0	0.7	174.1	1.0	1.0	1.2	4199.5	0.4	201.8	8.1	1.3	420.3	3.8	4.4	4.1	8.7	3.6	8.1	15.2	8.2	11.9	8.6	9.9	18.2	0.1	16.0	25.7	0.0	1.8	0.6	0.3	0.0	0.0	1.0	0.1	0.3	0.2	0.0	15.5	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.8	0.0	0.1	6.3	0.0	2.5	0.2	0.0	1.6	4.7	0.5	0.1	26.5	0.0	2.5	2.1	119.6	0.0	0.1	0.0	0.0	215.3	4.7	2.0	0.3	178.5	0.0	3.7	89.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.4	8.8	0.3	6.6	0.6	0.8	0.6	0.8	0.2	0.0	3.0	2.5	0.0	0.0	0.1
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770531	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.0;Hofbauer cells: 12.7;Kupffer cells: 18.8;Late spermatids: 26.8;Macrophages: 61.3;monocytes: 23.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	10	"neutrophil: 1187.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 1187.9"	"Cell line enriched"	"Detected in some"	20	"U-937: 32.7"	"Not detected"	"Not detected"							HPA029154	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	13.6	1.2	0.3	56.1	0.6	16.6	0.6	0.3	2.6	0.5	0.9	0.8	1.0	0.5	0.1	1.8	1.8	5.9	0.9	0.3	0.3	0.4	4.9	9.4	1.9	0.6	0.5	1.5	2.3	0.3	0.2	7.6	0.9	0.4	0.5	0.1	0.5	0.3	0.3	0.4	1.3	6.7	0.3	17.2	0.7	2.4	1.2	1.6	0.7	4.2	0.8	15.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.9	32.7	0.0	3.6	122.0	5.8	0.2	122.7	0.7	0.1	0.2	0.2	16.6	0.2	0.1	0.2	1187.9	0.2	85.0	3.3	0.1	46.0	0.3	0.6	0.3	2.6	0.3	0.3	0.6	0.5	0.9	0.3	1.2	0.5	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	9.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	5.1	0.0	0.4	0.4	12.7	0.0	0.0	0.0	0.0	18.8	0.8	26.8	0.0	61.3	0.0	0.0	23.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0
FXYD5	OIT2	ENSG00000089327	"FXYD domain containing ion transport regulator 5"	Q96DB9	19	35154730-35169881	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 462.9;Hofbauer cells: 430.3;Langerhans cells: 492.1;Pancreatic endocrine cells: 585.0;T-cells: 459.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA010817	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum"		"HPA010817: AB_1849214"	"unprognostic (3.97e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.66e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.71e-9)"	"unprognostic (6.07e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"	203.1	39.2	30.8	130.8	31.0	275.2	171.1	31.9	47.2	226.2	36.9	59.0	28.6	75.5	20.1	116.1	103.6	68.8	82.3	29.9	36.6	42.0	40.2	148.5	187.4	43.4	34.7	28.6	28.0	17.2	39.8	91.7	37.9	68.8	43.3	3.5	70.3	46.5	28.6	85.8	106.6	59.8	35.4	238.3	67.9	9.2	40.0	85.0	59.2	32.6	187.8	104.8	183.8	39.9	932.2	216.7	0.2	0.9	310.5	390.2	213.6	521.7	686.4	362.8	269.3	61.9	263.6	212.9	139.3	632.2	130.3	212.3	132.5	321.3	231.4	265.7	87.9	397.7	111.8	0.5	244.3	228.6	378.0	233.6	141.6	265.3	452.2	213.2	348.5	58.0	380.0	989.0	229.5	1.5	27.4	95.1	66.4	853.4	126.0	127.6	45.0	272.7	134.0	5.2	38.8	0.3	287.1	148.6	316.6	115.0	78.0	180.4	494.8	443.6	170.0	487.7	40.2	1.5	16.2	54.4	675.9	524.8	694.4	644.0	596.4	111.1	451.5	628.4	422.0	602.8	756.5	467.4	718.7	545.6	489.2	405.6	140.1	840.8	636.9	325.0	894.6	934.1	30.8	31.0	31.9	47.2	29.9	36.6	43.4	34.7	37.9	35.4	40.0	39.9	291.0	3.2	13.4	0.0	330.7	107.1	73.4	106.3	54.1	0.6	80.2	51.2	5.2	32.9	27.8	99.3	0.0	18.9	349.7	2.9	0.0	156.1	1.7	3.4	63.5	276.5	10.7	111.2	2.2	197.3	462.9	93.1	71.9	2.2	361.5	0.3	323.8	6.1	430.3	0.0	0.4	8.2	4.1	385.9	492.1	4.6	6.5	403.9	209.9	10.3	243.7	0.4	260.6	1.0	0.1	585.0	7.8	0.7	302.5	72.2	0.2	4.4	5.5	0.4	65.7	5.7	107.6	1.6	8.1	24.0	69.2	50.9	459.5	0.7	10.0	100.3
GNA13	"G13, MGC46138"	ENSG00000120063	"G protein subunit alpha 13"	Q14344	17	65009289-65056740	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 144.5"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 537.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010087	Approved		Supported	Cytosol		NA	NA		320000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010087: AB_10601478"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.21e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	23.7	22.5	21.3	41.5	23.9	144.5	15.8	25.0	22.5	17.6	21.3	27.7	21.0	17.9	10.5	18.2	15.9	26.5	12.6	20.2	26.6	17.6	27.0	27.1	46.8	26.9	21.7	22.6	15.3	15.8	8.3	39.3	30.1	15.1	26.2	17.2	10.4	16.1	36.8	12.1	23.3	22.9	25.4	33.5	18.0	15.4	23.7	49.9	17.9	38.6	44.6	30.5	12.3	35.2	33.3	36.9	32.6	21.6	31.8	29.5	32.2	25.3	28.7	35.0	39.7	20.7	23.0	130.0	16.1	26.6	42.0	22.5	35.0	29.4	51.5	35.4	19.5	69.0	20.7	38.7	45.7	54.2	45.5	23.9	43.8	32.2	42.0	29.1	48.6	33.6	29.7	82.3	36.9	29.3	88.9	18.8	19.4	30.2	25.7	49.0	64.8	47.2	32.0	53.3	24.5	48.8	19.7	34.8	43.8	62.1	40.7	50.0	37.9	58.4	48.8	25.0	33.2	57.3	79.4	151.4	20.1	32.2	30.4	7.3	6.0	7.6	5.6	12.5	5.7	4.5	6.8	6.8	5.2	4.0	3.9	4.4	13.8	6.8	8.5	2.1	9.7	4.0	21.3	23.9	25.0	22.5	20.2	26.6	26.9	21.7	30.1	25.4	23.7	35.2	34.5	12.8	13.0	68.9	80.9	67.8	27.8	13.1	42.1	5.3	21.0	13.0	11.7	18.6	10.1	9.2	4.2	16.6	60.5	82.2	7.9	11.8	4.5	25.3	23.6	35.4	16.8	21.2	20.7	11.6	15.1	24.3	23.9	49.9	30.4	21.9	32.5	13.8	57.4	6.7	27.3	11.6	12.2	57.9	537.6	8.0	11.5	123.8	69.4	44.0	44.1	34.4	29.9	29.1	36.7	13.4	30.7	24.0	45.9	28.3	23.5	16.4	13.8	6.1	32.9	19.2	19.9	6.7	13.6	33.7	65.9	14.0	66.5	15.4	13.7	36.2
GNAI2	"GIP, GNAI2B"	ENSG00000114353	"G protein subunit alpha i2"	P04899	3	50226292-50259362	"Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 656.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007704	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		4000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA007704: AB_1849230"	"prognostic favorable (1.03e-4)"	"unprognostic (3.89e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.01e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.38e-1)"	210.2	100.3	155.2	217.9	167.3	367.1	152.8	166.3	181.6	146.0	120.2	142.1	69.9	141.7	66.9	124.4	136.9	152.5	157.1	144.3	184.6	79.4	126.5	214.5	251.3	199.8	170.2	147.7	64.1	66.9	99.2	241.8	194.8	103.6	64.3	35.6	71.9	156.9	69.3	87.0	103.0	154.0	173.6	262.1	73.6	69.6	173.3	160.3	101.3	89.4	170.4	169.7	108.4	193.2	128.2	63.0	186.3	197.6	220.7	277.5	35.5	271.1	399.6	354.9	361.1	70.4	173.2	149.1	119.2	567.0	193.4	100.1	132.8	350.3	222.8	331.2	50.9	364.8	158.0	110.2	219.8	329.2	479.8	270.3	152.9	319.1	129.8	289.6	837.8	124.1	26.1	307.1	357.5	155.7	313.6	433.0	109.7	59.0	302.4	185.0	89.8	219.7	232.6	130.9	48.4	86.1	189.5	57.1	124.4	150.4	94.3	346.1	792.3	330.9	187.5	309.2	274.7	199.4	278.3	127.0	373.6	466.9	398.1	16.6	59.3	113.7	33.7	80.9	20.2	28.8	26.8	34.3	57.3	26.1	20.2	25.8	145.2	23.5	74.5	47.2	34.0	27.3	155.2	167.3	166.3	181.6	144.3	184.6	199.8	170.2	194.8	173.6	173.3	193.2	656.8	41.7	32.1	25.1	119.5	56.7	59.7	32.3	45.5	29.0	61.6	83.8	22.9	55.8	26.6	44.1	14.6	79.5	311.4	11.7	5.9	124.3	203.3	57.8	115.7	340.3	92.2	52.1	12.4	60.5	84.4	101.9	21.9	71.8	89.9	150.0	221.3	79.7	336.0	6.7	14.8	24.6	18.3	342.7	291.7	302.0	90.7	386.1	83.6	58.1	356.6	292.6	151.4	26.7	45.4	160.3	40.9	95.5	104.8	46.1	30.3	24.5	24.4	21.9	52.6	85.3	163.1	16.6	22.6	37.6	62.9	116.4	164.9	156.3	20.5	70.1
GNG10		ENSG00000242616	"G protein subunit gamma 10"	P50151	9	111661605-111670226	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.7;Gastric mucus-secreting cells: 40.8;Macrophages: 49.7;Squamous epithelial cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 513.9"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 513.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"				"unprognostic (3.25e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.68e-2)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.62e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.91e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.42e-1)"	98.6	93.1	48.4	93.6	49.6	86.5	50.3	47.1	80.1	58.2	50.6	47.0	37.2	48.8	49.8	41.4	42.9	59.0	69.1	50.9	56.8	52.9	72.2	63.5	78.6	52.1	52.7	33.9	39.7	98.7	45.3	83.5	50.7	80.4	46.2	11.3	53.8	42.0	36.2	23.2	44.2	68.9	50.5	48.9	41.5	26.6	56.2	37.2	57.6	58.9	42.3	122.9	26.7	53.2	126.1	60.3	54.7	81.8	186.1	138.5	86.6	128.4	159.0	119.2	110.0	92.0	90.4	7.5	54.0	165.0	182.2	91.6	94.4	124.4	148.0	42.4	92.8	16.7	64.3	69.7	121.3	51.6	44.2	120.8	94.8	104.2	149.8	133.7	146.1	55.3	54.9	32.3	204.3	81.6	35.6	45.2	90.2	189.8	134.3	26.3	246.9	6.8	230.4	79.5	81.4	69.2	126.7	61.0	127.6	82.1	138.0	81.5	101.2	111.5	92.2	234.2	138.7	21.5	43.1	15.8	161.2	124.3	74.2	27.6	57.9	83.8	13.0	54.8	20.4	10.8	16.8	16.2	49.4	14.7	17.8	13.7	513.9	12.6	47.0	31.9	32.6	35.7	48.4	49.6	47.1	80.1	50.9	56.8	52.1	52.7	50.7	50.5	56.2	53.2	3.8	12.8	15.3	0.0	10.9	1.8	1.5	3.7	75.7	0.7	3.8	2.4	0.2	4.3	7.7	1.8	0.0	4.5	0.7	6.2	0.0	22.1	0.1	2.2	7.2	13.1	13.8	28.4	0.0	20.8	5.5	16.4	40.8	2.3	10.1	0.9	5.0	2.9	7.2	0.0	0.0	9.0	2.0	9.9	2.8	0.2	1.8	49.7	0.0	0.0	8.5	1.1	1.0	0.0	0.0	21.9	20.2	2.2	25.8	1.4	14.2	3.9	8.1	0.6	0.0	2.4	12.1	0.1	0.1	51.0	1.1	1.5	11.1	1.3	10.4	1.5
GNLY	"D2S69E, LAG-2, LAG2, NKG5, TLA519"	ENSG00000115523	Granulysin	P22749	2	85685175-85698852	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 288.7;endometrium 1: 71.9;lymphoid tissue: 86.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5070.6;NK-cells: 8318.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"NK-cell: 17623.2"	"Group enriched"	"Detected in all"	63	"NK-cells: 17623.2;T-cells: 7874.6"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"CAB025186, HPA058021"	Enhanced				"Secreted to blood"	NA	NA	2920000	17000	"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025186: , HPA058021: AB_2683581"	"unprognostic (5.80e-2)"	"unprognostic (5.64e-3)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.48e-5)"	"unprognostic (4.34e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.79e-2)"	"prognostic favorable (6.60e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.46e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (8.07e-4)"	6.9	2.7	8.1	11.6	7.8	288.7	5.2	8.1	18.7	4.3	7.1	5.7	4.0	71.9	3.9	2.6	6.1	6.5	4.3	7.8	9.8	2.9	10.4	36.8	21.9	12.7	11.6	1.5	1.2	0.8	1.8	17.0	10.6	2.0	6.1	0.5	2.0	5.3	9.2	1.5	10.3	4.3	8.8	86.3	5.0	0.9	9.8	3.5	3.6	3.5	17.6	6.4	2.5	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.1	0.0	177.1	26.2	17.7	7874.6	26.3	2145.8	34.2	837.4	3344.7	22.4	23.0	231.3	2928.7	202.5	17623.2	32.3	58.2	40.3	8118.6	8.1	7.8	8.1	18.7	7.8	9.8	12.7	11.6	10.6	8.8	9.8	9.8	26.8	12.8	78.9	0.0	23.3	7.0	0.2	0.0	0.0	0.1	7.2	3.7	3.0	10.0	6.2	0.0	2.1	2.3	5070.6	1.3	1.9	1.9	0.0	7.5	12.0	13.0	1.8	47.2	0.2	0.0	3.4	29.3	0.5	10.6	52.4	0.1	23.2	5.3	6.0	0.0	0.1	3.3	0.0	22.4	7.2	0.2	0.3	28.4	80.0	9.4	48.6	0.1	8318.3	0.0	0.1	0.0	1.2	0.0	247.4	0.1	2.4	9.5	3.6	0.2	0.0	7.0	5.4	0.2	0.6	0.6	7.7	1.1	1230.0	1.0	1.6	0.6
GOLT1B	"CGI-141, GOT1, YMR292W"	ENSG00000111711	"Golgi transport 1B"	Q9Y3E0	12	21501781-21518408	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055909, HPA066383"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	Nucleoplasm	"HPA055909: AB_2682967, HPA066383: AB_2685667"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.37e-3)"	"prognostic unfavorable (1.99e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.83e-10)"	"unprognostic (3.13e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.04e-1)"	17.5	22.1	12.7	16.9	14.1	25.8	18.5	13.4	18.9	18.0	12.7	13.4	10.6	14.6	15.6	13.6	12.5	13.9	14.8	13.9	15.1	15.5	18.8	17.6	15.0	13.2	14.6	10.9	21.6	11.9	19.0	29.0	13.8	16.1	14.8	14.1	16.1	13.2	15.5	12.9	11.3	17.7	13.9	12.4	14.2	10.6	14.7	11.2	15.9	11.8	14.1	17.8	12.2	16.3	31.2	30.0	28.5	36.5	56.5	83.2	46.1	126.5	48.2	40.4	63.3	45.4	48.1	19.4	29.8	66.6	71.0	30.1	23.4	27.2	69.5	29.4	22.8	29.7	19.6	32.8	61.0	37.0	36.8	44.2	50.1	44.9	85.6	67.7	35.8	24.4	18.6	21.1	59.2	30.7	17.3	62.1	75.7	27.8	23.5	14.0	65.0	39.4	32.2	18.7	7.2	23.1	49.0	20.6	70.4	90.2	28.2	39.4	40.6	46.5	49.5	57.1	67.2	20.3	45.9	51.8	63.6	35.5	64.2	48.0	26.6	20.8	22.1	31.4	26.6	22.7	25.8	24.4	27.0	25.9	23.3	23.8	7.2	21.6	29.4	29.4	28.0	27.6	12.7	14.1	13.4	18.9	13.9	15.1	13.2	14.6	13.8	13.9	14.7	16.3	23.4	9.6	15.6	15.0	38.9	46.7	23.4	42.7	27.3	27.6	20.4	11.2	18.9	22.8	36.8	16.5	10.4	29.0	34.9	13.8	27.4	31.6	3.4	10.9	26.3	28.7	13.1	22.9	70.4	33.4	72.4	45.7	15.3	21.7	21.5	10.3	16.8	23.2	41.0	18.5	49.3	31.7	38.7	23.6	65.1	5.2	17.4	35.4	53.4	14.0	26.0	17.5	18.6	25.1	25.4	38.6	15.4	19.9	75.8	49.0	8.7	21.7	18.2	7.7	13.1	24.6	39.3	23.7	32.4	22.8	63.9	64.0	39.1	9.6	14.6	44.9
GPCPD1	"GDE5, GDPD6, KIAA1434"	ENSG00000125772	"Glycerophosphocholine phosphodiesterase 1"	Q9NPB8	20	5544439-5611006	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 208.7;Microglial cells: 291.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042987			Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA042987: AB_2678254"	"unprognostic (2.25e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.30e-4)"	"unprognostic (2.93e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-2)"	17.5	15.5	17.4	16.3	18.6	75.5	13.5	21.6	23.4	16.3	13.0	12.9	7.9	13.3	7.1	13.3	17.2	12.1	17.1	16.1	19.1	19.5	10.2	27.4	17.9	21.2	17.8	23.3	9.7	4.0	13.2	14.9	22.1	13.1	11.1	12.2	26.5	13.1	17.5	11.1	16.6	12.8	18.6	31.9	11.2	9.1	19.2	13.3	15.5	10.2	17.0	12.9	13.0	16.8	6.5	12.1	8.0	6.5	5.2	6.1	9.1	10.0	7.9	5.7	3.8	6.3	5.0	14.4	1.8	5.6	5.0	2.2	10.1	19.8	5.5	3.1	3.2	19.6	1.5	7.4	25.0	12.2	8.6	13.0	25.3	3.4	41.3	5.7	6.0	8.8	11.5	7.3	5.2	3.5	11.1	6.7	4.4	11.3	6.7	8.0	9.5	5.2	7.7	5.3	3.0	4.0	4.4	19.2	9.5	7.9	4.6	33.7	6.8	4.8	3.6	13.2	6.4	6.9	12.7	15.1	1.5	14.8	5.4	2.9	7.4	9.2	3.7	5.5	2.9	4.2	2.8	3.2	4.5	3.6	4.2	2.9	16.0	3.9	5.8	2.0	2.5	3.9	17.4	18.6	21.6	23.4	16.1	19.1	21.2	17.8	22.1	18.6	19.2	16.8	34.8	22.4	56.4	31.6	59.6	16.6	15.8	23.0	17.1	18.0	25.7	39.6	36.8	12.8	48.5	22.0	6.2	29.9	59.1	13.2	3.9	11.9	208.7	37.8	41.2	41.1	19.7	89.0	30.9	9.1	16.8	27.1	35.7	66.9	43.1	26.0	17.9	14.4	43.9	11.8	22.8	25.7	24.4	69.2	54.9	54.6	5.6	125.0	10.6	291.4	60.9	8.5	33.0	63.3	13.4	7.3	12.7	3.4	55.2	21.1	16.6	7.7	24.6	20.3	6.6	31.9	35.1	44.1	11.3	25.8	27.4	48.7	63.1	12.7	12.8	57.7
GPR183	EBI2	ENSG00000169508	"G protein-coupled receptor 183"	P32249	13	99294539-99307399	"G-protein coupled receptors, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.7;lymphoid tissue: 84.5"	"Group enriched"	"Detected in many"	4	"Langerhans cells: 2572.5;Macrophages: 809.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1050.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	23	"HDLM-2: 157.7;HL-60: 108.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033690, HPA075590"	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB033690: AB_2114269, HPA075590: "	"unprognostic (3.28e-3)"	"prognostic favorable (9.77e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.31e-3)"	"unprognostic (9.86e-3)"	26.2	12.8	1.9	84.5	2.1	112.7	11.2	2.2	3.5	12.6	7.1	14.8	8.0	6.6	2.4	15.2	6.5	40.5	13.1	1.8	5.5	3.8	17.1	20.1	67.7	8.1	3.0	3.5	4.6	3.8	5.1	27.8	5.2	9.4	21.3	2.0	5.2	3.9	2.0	5.9	23.6	21.9	3.9	35.1	15.7	1.5	3.5	31.8	15.2	4.1	75.6	52.3	5.3	7.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.7	0.2	0.8	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.4	157.7	0.0	1.4	0.4	0.0	0.0	108.6	0.3	0.0	0.0	1.5	0.0	0.0	0.0	5.7	2.6	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.8	0.3	0.7	0.0	1050.9	10.4	391.6	43.7	3.8	264.5	364.1	463.0	240.9	77.9	172.1	286.1	39.8	9.9	487.0	3.9	255.2	401.6	255.9	1.9	2.1	2.2	3.5	1.8	5.5	8.1	3.0	5.2	3.9	3.5	7.3	6.0	16.0	26.3	0.0	413.9	61.6	0.8	0.5	2.2	0.3	2.5	3.9	4.6	1.5	6.3	0.0	6.2	1.0	168.8	0.5	1.9	0.2	0.7	0.6	1.3	17.1	0.0	4.4	0.2	2.9	1.5	12.8	11.2	0.9	60.9	0.1	0.7	1.2	113.4	0.0	0.2	0.0	18.3	119.1	2572.5	2.8	0.3	809.4	145.9	46.9	248.7	0.1	1.0	0.5	0.3	1.0	0.0	0.0	85.5	0.4	0.0	0.8	3.8	0.9	6.6	2.1	9.1	0.4	0.2	1.3	53.4	1.8	245.2	0.0	0.3	0.6
GPR84	EX33	ENSG00000139572	"G protein-coupled receptor 84"	Q9NQS5	12	54362445-54364487	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.8;urinary bladder: 15.8"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 21.9;Langerhans cells: 17.7;Macrophages: 31.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	23	"basophil: 9.0;classical monocyte: 9.9;myeloid DC: 14.8;neutrophil: 6.0"	"Group enriched"	"Detected in many"	62	"dendritic cells: 14.8;granulocytes: 9.0;monocytes: 9.9"	"Group enriched"	"Detected in some"	5	"HL-60: 13.0;NB-4: 40.0"									HPA027603	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA027603: AB_10612115"	"unprognostic (5.40e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.16e-3)"	"unprognostic (7.43e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.36e-9)"	"unprognostic (1.27e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.44e-2)"	4.5	1.1	1.0	8.3	1.1	22.8	0.3	1.0	1.8	0.4	1.4	0.4	0.3	0.3	0.3	0.5	0.7	1.0	0.6	1.0	1.7	0.9	0.4	2.4	0.3	2.6	1.6	0.3	0.4	0.1	0.8	3.1	1.7	0.6	0.6	2.7	0.6	0.2	0.0	0.7	0.4	1.9	1.7	3.6	0.6	0.3	1.8	0.5	0.6	0.2	0.8	15.8	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.0	2.2	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.1	0.0	9.0	9.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	14.8	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	2.1	1.0	1.1	1.0	1.8	1.0	1.7	2.6	1.6	1.7	1.7	1.8	3.1	0.2	0.0	0.5	2.0	0.3	0.9	0.1	4.6	0.0	2.6	0.2	0.3	0.1	0.0	1.2	0.0	4.2	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	1.6	0.0	0.0	0.8	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	1.1	0.0	0.0	2.8	17.7	0.2	0.0	31.8	0.0	0.0	1.2	0.1	0.0	1.5	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.5	0.0	0.1	0.4	0.3	0.1	0.1	0.4	0.8	0.1	0.0	0.0	0.1
GRK6	GPRK6	ENSG00000198055	"G protein-coupled receptor kinase 6"	P43250	5	177403204-177442901	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 134.1"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 90.6;NK-cells: 123.6;Plasma cells: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015327, HPA018903"	Approved		Approved	Mitochondria		NA	NA		170000	"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria		"HPA015327: AB_1850334, HPA018903: AB_1850335"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.66e-6)"	"unprognostic (2.63e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.96e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.47e-1)"	14.0	10.8	12.6	36.7	12.3	134.1	12.7	8.1	16.0	11.3	9.2	19.7	18.5	14.8	2.4	21.5	13.3	12.4	13.3	12.7	9.6	11.0	13.6	21.8	61.6	13.3	10.5	11.1	13.3	5.5	10.5	6.8	11.1	15.8	8.8	2.2	17.9	7.4	15.7	15.5	29.1	9.2	8.9	63.3	15.9	22.3	10.7	35.9	10.2	6.2	30.2	16.6	13.2	13.9	41.1	44.2	15.7	67.8	4.6	7.4	66.4	29.4	15.1	36.2	35.5	103.0	34.1	48.7	44.0	15.6	53.5	29.1	24.3	67.0	14.3	133.9	77.3	43.5	36.2	36.0	24.1	58.6	52.8	11.7	16.1	36.2	21.4	8.8	20.5	87.8	45.6	170.9	11.2	117.4	61.3	61.4	26.7	20.4	48.1	57.1	25.5	71.2	10.7	32.9	36.0	48.6	24.3	42.5	56.8	7.1	32.6	63.4	26.3	29.6	43.8	31.2	75.1	48.8	64.2	40.7	20.0	95.0	29.2	12.7	20.9	74.5	23.6	36.5	17.0	19.3	19.6	21.9	11.9	19.5	20.3	18.0	50.6	40.3	51.9	12.5	26.4	22.6	12.6	12.3	8.1	16.0	12.7	9.6	13.3	10.5	11.1	8.9	10.7	13.9	9.2	0.0	2.2	2.6	71.7	23.7	60.3	4.9	5.7	10.5	14.7	17.3	3.0	10.0	4.6	3.7	6.2	13.9	70.8	18.2	15.6	6.0	37.2	7.4	8.2	6.6	11.4	41.7	3.7	8.3	12.6	9.7	16.8	6.4	14.7	13.9	10.0	6.5	20.4	16.8	3.5	14.3	4.1	29.8	18.8	90.6	6.2	41.2	14.2	2.8	26.4	9.0	123.6	2.0	3.3	10.3	14.0	5.3	112.2	61.1	11.8	8.5	2.0	8.6	13.1	8.4	10.7	3.9	4.2	11.9	20.3	12.7	66.5	12.1	17.1	56.6
GYPE	"GPE, MNS"	ENSG00000197465	"Glycophorin E (MNS blood group)"	P15421	4	143870864-143905563	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 13.3"	"Cell type enriched"	"Detected in some"	11	"Erythroid cells: 188.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"HEL: 120.9;K-562: 39.8"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"				"unprognostic (2.17e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.09e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.10e-4)"	"unprognostic (7.81e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.49e-2)"	1.4	0.3	0.1	1.4	0.8	13.3	0.7	0.0	1.4	0.7	0.0	0.2	0.0	0.3	0.7	0.3	0.2	0.7	1.4	0.6	0.0	0.4	0.1	2.9	1.1	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.0	0.3	0.4	0.2	0.3	0.6	0.1	0.4	0.9	0.4	0.0	3.2	0.3	0.5	0.0	1.1	0.7	0.0	2.5	0.7	0.2	0.1	0.0	0.0	0.0	0.0	6.8	6.6	0.0	2.8	6.4	1.4	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.2	0.0	1.6	0.0	0.0	120.9	0.0	0.0	1.3	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	39.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	16.0	1.5	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	188.4	5.3	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.8	0.5	0.3	0.0	0.3	3.6	1.0	0.0	0.0	1.0	6.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.0	0.0	0.1	0.3	0.7	0.0	0.0
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.2;lymphoid tissue: 37.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2050.2;NK-cells: 1704.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 6765.2"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 6765.2"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 22.0"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA	2170		"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"	8.2	1.7	1.2	17.8	1.3	68.2	2.1	1.2	3.9	1.2	1.4	2.5	2.3	7.1	1.6	3.8	1.5	6.5	1.8	1.2	7.9	1.5	4.1	15.3	37.1	1.5	1.5	0.3	1.0	0.7	0.7	3.3	1.6	1.4	2.2	0.0	2.3	1.4	2.0	0.4	4.4	4.3	1.4	28.9	3.5	0.5	1.8	9.7	1.9	1.5	34.6	18.5	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.7	2.8	9.9	3.0	5.3	1338.5	4.0	16.0	7.0	95.2	641.6	6.3	3.1	29.1	607.5	43.1	507.8	6.0	6765.2	2.7	1607.1	1.2	1.3	1.2	3.9	1.2	7.9	1.5	1.5	1.6	1.4	1.8	1.3	4.3	6.4	36.0	0.0	15.9	2.8	0.3	0.0	0.0	0.0	0.9	0.8	1.1	4.3	7.4	0.0	0.0	0.4	2050.2	0.6	0.0	1.6	0.0	0.4	0.5	2.7	0.0	11.8	0.0	0.0	0.1	5.1	9.2	0.5	17.7	0.0	4.2	1.2	0.2	0.0	0.0	0.6	0.0	4.8	9.0	0.2	0.0	27.1	42.7	1.0	11.6	0.0	1704.4	0.0	0.1	0.1	2.3	0.0	86.8	0.2	0.6	3.1	4.4	0.0	0.0	1.3	1.3	0.0	0.1	0.4	4.1	0.3	373.8	0.0	0.6	0.1
HACD4	"Em:AL662879.1, PTPLAD2"	ENSG00000188921	"3-hydroxyacyl-CoA dehydratase 4"	Q5VWC8	9	20999509-21031640	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 60.7;Kupffer cells: 78.8;Macrophages: 99.3;monocytes: 87.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.2;HDLM-2: 10.8;TIME: 8.6;U-937: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058666	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA058666: AB_2683793"	"unprognostic (1.71e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-4)"	"prognostic favorable (3.14e-4)"	"unprognostic (8.72e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.89e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-3)"	1.9	2.8	1.3	3.5	1.2	12.0	2.4	2.0	2.5	5.3	2.7	4.2	2.0	3.5	1.1	2.6	3.9	3.0	0.8	1.2	1.1	2.0	1.1	8.3	4.4	1.1	0.7	3.9	0.5	1.1	0.6	6.4	0.9	2.7	3.1	1.3	1.4	2.2	0.4	2.5	2.9	4.2	0.5	3.9	2.0	1.0	1.0	5.2	2.1	1.5	4.0	2.7	1.8	1.5	4.2	1.2	0.4	0.1	0.0	0.1	0.1	3.8	17.2	3.0	3.4	0.0	0.0	3.7	2.1	7.4	0.0	1.1	0.2	1.6	3.8	10.8	0.1	0.0	1.3	0.0	2.3	3.1	3.2	6.6	6.7	2.7	0.0	0.0	1.0	4.3	0.0	2.1	0.6	0.1	0.0	4.3	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.7	0.0	0.9	0.3	0.0	2.4	3.0	5.9	8.6	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	13.4	0.1	21.4	8.8	14.4	2.5	10.9	2.4	1.4	2.7	2.8	10.2	1.3	1.9	2.7	12.4	3.7	11.3	1.1	3.7	5.0	1.3	1.2	2.0	2.5	1.2	1.1	1.1	0.7	0.9	0.5	1.0	1.5	6.3	48.1	6.1	2.3	15.8	0.0	10.7	0.0	16.5	1.6	5.4	5.8	2.1	2.8	11.2	12.9	0.0	12.2	26.1	0.1	5.9	0.6	0.5	33.0	8.4	5.6	0.0	27.1	4.3	0.5	37.9	23.1	4.1	5.6	3.8	17.7	11.7	1.0	60.7	0.0	2.4	0.1	0.0	78.8	0.0	0.4	3.7	99.3	0.0	11.2	87.7	11.0	36.0	0.0	0.4	0.1	0.1	1.2	20.1	3.7	0.0	9.3	48.8	1.6	13.1	4.6	13.4	0.3	7.8	11.7	0.0	5.1	33.1	11.9	0.3	4.5
HCST	"DAP10, DKFZP586C1522, KAP10, PIK3AP"	ENSG00000126264	"Hematopoietic cell signal transducer"	Q9UBK5	19	35902529-35904377	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 253.7;lymphoid tissue: 115.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 993.2;Hofbauer cells: 571.1;Kupffer cells: 396.6;Langerhans cells: 584.5;Macrophages: 392.7;NK-cells: 1687.0;T-cells: 769.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 239.9;HL-60: 139.6;HMC-1: 154.3;THP-1: 177.8;U-937: 272.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034435, HPA063026"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB034435: AB_2117803, HPA063026: "	"unprognostic (1.40e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.59e-10)"	"unprognostic (3.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	27.2	9.5	14.0	53.6	13.8	253.7	14.1	13.7	18.5	9.6	16.6	12.7	11.3	8.3	4.7	5.5	9.9	11.5	8.3	13.5	17.0	10.6	14.5	40.3	68.0	18.3	14.7	5.7	6.7	2.5	9.6	24.7	17.6	9.4	8.6	2.2	10.7	8.2	4.2	6.6	28.2	11.2	17.1	115.6	15.4	3.4	18.2	59.6	7.9	3.0	37.8	16.4	8.0	22.2	0.9	0.0	0.3	0.5	1.1	0.0	0.3	1.9	1.1	0.0	0.6	0.8	1.2	26.9	1.7	2.0	0.4	0.9	0.0	0.2	0.0	0.6	0.0	239.9	0.5	0.7	0.9	139.6	154.3	1.6	0.3	0.0	0.0	0.7	0.0	14.8	2.1	33.4	0.4	0.4	16.9	54.7	0.3	0.3	0.7	0.8	0.5	2.0	0.4	0.1	0.9	0.4	1.3	0.7	0.9	0.2	0.5	177.8	0.5	1.4	1.8	0.2	0.2	1.6	1.1	39.5	1.4	272.2	0.3	124.7	725.8	105.8	1583.4	546.1	1172.3	78.6	664.6	1293.3	409.8	51.0	550.6	1108.0	196.1	1290.7	314.4	823.7	629.9	1421.2	14.0	13.8	13.7	18.5	13.5	17.0	18.3	14.7	17.6	17.1	18.2	22.2	12.3	6.4	43.3	0.0	85.3	28.6	1.3	1.7	2.8	0.4	11.4	12.8	1.2	15.7	7.1	9.2	0.0	3.8	993.2	1.8	0.0	2.8	1.3	4.0	2.5	18.3	0.0	84.2	0.1	1.2	4.7	9.5	14.8	5.5	240.4	0.3	21.0	14.3	571.1	1.7	0.1	0.9	2.0	396.6	584.5	3.0	2.1	392.7	44.4	5.6	309.9	0.7	1687.0	0.0	0.1	1.0	1.4	0.0	97.7	0.6	2.0	6.1	5.1	2.2	19.7	4.2	6.2	2.2	4.9	2.7	21.0	6.0	769.9	1.0	2.7	1.2
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689955-92695647	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 84.7;liver: 91.2;thyroid gland: 102.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5"	"Group enriched"	"Detected in all"	5	"liver cancer: 20.1;thyroid cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	43	"basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7"					"Low region specificity"	"Detected in many"			"HPA003257, HPA051894"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA003257: , HPA051894: AB_2681653"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	16.2	18.5	5.0	22.2	5.4	84.7	11.2	5.6	8.8	7.1	5.1	7.8	6.4	6.4	3.5	4.1	6.1	27.4	6.1	4.8	5.2	7.0	91.2	16.9	39.1	6.3	5.4	3.0	38.1	1.9	2.2	14.6	6.4	4.7	6.5	0.3	3.5	4.0	2.9	4.6	19.0	5.8	6.2	39.9	5.2	2.4	6.0	4.4	102.1	6.3	30.4	12.7	5.0	6.7	11.2	20.6	10.5	0.1	0.9	0.7	0.2	5.6	46.4	7.4	6.6	4.0	2.6	10.7	87.7	0.7	0.0	2.1	9.5	0.3	9.1	0.1	11.1	99.9	8.8	67.4	21.0	58.6	105.6	0.3	0.2	6.5	0.0	3.7	106.1	0.3	154.8	0.1	0.5	3.2	0.4	101.8	0.2	30.2	11.8	34.0	3.0	0.1	0.9	4.3	4.9	1.0	6.2	0.0	0.1	0.5	3.3	30.6	37.2	0.0	0.6	0.1	0.1	2.6	1.8	21.2	0.0	79.7	51.4	28.0	41.5	61.8	0.8	45.7	0.3	59.3	0.0	0.1	30.8	65.8	0.1	0.1	31.4	1.0	50.7	36.3	0.4	15.5	5.0	5.4	5.6	8.8	4.8	5.2	6.3	5.4	6.4	6.2	6.0	6.7	31.9	0.0	3.0	0.0	77.2	6.4	2.1	0.9	2.2	0.0	3.0	3.2	3.6	125.8	1.6	0.0	0.0	0.7	57.6	0.4	0.0	107.9	0.3	0.8	0.5	80.0	5.3	28.2	0.0	12.0	0.7	2.2	0.5	1.0	7.0	0.0	88.9	58.3	72.6	0.0	0.0	1.6	0.0	63.5	29.1	1.1	0.3	51.7	7.2	5.6	50.4	0.0	9.2	0.5	0.0	10.5	0.0	1.2	1.6	3.2	0.0	0.2	0.9	0.2	0.0	1.9	2.1	0.3	6.3	1.0	3.7	1.1	8.3	3.4	0.7	1.3
HIF1A	"bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8"	ENSG00000100644	"Hypoxia inducible factor 1 subunit alpha"	Q16665	14	61695513-61748259	"Cancer-related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 448.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 155.0"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 155.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 941.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000907, HPA001275, CAB017442"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057"	"unprognostic (1.07e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.35e-2)"	"unprognostic (3.88e-2)"	64.9	133.7	22.1	146.6	24.0	448.3	36.2	28.2	26.1	132.9	24.7	42.8	33.6	52.4	74.8	62.1	41.1	145.4	36.5	21.1	28.4	104.2	51.6	75.7	71.4	29.7	29.7	35.3	36.0	91.7	30.7	77.6	33.3	46.9	41.7	35.5	45.3	67.2	12.1	34.2	37.3	59.1	27.2	72.4	37.6	32.4	38.5	55.8	49.5	17.6	88.2	169.9	43.1	26.5	313.6	123.6	112.7	344.7	185.2	297.1	161.5	253.8	270.1	288.7	258.9	54.1	100.3	75.8	186.2	293.0	73.6	71.8	71.0	416.1	352.5	33.7	41.0	46.5	105.3	93.1	414.8	20.1	49.3	523.4	129.2	216.5	225.6	408.6	198.1	44.4	32.3	0.4	941.4	65.6	59.2	24.3	108.9	49.6	159.7	4.3	269.1	22.8	400.2	204.3	100.3	111.9	472.5	67.0	170.7	148.9	70.6	36.3	119.2	700.2	157.3	235.9	215.2	39.1	61.2	84.1	369.9	38.5	194.7	43.8	22.3	155.0	11.5	18.0	14.4	19.5	15.0	13.3	19.6	19.0	22.6	15.6	56.3	19.7	19.4	9.2	11.0	18.4	22.1	24.0	28.2	26.1	21.1	28.4	29.7	29.7	33.3	27.2	38.5	26.5	93.3	70.5	116.0	69.2	157.3	106.4	101.8	102.6	97.9	54.1	38.5	30.1	43.5	87.2	69.0	261.1	50.1	24.8	65.1	44.1	103.7	278.5	3.6	95.6	131.3	152.3	66.4	35.3	45.6	251.6	67.1	81.4	49.5	272.3	223.6	339.7	176.0	30.7	136.4	156.5	39.3	39.0	57.0	145.9	111.7	6.2	24.2	240.2	103.2	53.4	87.1	134.0	26.8	78.9	35.8	236.9	21.9	48.5	60.0	59.3	20.2	192.1	37.7	54.8	52.6	75.8	136.9	80.5	44.2	128.7	87.9	25.4	91.6	92.2	51.8	116.0
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899346	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 129.3;lymphoid tissue: 76.6"	"Group enriched"	"Detected in some"	13	"Early spermatids: 11.1;Hofbauer cells: 34.5;Kupffer cells: 43.9;Macrophages: 38.8;monocytes: 14.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 1.4;cerebral cortex: 1.6;thalamus: 2.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 569.7"	"Group enriched"	"Detected in many"	13	"granulocytes: 569.7;monocytes: 200.9"	"Cell line enriched"	"Detected in some"	5	"U-937: 20.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					NA	NA		2000000	"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	8.4	4.5	0.0	19.0	0.2	129.3	2.6	1.4	1.6	0.8	0.2	2.5	2.0	1.0	0.1	0.9	5.1	2.1	4.0	0.2	0.0	1.8	5.2	25.1	4.2	0.0	0.0	1.0	1.5	0.1	0.7	2.8	0.0	1.1	1.4	0.1	1.5	0.3	0.9	0.5	3.1	7.9	0.0	76.6	2.1	1.3	2.4	1.4	1.3	0.5	0.7	4.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.5	0.1	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.6	0.0	569.7	92.5	204.8	0.3	179.4	0.2	0.4	0.2	0.1	30.2	0.2	0.1	0.1	32.2	0.2	200.9	1.4	0.2	43.6	0.0	0.2	1.4	1.6	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.1	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	11.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.4	1.3	0.0	0.4	0.2	34.5	0.0	0.4	0.0	0.0	43.9	0.9	1.8	0.0	38.8	0.0	1.0	14.6	0.0	2.1	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.2	0.1	0.3	0.3	0.1	0.0	0.0
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10271093-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 219.3;urinary bladder: 215.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 612.2;Alveolar cells type 2: 561.6;Endothelial cells: 240.8;Langerhans cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 158.3;Karpas-707: 459.7;RPMI-8226: 148.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA	87900000	2200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Vesicles, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favorable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	87.9	23.6	9.1	44.6	9.6	117.1	32.4	7.9	12.0	11.2	9.9	17.7	16.8	23.9	3.5	11.0	26.2	56.4	39.1	8.8	9.9	43.9	67.1	219.3	38.3	12.3	8.7	13.0	11.1	8.3	9.3	27.8	10.2	22.2	18.1	10.5	18.0	6.3	15.1	17.9	22.6	23.4	10.0	55.9	21.5	5.6	15.4	28.4	30.8	12.8	32.9	215.3	12.5	10.2	46.3	0.5	7.9	0.2	2.0	4.4	9.7	8.6	91.6	21.8	62.0	14.0	49.8	39.6	130.3	3.8	99.3	8.9	1.7	0.4	45.6	123.8	0.1	3.8	1.4	62.0	158.3	1.3	23.9	55.7	4.0	13.7	20.3	2.0	10.7	4.9	15.0	459.7	1.5	3.3	0.5	34.9	3.1	0.5	24.7	1.0	0.2	148.5	36.8	0.3	0.3	1.1	61.2	3.3	94.5	3.7	6.9	2.8	34.3	22.3	1.9	12.3	0.8	137.4	142.7	25.5	35.1	26.3	32.6	5.0	28.3	5.2	5.3	25.8	9.8	3.8	4.0	6.3	24.7	1.5	1.9	3.8	40.8	15.2	17.0	14.1	6.1	20.8	9.1	9.6	7.9	12.0	8.8	9.9	12.3	8.7	10.2	10.0	15.4	10.2	150.3	612.2	561.6	0.3	31.7	85.3	22.2	62.6	28.5	0.0	50.2	24.9	1.1	21.5	133.5	3.7	0.0	1.1	28.9	2.9	0.0	176.8	2.0	14.1	15.5	240.8	2.4	1.3	0.5	98.7	3.3	136.6	13.7	29.8	139.8	0.1	48.2	12.1	86.7	0.0	0.4	0.7	32.6	53.6	232.6	1.3	4.7	168.3	76.5	7.5	101.9	4.6	5.2	0.5	0.2	113.7	0.3	1.5	57.6	27.1	0.3	15.0	83.2	0.4	6.6	38.2	57.6	0.8	1.6	4.3	69.3	1.2	28.8	0.5	1.6	14.1
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339661	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 206.5;liver: 73.2;lymphoid tissue: 85.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 151.9;dendritic cells: 164.6;Hepatocytes: 168.8;NK-cells: 313.1;Plasma cells: 137.2;T-cells: 183.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1948.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 1948.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 324.6;NB-4: 222.3;RPMI-8226: 257.6;U-266/84: 188.8;U-937: 179.0"					"Not detected"	"Not detected"			"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA		390000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: AB_2680897"	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	18.9	7.4	4.8	50.4	4.6	206.5	10.0	4.5	6.4	4.9	4.4	16.1	15.1	3.6	2.8	7.6	6.2	9.0	18.1	4.5	4.6	11.9	73.2	16.0	72.2	4.9	5.0	2.9	15.2	2.9	1.0	4.6	5.0	6.8	11.0	0.9	15.2	2.9	18.0	4.3	28.1	4.4	5.2	85.8	19.5	2.1	5.2	48.6	6.8	11.9	50.6	14.1	4.4	4.6	12.4	5.8	4.2	13.1	6.8	5.3	7.3	7.5	5.1	5.9	5.2	5.3	8.1	0.2	24.9	6.2	0.1	5.4	0.2	5.5	2.0	106.2	3.7	23.8	5.4	22.6	3.4	96.7	102.1	4.8	4.4	7.0	2.6	6.4	2.9	57.1	13.0	324.6	6.9	24.0	13.9	222.3	3.2	31.7	38.3	11.1	2.7	257.6	6.2	11.2	1.3	5.6	6.5	20.4	17.3	1.9	17.7	23.9	4.6	28.0	3.0	31.2	7.6	20.7	188.8	37.3	20.2	179.0	22.1	193.6	395.4	872.4	362.7	287.8	436.2	280.1	343.0	331.7	327.5	271.7	301.5	283.9	1948.5	380.1	417.4	52.9	436.3	614.5	4.8	4.6	4.5	6.4	4.5	4.6	4.9	5.0	5.0	5.2	5.2	4.6	22.6	3.2	29.7	0.7	151.9	8.2	6.5	7.0	10.2	0.3	23.1	20.6	0.1	21.5	9.8	5.5	0.0	12.0	164.6	49.1	62.6	16.9	7.7	10.7	9.4	19.2	5.4	37.4	0.2	35.4	24.7	10.2	16.8	9.9	30.4	5.5	31.1	168.8	24.0	1.7	0.1	33.2	4.1	70.0	50.4	10.0	6.2	52.9	55.2	1.0	127.7	6.4	313.1	0.0	0.1	23.2	43.8	4.1	137.2	12.3	79.9	54.4	9.0	1.2	0.0	7.3	10.7	5.7	0.7	8.3	8.4	4.7	183.3	5.4	36.4	10.2
ICAM4	"CD242, LW"	ENSG00000105371	"Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)"	Q14773	19	10286955-10288522	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 13.4;lung: 9.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 24.9;Alveolar cells type 1: 67.3;Alveolar cells type 2: 76.5;Erythroid cells: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in many"	6	"non-classical monocyte: 215.4"	"Lineage enriched"	"Detected in many"	7	"monocytes: 215.4"	"Cell line enhanced"	"Detected in some"		"HEL: 71.0;HMC-1: 17.1;K-562: 37.4;NB-4: 30.7;U-937: 17.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 11: Alveolar cells - Smell perception"																					0.9	0.3	0.3	0.8	0.4	13.4	0.4	0.3	1.0	0.2	0.0	0.7	0.9	0.3	0.2	0.3	0.4	1.1	0.6	0.3	0.0	0.3	0.8	9.3	1.0	0.6	0.0	0.5	0.1	0.3	0.1	1.8	0.3	0.7	0.5	0.7	1.0	0.4	0.4	0.5	0.9	0.4	0.0	1.2	1.5	0.3	0.1	1.1	0.3	0.1	1.4	1.8	0.2	0.5	0.2	0.1	0.3	0.4	0.0	0.0	5.9	0.6	0.2	0.0	0.0	7.8	0.4	0.8	0.8	0.0	0.3	0.6	0.1	0.1	0.1	0.6	0.2	71.0	0.6	10.6	1.9	1.2	17.1	0.4	0.0	0.2	0.2	0.0	0.1	11.2	37.4	3.1	0.1	0.2	2.0	30.7	0.2	0.0	0.3	5.2	2.9	13.6	0.1	0.3	0.1	0.2	0.6	0.1	0.3	0.8	0.2	2.1	0.4	0.2	0.1	0.5	0.0	1.0	2.0	0.2	0.6	17.1	0.4	24.0	10.0	10.2	0.9	38.5	1.8	2.2	1.1	0.8	30.8	2.2	1.3	0.3	2.3	0.5	215.4	10.2	2.6	9.1	0.3	0.4	0.3	1.0	0.3	0.0	0.6	0.0	0.3	0.0	0.1	0.5	24.9	67.3	76.5	0.3	2.3	1.0	1.9	8.0	1.2	0.0	4.9	3.6	0.0	0.0	21.0	0.0	0.0	0.3	3.0	0.4	0.0	0.6	0.0	2.9	2.0	18.3	0.0	46.7	0.0	2.1	0.6	10.3	1.5	5.6	22.1	0.0	2.5	0.2	5.6	0.0	0.0	0.0	0.0	5.5	6.9	0.0	0.0	16.8	5.4	0.0	14.6	0.2	0.0	0.0	0.0	0.9	0.0	0.0	17.5	1.4	0.0	0.1	4.4	0.1	0.0	9.1	3.3	0.0	1.0	0.7	1.3	0.8	1.8	0.2	0.0	2.4
IFI44	"MTAP44, p44, TLDC5"	ENSG00000137965	"Interferon induced protein 44"	Q8TCB0	1	78649796-78664078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 100.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 54.6;Endothelial cells: 54.5;Microglial cells: 53.4;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 176.5;BJ hTERT+ SV40 Large T+ RasG12V: 216.2;GAMG: 177.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA027148, HPA043858"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA027148: AB_1851411, HPA043858: AB_2678702"	"unprognostic (1.20e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.90e-2)"	18.8	16.8	19.0	25.3	20.0	100.8	16.6	17.7	33.0	19.3	17.6	9.7	20.0	15.4	34.9	10.8	12.1	45.4	21.8	17.6	19.0	21.6	21.0	30.9	20.0	27.0	19.6	13.9	8.8	3.8	14.2	21.4	21.2	9.7	9.3	1.3	71.7	11.4	5.8	10.3	14.5	18.5	24.4	65.0	21.0	7.5	20.3	31.0	16.5	10.9	11.6	21.1	9.6	21.0	7.7	0.3	1.3	0.3	5.3	35.9	0.2	5.0	65.5	176.5	216.2	0.0	22.0	10.3	49.9	4.7	177.9	4.1	0.0	2.9	28.6	22.5	0.0	26.8	20.6	0.0	7.3	0.0	0.0	22.7	0.3	76.8	1.0	13.8	33.5	6.7	0.0	35.1	42.5	0.2	22.7	1.9	0.0	0.1	14.4	17.4	53.6	1.2	5.2	5.0	0.6	1.4	1.8	0.5	82.9	0.0	0.0	1.1	41.6	32.3	13.4	3.6	33.9	3.0	3.8	0.3	50.1	30.4	9.2	0.4	15.4	0.1	6.9	15.4	13.8	2.4	10.0	6.6	7.1	1.7	4.2	5.6	4.5	7.8	8.4	2.0	5.1	6.0	19.0	20.0	17.7	33.0	17.6	19.0	27.0	19.6	21.2	24.4	20.3	21.0	54.6	28.9	16.2	10.7	4.7	3.6	10.2	16.3	5.7	0.0	4.6	5.2	5.4	2.8	21.0	9.2	0.0	0.2	9.9	1.1	0.0	13.1	0.6	6.7	4.4	54.5	6.7	4.6	0.0	12.3	0.3	15.8	11.7	7.0	18.3	25.1	43.5	3.6	29.5	0.0	2.1	1.7	6.1	34.2	7.6	1.1	13.4	38.1	5.4	53.4	27.8	0.6	5.2	51.8	0.5	11.8	0.1	17.3	3.2	5.1	3.8	2.7	20.7	0.3	19.7	12.3	12.4	0.3	0.5	4.4	4.5	0.0	22.4	24.8	2.5	14.0
IFIT3	"CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G"	ENSG00000119917	"Interferon induced protein with tetratricopeptide repeats 3"	O14879	10	89327307-89377473	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 89.5;Ductal cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 488.1"	"Group enriched"	"Detected in all"	19	"granulocytes: 488.1;monocytes: 125.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 198.8;BJ hTERT+ SV40 Large T+: 468.4;BJ hTERT+ SV40 Large T+ RasG12V: 540.2"					"Low region specificity"	"Detected in all"			HPA059914	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Mitochondria, Cytosol"		"HPA059914: AB_2684159"	"unprognostic (2.81e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.25e-3)"	"unprognostic (3.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.09e-2)"	21.3	20.1	10.5	20.4	22.7	42.9	14.3	15.9	14.8	11.5	1.5	11.2	25.4	12.9	11.7	6.8	17.7	24.6	15.5	11.8	15.9	19.3	28.6	44.2	9.0	24.7	17.0	18.1	7.4	5.4	6.1	31.1	25.0	6.0	9.0	3.8	34.6	12.5	7.1	6.4	18.7	18.1	37.2	47.6	12.6	6.8	15.7	33.1	7.4	14.8	5.3	13.5	7.8	35.0	38.7	2.7	0.9	10.3	41.7	43.9	0.5	25.4	198.8	468.4	540.2	2.0	54.3	3.3	11.2	39.0	112.0	33.6	0.6	4.9	34.0	5.6	0.7	15.9	10.1	1.2	23.8	4.5	13.8	27.8	0.6	40.6	3.4	17.9	2.8	1.5	1.1	8.3	12.7	0.3	10.7	11.7	0.7	0.1	12.1	10.2	3.3	2.4	13.3	19.1	0.4	0.2	5.9	0.7	96.8	1.4	1.4	5.7	4.0	8.2	1.9	14.7	7.4	13.8	11.3	0.9	12.0	19.9	7.9	105.7	45.8	172.5	4.6	101.9	1.0	9.7	6.6	3.0	15.6	10.9	3.7	4.5	488.1	2.1	125.0	3.5	16.3	19.4	10.5	22.7	15.9	14.8	11.8	15.9	24.7	17.0	25.0	37.2	15.7	35.0	89.5	51.3	10.1	5.9	8.0	3.2	6.7	13.0	4.0	10.7	3.1	5.5	32.5	10.0	12.5	9.2	4.2	5.2	8.3	6.8	21.5	70.6	0.9	26.0	16.6	66.4	0.0	10.3	9.1	36.3	12.8	20.1	4.6	39.3	13.9	19.8	20.0	13.6	34.6	60.6	8.4	4.0	4.1	21.7	4.4	0.5	30.4	26.8	3.6	17.8	22.0	20.8	8.2	6.0	50.2	23.3	9.4	28.2	2.5	10.0	34.6	14.5	12.3	2.1	46.0	16.0	22.2	1.2	1.6	2.9	1.8	1.9	6.3	14.4	3.7	6.2
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159740	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense, Growth regulation"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.5;lymphoid tissue: 7.4"	"Group enriched"	"Detected in many"	12	"dendritic cells: 283.2;T-cells: 200.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.5;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.6;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010344	Approved				"Secreted to blood"	NA	NA	1470		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 7: Non-specific - Mitochondria"			"CAB010344: AB_2123447"	"unprognostic (2.16e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-4)"	"unprognostic (5.14e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-4)"	"unprognostic (7.79e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.62e-9)"	"unprognostic (3.54e-2)"	"unprognostic (5.36e-1)"	"unprognostic (6.32e-2)"	"unprognostic (7.38e-3)"	0.7	0.7	0.1	3.5	0.2	11.5	0.3	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.0	0.0	0.3	1.5	1.8	7.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.9	0.2	0.0	0.0	0.3	0.2	0.0	1.3	0.4	0.1	0.1	0.5	0.3	0.0	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	2.4	6.6	0.0	0.4	0.5	3.7	0.1	0.9	0.0	0.0	0.1	0.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.7	0.0	0.0	0.0	3.1	3.2	1.3	0.0	0.0	0.0	4.8	5.5	0.2	1.5	0.0	0.0	0.0	0.0	283.2	0.1	0.0	0.0	0.2	1.0	1.1	1.3	0.0	0.4	0.0	0.0	0.0	1.5	6.1	1.1	0.0	0.0	1.4	1.2	0.1	0.0	0.0	0.5	0.0	4.4	5.5	0.0	0.0	10.4	7.2	0.0	0.0	0.0	19.6	0.0	0.1	0.0	1.1	0.0	10.9	0.2	0.0	0.3	0.0	0.0	0.0	1.0	2.9	0.0	0.0	0.8	4.0	0.0	200.1	0.0	0.2	0.2
IGHD2-15	"D2, IGHD215"	ENSG00000211918	"Immunoglobulin heavy diversity 2-15"		14	105897957-105897987	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"bone marrow: 2.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	8	"naive B-cell: 39.9"	"Lineage enriched"	"Detected in single"	400	"B-cells: 39.9"	"Cell line enriched"	"Detected in single"	28	"HEL: 2.7"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"																						0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHD2-8	"DLR1, IGHD28"	ENSG00000211925	"Immunoglobulin heavy diversity 2-8"		14	105907211-105907241	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.7;lymphoid tissue: 1.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	33	"naive B-cell: 3.2"	"Lineage enriched"	"Detected in single"	33	"B-cells: 3.2"	"Not detected"	"Not detected"																	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"																							0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHD3-3	"DXP4, IGHD33"	ENSG00000211930	"Immunoglobulin heavy diversity 3-3"		14	105914359-105914389	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 4.3;lymphoid tissue: 2.6;salivary gland: 3.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	5	"naive B-cell: 62.6"	"Lineage enriched"	"Detected in single"	626	"B-cells: 62.6"	"Group enriched"	"Detected in some"	48	"NB-4: 6.9;SH-SY5Y: 2.6"															NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"												"unprognostic (1.34e-1)"			"unprognostic (1.69e-1)"			"unprognostic (3.13e-1)"	"unprognostic (1.75e-1)"			0.0	0.0	0.0	0.9	0.1	4.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.0	0.0	1.0	0.0	0.0	1.9	1.6	0.1	0.0	0.1	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	62.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.9;Kupffer cells: 81.4;Macrophages: 61.4;monocytes: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 59.9;NB-4: 52.5;THP-1: 74.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		62000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	9.1	5.6	5.5	9.6	11.3	31.8	6.9	5.7	7.5	5.4	6.8	4.7	3.8	5.4	5.0	5.2	6.0	3.6	4.6	6.3	5.5	3.7	5.7	10.0	6.9	9.8	7.3	4.5	5.2	3.9	3.8	3.5	8.9	5.0	3.4	1.5	5.2	2.8	1.8	6.9	6.2	5.3	7.7	16.6	5.6	2.0	7.7	15.4	4.2	2.6	5.6	4.6	4.7	9.6	7.9	4.5	4.1	5.1	8.0	4.6	5.1	11.5	7.4	5.3	6.8	4.4	5.1	7.1	4.6	11.6	6.9	12.4	5.6	5.4	3.7	11.6	6.6	0.0	2.6	2.8	9.2	59.9	17.8	6.8	7.9	4.7	3.7	5.2	5.7	5.6	3.0	7.3	5.5	6.7	7.2	52.5	2.2	10.1	4.3	1.6	0.8	1.3	5.1	5.8	2.8	0.1	8.0	6.7	5.7	4.6	5.3	74.7	15.9	4.1	5.8	6.1	4.3	5.8	3.4	3.3	6.0	28.3	4.5	8.5	7.4	7.2	1.1	3.4	0.9	0.5	1.5	1.2	3.9	0.4	2.4	1.8	16.5	1.5	3.5	1.8	1.0	2.6	5.5	11.3	5.7	7.5	6.3	5.5	9.8	7.3	8.9	7.7	7.7	9.6	14.0	12.8	14.1	2.9	13.8	8.8	6.6	10.2	10.8	3.9	7.2	5.8	6.1	10.0	8.6	5.5	8.4	6.1	18.7	23.6	0.0	8.7	4.0	7.2	8.1	13.7	13.2	9.2	8.3	12.6	11.9	13.6	29.0	9.7	7.6	58.9	17.5	11.1	34.0	3.3	6.4	13.9	6.1	81.4	16.2	2.1	9.0	61.4	8.8	41.2	114.2	4.3	28.8	12.5	11.4	12.2	12.4	4.5	10.3	9.1	14.7	3.4	8.0	2.9	13.1	10.4	10.0	3.0	13.4	9.0	6.8	6.4	25.4	8.1	12.4	9.6
IL18RAP	"AcPL, CD218b"	ENSG00000115607	"Interleukin 18 receptor accessory protein"	O95256	2	102418689-102452565	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 104.6;lymphoid tissue: 46.7"	"Group enriched"	"Detected in some"	6	"dendritic cells: 42.2;NK-cells: 66.9;T-cells: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 118.1"	"Group enriched"	"Detected in many"	107	"granulocytes: 67.6;NK-cells: 118.1;T-cells: 65.2"	"Cell line enriched"	"Detected in some"	11	"U-937: 54.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025270	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025270: "	"unprognostic (1.73e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.07e-3)"	"unprognostic (4.64e-6)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.86e-5)"	"unprognostic (5.09e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.73e-2)"	6.8	0.6	0.4	12.0	0.4	104.6	1.5	0.3	1.1	0.7	0.7	2.0	2.3	0.5	0.3	1.1	5.5	3.0	1.6	0.3	0.4	1.5	3.5	16.2	2.6	0.4	0.4	0.4	0.6	0.1	0.6	1.4	0.7	1.1	1.7	0.0	0.8	0.6	0.5	0.4	6.3	1.0	0.5	46.7	2.6	0.1	0.6	0.8	1.1	1.1	2.8	2.5	1.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.1	2.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.3	0.2	0.1	19.3	46.2	0.1	65.2	0.0	5.9	12.6	0.5	0.0	0.2	1.5	67.6	118.1	0.0	0.7	0.4	6.4	0.4	0.4	0.3	1.1	0.3	0.4	0.4	0.4	0.7	0.5	0.6	0.4	0.4	3.2	1.1	0.0	0.8	0.3	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.1	1.3	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.8	5.3	0.0	0.0	1.9	0.0	1.9	0.6	0.0	66.9	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	22.5	0.0	0.0	0.0
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836816	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 201.7;urinary bladder: 126.2"	"Group enriched"	"Detected in many"	11	"Langerhans cells: 1451.9;Macrophages: 1510.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 94.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 649.3;HBEC3-KT: 293.3;HMC-1: 235.1;hTEC/SVTERT24-B: 319.1;hTERT-RPE1: 277.0;U-87 MG: 571.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	2330		"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.55e-3)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (1.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.01e-2)"	43.9	7.6	2.5	53.6	2.2	201.7	2.0	3.1	4.6	3.7	4.2	8.1	3.0	7.4	2.0	3.4	4.1	19.0	3.3	2.3	3.4	7.7	9.1	17.4	9.5	4.8	4.6	0.8	4.4	3.0	2.6	7.8	3.8	6.1	6.5	0.3	3.8	1.8	0.1	0.7	3.5	9.2	4.4	17.8	25.5	1.1	2.8	9.4	2.6	7.0	12.8	126.2	1.0	6.6	6.3	0.1	0.2	0.0	0.4	0.0	0.0	2.1	649.3	3.1	6.5	0.0	0.0	0.0	18.0	0.5	11.3	14.7	0.0	293.3	39.2	0.0	0.0	29.5	0.4	0.0	2.2	0.0	235.1	1.1	8.9	319.1	103.5	277.0	0.0	0.1	0.0	0.8	0.6	0.0	0.0	2.9	0.1	1.2	26.2	1.0	0.0	0.0	0.0	48.2	0.0	0.0	1.7	0.0	2.5	0.0	0.0	2.8	0.0	15.3	0.2	0.7	0.5	0.1	0.0	0.2	571.5	14.0	22.7	1.7	12.3	4.4	0.0	19.5	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	94.1	0.2	7.7	0.0	0.0	3.4	2.5	2.2	3.1	4.6	2.3	3.4	4.8	4.6	3.8	4.4	2.8	6.6	23.8	9.6	28.2	0.0	14.1	30.8	5.4	25.4	0.0	0.2	8.2	13.3	4.8	0.0	16.2	1.8	0.0	1.5	7.5	2.8	0.0	33.2	0.3	4.9	5.0	20.0	0.0	58.9	0.0	0.6	2.6	8.1	44.4	8.4	41.7	0.0	1.4	0.4	108.1	0.0	0.0	12.7	14.2	130.5	1451.9	0.7	0.0	1510.7	23.2	1.9	7.9	0.3	0.0	0.0	0.0	2.9	10.0	0.0	9.3	4.7	0.2	0.7	8.6	0.3	0.0	1.5	4.3	0.0	0.4	8.3	20.3	4.4	6.3	0.0	1.9	6.1
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.0;dendritic cells: 137.5;Endothelial cells: 83.2;Langerhans cells: 47.6;monocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 2665.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 2665.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 128.8;NB-4: 24.9;RPMI-8226: 54.1"									"HPA003539, CAB018374"	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB018374: AB_2233620, HPA003539: AB_1078438"	"prognostic favorable (9.78e-4)"	"prognostic favorable (4.27e-4)"	"unprognostic (8.13e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	25.2	2.9	7.1	15.8	13.6	25.0	20.6	16.1	11.7	6.4	0.2	8.1	5.5	8.7	1.6	5.4	8.0	11.3	13.0	5.9	8.1	9.2	1.8	25.0	25.1	11.7	10.6	8.8	5.4	3.4	2.8	6.2	11.1	7.0	6.6	22.0	9.5	3.2	12.1	12.7	9.2	12.3	7.5	11.1	6.9	3.5	10.1	4.4	10.3	8.6	13.0	12.4	6.3	20.5	0.2	9.4	3.6	1.3	0.1	0.0	1.1	1.2	0.3	0.0	0.1	0.9	1.5	1.2	7.2	0.2	0.6	9.6	0.0	0.0	0.0	128.8	3.9	0.6	2.1	0.4	0.0	0.8	15.6	0.0	0.0	0.0	0.0	4.1	8.2	0.9	0.3	6.1	0.0	1.4	0.7	24.9	3.1	0.8	0.5	1.4	4.2	54.1	0.0	1.4	0.6	0.4	0.6	0.3	2.8	1.8	1.2	17.8	0.4	0.5	1.5	0.5	0.3	12.5	3.9	1.1	9.8	2.8	0.1	2665.0	5.6	83.9	0.6	31.7	1.0	2.5	0.9	0.5	14.9	8.9	0.7	0.7	4.6	14.2	42.5	628.5	0.5	12.0	7.1	13.6	16.1	11.7	5.9	8.1	11.7	10.6	11.1	7.5	10.1	20.5	79.0	3.2	1.8	11.8	6.8	5.9	0.7	0.9	1.2	2.3	0.5	0.9	2.2	1.5	1.0	0.0	10.4	0.1	137.5	4.7	0.0	0.4	0.2	2.7	1.4	83.2	0.0	3.0	7.3	0.2	0.1	4.3	0.5	1.5	11.4	0.4	24.3	0.7	4.6	0.0	14.3	7.3	0.0	2.8	47.6	0.1	0.3	32.9	8.8	13.1	72.6	0.6	1.0	6.0	18.2	0.1	3.4	0.7	4.0	0.7	0.2	0.0	0.4	3.2	0.0	3.6	3.2	0.1	0.7	0.7	5.5	0.3	1.6	1.3	0.6	2.1
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66189195-66254622	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"			Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.3;Kupffer cells: 123.0;Macrophages: 126.3;Microglial cells: 114.3;monocytes: 96.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.7;classical monocyte: 23.4;intermediate monocyte: 24.2;myeloid DC: 11.5;neutrophil: 12.9;non-classical monocyte: 42.0"	"Group enriched"	"Detected in many"	12	"dendritic cells: 11.5;granulocytes: 12.9;monocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;ASC TERT1: 21.1;HEL: 22.9;HL-60: 30.8;NB-4: 25.1;THP-1: 37.3;U-937: 26.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	18.7	3.8	3.7	12.4	4.1	78.1	11.6	4.1	7.5	9.3	5.4	4.6	1.3	4.0	3.0	3.8	8.0	6.9	7.9	3.2	4.7	3.5	2.8	19.0	4.1	5.6	5.7	3.2	2.5	0.9	8.9	6.8	6.5	5.3	2.8	0.4	6.2	5.6	2.6	3.4	5.6	5.4	5.0	27.5	6.9	1.8	5.6	2.7	5.0	4.6	3.9	8.4	6.6	5.1	0.0	0.0	0.4	0.0	25.9	21.1	0.0	2.9	0.0	1.5	2.3	0.0	2.2	0.0	1.4	5.3	0.0	0.0	3.2	0.0	1.3	0.0	0.0	22.9	1.4	0.0	13.4	30.8	4.0	13.5	0.1	1.2	0.0	0.0	7.6	0.0	0.0	0.0	1.0	0.0	0.0	25.1	1.3	0.0	0.0	0.0	6.4	0.0	0.1	3.3	0.1	0.0	11.6	0.0	1.2	0.1	0.1	37.3	8.2	0.0	0.0	0.0	0.0	0.9	0.2	2.2	0.0	26.8	0.0	12.7	23.4	4.3	0.0	24.2	0.0	0.1	0.0	0.0	11.5	0.7	0.0	0.0	12.9	1.8	42.0	0.1	0.6	7.3	3.7	4.1	4.1	7.5	3.2	4.7	5.6	5.7	6.5	5.0	5.6	5.1	83.3	9.6	19.4	1.3	2.3	1.5	4.8	27.5	6.2	0.3	2.5	1.8	2.8	0.0	46.9	3.7	0.0	0.2	14.8	0.5	0.0	0.6	6.4	0.5	7.5	38.5	0.0	9.7	0.4	1.2	0.4	22.3	18.3	0.5	27.3	0.5	36.4	1.2	9.4	0.0	5.6	1.1	36.7	123.0	12.1	5.3	7.2	126.3	5.4	114.3	96.9	0.2	3.1	2.0	0.6	4.9	0.1	11.3	9.1	1.6	0.0	0.2	35.1	0.1	0.0	18.1	10.2	0.8	1.8	1.2	1.3	0.3	3.5	12.5	0.7	2.5
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 376.2;lymphoid tissue: 175.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 417.6;Hofbauer cells: 652.4;Kupffer cells: 485.9;Langerhans cells: 259.1;Macrophages: 527.4;monocytes: 463.8;NK-cells: 959.9;T-cells: 254.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"THP-1: 812.4;U-937: 615.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		NA	NA		3300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	54.5	23.2	8.2	175.2	9.5	376.2	15.4	13.1	9.3	15.5	11.7	25.2	23.8	8.5	2.8	16.2	17.0	36.4	11.8	7.7	14.2	8.4	23.4	78.0	169.1	29.5	19.9	7.2	11.3	5.1	4.6	44.4	28.1	8.8	13.9	1.1	19.5	9.2	6.8	9.3	32.8	46.4	23.9	137.2	29.1	5.9	26.2	87.2	7.3	7.6	68.4	46.3	5.9	50.4	1.9	4.8	0.0	0.0	0.0	0.3	1.7	0.0	2.7	0.1	0.0	0.4	0.4	17.9	128.1	0.2	0.6	0.5	0.0	0.2	0.0	1.5	1.4	18.2	0.0	3.2	0.1	106.6	27.5	1.6	0.1	0.5	0.3	0.1	0.3	58.0	0.7	1.4	7.0	4.0	117.8	126.1	0.4	0.4	2.4	1.5	23.2	64.6	4.7	0.0	0.6	1.3	3.4	2.5	1.7	0.0	0.4	812.4	2.5	0.2	6.6	0.4	3.7	0.8	5.9	2.9	0.1	615.0	0.9	186.6	1848.8	1224.1	726.7	1144.9	326.6	86.1	349.7	506.5	1031.4	115.2	233.1	396.5	1386.1	585.5	1183.5	165.5	288.0	3034.2	8.2	9.5	13.1	9.3	7.7	14.2	29.5	19.9	28.1	23.9	26.2	50.4	7.1	16.0	29.6	0.3	81.7	5.5	0.5	9.6	0.6	0.0	4.1	6.5	4.0	14.3	18.6	5.5	0.0	4.0	417.6	0.3	0.0	3.4	1.0	0.6	0.5	16.8	0.0	19.6	0.5	0.4	4.8	5.3	2.6	0.7	24.1	8.2	9.7	8.6	652.4	0.0	0.3	0.2	2.0	485.9	259.1	2.8	0.6	527.4	5.4	27.2	463.8	0.4	959.9	0.0	0.2	0.6	0.1	1.5	50.5	0.6	1.8	4.2	3.6	0.8	6.6	2.1	3.2	0.2	1.0	0.9	5.1	5.6	254.5	0.0	0.3	0.7
JDP2	JUNDM2	ENSG00000140044	"Jun dimerization protein 2"	Q8WYK2	14	75427716-75474111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.7;Kupffer cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 11.8;granulocytes: 7.7;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059511	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear speckles"		"HPA059511: AB_2684046"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.30e-3)"	53.5	20.0	23.2	29.3	22.0	78.6	40.2	22.8	28.2	31.6	22.0	31.6	22.5	22.7	3.7	25.4	28.5	27.7	39.1	23.5	24.2	18.9	20.5	47.2	13.1	24.6	22.9	21.6	23.1	8.1	17.3	17.5	22.6	21.8	11.3	16.4	24.2	15.0	21.9	29.1	30.1	20.9	22.6	66.8	23.3	4.7	25.4	4.8	25.1	16.7	10.6	25.3	31.6	21.8	15.5	13.5	2.5	26.8	81.5	60.2	90.5	47.5	51.0	30.4	38.1	33.0	13.5	12.4	23.5	90.7	5.6	59.5	16.7	16.2	13.1	16.7	1.9	17.0	26.0	11.9	167.1	24.1	1.3	106.5	95.2	12.4	30.6	11.9	1.5	13.8	2.2	23.0	27.7	76.4	1.4	39.8	9.1	30.4	8.7	8.2	0.3	34.0	14.8	8.6	2.1	10.4	48.9	69.4	55.1	29.7	66.4	52.1	6.2	38.1	57.5	2.4	7.0	18.7	6.0	28.8	11.5	90.0	19.1	0.1	4.5	4.4	0.0	8.1	0.0	11.8	0.2	0.0	2.4	5.1	0.0	0.0	7.7	0.1	13.2	2.1	0.2	1.4	23.2	22.0	22.8	28.2	23.5	24.2	24.6	22.9	22.6	22.6	25.4	21.8	70.7	12.8	33.5	26.8	9.9	16.4	6.0	5.8	19.9	21.8	26.2	18.2	17.7	12.8	8.1	9.2	10.4	1.4	1.2	20.0	0.0	2.4	0.3	21.6	18.4	21.2	5.4	0.8	18.9	6.6	5.6	49.5	10.2	23.9	2.5	10.1	10.4	8.5	9.7	8.4	20.8	14.9	4.1	87.7	25.7	1.5	18.0	47.3	12.4	14.0	13.8	38.6	2.1	18.1	3.0	8.5	8.2	16.6	9.8	2.6	17.7	3.0	7.4	31.1	6.6	47.2	19.5	0.1	0.9	19.7	8.9	0.3	2.2	5.3	8.7	11.5
KLF6	"BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9"	ENSG00000067082	"Kruppel like factor 6"	Q99612	10	3775996-3785281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 436.6"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 2075.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013529, HPA069585"	Supported		Supported	Nucleoplasm,Nucleoli,Vesicles,Cytosol		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Vesicles, Cytosol"	"CAB013529: AB_2533431, HPA069585: AB_2686157"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.35e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (8.07e-3)"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.37e-2)"	211.3	46.9	19.0	122.1	18.0	436.6	129.7	19.2	22.4	95.4	21.9	92.1	55.4	98.1	17.7	165.5	77.2	181.9	49.7	18.0	19.2	64.1	141.8	117.0	65.4	29.4	20.1	47.3	118.3	31.8	12.0	98.2	25.2	32.8	99.6	18.4	73.8	33.7	84.9	197.1	106.0	208.2	22.7	64.3	73.2	14.6	23.0	56.8	193.9	41.3	45.0	136.3	92.7	25.0	55.0	14.7	27.2	9.0	155.1	154.3	17.1	91.7	46.5	95.9	64.8	38.0	71.4	15.6	20.8	100.0	74.5	32.7	17.0	84.9	79.5	76.6	10.2	2.2	17.5	35.8	66.4	10.3	51.5	51.4	158.2	68.6	129.3	34.2	99.3	10.1	17.5	117.9	123.6	4.0	19.4	15.9	10.2	29.2	26.0	12.6	28.2	55.5	94.1	53.4	12.0	11.5	22.5	64.0	142.8	73.5	32.0	8.6	130.9	128.7	17.8	76.9	43.0	22.6	78.1	28.6	34.7	13.7	40.8	318.8	85.2	234.1	129.8	74.2	115.9	81.1	147.4	131.5	67.6	70.9	44.9	69.0	391.6	72.5	104.6	152.8	120.6	148.7	19.0	18.0	19.2	22.4	18.0	19.2	29.4	20.1	25.2	22.7	23.0	25.0	511.0	1246.8	489.4	14.0	716.9	585.5	1298.4	625.8	1227.0	39.6	985.9	630.0	63.6	544.7	451.9	138.0	33.3	163.1	518.3	1507.0	21.5	808.6	58.0	1065.6	618.9	469.9	397.3	77.9	18.5	553.0	473.8	545.5	1120.3	1905.9	626.7	195.9	248.4	309.9	583.6	37.0	10.0	746.7	429.3	968.7	885.1	53.2	130.5	992.1	483.8	58.1	609.8	42.9	150.4	7.5	4.3	857.9	949.9	133.9	1172.5	600.2	1009.9	97.4	342.0	90.1	138.1	194.8	441.8	9.0	19.4	2075.6	628.2	195.9	920.5	67.1	542.0	572.5
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757774	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1285.7;lymphoid tissue: 672.2"	"Group enriched"	"Detected in many"	4	"B-cells: 872.9;dendritic cells: 340.2;granulocytes: 639.8;Hofbauer cells: 1150.4;Kupffer cells: 942.2;Langerhans cells: 489.6;Macrophages: 925.0;monocytes: 446.1;NK-cells: 562.3;T-cells: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 554.0;HEL: 1053.2;HL-60: 676.4;HMC-1: 2382.4;REH: 785.2;U-698: 898.1;U-937: 542.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	144.7	82.1	47.6	443.0	49.7	1285.7	60.4	49.7	90.4	53.1	55.7	82.2	68.1	27.3	16.7	49.5	46.8	137.9	31.6	45.2	62.7	30.5	98.6	284.9	672.2	82.4	67.3	16.4	30.2	21.8	22.6	145.2	75.8	31.5	90.6	5.9	38.5	30.9	9.2	24.0	155.9	93.5	69.2	491.1	72.9	10.9	81.1	298.3	38.5	20.9	636.5	161.1	22.8	114.9	1.2	0.0	1.7	0.0	0.1	0.1	0.6	0.9	0.3	0.5	0.1	0.7	1.2	554.0	56.0	1.7	1.9	2.2	0.0	0.8	0.5	62.3	0.0	1053.2	0.0	1.6	0.9	676.4	2382.4	0.6	1.2	0.6	4.1	0.3	124.2	70.7	13.8	34.0	8.8	0.0	117.5	142.2	0.7	0.0	0.0	785.2	99.6	391.6	0.8	0.1	0.6	0.4	1.3	1.3	1.1	1.0	0.5	422.2	145.3	0.6	3.0	0.6	3.4	2.7	0.7	898.1	3.1	542.8	1.8	1094.2	1522.8	1446.7	538.5	1046.1	616.3	823.6	485.5	502.8	825.7	1089.4	481.2	481.2	1709.5	327.0	1075.7	392.7	656.9	2740.4	47.6	49.7	49.7	90.4	45.2	62.7	82.4	67.3	75.8	69.2	81.1	114.9	62.9	25.6	100.4	0.0	872.9	23.8	1.1	1.3	4.0	0.0	6.2	10.4	5.5	14.3	13.9	3.7	0.0	5.8	340.2	0.8	0.0	1.2	2.0	1.4	0.9	60.2	1.2	78.2	0.2	0.7	8.4	12.3	10.2	1.1	639.8	0.2	47.2	9.4	1150.4	0.0	0.8	0.9	0.0	942.2	489.6	4.9	1.5	925.0	49.8	43.1	446.1	0.3	562.3	0.5	0.5	1.4	0.2	0.4	144.8	0.9	0.5	3.0	11.4	1.3	0.0	4.1	5.6	0.3	1.1	1.8	20.0	8.9	432.7	18.2	2.4	1.9
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 701.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 2578.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 2578.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	139.3	43.7	53.5	165.8	81.9	207.0	95.5	79.6	70.0	121.2	70.5	121.1	46.3	100.5	77.8	62.7	108.2	114.1	63.9	52.2	63.0	182.3	107.7	192.1	112.3	94.0	79.4	67.6	64.6	56.5	39.0	71.3	92.7	105.9	116.1	63.9	116.4	83.4	36.3	71.6	57.9	93.5	77.3	119.6	70.7	10.6	77.6	68.6	116.8	37.6	123.7	214.1	83.1	109.4	79.2	157.8	89.4	43.8	13.9	11.0	90.7	100.2	309.0	93.6	139.1	62.6	206.3	39.9	126.8	86.1	108.7	95.5	40.1	186.4	88.4	304.2	45.8	2.8	117.1	310.3	212.9	12.5	12.9	35.0	320.8	79.6	210.7	84.4	0.3	2.7	25.3	149.5	1.5	75.8	1.8	183.3	146.4	104.0	0.6	12.1	19.6	228.2	79.0	110.4	22.2	68.0	172.9	219.4	183.9	136.3	122.5	66.7	0.8	38.7	65.3	23.0	24.2	59.2	140.6	100.5	45.1	95.8	225.5	508.8	149.5	284.0	459.6	130.2	277.2	174.0	284.0	412.7	178.0	173.9	318.9	381.4	2578.1	274.5	81.9	220.1	350.3	584.9	53.5	81.9	79.6	70.0	52.2	63.0	94.0	79.4	92.7	77.3	77.6	109.4	297.5	44.8	70.0	7.5	176.7	157.4	336.2	365.4	68.3	2.2	180.5	157.6	48.8	148.7	222.2	163.7	0.0	56.4	505.5	305.4	485.2	245.8	2.3	112.2	151.9	76.3	17.5	18.3	1.1	72.9	471.9	156.7	39.8	108.1	214.9	1.1	94.2	52.9	227.8	0.0	1.6	153.1	175.0	156.9	701.0	11.3	56.2	422.0	156.5	7.5	391.8	232.7	433.5	11.6	59.5	123.3	236.1	68.4	186.3	239.8	23.3	104.3	150.3	5.4	52.6	89.6	176.1	0.2	5.4	37.1	132.1	37.1	278.7	16.6	88.9	368.6
LOXL3		ENSG00000115318	"Lysyl oxidase like 3"	P58215	2	74532258-74555690	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Oxidoreductase	"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.0;Hofbauer cells: 17.9;Kupffer cells: 12.5;Macrophages: 12.3;Microglial cells: 30.0;Muller glia cells: 10.6;Oligodendrocyte precursor cells: 11.6;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 15.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 11.7;non-classical monocyte: 9.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 143.4;HDLM-2: 110.7;U-138 MG: 245.9;WM-115: 549.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035281	Approved				"Secreted to extracellular matrix"	NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA035281: AB_10601766"	"unprognostic (7.54e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.22e-2)"	"unprognostic (7.33e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-2)"	6.8	5.3	4.5	7.8	4.7	14.3	3.0	4.5	5.3	5.1	3.8	7.3	4.0	7.4	1.7	3.2	4.9	6.5	8.2	4.5	5.6	2.0	1.5	4.6	4.1	7.0	5.0	2.9	1.1	1.7	2.7	15.9	6.3	3.3	3.7	4.9	1.6	4.0	1.3	2.0	3.9	8.1	5.6	8.9	2.7	2.6	7.0	1.4	2.2	1.5	2.3	5.2	4.0	7.3	1.6	0.3	21.8	3.7	17.1	20.6	4.5	71.0	143.4	33.8	31.8	25.6	1.3	0.1	0.9	73.1	1.6	1.1	2.8	1.8	19.8	110.7	1.0	17.6	1.8	0.2	5.7	0.6	16.7	22.6	0.2	90.6	3.8	12.0	0.7	0.8	0.8	2.8	6.4	4.1	0.2	6.5	12.0	0.8	0.7	2.0	3.1	0.3	0.3	1.2	11.2	12.8	0.6	1.1	14.7	3.2	2.3	1.3	0.3	245.9	8.2	1.4	0.9	1.4	0.5	0.1	92.5	6.8	549.6	0.1	6.0	0.3	0.0	11.7	0.0	0.1	0.1	0.0	3.5	0.1	0.0	0.0	2.5	0.0	9.3	0.4	0.0	2.6	4.5	4.7	4.5	5.3	4.5	5.6	7.0	5.0	6.3	5.6	7.0	7.3	0.9	0.0	0.5	14.0	0.3	0.9	0.2	0.6	0.6	0.9	0.4	0.8	0.3	1.5	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.8	0.0	0.2	4.8	1.2	0.0	0.4	0.4	0.0	1.5	7.1	0.0	0.5	1.3	0.7	0.4	0.1	17.9	1.7	4.2	0.1	0.0	12.5	2.5	0.7	5.0	12.3	0.0	30.0	4.8	10.6	1.0	11.6	0.6	0.3	0.0	4.5	0.1	0.3	0.0	0.1	0.0	0.9	19.7	1.6	5.3	0.6	0.8	0.1	0.1	0.8	0.4	0.2	0.0	0.2
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lung: 52.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 502.2;Excitatory neurons: 92.0;monocytes: 133.1;Oligodendrocyte precursor cells: 256.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 17.1;thyroid cancer: 22.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 58.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 58.2"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;ASC TERT1: 5.6;BJ hTERT+: 3.2;RPTEC TERT1: 7.8;T-47d: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Supported	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"CAB037160: AB_1840989, HPA014293: AB_1853353"	"unprognostic (2.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.02e-6)"	"unprognostic (2.55e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.01e-3)"	"unprognostic (5.21e-3)"	4.8	3.1	1.1	10.1	1.9	9.0	2.6	0.9	2.1	5.1	1.2	4.3	0.6	4.8	1.9	7.0	4.1	6.2	3.9	1.3	1.1	10.9	5.6	52.4	6.8	1.7	1.1	5.4	3.6	8.4	2.1	1.2	1.4	2.6	1.8	1.5	3.5	2.0	5.5	2.1	3.6	4.0	1.1	10.8	2.1	0.8	1.2	2.5	2.9	7.9	5.4	4.5	5.5	1.9	0.0	4.6	0.0	0.0	2.3	5.6	0.0	1.3	3.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.4	0.0	2.1	0.4	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.3	0.0	0.5	2.7	0.1	3.1	1.5	1.0	0.4	0.5	0.6	0.4	0.0	0.0	0.0	1.3	0.0	1.7	0.0	7.2	2.2	0.0	5.2	0.0	1.8	0.0	0.0	2.1	1.7	0.0	0.0	58.2	0.0	6.9	0.3	0.0	1.3	1.1	1.9	0.9	2.1	1.3	1.1	1.7	1.1	1.4	1.1	1.2	1.9	7.4	32.1	502.2	17.3	29.9	2.4	1.8	0.4	2.8	8.6	1.3	1.4	7.8	5.7	17.3	27.6	0.0	0.0	1.9	0.0	1.9	1.3	0.5	0.4	2.6	7.0	0.0	2.1	92.0	2.7	0.1	16.1	0.5	0.4	13.9	2.7	13.2	8.2	4.6	47.1	28.0	0.0	0.0	55.8	8.7	1.2	19.0	52.2	12.4	73.1	133.1	8.6	3.1	256.9	3.1	0.8	1.1	12.0	2.8	0.6	0.0	22.5	3.4	1.0	0.0	22.5	4.8	0.3	1.0	12.6	3.1	0.4	3.4	11.2	0.0	0.7
LY6G6E	"C6orf22, G6e"	ENSG00000255552	"Lymphocyte antigen 6 family member G6E"		6	31711771-31714065	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;skin 1: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	114	"HEL: 23.7"									HPA056234			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"		Nucleoplasm		"HPA056234: AB_2732601"			"unprognostic (1.77e-1)"							"unprognostic (1.58e-2)"				"unprognostic (2.25e-1)"		"unprognostic (6.88e-2)"		0.1	0.0	0.2	0.0	0.2	1.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.4	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30434021-30461833	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 332.1"	"Cell type enhanced"	"Detected in many"		"Macrophages: 225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	69.1	18.8	7.2	39.9	5.8	332.1	31.8	5.9	8.0	15.1	22.1	19.6	8.3	18.3	5.9	23.2	38.0	37.4	18.5	6.7	13.5	12.7	16.2	64.5	33.7	10.7	8.1	12.0	7.4	6.9	8.4	46.5	8.8	11.1	16.4	10.9	12.5	11.2	6.6	36.0	21.1	35.6	9.3	41.7	20.3	3.0	15.9	9.3	14.7	6.1	28.8	49.4	20.4	7.9	15.5	13.7	3.6	7.7	18.3	15.4	17.3	3.8	20.3	8.2	9.6	9.4	34.2	10.3	9.2	8.1	8.1	28.2	8.4	3.7	3.0	23.3	4.4	19.2	25.6	30.8	16.0	6.0	44.2	19.5	2.1	7.4	1.6	7.7	3.6	0.2	8.8	14.7	1.4	8.8	0.2	22.3	1.4	8.3	4.9	1.3	3.0	5.8	7.9	30.8	0.3	1.6	13.7	11.3	1.9	10.0	3.7	12.7	0.1	4.8	4.3	18.0	0.6	22.4	22.7	3.2	6.9	25.3	0.2	45.8	14.7	53.1	15.7	26.4	8.7	20.8	3.3	10.3	14.5	38.0	0.2	6.0	35.5	28.3	38.7	30.0	1.0	10.3	7.2	5.8	5.9	8.0	6.7	13.5	10.7	8.1	8.8	9.3	15.9	7.9	51.0	38.5	49.6	11.8	147.3	116.9	50.0	91.1	109.8	19.0	51.7	24.3	10.1	11.5	67.5	3.7	0.0	29.3	203.6	13.6	1.9	31.4	0.5	149.3	51.4	55.7	12.0	21.2	7.7	11.3	86.8	66.2	33.1	205.6	71.1	1.1	25.0	3.1	128.2	0.0	7.1	6.3	83.4	113.8	205.5	1.1	8.4	225.1	42.7	30.9	64.7	6.1	36.0	2.0	0.7	23.4	20.7	4.1	107.8	46.8	3.9	3.5	78.8	1.6	6.6	23.6	62.3	0.3	0.8	129.1	84.8	159.4	97.8	1.5	6.5	195.6
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 65.9;lung: 74.2;lymphoid tissue: 35.1"	"Cell type enriched"	"Detected in some"	4	"Macrophages: 147.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Group enriched"	"Detected in some"	5	"classical monocyte: 102.1;neutrophil: 45.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 45.9;monocytes: 102.1"	"Group enriched"	"Detected in some"	6	"THP-1: 53.7;U-937: 166.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			HPA014731	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	4.0	0.5	0.0	19.7	0.0	65.9	0.5	0.0	2.1	0.1	0.0	0.4	0.2	0.1	0.0	0.5	1.7	0.6	1.3	0.0	0.0	0.7	1.5	74.2	0.1	0.0	0.0	0.2	0.7	0.0	0.2	1.8	0.9	0.5	0.1	0.0	0.8	0.0	0.3	0.1	0.6	5.1	0.0	35.1	0.9	0.2	0.7	0.9	0.4	1.5	0.1	4.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	1.4	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	166.6	0.0	0.0	102.1	2.8	0.2	6.0	0.0	0.0	0.3	0.0	14.9	0.0	0.0	0.3	45.9	0.6	0.4	0.9	0.2	38.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.4	19.2	34.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	11.2	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	2.2	0.0	3.6	0.0	0.0	1.0	2.9	0.0	0.0	7.6	0.0	0.0	0.3	28.8	0.0	0.0	0.0	0.0	28.3	0.0	0.1	0.0	147.5	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.2	5.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.8	2.9	0.0	0.0	0.1
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 72.8;NK-cells: 97.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 20.8;HMC-1: 16.4;U-698: 22.4;U-87 MG: 24.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA051176: AB_2681373, HPA070541: AB_2686277"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	4.1	3.8	1.0	6.6	1.8	18.0	2.9	0.0	6.8	5.4	0.8	10.6	6.9	1.8	8.6	3.9	4.1	4.5	0.6	1.1	2.8	2.3	1.5	8.7	6.1	0.0	0.3	1.6	5.7	3.5	7.3	19.3	1.0	5.4	12.2	2.6	5.9	4.1	0.1	3.6	6.4	1.6	0.0	21.1	4.7	1.0	1.3	3.0	5.5	0.4	6.2	6.6	3.7	0.6	3.6	0.0	0.1	0.0	0.0	0.0	2.5	1.9	1.1	0.3	0.1	2.4	4.4	10.3	0.5	0.1	0.1	8.0	0.1	6.6	0.0	2.1	0.8	20.8	2.9	1.2	1.4	4.4	16.4	1.1	7.8	0.1	8.2	0.0	0.0	3.6	0.8	5.9	0.0	0.0	2.0	11.4	0.8	3.6	3.7	4.7	0.1	4.0	0.5	10.7	1.9	0.4	0.2	3.4	1.3	0.8	0.0	0.3	0.2	0.1	1.7	0.0	0.0	12.0	0.3	22.4	24.1	11.1	1.2	6.6	0.8	12.1	6.1	0.2	3.0	3.5	1.7	2.8	0.0	3.6	0.7	2.7	32.1	10.9	0.9	0.3	0.1	1.9	1.0	1.8	0.0	6.8	1.1	2.8	0.0	0.3	1.0	0.0	1.3	0.6	1.1	3.2	18.6	1.0	38.9	4.2	12.9	8.6	22.8	15.6	3.8	4.3	1.1	7.2	13.2	3.7	0.0	17.0	72.8	39.4	0.0	3.4	4.0	6.5	3.4	1.8	15.6	35.7	15.6	4.7	7.3	7.8	5.6	6.6	36.2	0.3	1.4	1.4	9.6	0.0	10.3	43.8	8.2	8.7	2.1	4.8	0.3	11.1	1.8	25.3	4.7	0.1	97.9	0.0	0.7	4.2	24.6	0.0	45.8	14.2	18.1	1.9	8.7	0.6	0.0	2.5	1.6	3.4	2.5	15.0	2.3	24.5	26.6	0.5	21.5	19.6
MFSD1	"FLJ14153, Minerva, UG0581B09"	ENSG00000118855	"Major facilitator superfamily domain containing 1"	Q9H3U5	3	158732198-158829719	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 214.4;Kupffer cells: 289.7;Macrophages: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 254.5;granulocytes: 246.0;monocytes: 288.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065858	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Cytosol	"HPA065858: AB_2685569"	"unprognostic (9.94e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.57e-1)"	39.7	27.4	11.0	38.1	12.9	35.9	26.9	20.2	15.8	22.5	23.8	31.1	25.7	16.1	19.4	35.0	21.4	32.3	17.2	15.7	14.5	30.3	39.5	40.5	34.5	15.8	12.2	17.9	31.5	36.0	7.5	30.7	16.4	26.8	22.2	8.4	48.4	23.4	11.1	23.4	23.2	26.2	11.5	42.0	36.1	18.0	16.1	16.1	27.9	16.9	21.5	40.0	19.6	17.3	83.3	28.9	9.1	26.3	51.0	45.0	35.9	109.7	61.8	46.5	45.9	10.3	82.8	19.7	73.5	81.9	24.1	37.0	22.0	26.7	40.9	68.2	33.7	57.2	24.0	6.7	52.1	206.0	135.7	59.3	38.5	39.7	9.5	15.9	38.0	14.0	39.9	32.9	85.1	19.2	11.3	83.2	8.5	29.9	50.9	19.8	11.3	170.9	18.1	16.3	18.2	29.8	76.7	70.0	25.0	8.3	56.9	100.1	102.8	58.6	23.2	87.3	60.5	98.3	94.4	9.6	74.1	162.0	39.7	102.4	288.8	246.0	36.6	223.4	35.3	54.2	30.3	33.9	254.5	44.5	32.2	35.5	97.1	32.9	187.8	81.8	38.9	252.1	11.0	12.9	20.2	15.8	15.7	14.5	15.8	12.2	16.4	11.5	16.1	17.3	28.5	19.2	34.0	12.1	39.6	21.4	46.2	38.4	33.0	11.8	33.3	19.7	22.2	20.0	51.6	22.0	6.2	27.5	24.1	33.3	19.6	34.0	5.3	13.6	22.7	28.2	22.8	56.0	14.6	28.5	33.6	33.7	23.9	17.2	48.8	8.9	37.1	34.4	214.4	18.5	15.2	28.6	34.6	289.7	90.7	6.7	12.2	212.3	32.0	16.9	88.7	26.0	25.7	15.1	29.4	29.0	29.9	11.3	32.9	30.0	27.1	31.8	59.3	10.5	13.1	11.8	23.8	11.6	8.7	61.2	26.0	56.0	22.3	19.4	28.3	58.4
MFSD10	"IT10C3, TETRAN"	ENSG00000109736	"Major facilitator superfamily domain containing 10"	Q14728	4	2930561-2934834	"Predicted membrane proteins"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 251.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 275.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043209	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear membrane"	Nucleoplasm	"HPA043209: AB_2678364"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.76e-2)"	"unprognostic (9.43e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (8.32e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.00e-2)"	35.2	20.2	15.8	9.9	16.4	66.1	30.5	13.6	24.1	43.1	19.3	30.3	12.3	34.7	3.3	27.6	36.9	12.5	26.5	16.1	14.4	33.6	10.8	36.9	13.2	16.9	14.7	41.6	29.0	3.6	28.7	11.5	14.7	34.3	3.8	1.1	30.4	11.3	14.0	22.0	31.0	7.6	13.2	36.1	31.6	15.6	17.6	6.3	37.6	3.4	6.3	34.6	32.8	14.3	50.4	46.2	13.3	33.7	21.7	15.5	36.0	45.1	21.9	21.5	24.6	24.7	117.3	8.8	23.7	28.4	40.0	45.9	12.1	65.6	5.8	56.9	40.7	19.1	39.2	25.9	36.5	59.9	27.1	23.5	37.5	24.5	15.4	33.4	24.7	20.0	26.4	18.0	16.5	53.8	16.9	275.6	43.0	38.9	54.5	20.7	6.4	41.8	32.9	30.6	34.2	40.7	10.8	31.5	49.1	13.5	82.9	112.9	37.1	17.7	30.4	22.2	36.6	12.2	5.8	13.8	50.0	153.3	27.8	64.7	55.0	117.4	73.0	71.2	62.6	45.1	46.8	82.1	57.4	35.2	23.3	41.1	44.2	45.9	95.8	45.7	34.4	42.6	15.8	16.4	13.6	24.1	16.1	14.4	16.9	14.7	14.7	13.2	17.6	14.3	64.6	38.5	29.1	17.6	41.3	31.4	78.8	251.5	28.5	9.2	56.3	68.1	5.0	28.6	123.2	46.0	8.4	67.4	71.0	37.8	3.9	96.0	11.7	41.5	33.4	41.1	28.2	13.3	21.5	45.9	93.0	42.9	33.6	44.3	32.4	50.7	45.7	3.1	69.6	15.2	14.8	37.2	93.6	49.3	36.7	18.8	36.4	45.6	42.7	9.4	62.1	11.0	64.9	9.5	8.8	86.0	51.5	22.6	28.1	92.1	60.0	17.9	104.9	10.0	92.1	27.0	56.6	15.5	16.1	26.9	26.9	83.7	62.4	44.7	49.4	100.5
MICAL1	"DKFZp434B1517, FLJ11937, FLJ21739, MICAL, NICAL"	ENSG00000135596	"Microtubule associated monooxygenase, calponin and LIM domain containing 1"	Q8TDZ2	6	109444062-109465968	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 148.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030175, HPA030176, HPA030178"	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA030175: AB_2673359, HPA030176: AB_2673360, HPA030178: AB_10600824"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (2.05e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	20.6	6.3	17.8	27.6	17.5	65.9	14.2	17.8	25.6	48.6	16.1	21.7	37.8	29.6	2.5	11.8	32.7	14.7	11.1	17.8	19.9	18.8	5.4	35.2	32.8	20.7	18.4	13.6	8.7	9.2	17.9	10.7	20.6	30.8	10.1	6.2	11.0	18.8	5.1	16.0	43.2	9.1	18.1	56.7	18.3	18.7	20.3	18.3	12.6	3.9	16.6	62.2	30.8	22.4	4.1	5.1	15.8	0.2	55.9	43.6	10.7	31.3	22.0	6.7	11.0	7.3	4.7	23.2	6.6	33.1	19.4	5.4	9.6	12.3	2.8	20.3	4.0	9.9	12.0	11.5	22.8	6.5	0.3	25.7	6.2	15.5	12.6	25.2	20.0	14.0	2.7	40.2	40.6	5.1	8.0	36.0	9.9	5.5	5.4	21.9	10.0	3.3	15.0	10.0	5.3	28.1	2.9	2.7	50.4	10.0	4.9	148.8	21.6	16.7	5.9	9.8	12.2	29.7	9.6	20.8	13.9	21.4	12.3	14.6	7.3	13.6	6.5	13.2	3.9	3.5	6.4	5.2	12.8	5.1	4.3	3.1	9.3	5.1	14.2	14.4	9.4	6.8	17.8	17.5	17.8	25.6	17.8	19.9	20.7	18.4	20.6	18.1	20.3	22.4	5.3	44.8	14.4	3.3	26.2	6.1	1.3	2.3	1.2	3.4	2.5	3.6	4.4	0.0	4.2	1.8	4.2	1.3	31.0	24.9	1.9	7.8	13.2	2.0	29.8	5.9	32.2	4.6	13.8	6.5	10.9	9.7	76.9	2.4	15.2	3.1	4.6	0.3	32.2	0.0	12.9	34.9	6.1	28.3	44.5	23.1	20.8	34.7	16.0	8.4	34.0	2.2	21.6	12.5	4.2	11.6	27.6	37.6	15.4	1.3	49.6	4.6	10.7	18.3	0.0	31.6	27.3	7.9	9.5	0.7	4.8	4.8	22.5	2.9	13.9	1.5
MIDEAS	"C14orf117, C14orf43, ELMSAN1, LSR68"	ENSG00000156030	"Mitotic deacetylase associated SANT domain protein"	Q6PJG2	14	73715122-73790285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 59.4;Cardiomyocytes: 21.0;Cytotrophoblasts: 41.3;dendritic cells: 15.8;Extravillous trophoblasts: 32.5;Hofbauer cells: 25.8;Syncytiotrophoblasts: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003111	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA003111: AB_1078329"	"unprognostic (1.54e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.36e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-1)"	9.0	5.0	4.1	9.3	4.2	14.5	6.6	5.1	5.2	6.4	0.4	7.1	7.7	7.3	1.3	9.3	6.7	9.2	6.7	2.6	4.0	3.0	4.7	6.9	9.3	5.3	2.3	11.3	5.9	9.7	2.6	8.8	1.6	5.7	3.9	2.9	7.8	5.8	10.1	11.8	8.8	6.5	0.4	13.7	7.5	5.4	5.5	5.8	6.2	5.9	5.6	5.7	6.2	7.9	12.8	14.1	5.0	9.4	4.6	7.8	9.6	5.1	8.7	7.0	6.3	12.5	14.8	18.5	5.6	7.0	7.3	19.3	8.3	14.5	2.8	24.6	5.1	29.7	12.8	4.5	7.4	5.2	61.9	10.4	8.8	6.1	7.6	6.1	11.2	6.4	15.5	16.7	3.4	29.7	12.0	8.3	1.6	6.4	11.7	13.8	27.0	4.9	10.4	13.5	6.4	5.3	19.3	26.4	10.3	2.8	20.3	10.8	22.6	14.3	16.3	10.8	5.6	13.0	6.7	20.4	11.7	6.3	17.0	0.6	0.5	0.2	0.3	0.2	0.4	0.4	0.1	0.3	0.6	0.7	0.2	0.2	0.8	0.5	0.3	1.2	0.4	0.4	4.1	4.2	5.1	5.2	2.6	4.0	5.3	2.3	1.6	0.4	5.5	7.9	59.4	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	41.3	15.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	32.5	9.4	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	29.4	3.6	0.0	0.0	0.0
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Endothelial cells: 25.9;granulocytes: 29.1;Macrophages: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	20.0	7.1	8.4	20.3	8.7	30.7	12.1	8.6	12.7	9.0	9.6	11.0	11.0	6.0	2.0	15.6	8.0	11.5	10.6	7.8	8.2	15.4	9.3	25.6	15.4	10.1	9.8	3.0	9.9	1.6	3.7	9.2	9.3	8.4	11.4	0.3	13.3	4.3	3.1	4.9	14.4	7.6	9.1	36.1	10.8	1.2	10.3	6.7	8.7	3.1	13.8	12.3	11.5	9.6	13.5	24.4	0.1	0.1	6.0	12.4	0.2	17.0	14.8	15.4	22.4	13.9	26.6	0.3	19.1	14.2	13.7	21.7	4.3	24.9	5.8	8.3	0.6	18.8	17.6	16.2	4.2	12.3	18.6	8.5	2.4	16.8	5.7	9.0	37.3	21.3	2.7	2.5	11.9	22.0	7.0	24.3	2.2	29.3	30.0	13.5	1.8	23.8	22.0	10.2	1.0	0.8	13.4	8.7	7.2	0.1	6.2	12.5	41.4	7.8	4.8	7.0	11.7	11.2	40.2	3.2	13.7	42.3	3.9	21.9	36.2	45.8	11.2	22.2	15.4	8.1	12.6	12.0	18.9	6.7	6.8	10.4	48.6	3.6	23.3	1.2	17.4	16.0	8.4	8.7	8.6	12.7	7.8	8.2	10.1	9.8	9.3	9.1	10.3	9.6	32.1	3.2	10.7	1.0	9.8	3.4	6.8	3.1	7.4	0.2	3.3	3.4	3.1	2.8	5.5	1.8	0.0	0.2	9.6	8.9	1.9	4.6	3.5	1.2	1.9	25.9	1.2	3.4	0.5	5.2	0.8	7.1	15.3	1.6	29.1	0.3	16.8	1.3	16.6	1.7	0.5	10.9	0.0	18.2	7.8	5.2	0.9	28.9	7.2	11.2	16.7	0.1	11.3	1.5	5.2	4.9	9.4	0.4	18.5	2.8	5.5	0.6	2.0	0.6	0.0	3.0	3.1	0.1	0.2	13.4	2.8	0.3	16.5	0.2	9.5	7.5
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 376.0;lymphoid tissue: 105.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 260.1;Langerhans cells: 606.0;Macrophages: 230.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.1;thalamus: 4.8"	"Immune cell enriched"	"Detected in some"	127	"neutrophil: 272.2"	"Lineage enriched"	"Detected in single"	341	"granulocytes: 272.2"	"Cell line enriched"	"Detected in some"	13	"NB-4: 360.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	43300000	61000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	19.5	0.6	0.5	61.9	0.8	376.0	8.2	0.4	3.1	2.9	0.8	5.7	11.6	1.0	0.0	2.2	2.2	3.0	3.2	0.3	0.9	2.6	3.8	21.1	103.2	0.8	0.5	0.8	1.6	0.1	1.1	2.0	0.7	1.9	3.4	0.6	3.6	0.4	0.7	3.2	12.4	1.9	0.4	105.3	11.3	1.3	4.8	17.0	2.1	0.9	36.5	12.0	1.1	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.3	0.3	28.8	0.0	0.3	0.4	0.0	1.4	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	4.0	0.0	360.6	0.8	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.6	0.6	0.0	0.6	0.0	3.7	0.3	1.2	0.3	10.3	10.9	0.1	0.3	0.3	0.2	0.2	0.1	0.8	0.2	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	272.2	0.0	0.3	0.0	0.0	0.5	0.5	0.8	0.4	3.1	0.3	0.9	0.8	0.5	0.7	0.4	4.8	0.2	0.7	0.0	5.5	0.0	3.9	34.3	0.1	61.5	0.0	3.8	0.5	2.0	0.4	1.5	0.9	0.0	8.4	1.5	2.0	0.0	0.0	0.8	0.9	0.0	0.1	7.2	0.0	0.0	0.1	1.8	2.4	2.5	0.0	0.1	1.3	0.2	0.0	0.0	260.1	3.3	0.2	0.5	0.0	1.3	606.0	0.3	0.0	230.6	56.9	0.0	2.3	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.1	0.0	0.3	6.9	5.3	0.0	0.2	45.5	6.7	11.2	0.2	28.1	1.9	3.4	0.3	0.0	0.1
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831351-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 292.9;lymphoid tissue: 107.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 219.1;Kupffer cells: 408.5;Langerhans cells: 241.7;Macrophages: 412.0;monocytes: 1118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 6012.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 6012.8"	"Group enriched"	"Detected in some"	14	"NB-4: 151.8;THP-1: 282.7;U-937: 185.5"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol"		NA	NA		400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Nucleoli, Nucleoli rim, Vesicles, Cytosol"	"HPA034532: AB_10669677, HPA073215: AB_2686582"	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	24.2	14.9	2.7	82.4	2.8	292.9	6.0	2.9	4.4	6.3	3.2	6.7	3.7	4.0	1.4	7.4	5.7	26.6	4.3	2.6	3.1	3.6	11.5	47.3	15.6	5.2	4.3	2.2	4.8	3.7	1.6	20.4	4.3	3.8	7.7	12.1	5.7	3.5	3.8	5.1	7.7	20.7	5.1	107.8	4.5	5.1	4.2	14.4	3.8	19.0	14.5	23.4	1.8	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	282.7	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	185.5	0.0	155.4	1354.4	243.8	2.6	534.3	3.7	33.5	1.6	1.9	616.5	15.3	1.6	1.4	6012.8	2.8	270.6	9.6	1.5	1099.5	2.7	2.8	2.9	4.4	2.6	3.1	5.2	4.3	4.3	5.1	4.2	5.4	2.6	35.3	56.0	0.0	34.7	2.4	0.0	0.0	0.0	1.2	1.1	3.4	0.9	5.7	9.3	0.0	0.0	0.9	5.9	0.0	0.0	0.0	0.4	0.1	0.1	5.0	0.0	22.3	0.0	0.4	1.3	6.5	0.5	0.1	44.1	0.0	3.9	2.2	219.1	0.0	0.1	0.0	0.0	408.5	241.7	3.3	1.2	412.0	1.8	33.7	1118.9	136.1	26.8	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	1.7	8.0	4.8	13.1	1.5	8.2	0.9	0.3	0.4	2.3	1.0	11.7	0.0	0.0	0.1
MRTFA	"BSAC, KIAA1438, MAL, MKL, MKL1, MRTF-A"	ENSG00000196588	"Myocardin related transcription factor A"	Q969V6	22	40410281-40636719	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Actin-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.5;Cardiomyocytes: 8.7;Cytotrophoblasts: 8.9;Extravillous trophoblasts: 8.7;Fibroblasts: 4.3;Hofbauer cells: 12.7;Syncytiotrophoblasts: 7.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 189.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 93.1;granulocytes: 189.4;monocytes: 58.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030782	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA030782: AB_10600930"	"unprognostic (7.90e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (9.05e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.98e-1)"	21.1	15.4	15.8	27.3	18.0	80.7	19.9	10.9	22.8	25.5	12.3	20.8	11.7	33.1	7.3	16.6	22.6	11.7	21.3	20.2	10.0	14.6	12.3	24.5	27.5	9.3	8.7	20.9	16.1	8.9	13.8	18.3	7.9	19.4	8.8	11.1	18.2	15.2	19.1	24.4	18.6	16.3	6.7	29.7	19.1	35.9	9.5	21.7	22.1	8.0	22.8	22.0	19.6	15.3	26.5	33.9	14.5	17.5	21.6	15.9	27.8	25.6	16.6	23.1	22.8	19.1	7.9	27.2	10.2	27.0	20.3	35.5	12.7	31.9	13.8	32.0	29.2	46.3	39.9	24.7	17.8	53.5	79.8	15.5	36.7	22.4	15.1	17.5	18.3	15.0	12.9	12.3	11.5	25.3	20.7	57.4	11.7	14.2	12.1	35.4	17.5	16.4	16.9	22.1	8.7	8.7	43.7	19.4	13.8	18.3	16.0	59.0	27.8	14.7	38.7	21.4	20.9	16.1	16.5	39.1	12.1	25.6	26.5	49.0	53.5	189.4	18.5	43.7	16.9	13.0	15.8	13.6	64.3	18.6	21.1	18.1	57.2	16.8	58.8	93.1	22.0	34.2	15.8	18.0	10.9	22.8	20.2	10.0	9.3	8.7	7.9	6.7	9.5	15.3	4.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	8.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	8.7	4.3	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	7.8	0.6	0.0	0.0	0.0
MSN		ENSG00000147065	Moesin	P26038	X	65588377-65741931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 337.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		130000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054"	"unprognostic (1.03e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (5.68e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.21e-2)"	"unprognostic (6.81e-2)"	213.3	83.3	66.6	259.8	71.4	269.8	144.6	80.0	70.9	113.9	79.6	116.0	43.9	155.8	45.0	87.9	110.0	123.1	130.2	64.8	95.9	139.7	91.8	281.5	207.5	101.9	79.6	91.9	41.0	39.2	48.2	150.6	98.8	72.5	78.4	24.0	76.0	126.6	56.2	100.7	96.6	251.6	91.8	200.0	78.4	21.9	87.3	177.0	152.5	75.7	242.2	154.8	98.0	95.5	298.3	223.2	214.0	177.9	250.6	328.9	1.9	733.9	472.2	397.3	305.5	0.6	50.9	247.7	638.8	654.4	210.3	199.4	228.5	523.4	514.1	461.7	63.0	687.5	355.0	0.6	236.0	845.3	1063.8	248.1	110.7	733.1	641.5	384.2	892.3	338.5	339.5	747.1	638.4	0.6	503.0	631.0	266.1	0.3	418.9	259.8	384.0	189.0	426.5	0.2	1.7	0.8	590.6	4.4	231.5	239.7	2.7	453.8	1426.9	449.5	285.3	613.2	494.6	268.6	438.4	262.5	328.9	1053.3	513.0	219.9	312.4	194.0	214.8	359.3	160.4	91.9	116.9	170.6	225.3	76.9	78.3	121.9	334.3	177.5	460.3	31.9	97.0	673.8	66.6	71.4	80.0	70.9	64.8	95.9	101.9	79.6	98.8	91.8	87.3	95.5	243.4	179.5	163.0	19.9	140.8	205.5	62.2	56.5	38.7	0.7	27.9	30.9	27.5	11.5	45.4	68.0	4.2	6.0	227.3	7.5	29.4	177.3	1.4	35.7	64.9	256.2	0.0	71.9	2.2	170.0	16.0	85.7	16.3	62.9	164.6	22.6	100.3	51.2	167.2	5.0	3.8	3.2	2.0	255.3	206.2	5.3	73.7	251.9	69.4	67.5	291.9	43.6	337.8	7.1	14.7	327.7	3.3	109.4	105.7	102.2	0.0	113.6	25.6	2.4	72.3	85.0	131.0	1.9	3.6	24.3	149.5	4.2	206.9	24.4	2.2	54.0
MYLIP	"IDOL, MIR"	ENSG00000007944	"Myosin regulatory light chain interacting protein"	Q8WY64	6	16129086-16148248	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 352.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 57.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (1.54e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.79e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.03e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.11e-5)"	37.0	18.9	12.8	12.8	20.0	92.1	30.2	12.5	16.4	42.2	13.6	24.3	12.9	40.3	30.6	18.1	32.6	21.3	14.2	13.4	13.3	21.6	4.9	29.5	22.8	13.7	14.3	35.8	15.5	24.6	8.2	63.4	12.0	16.4	16.5	4.7	25.7	23.1	41.1	25.7	24.5	28.4	12.3	30.8	22.7	15.0	15.7	15.2	50.2	22.8	15.4	25.0	24.7	22.4	3.4	6.0	2.8	3.3	28.3	6.9	7.3	2.4	5.4	5.4	12.0	18.4	3.3	16.0	11.5	3.9	4.0	8.2	13.0	4.4	4.9	5.2	12.8	10.2	7.1	3.8	4.1	7.4	10.0	11.5	5.5	2.6	2.2	2.8	12.5	3.4	29.8	18.6	2.1	12.6	0.2	40.6	8.0	8.4	5.7	3.5	12.9	57.9	6.7	40.0	13.5	6.2	2.9	31.2	17.1	23.9	5.8	18.8	3.5	2.6	6.2	2.2	6.1	16.0	7.5	8.1	1.6	20.9	9.0	6.1	1.5	7.8	5.8	1.8	5.4	4.2	3.7	4.1	1.1	3.3	4.0	3.9	9.4	2.6	1.5	0.5	2.3	1.2	12.8	20.0	12.5	16.4	13.4	13.3	13.7	14.3	12.0	12.3	15.7	22.4	102.6	22.4	50.2	5.5	67.7	98.0	38.9	8.8	126.3	9.3	67.6	117.0	90.7	50.1	17.7	22.0	0.0	134.2	78.5	49.5	9.8	22.1	47.5	82.7	56.2	70.9	84.3	52.6	17.1	18.4	80.0	79.6	54.0	77.7	35.5	35.1	41.4	1.4	32.0	11.8	8.4	41.1	10.2	61.7	121.2	20.2	38.5	56.0	80.0	7.5	27.3	16.9	56.7	3.0	55.3	7.6	32.4	61.7	30.2	28.1	27.8	21.1	25.7	7.8	138.1	90.8	96.7	53.0	22.6	100.9	84.0	352.3	103.8	3.9	45.4	35.1
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520778-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 96.0;lung: 24.4;lymphoid tissue: 78.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 110.2;Kupffer cells: 235.4;Macrophages: 122.7;monocytes: 195.5;NK-cells: 616.9;T-cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 263.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.4;HL-60: 52.3;HMC-1: 87.9;NB-4: 210.2;THP-1: 154.3;U-937: 84.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055242, HPA056036"	Enhanced		Enhanced	Cytosol		NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA055242: AB_2682754, HPA056036: "	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	9.6	4.5	5.1	38.9	5.2	96.0	3.5	5.7	7.2	2.7	6.3	5.0	7.4	2.0	0.7	3.3	6.5	10.5	4.6	4.7	5.9	3.8	7.8	24.4	20.7	9.2	7.6	1.2	2.4	1.2	2.2	7.1	8.7	3.7	3.4	0.2	3.7	1.8	1.5	2.7	12.2	6.4	7.5	78.1	6.5	1.4	8.6	5.4	3.0	4.2	8.5	10.2	2.8	10.1	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	6.1	0.4	0.0	0.4	0.0	0.0	0.0	52.4	0.2	38.1	0.0	0.0	0.1	52.3	87.9	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.5	23.8	0.1	0.3	0.1	210.2	0.0	0.1	0.3	1.0	0.0	5.6	0.1	0.0	0.1	0.3	0.0	0.1	0.3	0.1	0.8	154.3	12.3	0.1	0.2	0.2	0.1	0.1	1.9	0.3	0.3	84.3	0.0	64.5	107.6	105.7	56.6	78.7	44.5	5.9	22.3	39.7	62.8	2.8	1.6	17.0	263.2	32.3	98.8	8.1	34.0	101.3	5.1	5.2	5.7	7.2	4.7	5.9	9.2	7.6	8.7	7.5	8.6	10.1	1.9	3.2	12.3	2.0	26.5	3.3	2.4	0.8	1.2	0.7	3.1	4.3	2.6	5.7	2.9	1.8	2.1	5.0	110.2	2.0	1.9	1.7	6.0	0.6	2.9	4.1	1.2	14.3	2.3	0.9	8.2	2.7	3.6	1.2	31.6	2.2	10.8	6.7	75.8	6.7	1.5	2.1	0.0	235.4	49.3	6.8	2.5	122.7	7.2	64.6	195.5	1.5	616.9	1.5	3.4	1.3	3.2	1.2	30.0	1.8	3.0	2.9	0.2	0.8	0.0	3.4	2.2	6.0	3.4	3.6	5.4	5.1	100.1	3.9	2.7	1.9
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248298-106285966	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 580.0;Langerhans cells: 1123.7;Macrophages: 947.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 279.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 279.2"	"Cell line enhanced"	"Detected in all"		"HHSteC: 387.5;U-87 MG: 434.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	1400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	308.5	74.2	14.4	360.5	15.6	312.5	103.3	15.2	35.4	47.3	21.7	62.5	38.5	38.6	6.9	228.2	107.6	113.7	103.1	15.2	20.9	82.9	317.9	218.5	23.2	75.7	24.9	58.4	80.9	25.9	30.1	87.3	30.3	70.1	30.3	17.2	126.0	13.4	135.9	54.1	55.9	48.0	21.3	88.2	102.4	11.7	46.3	15.6	42.2	44.4	39.9	283.3	86.7	21.5	103.6	41.0	14.6	16.8	85.8	95.0	34.4	26.1	194.7	57.0	90.6	25.7	38.7	77.7	78.8	32.1	131.5	58.2	38.8	88.1	93.8	50.5	51.7	35.8	17.2	22.6	387.5	61.3	49.4	94.8	94.2	114.9	115.0	70.6	187.3	32.0	70.5	225.6	68.1	49.4	58.1	19.4	36.6	33.6	59.7	25.8	30.4	147.6	46.2	60.8	33.4	19.3	46.0	61.1	107.9	43.0	25.4	9.4	168.2	75.6	52.9	105.9	51.9	212.1	142.7	115.7	434.3	69.3	105.6	39.6	6.5	16.0	1.8	21.8	2.4	3.9	2.2	2.7	7.0	3.4	2.8	2.2	279.2	4.4	30.5	5.5	7.1	4.8	14.4	15.6	15.2	35.4	15.2	20.9	75.7	24.9	30.3	21.3	46.3	21.5	323.8	131.4	245.7	12.1	78.0	207.6	321.0	105.7	169.0	23.8	184.2	132.0	94.8	197.3	161.4	42.3	12.5	26.2	67.5	105.8	46.9	320.6	12.2	128.0	160.8	192.8	25.1	29.5	25.3	141.3	58.9	239.6	132.0	296.5	188.4	18.8	159.5	580.0	107.0	40.4	28.8	51.9	63.1	390.3	1123.7	6.9	40.4	947.3	161.9	46.9	102.7	22.6	9.2	12.1	22.4	138.1	49.7	31.2	93.7	364.0	112.8	50.7	94.1	30.8	26.3	264.6	185.6	30.5	65.8	98.3	207.8	25.3	110.3	38.4	79.4	334.5
NBN	"AT-V1, AT-V2, ATV, NBS, NBS1"	ENSG00000104320	Nibrin	O60934	8	89933331-90003228	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 265.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001429, CAB003836"	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoplasm	"CAB003836: AB_562172, HPA001429: AB_1854460"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (5.05e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.03e-1)"	22.5	12.4	9.2	27.8	12.8	54.0	25.4	9.3	10.0	16.9	7.4	18.3	15.1	22.3	11.4	20.0	14.5	22.5	12.1	10.2	12.5	20.7	22.3	18.1	24.3	10.7	8.6	16.9	15.5	15.4	9.0	14.1	9.9	17.5	22.5	9.8	16.6	14.9	10.0	10.3	16.0	24.2	11.0	23.4	12.7	16.4	11.0	19.0	22.7	16.2	26.4	21.8	9.6	15.0	54.8	30.1	29.3	15.6	16.5	38.7	18.9	37.9	49.5	46.6	50.8	17.2	41.8	83.8	42.2	35.5	19.1	17.7	35.7	35.7	59.8	38.0	19.7	67.7	16.8	23.6	30.8	40.0	35.2	30.5	18.3	27.2	57.9	22.8	39.5	33.9	50.6	46.6	55.3	46.9	65.6	26.0	8.5	39.5	31.4	42.3	25.3	47.0	62.8	73.8	8.1	26.6	23.5	265.1	23.1	16.3	49.8	31.4	29.2	40.9	28.0	25.5	38.0	21.2	25.0	45.5	41.3	39.4	39.1	32.4	17.7	32.9	11.9	19.7	12.7	15.2	8.5	8.8	18.9	8.9	8.1	9.0	34.4	16.1	31.5	10.4	5.9	13.1	9.2	12.8	9.3	10.0	10.2	12.5	10.7	8.6	9.9	11.0	11.0	15.0	36.9	48.1	14.2	24.5	39.8	11.9	13.5	20.4	23.9	25.4	29.7	22.9	30.3	14.3	33.7	27.6	2.1	23.0	29.3	11.2	43.0	35.1	17.6	45.4	46.9	22.9	12.1	31.7	45.0	32.0	19.7	36.3	19.9	31.2	79.7	38.3	18.9	30.6	25.9	13.5	39.9	16.9	16.2	29.2	27.1	7.2	19.0	51.1	12.4	32.8	54.7	29.4	36.0	40.7	40.3	24.7	9.9	26.4	38.8	11.6	9.9	40.5	36.4	11.2	6.6	50.3	31.7	20.2	46.0	31.5	13.5	10.8	35.3	68.7	19.4	11.0
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555562-183590876	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 191.9;lung: 74.6;lymphoid tissue: 78.8"	"Group enriched"	"Detected in many"	5	"Ductal cells: 68.6;Hofbauer cells: 212.0;Kupffer cells: 137.9;Langerhans cells: 129.5;Macrophages: 194.4;monocytes: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1313.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 26.4;HMC-1: 21.4;hTERT-HME1: 51.6;RPMI-8226: 20.0;U-2 OS: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Cytosol		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	29.9	5.8	2.7	76.9	3.0	191.9	7.0	3.2	14.6	9.5	4.5	10.4	8.5	4.1	1.6	7.6	8.0	23.8	5.6	2.3	3.9	3.7	12.7	74.6	17.3	6.2	4.2	2.1	4.6	2.8	2.7	39.7	6.8	2.9	12.5	0.8	6.6	3.5	3.7	15.9	12.4	20.4	4.5	78.8	5.8	2.1	12.0	11.3	3.0	11.5	16.9	24.2	5.9	7.8	26.4	0.8	0.0	0.0	0.0	0.0	0.3	1.9	2.4	3.4	1.6	0.2	0.8	3.2	4.3	0.8	0.6	14.3	0.1	19.0	3.1	16.2	0.0	0.0	7.3	6.0	0.0	2.0	21.4	0.0	4.1	3.4	51.6	2.2	0.0	0.1	0.0	5.6	5.8	0.2	0.2	1.1	0.4	1.5	1.5	7.0	2.2	20.0	0.8	0.2	0.0	0.1	0.3	0.1	0.9	1.7	2.8	9.1	1.2	0.1	50.2	0.0	4.9	0.9	1.4	0.6	0.4	10.3	0.0	199.5	489.2	1313.6	1.0	348.8	1.6	14.1	4.0	1.6	246.0	10.8	2.2	1.3	799.7	2.1	326.1	13.5	11.1	298.9	2.7	3.0	3.2	14.6	2.3	3.9	6.2	4.2	6.8	4.5	12.0	7.8	0.7	9.6	15.7	0.0	8.4	5.5	0.2	13.7	1.8	0.3	0.1	0.3	1.3	7.2	17.3	0.0	0.0	1.0	9.6	0.1	3.9	68.6	1.1	1.9	0.5	3.5	0.0	1.7	0.3	3.9	1.1	2.0	0.5	1.3	7.6	0.0	3.3	1.0	212.0	0.0	0.3	0.2	26.4	137.9	129.5	2.9	0.6	194.4	7.2	3.7	223.6	0.0	6.2	0.0	0.2	27.3	2.6	0.0	3.2	0.6	0.0	0.3	32.0	0.7	13.1	0.7	6.8	0.1	0.6	0.6	4.3	1.9	3.7	0.2	0.0	1.2
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932034	"Predicted intracellular proteins, Transporters"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	53.9	60.4	19.5	45.8	30.6	42.7	27.4	21.4	50.2	29.0	0.0	30.1	33.0	22.3	5.2	30.4	15.9	46.6	16.0	28.2	23.9	56.6	32.9	52.1	30.1	47.5	12.3	14.8	19.9	8.8	29.7	12.9	45.0	18.6	29.2	18.2	38.2	12.9	6.9	11.1	39.2	28.3	10.6	24.4	30.8	7.8	19.0	21.7	25.1	9.2	28.5	101.8	19.7	48.3	13.7	36.6	2.2	16.0	78.2	46.3	23.7	18.2	71.9	22.1	30.1	34.3	12.7	55.2	96.5	10.0	108.0	78.7	12.6	12.4	13.3	120.2	16.5	28.0	43.7	12.3	44.5	16.4	25.4	33.3	29.4	21.1	16.3	39.1	46.7	18.0	38.7	30.6	13.9	13.7	16.1	16.2	2.7	33.8	7.6	12.3	5.7	10.3	39.1	90.4	36.9	33.5	93.7	22.6	42.1	6.5	3.8	19.3	27.7	5.1	10.9	26.3	14.1	39.9	34.1	28.8	11.5	21.2	18.7	17.0	11.4	4.0	19.2	9.1	24.1	17.7	18.1	15.6	10.0	11.1	9.6	9.4	6.4	13.6	14.2	34.1	8.1	5.1	19.5	30.6	21.4	50.2	28.2	23.9	47.5	12.3	45.0	10.6	19.0	48.3	144.6	314.1	371.9	27.7	33.7	98.1	270.8	311.2	709.7	50.2	94.2	47.9	11.4	98.7	324.1	62.5	43.8	9.3	84.6	113.2	80.3	241.7	0.9	160.1	90.2	130.2	35.8	29.8	144.9	139.2	8.9	94.8	142.8	298.2	37.3	18.5	106.7	23.2	13.6	37.0	89.5	119.3	288.9	33.8	57.4	6.8	42.3	41.9	51.6	75.9	33.4	76.8	59.8	34.2	303.9	108.7	160.1	29.3	44.1	129.5	24.3	103.2	335.8	53.3	13.1	33.8	49.3	11.2	33.9	515.9	59.2	3.8	63.5	36.5	130.6	294.4
NFAM1	CNAIP	ENSG00000235568	"NFAT activating protein with ITAM motif 1"	Q8NET5	22	42380407-42432403	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.9;lymphoid tissue: 19.9"	"Cell type enhanced"	"Detected in some"		"granulocytes: 11.4;Hofbauer cells: 17.0;Kupffer cells: 53.9;Macrophages: 27.2;monocytes: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 90.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 90.4;monocytes: 48.2"	"Cell line enriched"	"Detected in some"	4	"THP-1: 37.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031812	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA031812: AB_10603121"	"unprognostic (9.77e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.12e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	6.3	1.9	1.5	12.4	1.9	30.9	1.1	1.5	2.2	1.8	2.0	1.5	1.3	0.6	0.6	1.3	2.0	2.3	1.3	1.8	2.4	1.2	2.3	7.5	5.5	3.1	2.2	0.3	0.8	0.3	0.6	2.9	2.9	0.9	1.2	0.1	0.8	1.4	0.4	1.4	2.3	2.9	2.3	19.9	1.1	0.7	2.9	2.1	0.7	1.5	2.1	3.1	0.7	3.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	5.8	0.0	0.0	0.1	0.0	0.4	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.3	48.2	2.8	0.1	32.5	0.2	0.0	0.1	0.0	16.5	0.1	0.0	0.0	90.4	0.0	31.1	0.3	0.0	25.4	1.5	1.9	1.5	2.2	1.8	2.4	3.1	2.2	2.9	2.3	2.9	3.0	0.4	0.0	3.7	0.0	0.5	0.9	0.7	0.9	0.6	0.2	0.4	0.0	0.6	1.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.8	0.4	0.2	0.5	1.2	0.0	0.7	0.2	0.1	0.5	0.0	0.3	11.4	0.0	0.7	0.6	17.0	0.0	0.6	0.0	0.0	53.9	8.2	5.6	0.3	27.2	0.0	8.4	44.6	0.0	0.0	2.0	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.5	0.5	0.8	0.7	0.0	1.0	0.3	1.3	0.4	0.0	0.5
NFE2	NF-E2	ENSG00000123405	"Nuclear factor, erythroid 2"	Q16621	12	54292111-54301015	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 112.5;lymphoid tissue: 45.3"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 265.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 1489.2;neutrophil: 810.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 1489.2"	"Group enriched"	"Detected in some"	5	"HEL: 376.9;K-562: 168.1;NB-4: 118.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001914	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Actin filaments"		"HPA001914: AB_1079475"	"unprognostic (2.68e-4)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.90e-6)"	"unprognostic (1.81e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.46e-2)"	3.8	0.3	0.5	6.2	0.7	112.5	0.6	0.5	1.0	1.4	1.4	0.4	0.5	0.3	0.1	0.8	2.4	1.2	1.9	0.5	0.5	1.4	2.6	13.0	0.3	0.7	0.6	0.2	0.7	1.1	0.9	4.0	0.7	0.5	0.2	0.0	0.5	0.1	1.3	4.8	0.6	1.9	0.5	45.3	0.8	1.2	0.6	1.4	1.4	3.7	0.1	2.3	0.5	0.6	0.3	0.3	0.0	0.0	0.0	0.5	1.4	1.1	6.9	0.7	0.9	5.5	10.0	0.1	0.9	0.9	0.4	0.3	0.0	0.0	0.3	0.0	0.1	376.9	0.9	9.1	0.0	5.8	48.5	0.5	0.1	0.3	0.2	4.4	0.0	0.1	168.1	0.1	0.0	0.1	15.3	118.8	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.2	0.6	1.8	1.0	18.9	0.3	0.2	0.4	1.1	0.1	0.0	0.0	0.1	0.4	23.4	0.0	1489.2	241.7	232.3	0.6	66.7	1.0	0.3	0.8	0.5	156.7	0.5	1.0	0.7	810.6	1.1	42.0	2.7	0.2	160.2	0.5	0.7	0.5	1.0	0.5	0.5	0.7	0.6	0.7	0.5	0.6	0.6	0.0	0.0	3.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.1	5.9	0.1	0.0	0.0	0.0	265.6	0.0	0.0	0.5	0.4	0.0	0.1	3.8	0.1	0.4	0.2	1.0	0.0	0.0	0.0	0.0	22.8	0.2	19.0	0.0	44.3	1.8	0.0	33.9	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.3	1.2	1.1	0.0	0.1	0.1
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793741-53824394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 4.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.4;granulocytes: 7.6;Kupffer cells: 11.2;Macrophages: 7.8;monocytes: 20.5"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;classical monocyte: 18.1;eosinophil: 23.2;neutrophil: 29.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 56.9;monocytes: 18.1"	"Group enriched"	"Detected in some"	4	"HMC-1: 4.6;THP-1: 4.1;U-87 MG: 4.3;U-937: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042981	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"	0.9	0.0	0.1	2.2	0.1	6.0	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.3	0.3	0.2	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.1	4.3	0.1	0.1	0.3	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	3.8	0.0	56.9	18.1	23.2	0.0	5.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	29.8	0.0	3.0	0.1	0.0	5.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.3	6.4	7.4	0.0	0.5	0.4	1.0	0.1	0.0	0.7	0.2	0.1	0.5	0.0	3.7	0.0	0.0	0.2	1.4	0.2	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.7	0.0	0.2	1.5	0.0	0.3	7.6	0.2	0.7	0.0	2.4	0.0	0.8	0.0	0.0	11.2	1.6	0.2	0.3	7.8	1.8	0.0	20.5	0.2	2.1	0.0	0.5	0.1	0.0	0.0	0.3	0.8	0.0	0.1	2.2	0.7	0.0	0.7	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.7
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270470-151289894	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 207.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	20.6	15.7	7.3	44.5	7.1	74.5	23.3	7.0	10.4	15.2	7.4	25.9	33.7	13.9	16.6	19.0	19.8	24.0	7.5	7.1	7.7	14.0	35.5	28.6	43.4	8.6	7.7	16.8	7.8	6.3	4.2	34.2	8.2	13.2	26.7	1.4	20.2	17.2	4.8	19.4	33.8	20.9	8.2	47.5	24.9	6.6	7.9	44.4	16.9	8.3	33.5	27.9	10.5	8.2	53.2	25.7	1.3	0.0	14.4	39.4	49.3	14.6	36.8	74.1	112.0	5.9	119.9	51.0	55.4	23.5	24.5	29.6	5.6	13.8	18.6	110.0	3.0	144.9	27.3	3.1	63.1	139.9	40.2	25.7	18.3	44.1	10.0	32.1	91.8	56.4	74.0	12.6	14.4	41.6	116.4	207.7	29.5	10.9	37.6	125.5	2.9	45.8	60.9	46.1	7.4	0.3	32.0	35.1	20.5	5.1	5.6	157.9	47.5	10.5	23.3	33.8	22.3	1.8	2.0	3.2	24.5	166.4	11.3	251.3	121.3	140.5	62.7	172.8	74.3	64.8	66.1	63.4	108.8	58.5	52.1	54.3	466.8	98.1	170.0	43.3	62.3	104.3	7.3	7.1	7.0	10.4	7.1	7.7	8.6	7.7	8.2	8.2	7.9	8.2	37.3	25.6	24.9	2.9	22.9	16.7	21.1	47.0	15.4	0.3	13.8	15.1	7.0	18.6	35.6	12.9	0.0	76.4	33.4	21.4	15.6	66.6	3.4	36.2	9.0	41.1	18.0	55.5	0.4	41.1	69.4	19.1	15.3	23.8	36.1	17.7	27.5	17.8	80.2	0.0	0.2	25.1	8.2	49.7	25.6	1.7	19.6	51.5	1.8	12.2	86.5	7.4	57.7	5.0	0.7	40.2	34.5	13.9	12.9	19.1	35.3	35.3	47.4	0.1	6.6	11.7	15.2	3.6	2.2	19.4	17.8	54.5	36.2	23.1	24.9	23.3
NRROS	"ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030"	ENSG00000174004	"Negative regulator of reactive oxygen species"	Q86YC3	3	196639694-196662004	"Disease related genes, Predicted membrane proteins"		"Growth factor binding"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 40.2;Erythroid cells: 27.5;Hofbauer cells: 76.9;Kupffer cells: 35.5;Langerhans cells: 59.9;Macrophages: 33.3;Microglial cells: 31.9;NK-cells: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.3;granulocytes: 4.2;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HEL: 53.1;HMC-1: 106.4;Karpas-707: 66.7;MOLT-4: 59.8;NB-4: 138.5;RPMI-8226: 68.9;THP-1: 60.5;U-937: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031586	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA031586: AB_10601543"	"unprognostic (5.28e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	7.8	2.6	1.9	8.6	1.5	32.7	5.1	1.5	1.6	2.5	1.6	2.7	2.4	2.9	0.5	2.0	2.8	4.2	2.9	1.8	3.0	2.8	2.5	7.7	10.5	2.7	1.9	1.2	1.1	0.9	1.2	9.9	2.7	2.0	1.6	0.3	2.4	1.6	1.3	2.0	5.1	4.1	2.7	15.7	2.3	1.3	3.4	7.7	2.2	2.5	3.6	4.5	2.1	4.4	0.1	0.0	0.3	0.0	0.4	1.0	0.1	0.4	2.1	0.4	0.3	0.1	0.2	0.0	6.7	0.4	0.3	0.1	1.1	0.0	0.1	4.0	0.1	53.1	0.0	0.0	0.5	43.7	106.4	0.4	0.0	1.7	0.7	2.1	4.3	48.6	5.5	66.7	1.2	0.1	59.8	138.5	4.4	0.0	0.1	15.7	0.1	68.9	0.1	0.4	0.3	0.0	0.1	0.1	28.0	0.9	0.1	60.5	0.5	0.5	0.2	1.9	0.1	26.5	43.1	12.1	3.4	76.1	0.7	4.2	1.0	1.8	0.3	1.0	0.1	0.3	0.2	0.2	1.3	0.2	0.1	0.2	0.0	0.3	1.1	0.2	0.3	0.7	1.9	1.5	1.5	1.6	1.8	3.0	2.7	1.9	2.7	2.7	3.4	4.4	5.6	0.0	0.5	0.0	40.2	1.5	0.1	0.0	2.2	0.4	0.4	0.3	0.3	0.0	0.6	0.0	4.2	0.3	15.5	0.0	0.0	0.0	1.4	0.0	0.4	10.1	0.0	27.5	1.8	0.0	0.7	0.7	0.5	0.1	14.5	0.1	15.4	0.2	76.9	0.0	2.7	0.0	0.0	35.5	59.9	0.4	0.6	33.3	8.8	31.9	24.1	0.1	33.0	1.0	0.3	0.0	0.0	0.7	25.7	0.0	0.0	0.1	0.0	0.4	6.6	0.3	0.3	2.7	0.4	0.2	0.9	0.5	10.8	0.5	0.0	0.0
OTULINL	"FAM105A, FLJ11127, NET20"	ENSG00000145569	"OTU deubiquitinase with linear linkage specificity like"	Q9NUU6	5	14581792-14616180	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 29.5;dendritic cells: 36.7;Endometrial stromal cells: 16.6;Hofbauer cells: 100.7;Macrophages: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 17.7;HMC-1: 55.6;OE19: 16.1;THP-1: 16.9;U-937: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli, Cytosol"		"HPA046638: AB_2679731"	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	3.1	2.7	1.2	6.8	1.1	30.3	4.1	1.3	1.6	3.8	4.8	12.3	6.6	1.5	1.4	1.7	1.4	2.7	0.9	1.1	1.8	3.6	1.4	13.1	5.4	2.3	1.5	2.0	7.6	1.2	2.5	4.2	2.1	8.3	13.3	0.5	1.4	10.0	0.4	1.7	9.4	2.5	2.4	7.9	3.3	2.5	1.9	3.4	2.8	0.8	3.6	5.2	3.1	3.6	0.0	0.8	1.6	0.0	0.3	0.0	6.9	2.0	1.8	0.5	1.0	2.8	1.7	0.1	1.1	0.9	2.8	0.1	3.7	1.6	0.7	1.1	4.9	4.6	17.7	0.4	1.7	0.1	55.6	0.1	0.3	0.2	0.0	0.0	0.1	2.9	0.0	7.1	0.2	1.4	0.0	1.7	2.5	16.1	11.9	0.5	0.7	2.0	0.0	13.9	6.0	7.0	0.9	0.6	0.0	1.7	0.6	16.9	0.0	0.9	4.4	0.4	1.6	0.0	0.0	0.1	1.0	27.2	0.4	0.2	33.4	0.3	5.5	16.2	7.3	0.1	6.7	7.2	33.8	0.1	9.0	9.1	8.6	19.2	12.7	25.0	12.8	24.6	1.2	1.1	1.3	1.6	1.1	1.8	2.3	1.5	2.1	2.4	1.9	3.6	10.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	7.4	7.9	0.0	0.0	0.0	29.5	0.0	0.9	36.7	0.0	1.9	0.4	0.0	0.9	16.6	1.1	0.0	0.0	0.0	6.2	2.2	1.4	0.0	1.2	0.0	0.5	0.0	0.0	100.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	12.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	8.8	0.2	0.0	0.0
PARP8	"ARTD16, FLJ21308, pART16"	ENSG00000151883	"Poly(ADP-ribose) polymerase family member 8"	Q8N3A8	5	50665899-50846519	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 124.9;Excitatory neurons: 197.9;Inhibitory neurons: 139.3;Microglial cells: 112.4;Oligodendrocyte precursor cells: 158.3;T-cells: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 91.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049183	Approved		Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Midbody ring, Cytosol"	"HPA049183: AB_2680667"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.86e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (1.12e-4)"	11.7	13.1	4.6	26.8	8.8	78.2	9.2	0.0	7.9	8.3	0.3	8.8	14.5	6.6	4.2	7.7	9.9	25.7	6.9	14.7	12.6	7.0	8.0	19.8	42.0	3.4	4.5	11.6	12.2	13.8	4.9	12.4	0.1	11.3	9.3	4.6	10.3	7.4	4.8	7.6	15.0	8.4	2.7	43.6	20.2	9.1	7.7	19.2	43.1	2.1	22.5	14.5	5.4	2.0	24.8	0.1	12.2	18.8	3.2	5.7	18.0	4.3	15.7	4.1	12.0	0.9	33.5	14.8	16.9	0.5	43.3	12.4	2.1	13.1	10.0	20.2	15.9	10.6	9.2	1.1	6.3	28.1	0.2	6.8	10.9	8.5	6.0	24.6	0.2	23.1	1.6	9.1	5.9	8.8	31.8	32.5	12.3	0.4	6.0	15.4	24.0	17.1	7.6	12.8	13.0	19.0	13.8	21.6	3.7	17.6	1.0	91.2	0.0	1.0	15.4	1.2	12.6	6.9	0.2	29.5	13.8	7.6	17.7	27.4	13.7	31.9	43.6	4.0	70.6	13.4	34.3	50.5	9.2	16.7	20.9	34.9	28.6	39.5	2.9	4.2	22.5	22.7	4.6	8.8	0.0	7.9	14.7	12.6	3.4	4.5	0.1	2.7	7.7	2.0	6.2	32.1	21.1	29.4	51.7	8.0	5.2	12.7	26.2	13.6	10.4	6.5	5.6	14.3	19.1	22.0	0.0	22.5	124.9	17.2	7.9	14.2	28.7	11.8	8.4	3.9	15.0	7.4	197.9	10.2	6.4	13.4	46.9	10.6	14.5	12.6	6.8	5.0	14.3	6.7	139.3	4.2	8.2	26.1	16.9	15.3	1.2	27.1	8.8	112.4	43.4	0.7	93.7	158.3	7.3	18.7	8.4	3.0	65.0	7.7	8.2	4.3	25.6	2.1	6.6	12.3	13.0	12.8	6.0	14.3	4.0	24.8	157.3	6.5	9.6	13.7
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73980811-73982027	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 66.5;lymphoid tissue: 31.5"	"Cell type enriched"	"Detected in some"	23	"Macrophages: 1360.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 2.2"	"Group enriched"	"Detected in many"	12	"basophil: 85.2;neutrophil: 43.0"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 85.2"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.8"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"	NA	NA	7700000		"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB026008: , HPA052485: AB_2681847"		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.8	0.2	0.1	0.7	0.3	66.5	0.3	0.1	2.2	0.1	0.7	1.0	0.0	0.1	0.0	0.1	0.3	0.7	0.9	0.1	0.1	0.6	2.2	10.5	0.3	0.3	0.2	0.1	0.3	0.0	0.3	3.0	0.3	0.1	0.8	0.0	0.4	0.1	1.0	0.0	0.2	0.1	0.4	31.5	0.9	0.1	0.2	0.0	0.6	2.5	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.8	0.0	0.0	1.5	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.2	3.8	1.4	0.8	1.2	0.8	0.0	0.2	0.0	1.5	0.7	0.7	0.3	43.0	0.1	3.9	5.4	0.6	148.4	0.1	0.3	0.1	2.2	0.1	0.1	0.3	0.2	0.3	0.4	0.2	0.3	0.7	0.0	0.0	0.0	10.8	0.0	0.2	0.4	0.0	0.0	0.1	0.3	0.0	2.8	1.5	1.8	0.0	0.0	4.1	5.3	0.0	6.0	0.0	0.0	0.0	7.1	13.3	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	24.7	0.2	0.3	0.0	0.0	1.8	0.0	9.5	0.0	0.1	0.0	1360.7	0.0	0.0	59.0	0.0	57.7	0.0	0.0	7.6	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.4	0.0	0.0	0.3	5.8	0.0	7.4	0.2
PGS1	DKFZP762M186	ENSG00000087157	"Phosphatidylglycerophosphate synthase 1"	Q32NB8	17	78378649-78425114	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022526	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"			"HPA022526: AB_1855271"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.46e-3)"	"prognostic favorable (7.33e-5)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (9.94e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.72e-2)"	16.1	10.0	12.6	17.9	14.9	39.6	15.4	13.3	25.3	14.2	15.8	13.0	11.7	14.9	6.0	10.8	14.0	13.2	11.1	13.0	16.6	13.8	7.0	23.5	16.9	18.0	15.4	13.9	10.9	11.5	11.5	19.7	15.6	12.4	7.8	6.6	11.9	10.8	13.5	11.5	14.7	10.3	12.9	19.8	11.4	8.9	18.8	14.0	16.4	7.6	11.6	14.5	12.0	18.1	19.9	16.7	17.8	13.5	14.6	23.0	18.8	18.3	17.2	19.3	21.2	17.8	15.8	20.2	10.8	10.8	19.4	15.5	19.8	12.5	15.1	30.3	24.1	22.2	25.0	17.5	15.2	17.7	16.9	23.6	16.1	14.6	12.6	19.1	37.8	15.9	26.0	14.2	13.2	10.8	39.5	19.5	17.4	8.5	15.9	19.4	29.6	16.8	21.0	19.5	21.4	33.2	15.4	16.4	18.5	17.8	17.4	23.8	22.8	24.9	16.6	13.5	15.4	16.0	9.5	15.2	19.1	19.0	18.7	2.1	17.7	19.3	11.0	15.0	13.6	10.3	11.6	11.7	20.6	11.9	14.5	10.6	33.9	11.2	7.2	9.4	15.1	12.0	12.6	14.9	13.3	25.3	13.0	16.6	18.0	15.4	15.6	12.9	18.8	18.1	25.9	12.8	16.8	10.1	11.6	4.5	12.0	16.3	7.4	13.0	6.4	8.8	5.8	4.3	12.0	12.9	2.1	20.2	11.2	7.7	3.9	5.8	20.0	9.0	8.7	21.5	4.2	5.5	14.8	7.0	8.1	9.7	12.2	6.7	7.6	13.3	15.0	3.9	15.4	20.2	15.0	6.1	6.1	13.9	8.3	10.8	10.5	19.2	5.4	17.8	12.1	11.0	10.3	11.6	20.4	7.2	15.6	8.6	9.4	9.2	8.0	5.2	14.4	11.4	32.9	6.8	10.8	17.9	18.4	5.8	3.8	19.3	10.8	14.7	8.5	10.9
PIK3R5	"p101, P101-PI3K"	ENSG00000141506	"Phosphoinositide-3-kinase regulatory subunit 5"	Q8WYR1	17	8878911-8965712	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 87.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 29.9;Kupffer cells: 35.7;Langerhans cells: 40.5;Macrophages: 36.8;Microglial cells: 79.6;NK-cells: 32.0;Plasma cells: 24.7;T-cells: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 39.2;HMC-1: 5.7;JURKAT: 13.7;U-937: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044505, HPA052247, HPA052412"	Uncertain		Supported	"Centriolar satellite,Cytosol"		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Centriolar satellite"	"HPA044505: AB_2678964, HPA052247: AB_2681772, HPA052412: AB_2681823"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.24e-1)"	6.5	3.6	1.4	19.7	1.3	87.4	2.7	1.3	7.5	2.1	1.6	3.3	3.3	1.4	0.8	2.5	3.0	6.6	1.8	1.3	1.7	1.4	2.9	14.1	13.7	4.0	2.7	0.8	1.3	0.8	0.8	3.1	3.6	1.5	2.6	0.0	2.1	1.0	0.7	1.5	9.5	3.9	2.8	22.4	3.6	2.2	6.8	12.3	1.7	0.9	8.9	6.5	1.4	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.4	1.5	0.0	0.0	0.0	0.5	5.7	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.3	1.5	2.5	0.6	0.0	0.0	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	9.5	16.1	5.7	18.1	14.3	11.8	4.3	10.1	15.6	11.5	5.7	7.5	12.0	34.4	8.6	19.0	9.0	13.2	16.2	1.4	1.3	1.3	7.5	1.3	1.7	4.0	2.7	3.6	2.8	6.8	5.4	0.2	0.0	6.1	0.7	11.7	1.0	0.0	0.0	0.0	0.0	0.2	0.3	2.1	1.5	0.0	0.0	0.0	0.1	29.9	0.0	0.0	0.1	4.5	0.1	0.1	0.7	0.0	4.0	0.3	0.0	0.3	0.5	1.5	0.1	5.1	0.0	1.4	0.4	18.3	0.0	0.5	0.0	0.0	35.7	40.5	12.2	0.3	36.8	1.8	79.6	19.8	0.0	32.0	1.0	0.3	0.0	0.0	0.0	24.7	0.1	0.0	0.2	0.0	0.0	0.0	0.4	1.4	0.6	0.4	0.1	0.9	0.4	25.7	0.0	0.0	0.0
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73986439-73988190	"Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 98.7;lymphoid tissue: 53.6"	"Cell type enriched"	"Detected in some"	18	"Macrophages: 1497.3"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	13	"basophil: 394.2;neutrophil: 132.3"	"Lineage enriched"	"Detected in all"	20	"granulocytes: 394.2"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.0;HEL: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	NA	NA	24500000	2900000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.3	0.5	0.3	0.5	0.4	98.7	0.6	0.3	2.2	0.1	1.0	0.1	0.0	0.1	0.0	0.2	0.8	0.8	1.3	0.2	0.3	0.9	2.9	19.4	0.0	0.5	0.4	0.1	0.1	0.0	0.4	5.2	0.8	0.1	0.0	0.0	0.6	0.0	1.4	0.1	0.0	0.1	0.8	53.6	0.2	0.0	0.7	0.1	1.0	4.2	0.0	8.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	394.2	13.0	9.3	2.0	5.3	2.9	1.5	1.2	0.6	8.0	2.3	4.1	1.0	132.3	1.9	5.0	20.1	2.1	1791.5	0.3	0.4	0.3	2.2	0.2	0.3	0.5	0.4	0.8	0.8	0.7	0.4	0.3	3.2	1.1	0.0	10.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	4.0	1.8	0.0	0.0	9.3	0.1	0.0	4.7	0.0	0.0	0.0	12.3	0.0	2.7	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	36.8	1.1	0.1	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	1497.3	0.0	0.0	80.8	0.0	75.2	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.0	0.3	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919425-21952848	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endothelial cells: 42.2;Hepatic stellate cells: 56.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 28.6"	"Group enriched"	"Detected in all"	7	"dendritic cells: 8.9;granulocytes: 28.6;monocytes: 24.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 109.1;K-562: 173.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		510000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	24.1	18.1	14.9	21.6	13.9	26.8	17.6	11.6	15.7	18.5	11.8	17.1	8.9	19.9	3.8	22.1	15.0	12.2	16.8	14.5	19.4	18.4	8.0	26.1	15.2	16.8	16.4	12.5	12.3	6.4	8.5	26.6	17.3	15.8	4.2	3.7	10.9	14.3	17.0	14.8	13.8	12.1	15.3	35.8	12.0	6.3	17.1	7.8	12.4	10.5	7.8	22.0	15.9	15.4	28.9	30.1	19.0	18.6	10.4	18.1	23.9	32.1	18.9	27.7	19.0	13.8	11.3	17.3	39.0	22.7	11.8	33.9	8.3	19.9	9.8	24.7	27.1	66.8	14.5	13.2	17.1	25.0	17.4	17.1	5.9	27.1	12.6	19.6	109.1	16.9	173.4	7.2	35.9	26.2	15.0	19.3	8.0	9.2	32.7	21.9	49.0	5.2	9.4	12.1	7.7	29.6	30.4	10.0	25.7	7.4	12.5	17.2	93.1	33.1	33.4	30.5	31.1	14.1	12.2	19.6	33.5	46.7	64.7	0.0	12.8	5.9	1.7	21.0	1.0	1.1	1.1	0.9	8.9	0.9	1.0	1.3	28.6	3.1	24.4	2.2	2.4	5.4	14.9	13.9	11.6	15.7	14.5	19.4	16.8	16.4	17.3	15.3	17.1	15.4	32.1	6.4	6.0	11.8	5.5	8.2	5.2	4.9	8.6	8.3	7.4	9.9	11.9	8.6	4.1	1.8	2.1	16.6	5.1	1.4	3.9	5.2	2.0	3.0	9.4	42.2	6.0	5.5	11.6	5.1	10.0	8.4	3.1	3.8	3.8	10.4	56.4	6.5	20.6	8.4	12.7	4.2	6.1	37.0	22.0	1.5	7.2	23.4	7.2	18.7	30.9	4.1	6.2	12.5	6.8	7.4	1.1	6.8	5.0	7.4	2.6	4.4	4.0	6.5	6.6	17.2	8.2	14.2	13.1	8.5	5.7	3.0	6.4	7.1	4.5	6.6
PPP1R15B	FLJ14744	ENSG00000158615	"Protein phosphatase 1 regulatory subunit 15B"	Q5SWA1	1	204403381-204411817	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"		"Diabetes mellitus, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061088			Approved	"Golgi apparatus"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA061088: AB_2684426"	"unprognostic (2.91e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (9.52e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.50e-2)"	40.7	23.1	12.9	31.0	15.3	125.7	23.0	17.8	13.9	19.6	16.4	23.4	22.4	21.4	13.1	25.9	21.5	30.8	13.0	11.7	13.2	21.0	48.1	24.2	29.1	14.4	15.2	24.5	36.8	18.7	10.5	32.6	14.6	22.5	24.1	16.0	22.1	15.9	13.2	18.1	24.3	29.9	14.6	23.8	27.0	11.7	15.2	33.3	28.2	18.2	24.7	53.2	14.7	19.7	29.3	23.0	26.9	22.8	34.1	23.2	108.7	23.6	28.3	31.9	28.7	27.6	40.3	48.2	16.0	28.9	22.2	36.3	40.2	23.9	29.5	37.3	28.7	28.5	55.7	17.8	41.5	49.1	49.0	29.3	30.4	31.4	34.5	22.9	35.1	40.4	44.4	92.8	21.8	29.1	47.1	30.6	46.2	26.8	32.9	33.2	48.9	49.8	32.0	35.4	25.7	39.3	42.6	59.8	49.3	36.0	39.4	50.2	19.8	22.2	31.3	28.6	40.3	62.5	30.0	47.3	20.0	33.1	23.4	13.1	5.5	5.7	3.2	5.1	3.4	2.0	3.2	3.0	5.0	2.1	4.9	3.5	11.8	3.2	6.2	2.0	4.4	2.9	12.9	15.3	17.8	13.9	11.7	13.2	14.4	15.2	14.6	14.6	15.2	19.7	72.2	48.1	37.9	15.3	40.8	73.7	43.0	23.1	48.3	18.5	43.7	24.6	15.6	32.9	25.9	18.4	20.9	22.9	40.3	70.4	3.9	15.9	9.0	72.0	90.8	50.9	44.7	27.3	12.3	24.0	42.7	54.7	76.5	146.7	49.4	31.0	28.9	48.6	31.8	8.4	13.0	43.3	22.4	42.0	171.9	4.6	13.1	97.9	49.8	10.3	36.8	14.4	11.3	18.1	23.2	30.3	40.5	12.8	50.9	55.0	39.5	11.0	43.0	18.5	6.6	72.7	48.6	17.2	13.2	39.8	64.2	49.3	46.8	31.2	35.6	104.5
PROK2	"BV8, KAL4, MIT1, PK2"	ENSG00000163421	"Prokineticin 2"	Q9HC23	3	71771655-71785206	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Biological rhythms"	Neuropeptide	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 64.5;lymphoid tissue: 22.5"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 5.9;Kupffer cells: 8.0;Macrophages: 11.3;monocytes: 6.9;Spermatocytes: 23.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.1"	"Region enriched"	"Detected in many"	7	"cerebral cortex: 13.3"	"Immune cell enriched"	"Detected in many"	50	"neutrophil: 414.4"	"Lineage enriched"	"Detected in many"	50	"granulocytes: 414.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 9.2;NB-4: 8.9;NTERA-2: 5.5;U-266/70: 12.0;U-266/84: 20.8;U-937: 8.3"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.7;hypothalamus: 1.1;olfactory bulb: 3.5"	"Low region specificity"	"Detected in all"			HPA041408	Approved				"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA041408: AB_10964057"	"unprognostic (5.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.51e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.91e-3)"	"unprognostic (6.89e-2)"	"unprognostic (5.73e-1)"	"unprognostic (1.59e-4)"	"unprognostic (2.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	7.2	0.3	0.7	17.7	0.5	64.5	0.3	0.1	13.3	0.4	0.7	0.4	0.3	0.2	0.0	0.4	2.7	1.2	1.0	0.2	0.5	0.6	2.5	13.1	0.2	0.5	1.0	0.2	1.1	0.0	0.4	3.1	1.2	0.2	0.2	0.1	0.3	0.0	0.5	0.1	0.5	1.5	0.2	22.5	0.6	11.4	1.9	1.1	0.5	4.2	0.5	6.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.6	0.0	0.0	0.0	0.3	8.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	20.8	0.0	0.0	8.3	0.0	0.0	8.2	3.5	3.4	0.7	0.0	0.0	2.7	2.9	0.7	0.0	0.9	5.0	414.4	0.0	0.2	0.3	1.7	3.1	0.7	0.5	0.1	13.3	0.2	0.5	0.5	1.0	1.2	0.2	1.9	0.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	1.8	0.0	0.0	2.5	0.0	0.0	0.0	1.6	0.1	0.1	0.1	0.0	5.9	0.0	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	8.0	0.3	2.8	0.3	11.3	1.8	0.0	6.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	23.8	2.9	0.0	0.0	0.0	3.5	0.1	0.0	0.0
PSTPIP1	"CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP"	ENSG00000140368	"Proline-serine-threonine phosphatase interacting protein 1"	O43586	15	76993359-77037475	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 56.6;lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 60.0;Enteroendocrine cells: 60.0;Hofbauer cells: 42.5;Kupffer cells: 41.8;Macrophages: 41.8;monocytes: 51.1;NK-cells: 91.6;T-cells: 68.4;Theca cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 55.1;HL-60: 14.4;NB-4: 20.9;THP-1: 14.7;U-937: 59.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010116, HPA010600, HPA072744"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA010116: , HPA010600: AB_1855870, HPA072744: "	"unprognostic (4.42e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.56e-2)"	"prognostic favorable (4.74e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (7.36e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.42e-2)"	6.0	2.6	2.8	11.7	2.7	56.6	2.3	2.7	3.1	2.0	3.4	3.3	2.5	1.6	0.1	2.0	3.1	2.9	2.4	2.7	2.8	3.4	3.4	10.4	13.5	3.1	3.1	1.0	1.3	0.2	1.6	1.8	3.0	2.9	0.8	0.1	2.4	1.0	1.5	1.8	9.4	1.4	3.1	33.9	2.9	0.7	3.6	4.2	2.9	1.0	5.5	4.3	2.7	3.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	55.1	0.0	0.0	0.0	3.3	0.0	14.4	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	20.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	4.0	0.6	0.0	0.1	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.1	0.0	0.0	1.3	2.4	0.1	59.8	0.0	4.8	71.5	71.4	39.9	33.5	30.8	13.3	27.2	32.7	59.0	18.5	14.3	22.3	85.3	41.6	38.3	5.2	27.0	42.2	2.8	2.7	2.7	3.1	2.7	2.8	3.1	3.1	3.0	3.1	3.6	3.1	1.1	0.0	5.1	1.0	19.2	9.3	1.2	0.4	0.0	1.1	0.9	1.1	1.9	0.0	2.5	0.0	0.0	0.3	60.0	3.1	0.0	0.0	9.6	0.3	0.3	0.8	60.0	4.8	0.4	0.2	0.7	1.9	0.0	0.3	2.5	0.1	2.2	0.9	42.5	0.0	0.1	6.1	2.0	41.8	36.5	18.6	0.9	41.8	7.2	0.0	51.1	0.2	91.6	5.5	1.0	0.1	2.5	2.6	8.5	0.3	0.3	0.4	0.0	0.4	0.0	0.8	3.1	0.2	1.2	0.2	4.8	0.5	68.4	78.1	0.3	1.2
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 72.4;lymphoid tissue: 63.4;skeletal muscle: 33.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 44.6;Erythroid cells: 46.7;Macrophages: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 112.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 102.0;HMC-1: 108.3"	"Low region specificity"	"Detected in all"							"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		No	No		1500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Mitochondria"	Nucleoplasm	"HPA040923: AB_10794429, HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.4	4.6	0.9	11.1	0.9	72.4	8.5	0.8	1.5	4.2	1.8	4.4	3.6	2.9	1.4	5.1	4.0	5.3	2.1	0.8	1.1	3.7	10.0	11.4	6.3	1.8	1.2	3.6	3.5	3.8	2.9	12.1	1.5	8.0	5.1	2.8	5.9	2.7	33.0	8.8	4.5	4.6	1.1	63.4	6.4	1.3	1.2	3.9	2.1	5.8	4.9	9.6	4.3	1.4	2.9	0.0	3.8	0.1	0.9	6.7	20.6	15.0	7.4	5.3	4.5	11.6	4.0	0.1	0.9	5.0	0.0	36.2	20.3	28.1	6.6	0.0	3.2	102.0	4.6	0.2	5.9	6.0	108.3	5.0	34.4	5.0	16.3	4.8	10.6	0.2	24.8	0.1	23.1	3.6	0.9	0.1	2.3	0.0	0.1	0.1	7.5	4.9	11.2	37.0	0.3	2.1	2.4	10.3	0.5	28.2	32.6	12.0	7.6	0.6	8.2	0.8	0.2	0.1	0.3	0.1	1.3	0.2	0.4	77.3	25.3	112.8	10.4	35.0	3.6	0.1	6.2	7.7	25.3	0.1	7.2	8.8	13.5	2.9	36.4	0.9	4.1	20.0	0.9	0.9	0.8	1.5	0.8	1.1	1.8	1.2	1.5	1.1	1.2	1.4	1.7	12.8	11.6	0.7	2.4	13.8	19.4	44.6	15.4	0.7	11.1	17.1	3.5	2.8	24.9	0.0	0.0	26.6	21.8	0.6	3.9	9.6	2.0	4.1	2.6	3.1	1.2	46.7	1.6	3.9	3.3	4.2	11.2	11.2	43.6	20.6	7.1	17.3	14.6	0.0	1.4	4.2	6.1	42.5	5.5	7.3	2.8	58.7	7.2	2.8	37.4	10.9	25.7	2.0	0.9	17.7	0.3	2.2	3.6	39.7	0.5	4.1	13.0	0.4	6.6	3.1	7.7	1.1	1.6	7.3	10.2	8.8	17.8	7.1	2.4	21.8
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.1;lymphoid tissue: 30.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 75.4;Hofbauer cells: 71.7;Kupffer cells: 93.0;Langerhans cells: 67.8;Macrophages: 64.5;monocytes: 52.8;Pancreatic endocrine cells: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 256.7;eosinophil: 906.5;neutrophil: 747.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 906.5;monocytes: 256.7"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 36.6;HMC-1: 131.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	10.4	2.4	4.3	30.8	4.7	41.1	3.4	4.7	5.6	3.4	4.1	5.5	4.1	1.7	1.2	7.2	2.6	7.2	2.0	3.8	5.1	2.7	4.1	17.8	13.5	8.9	6.6	1.3	2.0	1.6	0.6	7.3	7.7	1.5	6.7	0.5	2.3	1.5	0.7	5.4	6.3	7.9	8.1	14.4	3.8	1.3	7.2	3.6	1.9	2.6	18.0	14.4	1.9	11.8	20.1	0.2	0.1	0.4	0.2	0.0	0.5	0.0	0.0	0.7	0.2	0.2	5.7	1.3	0.1	0.1	0.3	13.5	0.5	36.6	0.8	0.4	0.6	7.7	0.2	0.9	0.1	1.9	131.3	0.0	6.0	0.4	0.4	0.0	0.2	0.1	0.5	0.4	0.0	1.3	0.2	19.3	0.6	0.5	0.2	0.3	0.1	0.1	8.7	2.1	0.3	0.1	0.1	18.1	0.2	0.4	0.4	5.4	0.1	0.2	0.7	0.0	0.2	1.2	1.1	5.6	0.1	2.4	0.6	61.7	256.7	906.5	0.6	77.9	1.2	12.5	0.4	0.4	116.1	6.7	0.5	0.7	747.1	0.7	34.1	1.3	1.2	112.4	4.3	4.7	4.7	5.6	3.8	5.1	8.9	6.6	7.7	8.1	7.2	11.8	2.1	6.4	6.7	0.0	4.1	6.5	2.0	37.9	5.2	1.5	0.8	0.5	2.2	1.5	20.9	1.8	2.1	0.6	2.9	0.4	0.0	18.1	0.4	0.5	0.2	7.3	0.0	4.0	0.9	5.1	0.5	1.3	1.1	0.5	75.4	2.0	2.9	1.0	71.7	0.0	0.7	0.0	18.3	93.0	67.8	0.2	0.6	64.5	0.0	15.0	52.8	0.2	0.0	1.5	6.6	89.8	0.6	0.0	0.5	0.6	0.3	0.2	20.2	0.9	0.0	0.6	1.0	2.3	0.7	3.2	2.8	1.5	2.0	0.0	0.4	9.4
PTGER2	EP2	ENSG00000125384	"Prostaglandin E receptor 2"	P43116	14	52314305-52328598	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 55.6;Macrophages: 33.2;NK-cells: 177.1;T-cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.1;ASC TERT1: 68.3;HHSteC: 43.8;HL-60: 25.2;HSkMC: 56.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.48e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (8.48e-3)"	"unprognostic (5.26e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.74e-2)"	8.7	1.4	0.1	12.6	0.6	38.4	3.6	0.0	0.4	17.2	3.0	8.0	6.2	9.4	0.6	1.8	4.6	9.7	1.1	0.1	0.2	3.2	3.6	5.4	4.5	0.7	0.5	8.2	1.2	0.4	0.7	14.4	0.3	9.9	6.6	0.0	3.2	2.8	0.7	1.3	9.4	5.1	0.6	11.8	17.5	2.9	0.3	3.2	1.7	0.3	1.7	5.8	2.2	0.3	1.3	0.5	0.0	0.0	26.1	68.3	0.1	2.1	0.4	2.3	2.8	0.0	0.1	0.0	1.8	1.4	0.0	9.3	0.0	0.5	3.3	0.0	13.2	0.0	0.7	0.0	43.8	25.2	0.3	56.2	1.1	5.8	0.9	7.4	0.0	0.0	0.0	0.0	13.4	1.2	0.0	1.0	1.0	4.5	8.8	0.2	0.0	0.0	20.6	0.1	0.7	20.6	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.9	1.5	15.5	0.0	0.0	0.0	0.0	6.1	14.2	0.2	5.8	35.9	35.5	106.7	30.6	129.3	0.2	91.0	114.3	19.0	0.1	21.7	67.7	4.7	73.5	61.5	0.9	50.0	66.3	0.1	0.6	0.0	0.4	0.1	0.2	0.7	0.5	0.3	0.6	0.3	0.3	4.0	3.2	1.7	0.0	3.2	1.8	0.4	0.8	1.2	0.0	2.0	2.5	1.2	1.5	0.7	3.7	0.0	0.1	55.6	0.7	0.0	0.3	0.0	24.0	1.6	0.9	6.0	3.0	0.1	0.0	0.3	13.9	15.3	7.7	20.8	2.9	4.2	0.6	10.0	0.0	0.1	6.0	0.0	28.0	19.6	0.5	4.1	33.2	3.6	0.0	16.6	0.0	177.1	0.0	0.0	1.5	0.1	3.0	3.7	1.4	0.0	0.3	9.6	0.0	0.0	1.3	11.6	0.1	1.2	0.2	1.6	0.3	63.1	0.2	0.6	0.2
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase non-receptor type 12"	Q05209	7	77537295-77640069	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		770000	"Cluster 40: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	60.5	30.1	24.2	43.9	26.6	69.9	50.3	29.2	31.6	40.9	25.9	48.9	18.9	38.6	18.6	38.5	39.6	40.2	39.0	25.1	27.3	36.1	30.9	65.0	27.5	28.5	27.8	34.6	20.1	21.0	21.9	74.7	30.5	26.4	27.7	30.9	23.8	33.2	24.6	36.9	29.7	40.2	26.7	52.7	27.1	30.1	32.7	33.9	31.0	44.5	27.5	46.7	39.6	30.2	72.4	43.5	100.6	51.8	69.1	71.7	54.2	73.3	93.0	56.6	80.0	21.6	109.9	8.6	23.2	86.3	123.6	50.2	34.2	73.4	113.3	21.2	19.2	44.9	44.2	88.4	67.7	25.8	28.8	59.0	80.3	123.2	157.6	101.0	121.6	2.1	54.9	12.2	182.6	49.4	3.6	71.9	81.7	97.6	49.2	15.1	80.6	4.5	97.6	38.5	12.5	66.6	90.4	81.5	73.4	172.2	39.5	93.9	89.3	121.4	73.1	45.0	141.3	12.6	7.4	22.2	71.6	65.9	215.7	3.6	4.1	6.8	3.1	2.8	1.3	2.3	1.1	2.6	3.8	1.0	0.6	3.3	9.5	13.3	5.3	0.3	1.6	2.7	24.2	26.6	29.2	31.6	25.1	27.3	28.5	27.8	30.5	26.7	32.7	30.2	139.3	70.5	56.2	30.0	18.2	68.8	60.0	55.9	23.9	16.7	40.9	26.3	41.3	28.6	46.4	20.2	8.4	40.0	89.0	31.2	3.9	42.1	3.5	43.9	62.4	114.4	12.1	16.6	65.8	39.6	58.7	54.6	21.4	87.2	14.5	21.7	119.2	24.6	50.1	35.3	58.0	21.7	28.5	82.0	121.3	6.7	46.6	96.1	35.6	93.7	54.9	66.9	163.7	70.4	67.3	75.0	21.4	47.0	17.6	62.0	10.9	19.2	23.2	15.2	65.7	127.9	66.8	51.2	71.4	29.8	101.4	72.1	27.3	24.4	23.3	104.8
PTPRE	PTPE	ENSG00000132334	"Protein tyrosine phosphatase receptor type E"	P23469	10	127907103-128085855	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 46.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 256.6;Inhibitory neurons: 191.6;Langerhans cells: 307.9;Macrophages: 276.3;Oligodendrocyte precursor cells: 247.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 634.6;plasmacytoid DC: 475.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 475.9;granulocytes: 634.6;monocytes: 175.4"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 38.6;HUVEC TERT2: 41.6;NB-4: 32.5;TIME: 79.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015870, HPA021872"	Supported		Approved	"Intermediate filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments"		"HPA015870: AB_1855759, HPA021872: AB_1855760"	"unprognostic (5.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.59e-2)"	13.6	16.7	13.9	25.3	8.9	46.9	6.7	5.7	13.9	3.9	7.7	9.2	9.5	3.5	2.6	7.9	4.9	10.3	10.6	14.2	11.1	4.3	4.4	16.0	16.4	11.6	9.0	1.6	2.7	2.7	5.0	7.8	10.7	3.4	9.3	1.0	5.8	2.4	1.3	4.7	12.9	7.4	10.8	20.6	7.4	2.6	10.7	8.6	5.5	3.1	9.8	12.7	4.4	14.2	4.3	0.9	0.5	0.0	2.5	0.4	7.5	0.1	0.0	1.6	3.6	1.7	25.1	3.3	2.6	2.1	5.2	2.3	2.1	12.2	0.7	4.0	1.9	0.4	1.4	0.0	4.1	16.2	11.6	0.8	6.9	6.1	12.1	38.6	41.6	10.3	0.0	1.9	2.6	4.0	4.9	32.5	0.2	4.6	1.5	19.1	2.6	6.4	6.8	18.0	0.0	2.5	7.4	1.3	0.3	1.8	0.6	20.1	79.5	1.7	1.8	7.8	8.9	0.9	1.3	4.6	11.3	12.5	0.0	174.3	175.4	147.2	36.6	64.5	22.3	7.7	16.5	25.1	97.9	8.3	11.5	19.6	634.6	31.6	54.9	475.9	26.7	43.3	13.9	8.9	5.7	13.9	14.2	11.1	11.6	9.0	10.7	10.8	10.7	14.2	25.0	83.3	57.2	22.5	26.2	59.5	54.3	42.4	15.9	5.2	14.2	23.6	20.3	8.6	23.7	3.7	0.0	43.2	256.6	15.7	0.0	3.7	2.1	3.6	10.6	78.0	6.7	10.3	112.7	4.4	67.4	17.5	10.7	7.7	31.6	3.7	47.5	2.3	57.5	0.0	191.6	15.8	18.3	166.7	307.9	2.5	0.6	276.3	24.9	165.8	139.5	0.0	150.4	247.3	93.4	49.2	13.3	0.4	38.5	21.3	13.9	2.2	7.8	0.9	0.0	86.0	12.8	0.5	1.9	20.4	64.6	17.0	59.3	9.2	11.7	40.3
RAB32		ENSG00000118508	"RAB32, member RAS oncogene family"	Q13637	6	146543833-146554953	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 175.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 232.6;Kupffer cells: 254.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 86.5"	"Group enriched"	"Detected in many"	42	"dendritic cells: 42.5;granulocytes: 86.5;monocytes: 46.8"	"Low cell line specificity"	"Detected in many"											HPA025731	Approved		Approved	Cytosol		NA	NA		63000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA025731: AB_1856001"	"unprognostic (3.07e-1)"	"unprognostic (5.32e-2)"	"prognostic favorable (1.56e-4)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.64e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	35.0	16.5	7.5	29.7	7.8	175.1	27.0	8.6	11.0	19.0	9.2	38.3	17.4	26.5	14.6	11.6	20.8	24.1	17.9	7.1	8.2	21.3	50.2	32.1	22.3	9.9	8.2	13.0	12.2	8.3	5.0	14.8	8.9	14.5	37.7	2.2	18.1	16.9	4.6	20.2	18.4	46.5	9.2	54.1	19.4	33.3	8.8	22.5	11.0	8.3	15.2	28.6	15.4	11.7	65.5	34.5	38.7	65.3	58.0	98.5	0.1	123.3	138.4	167.7	276.7	21.2	31.6	0.1	43.9	132.2	183.5	84.2	2.4	80.4	225.2	0.4	29.1	82.4	78.3	77.3	252.1	114.2	115.9	87.6	133.1	95.8	135.3	86.7	110.5	0.0	15.8	0.4	92.8	15.8	52.0	61.8	5.0	0.0	65.2	0.0	41.5	0.9	65.6	45.2	0.1	50.6	144.7	17.6	219.3	34.3	33.7	91.7	88.0	50.2	67.7	133.1	152.6	0.2	9.4	0.4	115.1	86.0	69.3	86.5	46.8	8.2	0.0	21.2	0.0	0.0	0.0	0.1	42.5	0.0	0.1	0.0	16.5	1.3	15.4	2.2	0.0	14.4	7.5	7.8	8.6	11.0	7.1	8.2	9.9	8.2	8.9	9.2	8.8	11.7	30.8	48.1	9.4	2.9	4.1	53.5	95.3	92.6	17.6	1.4	29.0	38.9	2.0	52.9	36.8	11.0	4.2	2.2	3.4	64.1	25.4	164.4	96.9	8.5	40.3	34.3	60.1	14.9	2.3	105.7	6.9	51.5	18.3	12.4	57.8	27.7	27.5	75.4	232.6	0.0	1.3	31.3	22.4	254.6	101.7	156.7	24.5	146.7	168.9	24.4	147.2	9.0	2.1	4.0	4.6	154.3	46.3	25.6	0.5	99.6	33.3	83.2	9.5	1.4	19.7	46.1	46.3	70.9	14.2	2.5	19.0	3.1	7.0	33.1	62.5	65.6
RAB5C	"RAB5CL, RABL"	ENSG00000108774	"RAB5C, member RAS oncogene family"	P51148	17	42124978-42155044	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA003426, HPA004167"	Approved		Enhanced	Endosomes		NA	NA		480000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Endosomes		"HPA003426: AB_1079735, HPA004167: AB_2667156"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.56e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.06e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.12e-2)"	133.5	118.1	91.7	113.7	99.2	203.5	119.4	97.4	107.9	90.9	77.1	106.9	135.7	103.1	67.3	92.3	87.3	88.6	69.7	89.0	101.9	145.9	99.7	120.1	94.6	98.5	98.1	82.4	76.4	102.6	48.7	106.8	98.5	70.6	86.3	40.5	84.5	84.3	46.7	91.5	124.1	97.6	96.7	116.4	118.0	41.7	104.3	87.1	109.7	54.6	79.2	115.1	83.0	100.6	169.5	311.3	96.2	140.1	210.7	144.8	184.7	201.6	212.5	273.9	238.1	223.5	163.5	81.5	172.9	254.4	194.8	231.8	179.1	197.9	175.7	104.9	232.6	124.8	120.6	326.1	206.4	165.8	195.6	187.3	204.7	208.1	144.6	143.1	292.6	110.2	145.8	123.6	189.7	154.7	170.3	148.6	95.2	294.7	0.9	110.0	165.2	139.4	209.0	246.1	53.6	136.2	103.7	651.5	220.6	149.5	288.7	159.9	276.6	279.8	155.0	237.9	218.5	113.0	157.1	104.1	185.1	127.6	290.4	56.9	119.7	129.5	45.7	103.4	40.6	42.8	44.5	46.2	83.4	43.6	36.5	37.2	194.5	56.8	110.0	55.1	56.0	99.2	91.7	99.2	97.4	107.9	89.0	101.9	98.5	98.1	98.5	96.7	104.3	100.6	185.1	6.4	9.7	23.5	83.7	111.3	89.6	139.6	62.0	51.0	86.8	80.0	5.4	77.2	66.3	106.7	12.5	189.6	95.3	198.8	252.4	207.0	63.7	43.5	51.3	146.6	78.6	64.6	12.0	173.8	210.6	81.8	78.0	51.1	44.4	59.1	165.2	63.9	443.6	38.7	12.6	115.2	142.4	204.1	213.8	100.4	108.7	171.2	158.3	24.4	207.5	105.7	133.9	18.6	21.2	247.2	189.9	155.7	64.3	105.0	243.3	408.8	33.7	43.1	131.5	57.5	137.3	28.9	60.8	74.8	130.8	274.9	83.0	65.0	99.9	145.1
RAB8B		ENSG00000166128	"RAB8B, member RAS oncogene family"	Q92930	15	63189560-63267776	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 81.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 220.6;Langerhans cells: 195.6;Late spermatids: 399.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 125.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		4700000	"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (7.67e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.47e-2)"	26.7	14.7	10.6	30.0	12.3	81.1	13.3	11.0	13.1	19.3	14.3	12.5	18.8	17.7	8.4	13.5	10.8	24.4	12.6	12.7	12.2	12.6	15.3	22.4	43.2	10.1	12.3	32.0	7.4	7.7	5.7	30.3	11.5	14.6	11.5	12.0	7.1	10.0	5.4	7.4	17.5	18.7	13.4	34.4	13.2	15.9	13.0	37.8	21.6	10.1	38.9	27.9	9.3	15.3	13.9	12.0	43.4	18.6	82.1	67.0	12.9	13.3	30.3	24.1	46.5	12.7	11.6	38.2	11.8	29.6	26.3	7.0	37.5	18.0	40.8	54.9	7.4	45.4	9.9	8.4	76.1	17.9	28.0	40.8	9.5	45.2	26.7	31.0	60.4	37.1	19.1	36.2	44.3	9.4	27.5	10.3	27.6	12.8	11.2	24.7	57.3	5.6	19.5	66.7	3.8	9.4	20.1	2.8	39.0	27.5	9.4	19.0	68.6	44.8	27.1	24.2	18.2	23.1	24.0	34.6	28.7	50.4	125.5	62.1	26.3	22.4	26.5	23.3	23.6	18.8	20.9	25.9	18.1	17.3	15.8	20.2	56.4	25.0	22.7	2.4	35.7	30.0	10.6	12.3	11.0	13.1	12.7	12.2	10.1	12.3	11.5	13.4	13.0	15.3	32.9	19.2	13.7	18.9	71.8	31.1	7.8	18.8	12.5	2.2	14.8	10.3	5.4	11.5	12.4	7.3	12.5	13.8	140.6	2.4	11.7	37.4	220.6	4.3	28.2	29.5	10.7	19.1	23.7	13.5	102.8	58.9	14.3	8.1	39.3	11.2	33.5	6.6	56.1	20.2	45.4	4.1	14.2	76.9	195.6	399.8	31.7	79.3	35.6	40.3	142.7	13.9	97.9	64.3	62.9	33.3	1.1	38.0	37.6	11.7	11.4	32.8	10.3	14.8	19.7	15.8	29.3	71.3	17.2	7.7	22.4	37.4	105.0	16.3	3.4	22.5
RAP1B	"DKFZp586H0723, K-REV, RAL1B"	ENSG00000127314	"RAP1B, member of RAS oncogene family"	P61224	12	68610855-68671901	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.20e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.22e-1)"	156.1	107.5	48.2	166.5	53.4	277.9	118.2	55.8	64.2	89.8	62.5	126.4	84.2	120.2	69.7	86.3	78.7	129.7	67.9	49.5	60.0	107.3	141.1	134.9	211.8	58.3	53.5	69.3	78.8	74.1	52.0	133.0	59.7	85.1	111.5	57.6	70.0	135.9	49.5	73.5	121.0	146.4	52.4	153.3	104.4	89.6	55.6	162.5	89.1	57.3	181.1	198.1	83.8	66.2	199.9	133.1	153.2	131.2	317.6	253.1	140.2	414.9	252.1	269.5	203.5	178.9	130.2	280.0	232.8	580.5	124.2	113.4	146.5	202.9	379.8	496.2	125.7	725.2	156.7	120.9	370.8	282.0	407.1	254.8	203.3	289.5	346.0	218.6	298.7	232.1	261.2	445.6	272.0	127.9	265.4	361.7	173.9	86.8	191.3	235.8	181.9	211.1	204.9	488.3	59.6	93.3	209.1	124.8	206.1	174.7	160.3	327.2	330.4	243.0	108.9	275.6	229.9	227.1	452.4	342.3	224.7	191.8	212.3	399.1	215.4	205.7	340.1	407.0	221.2	154.1	206.1	297.6	196.2	140.3	222.2	303.4	149.8	469.5	464.3	99.0	186.2	820.8	48.2	53.4	55.8	64.2	49.5	60.0	58.3	53.5	59.7	52.4	55.6	66.2	210.9	80.1	79.9	41.1	166.2	294.4	72.4	150.9	70.6	14.0	73.3	61.0	14.7	37.1	108.9	80.9	22.9	35.5	373.9	176.1	109.5	157.9	99.6	78.5	154.3	132.4	189.5	104.7	45.0	130.8	75.2	123.4	52.0	119.6	147.8	60.5	85.3	32.7	78.5	33.7	46.8	93.5	95.6	111.3	437.6	44.6	38.8	273.1	188.5	105.9	257.3	28.6	362.5	45.8	67.8	186.0	215.6	36.5	228.4	61.4	72.3	182.2	104.0	23.3	6.6	40.3	204.8	46.3	50.2	78.9	297.8	154.5	256.9	123.2	92.2	92.4
RAPGEF2	"DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF"	ENSG00000109756	"Rap guanine nucleotide exchange factor 2"	Q9Y4G8	4	159103013-159360174	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, GTPase activation, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 456.2;Inhibitory neurons: 264.1;Microglial cells: 238.9;Oligodendrocyte precursor cells: 199.0;Oligodendrocytes: 236.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.9;NK-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 104.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068798			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA068798: "	"unprognostic (4.88e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.16e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.76e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	22.7	9.4	8.7	13.4	19.8	87.5	24.1	4.1	32.1	16.7	0.0	21.8	15.9	16.1	9.8	13.8	14.0	20.1	23.2	27.4	0.3	22.7	30.5	26.6	11.9	0.0	0.7	13.5	19.5	23.5	15.3	38.5	0.3	12.2	20.8	35.1	25.3	12.6	21.7	17.5	17.0	19.7	0.6	29.7	19.3	9.8	6.0	17.5	39.5	31.4	11.5	14.8	11.8	18.6	8.9	11.9	55.4	17.2	21.4	23.9	84.9	17.0	21.3	15.2	10.9	36.7	19.4	50.7	6.1	17.0	22.0	8.0	19.1	21.8	18.0	8.6	13.2	79.0	25.3	21.4	15.5	9.7	104.5	14.1	12.1	36.5	12.9	32.0	44.1	20.7	17.6	46.0	19.0	15.6	24.1	1.5	23.7	10.4	11.8	19.7	14.0	2.0	13.6	20.2	15.7	21.0	24.9	12.1	20.0	26.5	6.0	6.3	47.0	23.9	25.2	30.7	14.2	51.0	32.9	0.8	28.3	4.1	14.8	2.2	1.0	0.7	0.5	0.5	0.6	0.2	0.4	0.3	0.5	0.2	0.6	0.3	5.9	3.3	0.6	1.0	1.0	0.3	8.7	19.8	4.1	32.1	27.4	0.3	0.0	0.7	0.3	0.6	6.0	18.6	66.7	57.7	30.1	110.7	12.9	20.4	11.2	7.5	9.6	19.7	23.5	11.9	39.0	11.5	13.8	7.3	41.7	11.1	20.2	24.8	0.0	9.2	5.3	43.5	19.5	49.2	14.4	38.9	456.2	12.6	9.6	16.9	7.7	59.2	51.8	22.9	32.2	30.5	10.8	33.7	264.1	12.0	2.0	24.6	20.1	5.3	7.8	29.5	33.8	238.9	15.6	30.2	2.1	199.0	236.2	22.1	17.7	8.6	40.5	17.6	7.1	8.7	18.7	22.4	52.6	28.1	37.2	3.5	8.9	10.7	20.0	5.9	12.9	7.2	7.9	15.1
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 20.8;lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 18.1;granulocytes: 26.6;Hofbauer cells: 15.1;Kupffer cells: 32.9;Langerhans cells: 11.6;Macrophages: 19.1;monocytes: 25.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 39.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;HMC-1: 24.0;U-937: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	3.2	0.8	0.3	6.7	0.3	20.8	0.7	0.3	0.9	1.1	0.4	1.2	1.2	0.5	0.1	1.0	1.0	1.9	0.6	0.2	0.3	0.3	0.7	3.3	1.1	0.9	0.4	0.4	1.1	0.3	0.2	2.3	0.6	0.5	0.8	0.0	0.4	0.5	0.8	0.5	1.8	2.0	0.7	8.9	0.9	0.2	1.1	1.1	0.2	1.4	0.7	2.5	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.7	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	12.5	13.5	20.1	0.0	15.4	0.0	0.1	0.3	0.0	9.4	0.1	0.0	0.0	39.4	0.0	17.9	0.7	1.4	4.4	0.3	0.3	0.3	0.9	0.2	0.3	0.9	0.4	0.6	0.7	1.1	1.0	0.2	0.0	0.6	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.3	18.1	0.0	1.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.7	0.0	0.2	0.4	0.0	0.0	26.6	0.0	1.4	0.0	15.1	0.0	0.4	0.0	0.0	32.9	11.6	0.0	0.0	19.1	1.8	0.0	25.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.1
RBM17	"MGC14439, SPF45"	ENSG00000134453	"RNA binding motif protein 17"	Q96I25	10	6089034-6117457	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037477, HPA037478"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037477: AB_10671372, HPA037478: AB_2675494"	"unprognostic (8.55e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.57e-8)"	"unprognostic (3.78e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-2)"	72.4	47.0	46.3	75.3	51.6	139.5	64.4	47.2	53.5	50.2	40.1	57.6	63.8	63.5	38.7	51.9	55.3	52.6	60.8	46.9	52.3	54.6	44.6	78.0	87.4	53.5	49.5	54.7	62.9	45.5	35.8	75.7	52.7	41.5	65.2	41.6	49.9	39.4	95.4	47.0	70.5	60.4	47.3	77.6	51.6	61.9	52.5	87.7	63.3	72.1	85.4	63.5	49.4	52.4	195.9	113.0	141.1	122.7	76.5	69.4	175.5	128.4	58.0	130.2	139.8	184.7	151.2	234.1	89.3	94.4	48.5	188.1	130.3	136.4	138.6	233.7	132.1	199.3	120.4	158.5	96.7	110.0	93.6	71.7	104.0	132.4	72.4	67.9	159.6	168.1	219.0	112.1	84.1	223.6	198.8	66.2	90.3	227.8	81.3	211.4	79.9	120.8	93.5	117.3	60.5	78.9	124.1	110.1	99.0	119.5	146.3	111.3	97.3	76.9	153.4	169.0	138.1	110.2	135.6	386.7	72.0	140.3	51.7	79.7	78.2	102.6	71.6	79.0	75.2	101.8	71.8	73.4	69.9	110.2	71.8	68.1	38.7	77.8	62.3	77.0	101.1	59.8	46.3	51.6	47.2	53.5	46.9	52.3	53.5	49.5	52.7	47.3	52.5	52.4	152.3	89.8	56.0	24.8	107.7	129.2	97.4	72.7	108.7	71.3	68.5	85.3	86.0	65.8	68.1	66.2	50.1	125.6	83.3	80.8	90.1	92.0	90.2	74.7	99.5	123.9	72.7	100.5	42.2	70.9	188.5	89.5	58.6	83.9	96.8	79.7	69.7	65.3	98.8	92.5	41.4	87.1	63.1	73.6	128.6	26.3	66.2	93.9	51.6	38.4	161.5	77.9	96.8	23.6	40.7	88.0	86.4	60.5	153.8	122.3	79.8	75.7	41.3	62.2	72.3	115.6	117.4	266.4	233.3	114.4	108.7	97.0	97.4	78.9	106.5	112.6
REM2	FLJ38964	ENSG00000139890	"RRAD and GEM like GTPase 2"	Q8IYK8	14	22883222-22887678	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Early spermatids: 29.2;Endometrial ciliated cells: 10.9;Late spermatids: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 3.1"	"Region enhanced"	"Detected in all"		"basal ganglia: 44.8"	"Group enriched"	"Detected in some"	5	"basal ganglia: 8.3;cerebellum: 4.6;hippocampal formation: 3.2;midbrain: 2.2"							NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (4.56e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.49e-5)"	"unprognostic (9.40e-2)"	"unprognostic (4.63e-5)"	"unprognostic (3.56e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-2)"	0.7	0.4	1.0	0.9	3.3	9.9	0.7	1.4	2.1	1.2	2.0	1.3	0.3	0.8	0.4	0.7	2.6	0.3	0.4	1.3	1.6	1.6	0.6	2.3	0.9	1.1	1.2	1.1	0.6	1.3	5.8	0.2	0.8	1.5	0.1	0.5	0.8	0.3	0.8	2.2	2.0	0.3	0.8	5.8	0.9	4.8	2.2	0.6	1.0	0.3	0.5	1.0	0.9	0.8	0.7	0.3	3.1	0.1	0.3	0.4	0.4	0.0	0.2	0.0	0.2	0.3	1.0	0.3	0.1	0.0	0.1	1.3	0.0	0.1	0.2	0.5	0.7	0.1	1.5	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	1.3	0.2	1.0	0.0	0.3	0.1	0.3	0.6	0.0	0.1	0.3	0.1	0.1	0.4	1.5	0.3	0.4	0.5	0.1	0.5	0.2	0.0	0.0	0.7	0.0	0.1	1.2	0.5	0.8	0.1	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.3	0.6	0.2	0.3	0.0	0.9	0.4	0.5	3.7	0.0	0.4	0.2	0.2	0.1	1.0	3.3	1.4	2.1	1.3	1.6	1.1	1.2	0.8	0.8	2.2	0.8	1.6	12.8	2.4	0.0	4.0	2.8	0.9	1.2	4.0	0.1	4.7	4.3	1.7	1.5	1.9	1.8	0.0	0.5	3.5	1.4	0.0	0.7	29.2	10.9	1.3	1.1	6.6	0.4	0.2	0.0	0.3	0.7	1.5	4.7	0.0	0.6	0.4	0.0	0.4	0.0	0.1	1.9	0.0	0.6	1.0	9.6	1.2	0.6	3.6	0.0	1.3	0.7	0.0	0.0	0.1	0.4	0.2	1.2	3.1	0.9	0.4	0.5	4.6	0.9	0.0	0.4	0.9	0.8	0.8	4.5	3.0	0.4	1.7	0.3	1.2	1.3
RILPL2	"FLJ30380, FLJ32372, MGC7036"	ENSG00000150977	"Rab interacting lysosomal protein like 2"	Q969X0	12	123415039-123436684	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 116.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 149.8;Macrophages: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 103.8;NB-4: 235.2;THP-1: 149.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028958	Approved		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA028958: AB_10602124"	"unprognostic (1.94e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.24e-7)"	"unprognostic (2.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.74e-2)"	21.4	7.5	9.3	27.4	9.7	116.2	15.8	8.2	11.1	26.3	14.2	6.3	5.4	19.3	11.2	7.6	18.4	15.7	8.2	9.5	10.2	18.6	11.9	24.1	23.8	9.7	9.7	13.1	8.0	11.4	3.5	14.4	9.2	18.6	5.8	1.4	23.2	23.7	4.6	5.5	6.5	13.8	9.1	26.7	10.3	3.2	10.3	15.2	27.8	5.9	17.7	20.5	7.0	8.6	14.2	12.7	4.6	21.8	29.8	23.6	13.3	16.1	41.0	15.3	12.7	16.2	5.5	7.6	15.2	25.1	8.4	9.2	10.3	12.3	14.2	29.1	9.8	103.8	9.9	24.2	33.2	81.2	50.6	18.3	9.3	16.0	11.6	19.8	15.7	20.4	11.1	3.8	12.4	9.4	28.0	235.2	2.9	4.5	13.9	19.8	14.1	15.4	16.0	26.1	1.0	6.7	21.9	0.7	16.9	9.2	19.5	149.0	17.0	12.5	9.2	22.8	9.9	6.2	8.0	18.2	12.3	55.1	5.3	98.6	133.3	159.3	24.0	106.0	22.4	55.8	51.1	42.7	98.7	41.9	19.7	22.5	176.8	22.4	121.5	46.7	67.7	63.8	9.3	9.7	8.2	11.1	9.5	10.2	9.7	9.7	9.2	9.1	10.3	8.6	75.7	35.3	75.2	7.2	149.8	24.5	68.4	67.8	32.5	1.4	45.3	35.9	5.1	17.2	43.3	22.0	2.1	10.1	75.0	2.4	25.4	20.1	2.1	51.9	24.8	73.2	4.2	24.2	7.5	21.0	5.4	28.2	9.2	27.0	62.6	8.4	84.3	13.3	72.9	1.7	2.6	8.1	0.0	112.5	129.7	2.7	50.4	288.7	37.4	10.3	117.8	18.7	42.2	5.5	2.3	22.7	6.4	66.2	25.7	82.6	1.5	63.5	47.1	2.1	6.6	13.1	30.1	1.4	13.0	12.5	15.3	8.1	92.5	10.1	4.8	69.2
RIN3	FLJ22439	ENSG00000100599	"Ras and Rab interactor 3"	Q8TB24	14	92513781-92688994	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 46.3"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 125.1;Macrophages: 78.7;Microglial cells: 100.2;monocytes: 109.8;NK-cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 35.7;classical monocyte: 43.4;eosinophil: 54.1;intermediate monocyte: 40.4;myeloid DC: 41.6;neutrophil: 40.2;NK-cell: 21.5;non-classical monocyte: 50.8"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"HMC-1: 108.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA079218	Approved					NA	NA		7400	"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA079218: "	"unprognostic (1.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.69e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	10.5	13.6	4.3	9.6	3.6	46.3	8.1	4.1	5.3	7.3	2.8	19.1	6.6	15.4	1.6	6.7	8.7	8.1	8.6	4.4	6.6	4.5	12.4	16.3	6.1	9.6	5.9	6.7	2.2	5.4	2.7	6.4	7.0	7.0	4.8	0.2	5.1	5.1	3.2	5.3	9.7	10.2	7.5	22.8	6.4	5.2	9.1	10.9	5.0	2.9	5.3	10.6	8.6	8.6	10.3	19.8	4.4	1.7	1.7	14.3	15.0	12.9	14.0	12.0	8.0	7.5	17.5	0.0	12.1	19.1	8.2	22.0	3.1	0.1	5.5	10.6	3.9	21.4	1.5	8.1	8.7	6.9	108.1	8.1	7.7	11.5	4.8	4.7	7.1	2.6	3.1	0.5	5.0	6.5	3.3	16.3	2.7	1.1	6.0	2.7	2.1	0.2	4.9	6.9	1.0	0.0	6.2	2.1	9.5	4.3	0.1	2.5	12.5	13.8	10.8	20.1	10.9	3.1	0.0	0.2	13.5	0.3	18.1	35.7	43.4	54.1	10.1	40.4	3.4	7.8	4.7	4.9	41.6	8.5	6.8	7.7	40.2	21.5	50.8	1.8	3.0	24.5	4.3	3.6	4.1	5.3	4.4	6.6	9.6	5.9	7.0	7.5	9.1	8.6	19.2	0.0	8.9	18.3	28.2	3.8	2.0	3.4	0.6	2.2	3.7	5.5	4.7	1.5	2.2	0.0	0.0	5.1	44.0	9.2	0.0	1.6	10.2	2.2	3.5	15.4	0.0	12.6	6.9	1.4	3.1	4.2	1.1	2.6	51.4	5.4	8.2	14.9	49.3	0.0	5.2	7.3	4.1	125.1	50.8	6.6	5.3	78.7	12.4	100.2	109.8	0.0	114.4	20.6	0.9	10.1	3.8	18.8	9.7	3.8	9.5	6.2	2.5	0.3	13.1	10.1	4.6	19.1	4.0	1.1	2.7	12.7	32.5	1.9	8.9	3.6
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	"Receptor interacting serine/threonine kinase 2"	O43353	8	89757806-89791064	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 156.1;Langerhans cells: 121.3;Macrophages: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.84e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.05e-4)"	4.1	1.6	4.0	5.6	4.0	8.9	5.1	4.0	5.5	4.7	3.3	2.9	1.7	5.5	2.4	3.0	2.7	9.4	4.4	4.1	5.5	3.7	5.6	6.0	6.5	4.6	4.0	2.5	4.4	4.2	1.9	4.7	5.1	5.3	2.9	1.5	5.0	2.7	0.6	4.2	2.4	5.7	5.3	4.8	2.9	2.9	3.7	2.8	4.2	1.3	6.7	9.4	2.6	6.0	17.8	6.0	3.2	4.9	7.9	10.8	5.5	19.2	36.1	10.7	13.6	4.6	9.7	14.4	28.0	11.7	7.6	4.2	8.9	6.9	20.2	8.7	8.0	11.9	2.8	5.5	22.2	4.5	5.8	8.8	5.6	15.6	49.8	11.4	11.4	0.0	5.4	4.7	10.2	3.4	0.0	9.6	1.5	8.4	14.4	3.2	4.1	7.5	26.1	8.4	0.4	3.1	4.7	12.6	10.0	4.0	12.0	5.6	10.1	6.5	6.0	11.2	9.1	8.9	4.2	8.8	16.2	0.4	4.3	13.7	6.6	23.2	3.5	12.5	4.1	7.6	5.4	4.6	8.1	4.8	4.9	5.4	5.1	4.4	14.9	2.6	1.3	4.6	4.0	4.0	4.0	5.5	4.1	5.5	4.6	4.0	5.1	5.3	3.7	6.0	19.3	35.3	18.1	25.5	29.8	57.6	33.7	13.3	16.5	2.1	17.2	8.9	5.2	4.3	22.9	3.7	0.0	13.3	32.8	2.8	5.9	80.1	6.6	82.3	23.7	15.0	0.0	9.9	12.9	60.8	45.7	27.3	9.7	156.1	43.1	7.1	6.1	3.2	41.7	3.3	9.1	5.4	24.4	32.4	121.3	2.5	7.8	105.1	19.6	15.0	42.1	12.1	8.2	15.6	12.8	50.0	2.7	6.0	22.0	59.2	2.2	10.4	11.6	0.3	13.1	19.2	19.6	7.9	12.8	14.7	48.3	83.7	30.4	7.5	8.1	49.5
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 278.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 619.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 619.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.91e-4)"	26.7	15.2	7.7	40.3	7.5	52.3	16.3	7.7	9.7	17.7	12.3	15.7	16.8	12.4	16.3	35.5	16.9	18.9	12.5	7.6	8.9	16.3	26.6	30.5	18.3	9.9	8.5	15.9	22.3	17.9	10.4	21.8	9.6	12.6	15.8	7.8	18.3	10.1	8.5	25.6	18.2	12.9	8.5	53.1	19.1	15.8	9.1	15.2	12.2	9.4	19.6	29.1	22.7	10.9	19.9	11.4	8.8	11.3	31.6	31.3	49.7	24.0	31.8	32.1	35.8	29.0	51.6	6.1	28.3	23.9	42.9	39.0	12.5	24.6	29.7	16.9	16.6	12.4	9.9	50.0	42.1	13.4	19.2	28.9	40.0	37.9	25.1	24.7	58.9	13.0	10.7	18.0	32.4	16.9	18.8	14.0	6.1	27.1	20.0	11.5	14.2	23.4	38.0	48.0	11.5	8.5	14.4	36.0	37.2	9.5	9.7	17.8	39.6	16.2	9.1	24.5	5.3	35.5	22.5	0.2	5.2	18.6	12.2	44.0	73.6	90.3	43.8	118.1	41.8	13.2	40.0	45.3	27.9	8.5	28.2	30.2	619.9	15.3	134.1	52.5	53.8	69.8	7.7	7.5	7.7	9.7	7.6	8.9	9.9	8.5	9.6	8.5	9.1	10.9	19.9	48.1	48.1	44.7	55.2	76.9	78.1	63.5	54.7	20.4	29.7	15.9	13.0	41.5	48.4	55.2	56.3	65.2	112.4	53.1	1.9	59.1	97.9	41.8	31.9	30.0	8.5	22.7	82.8	42.2	73.0	53.5	37.2	63.1	39.2	17.3	27.1	46.2	85.9	8.4	71.6	31.7	12.2	278.6	144.2	37.2	30.7	209.0	40.9	50.6	116.5	11.6	61.8	34.7	59.6	54.3	52.3	19.5	125.5	73.5	45.9	25.8	44.8	20.7	59.2	40.5	30.1	36.6	40.3	128.3	91.6	128.1	115.7	23.8	32.8	154.1
RP2	"NM23-H10, NME10, TBCCD2"	ENSG00000102218	"RP2 activator of ARL3 GTPase"	O75695	X	46837043-46882358	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.5"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 62.8;Langerhans cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000234, HPA000909"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA000234: AB_1079831, HPA000909: AB_2666140"	"unprognostic (2.26e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.76e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.79e-3)"	"unprognostic (9.75e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.96e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.28e-3)"	10.9	8.9	1.9	15.6	2.3	49.5	7.2	2.6	2.3	7.9	3.6	10.1	10.6	6.9	4.0	12.9	6.8	12.7	4.8	1.7	2.7	6.7	13.2	11.8	12.9	3.3	2.8	6.5	4.6	7.4	1.7	25.2	3.5	6.7	10.5	4.2	4.4	5.3	2.0	5.3	11.0	9.0	3.5	13.2	8.1	4.0	2.3	9.8	6.1	3.6	11.2	10.4	4.2	4.6	21.8	10.3	20.4	11.0	15.7	19.4	48.0	27.4	21.5	23.8	23.9	44.6	18.2	25.8	10.7	29.3	20.1	14.0	19.8	20.0	32.1	11.5	11.5	13.9	11.7	10.7	17.9	29.2	46.4	15.1	13.0	18.8	10.1	13.3	30.5	11.4	6.2	13.1	27.0	1.9	18.1	26.8	12.5	14.8	19.5	22.9	27.9	13.8	15.3	22.0	7.4	10.0	24.4	14.9	12.4	36.2	16.8	27.1	27.1	18.3	13.6	29.1	9.8	4.9	6.8	15.4	9.5	20.4	19.5	62.6	22.6	35.5	6.1	30.8	5.0	10.3	4.9	5.3	22.6	9.6	6.0	5.7	43.5	7.6	36.3	7.6	6.1	12.2	1.9	2.3	2.6	2.3	1.7	2.7	3.3	2.8	3.5	3.5	2.3	4.6	9.6	9.6	7.4	3.9	18.9	15.8	3.2	6.1	15.4	3.1	7.8	6.1	1.7	7.2	5.1	9.2	2.1	23.2	12.0	28.6	0.0	4.7	2.8	15.8	14.5	8.6	3.6	10.3	3.1	5.3	6.4	10.3	12.8	14.9	12.0	4.0	12.5	20.1	24.3	0.0	4.0	9.4	2.0	62.8	72.9	1.7	5.6	44.7	21.4	6.5	36.6	3.6	6.2	12.1	5.9	11.6	13.4	5.7	13.2	8.2	9.8	3.6	14.5	5.5	6.6	7.7	10.5	7.8	4.6	36.4	14.9	38.2	11.4	4.7	10.5	13.6
RRAGC	"FLJ13311, GTR2"	ENSG00000116954	"Ras related GTP binding C"	Q9HB90	1	38838198-38859772	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 224.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018247, HPA055489"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Vesicles"		"HPA018247: AB_1856475, HPA055489: AB_2682832"	"unprognostic (2.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (9.97e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-2)"	37.0	16.9	18.0	16.6	19.2	30.2	25.2	20.0	19.4	17.1	16.4	21.5	18.7	16.1	14.0	24.9	13.9	17.7	21.6	17.6	20.4	24.5	18.5	19.3	20.5	20.4	21.3	21.6	14.2	24.0	10.0	28.5	21.3	14.9	17.0	16.1	14.2	16.9	17.4	29.8	16.2	21.9	19.5	17.3	15.1	17.5	19.8	18.8	16.7	18.9	21.8	19.0	18.1	21.3	37.0	16.6	21.3	23.3	110.7	74.6	33.0	33.7	68.6	44.8	47.2	12.7	23.9	23.0	18.9	52.6	71.8	21.7	40.1	22.2	36.8	37.6	28.3	22.1	19.2	14.7	135.6	26.0	23.9	66.7	55.2	48.0	61.9	35.4	47.5	24.5	22.9	44.9	65.7	10.2	19.0	14.7	27.2	15.9	28.0	18.1	37.6	15.6	31.6	42.5	11.1	16.5	27.0	20.0	73.2	47.5	18.3	19.5	42.5	54.3	22.4	60.0	29.2	35.0	60.5	26.8	50.5	29.1	28.8	0.5	2.4	5.5	1.7	2.3	2.9	3.3	2.6	2.2	2.3	3.6	2.2	2.1	5.9	1.7	1.8	8.4	2.5	1.6	18.0	19.2	20.0	19.4	17.6	20.4	20.4	21.3	21.3	19.5	19.8	21.3	31.2	32.1	28.0	6.5	42.1	111.9	47.1	19.2	40.9	20.0	31.0	25.0	22.2	24.3	16.1	12.9	12.5	84.9	38.4	30.3	11.7	55.7	56.3	32.0	26.6	34.3	14.4	24.0	7.4	48.1	57.7	39.4	12.2	42.9	16.5	16.9	35.7	14.2	72.1	38.7	8.3	10.3	20.3	34.4	65.0	49.8	30.7	49.2	53.4	9.4	63.3	43.4	10.3	7.5	15.8	47.0	14.0	37.2	20.1	47.3	21.5	30.4	15.0	22.8	19.7	28.1	37.5	24.7	28.5	46.1	140.5	224.1	23.3	18.6	12.2	51.1
RSAD2	"cig5, vig1, Viperin"	ENSG00000134321	"Radical S-adenosyl methionine domain containing 2"	Q8WXG1	2	6865557-6898239	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Lyase	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 21.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.6;Alveolar cells type 1: 35.3;Distal enterocytes: 72.3;Erythroid cells: 44.2;Paneth cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 30.7;eosinophil: 43.3;neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 43.3"	"Group enriched"	"Detected in some"	5	"BJ hTERT+ SV40 Large T+: 75.7;BJ hTERT+ SV40 Large T+ RasG12V: 117.6;HMC-1: 55.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041160, HPA049409"	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA041160: AB_10795489, HPA049409: AB_2680751"	"unprognostic (8.91e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (3.27e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-3)"	"unprognostic (9.47e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.79e-1)"	4.2	2.3	2.9	4.0	3.7	13.7	3.0	2.1	3.7	6.5	4.6	5.2	3.6	2.1	2.1	1.5	2.8	5.5	5.7	2.7	2.7	2.7	3.5	8.3	2.9	5.1	3.1	2.1	1.5	1.1	3.9	6.6	4.7	1.7	3.0	1.1	21.0	1.9	5.7	0.8	2.9	4.5	11.8	10.1	6.3	2.0	3.0	7.4	1.8	7.6	1.8	2.5	1.4	3.3	0.2	0.0	0.2	0.1	0.0	0.5	0.9	0.0	1.2	75.7	117.6	0.0	2.5	1.1	0.1	0.0	11.6	1.2	0.0	0.0	0.2	0.2	0.0	17.8	0.1	0.0	0.1	0.0	55.7	0.1	0.0	5.7	0.0	0.0	0.0	2.6	1.6	1.0	0.0	0.1	7.0	1.5	0.2	0.0	0.4	0.3	0.0	0.1	0.1	1.1	0.1	0.3	0.1	0.1	3.6	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	1.4	1.5	0.0	0.1	1.2	0.4	30.7	4.9	43.3	2.3	7.5	2.8	0.3	2.6	2.2	2.7	0.4	3.7	3.0	25.2	2.5	7.0	0.3	1.3	2.7	2.9	3.7	2.1	3.7	2.7	2.7	5.1	3.1	4.7	11.8	3.0	3.3	35.6	35.3	3.9	3.9	1.5	0.5	3.3	2.4	1.2	0.8	1.0	0.6	5.2	2.8	3.2	0.0	2.1	0.6	1.9	72.3	0.0	3.8	1.3	19.2	3.1	21.7	9.0	44.2	12.6	6.2	0.8	3.8	34.7	16.1	23.5	8.3	8.9	0.6	9.5	0.0	13.2	2.6	6.1	1.6	2.2	1.1	1.5	8.5	0.0	21.5	7.0	6.3	6.2	17.1	0.9	7.7	107.7	2.2	1.7	4.1	1.7	0.1	13.4	0.7	0.0	2.5	2.8	0.4	0.5	1.2	0.3	2.9	3.6	1.7	1.0	7.4
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 2708.8;Langerhans cells: 5952.7;Macrophages: 2786.0;monocytes: 3172.6;NK-cells: 2130.8;Skeletal myocytes: 2034.0;T-cells: 2111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 2614.3;ASC diff: 3300.1;BJ hTERT+: 6738.6;fHDF/TERT166: 4819.1;RPMI-8226: 2700.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.6"	"CAB002618, HPA007486, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		9600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007486: , HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favorable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	982.3	77.1	25.5	353.9	26.2	1090.8	561.9	27.5	53.1	566.3	32.0	301.7	91.7	177.8	124.5	224.0	217.6	167.6	268.5	24.7	27.4	247.0	64.3	874.2	221.0	31.7	26.4	51.0	53.8	18.1	24.8	182.9	29.8	223.7	331.5	10.0	245.4	155.8	163.0	371.5	234.3	297.7	27.8	443.0	133.3	32.2	33.7	112.6	191.9	424.6	315.4	391.6	455.2	34.1	11.8	2614.3	13.2	77.0	3300.1	2410.9	3.7	1664.4	6738.6	32.1	148.4	20.0	180.3	0.8	299.7	4819.1	3.5	65.3	8.8	20.9	23.6	405.2	2.3	1186.8	529.0	59.4	4.3	106.9	1924.6	364.2	21.5	62.2	13.0	4.9	2.6	0.7	9.9	4.2	2468.1	10.6	3.8	1273.9	7.2	189.7	1050.4	64.1	3.7	2700.2	103.5	71.3	108.5	11.6	24.9	1286.6	9.4	412.5	77.1	1493.7	3.1	8.5	13.7	2159.5	9.3	82.8	647.5	14.3	6.1	1367.9	127.2	2789.7	13536.2	1408.0	5800.5	9099.6	6077.0	761.6	5167.7	4700.0	9268.4	282.5	882.4	2641.3	12129.7	837.1	11862.4	1626.0	7406.7	24075.8	25.5	26.2	27.5	53.1	24.7	27.4	31.7	26.4	29.8	27.8	33.7	34.1	226.0	490.4	398.4	0.0	266.1	772.9	19.5	159.0	93.9	0.7	44.9	65.9	14.9	35.8	273.8	893.8	0.0	52.4	1345.4	8.9	111.6	21.9	7.3	53.0	473.0	209.1	4.8	730.9	0.0	23.5	255.5	1378.8	54.0	41.9	1395.8	0.6	96.4	18.6	1966.1	45.4	0.0	10.0	345.8	2708.8	5952.7	24.0	235.8	2786.0	1193.5	12.2	3172.6	3.6	2130.8	0.0	0.1	35.7	17.0	45.9	266.5	12.9	3.2	19.7	154.9	2.3	151.2	2034.0	1309.6	1.9	5.5	77.6	694.0	53.4	2111.1	32.5	11.3	73.1
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 1174.1;Langerhans cells: 317.9;Macrophages: 414.6;monocytes: 829.9;T-cells: 332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HEL: 273.7;K-562: 331.6;Karpas-707: 137.3"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 20.7"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	32.3	6.7	2.4	80.1	2.8	192.9	4.7	3.3	4.9	5.7	4.2	11.0	7.0	3.4	1.9	5.3	6.3	22.7	4.5	2.5	3.5	4.2	17.5	22.9	35.4	6.2	4.5	1.3	3.1	2.0	2.1	15.5	6.1	3.9	15.3	12.7	2.8	2.2	0.7	1.5	15.1	10.8	5.1	32.0	9.3	1.2	4.6	22.4	2.2	1.2	41.0	39.7	2.5	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	0.0	1.8	0.0	14.0	0.0	273.7	0.0	0.0	0.0	32.5	12.7	0.1	0.0	0.0	37.9	10.2	3.6	4.8	331.6	137.3	0.0	0.0	15.9	39.5	0.1	0.0	0.2	26.8	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	35.0	0.0	0.0	0.0	0.0	58.2	0.5	0.3	1.4	20.7	0.0	314.2	38.7	234.6	22.1	52.3	15.4	27.3	42.8	33.3	25.0	15.4	26.8	19.1	49.4	18.0	83.0	0.9	60.3	33.6	2.4	2.8	3.3	4.9	2.5	3.5	6.2	4.5	6.1	5.1	4.6	8.9	4.8	22.4	54.9	0.7	127.5	15.6	1.1	0.0	1.8	64.9	2.7	3.0	1.2	1.5	11.2	36.8	0.0	0.5	147.9	0.7	0.0	0.6	0.0	0.8	0.2	8.0	0.0	13.7	1.0	6.5	0.7	11.3	10.7	0.6	1174.1	0.1	4.6	1.8	62.0	0.0	0.8	0.8	0.0	183.7	317.9	0.4	0.6	414.6	21.4	131.2	829.9	1.6	24.7	2.5	0.6	0.7	1.1	0.0	119.3	0.5	0.0	0.5	8.0	4.7	0.0	2.2	3.7	0.1	0.2	1.2	13.2	0.5	332.8	0.1	0.9	0.9
SAT1	"SAT, SSAT"	ENSG00000130066	"Spermidine/spermine N1-acetyltransferase 1"	P21673	X	23783173-23786226	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 8151.3;Langerhans cells: 13855.3;Prostatic glandular cells: 7419.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 3422.0;non-classical monocyte: 2519.0"	"Group enriched"	"Detected in all"	9	"granulocytes: 3422.0;monocytes: 2519.0"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 551.5;hTERT-HME1: 821.9;RPTEC TERT1: 694.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB047343, HPA055312, CAB069914"	Supported					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB047343: , CAB069914: AB_830224, HPA055312: AB_2682781"	"unprognostic (4.19e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (8.58e-2)"	"unprognostic (7.90e-3)"	"unprognostic (8.52e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.58e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	843.8	307.2	171.6	568.4	175.0	1484.9	454.0	167.0	279.5	337.8	219.7	339.0	630.9	319.0	170.8	407.4	322.7	600.8	604.4	171.8	202.0	739.5	885.0	1252.9	431.3	186.2	178.6	197.9	229.3	268.7	548.5	603.5	188.6	413.1	364.3	108.3	786.6	342.2	66.2	200.1	509.5	175.4	185.5	706.6	562.6	116.2	197.7	231.8	757.0	79.0	333.4	536.2	241.6	206.6	62.2	123.1	30.8	48.3	256.0	103.8	83.6	89.2	149.8	21.7	50.2	59.0	179.3	102.7	160.0	21.1	172.4	91.9	16.4	551.5	78.8	34.1	74.3	49.9	60.0	503.5	327.5	48.8	46.1	216.2	412.0	169.0	821.9	197.2	181.5	16.4	21.4	88.4	63.8	59.1	35.9	219.1	20.6	455.2	56.3	30.0	19.8	126.1	694.6	126.0	8.7	8.9	91.2	204.8	179.2	222.3	31.5	10.7	68.9	175.6	8.9	106.6	44.7	37.1	9.6	23.1	104.8	28.8	34.2	557.6	720.4	478.9	66.0	1930.3	41.6	125.3	77.4	53.8	324.8	79.1	45.9	53.3	3422.0	33.8	2519.0	161.2	231.5	742.5	171.6	175.0	167.0	279.5	171.8	202.0	186.2	178.6	188.6	185.5	197.7	206.6	798.0	734.0	1585.4	98.9	875.4	2435.0	3753.4	8151.3	1203.6	54.9	895.9	574.4	454.2	574.7	5509.5	829.4	116.7	853.1	409.5	1249.8	1189.5	5869.5	17.3	3940.5	859.6	1554.6	526.9	195.2	40.3	3065.2	1643.7	1211.3	1347.1	5651.2	870.6	110.6	558.3	994.1	2115.2	72.3	77.6	852.3	3733.2	4693.0	13855.3	55.2	165.3	5207.7	3922.0	213.6	5274.6	501.9	189.5	90.5	14.2	2774.1	1293.8	92.2	1091.8	7419.8	1851.7	2065.2	4274.2	114.4	151.2	765.7	857.5	31.6	14.7	1022.4	1468.3	2880.9	899.3	260.2	804.4	6549.5
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582859	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 959.8;Melanocytes: 889.4"	"Cancer enriched"	"Detected in all"	4	"melanoma: 244.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1908.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1908.0;monocytes: 562.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 787.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	228.5	126.4	94.1	160.8	111.8	245.6	167.1	102.0	130.1	160.9	112.2	119.6	83.1	109.8	83.6	88.8	95.7	194.8	120.6	103.7	112.6	126.6	174.0	223.9	121.2	113.7	103.8	89.1	80.8	132.9	45.8	264.3	113.5	70.8	134.7	26.8	124.9	78.3	65.9	84.8	92.8	151.2	107.4	203.0	130.0	41.1	110.8	129.9	120.7	113.7	92.8	248.8	91.9	123.7	123.5	185.9	194.2	101.4	711.7	607.1	86.1	122.9	439.6	175.3	228.9	74.8	250.7	0.4	194.8	166.4	321.2	49.7	106.0	142.4	215.7	22.6	91.3	184.3	156.0	60.6	787.9	47.7	287.1	417.9	188.1	176.5	525.2	273.0	428.0	125.2	92.3	104.6	403.4	32.4	104.1	55.9	122.2	478.6	52.3	49.6	59.4	24.3	282.1	127.0	84.9	153.5	133.8	56.1	630.0	213.8	51.0	127.9	382.3	168.8	72.5	200.8	81.5	31.4	45.6	74.8	428.9	0.5	155.1	777.4	562.9	528.1	61.2	349.6	78.0	69.4	82.0	67.3	251.8	61.0	103.9	80.2	1908.0	42.6	329.1	69.9	103.0	453.2	94.1	111.8	102.0	130.1	103.7	112.6	113.7	103.8	113.5	107.4	110.8	123.7	382.7	211.5	115.9	26.8	170.3	338.7	321.2	312.5	108.1	10.8	86.7	54.6	70.6	88.6	181.3	206.0	16.7	284.3	220.2	192.9	225.0	392.9	7.8	110.9	87.0	412.7	112.3	116.6	18.5	291.6	756.8	308.1	162.1	120.5	396.9	62.9	378.3	101.9	782.5	15.2	23.7	180.3	248.2	552.1	959.8	15.9	233.9	626.0	889.4	71.2	312.4	94.3	51.5	21.6	16.3	297.9	152.9	159.9	65.1	307.4	78.4	211.2	169.8	11.1	98.6	82.7	177.4	14.8	8.4	73.3	173.2	483.0	256.2	117.0	129.2	457.6
SH2B3	"IDDM20, LNK"	ENSG00000111252	"SH2B adaptor protein 3"	Q9UQQ2	12	111405923-111451623	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.7"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 113.6;Langerhans cells: 130.9;Macrophages: 84.1;monocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 122.2;hTEC/SVTERT24-B: 140.7;U-87 MG: 211.6;WM-115: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005483	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA005483: AB_1079260"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.65e-2)"	"unprognostic (8.17e-3)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (2.86e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.24e-2)"	22.2	10.9	10.2	21.9	6.8	60.7	13.3	3.5	9.3	8.6	8.5	11.4	8.1	8.5	3.3	7.7	8.1	18.6	23.4	5.8	6.5	14.3	17.4	20.5	21.0	12.0	7.3	5.5	10.2	5.8	8.0	24.4	10.0	7.3	13.5	3.7	5.3	5.9	9.6	4.1	12.5	13.6	10.1	37.1	7.1	9.5	12.1	10.5	11.1	9.5	15.8	15.7	6.0	14.7	9.2	5.5	7.0	7.3	23.9	35.5	4.8	29.2	79.5	21.9	23.3	8.4	5.2	15.6	20.3	44.6	73.6	1.7	5.5	16.9	35.2	13.3	2.7	53.2	2.6	6.2	23.3	23.5	122.2	21.2	3.8	140.7	12.7	48.4	119.1	12.8	38.9	6.1	80.2	3.2	9.7	46.7	11.0	2.4	21.0	9.5	15.9	10.2	10.5	3.7	4.6	4.9	5.4	0.6	42.2	6.2	3.5	33.4	93.0	20.0	11.3	17.4	48.1	13.9	15.8	17.6	211.6	16.6	165.3	0.9	3.5	1.2	1.2	8.4	1.0	1.5	1.1	1.3	4.8	0.5	0.7	1.0	3.0	1.8	6.6	4.9	0.4	1.8	10.2	6.8	3.5	9.3	5.8	6.5	12.0	7.3	10.0	10.1	12.1	14.7	26.8	3.2	22.0	2.6	26.2	6.8	1.5	4.2	1.2	4.6	4.3	3.8	17.5	4.3	4.3	1.8	2.1	0.4	40.6	15.0	1.9	3.6	13.1	1.0	2.2	39.2	3.5	11.2	11.0	9.0	1.4	8.1	0.5	1.2	38.6	0.8	46.1	11.1	40.4	3.3	7.3	3.0	6.1	113.6	130.9	5.3	2.8	84.1	16.0	38.4	67.1	1.1	18.6	11.1	9.0	7.2	5.9	4.1	4.9	3.0	0.8	1.5	3.5	3.4	0.0	4.0	12.7	12.5	4.5	0.7	4.1	1.0	12.1	4.4	3.2	1.2
SIGLEC5	"CD170, CD33L2, OB-BP2, SIGLEC-5"	ENSG00000105501	"Sialic acid binding Ig like lectin 5"	O15389	19	51611927-51645545	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 14.7;lymphoid tissue: 12.4"	"Cell type enhanced"	"Detected in some"		"granulocytes: 8.2;Hofbauer cells: 5.6;Kupffer cells: 10.4;Macrophages: 4.4;monocytes: 3.0"	"Cancer enriched"	"Detected in single"	5	"urothelial cancer: 1.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"neutrophil: 152.5;non-classical monocyte: 49.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 152.5;monocytes: 49.3"	"Group enriched"	"Detected in some"	5	"HMC-1: 59.2;U-937: 25.6"									"HPA009085, CAB024900"	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB024900: , HPA009085: AB_1079965"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	1.4	0.4	0.3	6.6	0.6	14.7	0.2	0.3	1.2	0.2	0.0	0.7	0.1	0.3	0.0	0.3	0.7	0.7	0.4	0.3	0.3	0.3	1.5	3.4	3.1	0.4	0.3	0.1	0.2	0.3	0.1	0.8	0.5	0.3	0.7	0.2	0.3	0.1	0.0	0.0	2.0	0.9	0.4	12.4	0.6	0.8	0.4	0.7	0.2	0.4	2.2	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	15.5	22.2	0.5	0.0	24.2	0.0	2.5	0.0	0.0	15.6	2.0	0.0	0.0	152.5	0.7	49.3	5.0	0.0	8.4	0.3	0.6	0.3	1.2	0.3	0.3	0.4	0.3	0.5	0.4	0.4	0.6	0.0	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	8.2	0.0	0.0	0.0	5.6	0.0	0.2	0.0	0.0	10.4	1.2	0.5	0.3	4.4	0.0	1.0	3.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1561385-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.2;lung: 19.4;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 10.9;Hofbauer cells: 14.7;Kupffer cells: 29.4;Macrophages: 30.9;monocytes: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1594.8"	"Group enriched"	"Detected in all"	6	"granulocytes: 1594.8;monocytes: 502.2"	"Group enriched"	"Detected in some"	4	"HMC-1: 54.0;NB-4: 76.2;THP-1: 58.9"									HPA047463	Uncertain		Uncertain	Vesicles,Centrosome		NA	NA		44000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	Centrosome	"HPA047463: AB_2680057"	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"	5.4	1.6	1.3	28.6	1.3	52.2	1.9	1.2	4.2	1.2	0.1	2.1	1.5	0.8	0.8	1.3	2.2	11.2	1.6	1.4	0.8	1.2	3.1	19.4	11.0	0.7	0.8	0.7	1.3	0.3	0.6	2.8	1.3	0.8	1.8	1.2	1.7	0.9	0.8	0.8	2.8	3.2	0.9	24.5	1.5	0.6	2.1	4.5	0.9	1.5	4.3	8.1	0.8	1.9	0.2	0.0	0.2	0.1	0.3	0.5	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.1	0.8	0.4	7.1	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	14.9	54.0	0.1	0.2	0.3	0.0	8.0	0.5	1.1	0.0	0.2	0.4	0.1	0.0	76.2	0.2	0.0	3.3	0.2	0.0	0.1	10.8	0.3	0.1	0.2	0.2	0.0	0.5	0.0	0.0	58.9	1.6	0.7	0.1	0.4	0.3	0.1	0.1	0.1	1.1	13.4	0.2	6.1	502.2	868.9	7.3	419.7	10.3	2.8	6.5	5.7	175.2	3.4	8.8	5.5	1594.8	8.2	357.6	165.7	11.8	287.0	1.3	1.3	1.2	4.2	1.4	0.8	0.7	0.8	1.3	0.9	2.1	1.9	0.6	3.2	5.2	0.3	1.2	0.0	0.1	0.2	0.6	0.2	0.1	0.0	0.5	0.0	1.6	0.0	0.0	0.2	10.9	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.1	0.7	0.0	0.2	7.0	0.0	1.8	0.2	14.7	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	30.9	0.0	0.0	26.7	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0
SKIL	"SNO, SnoA, SnoN"	ENSG00000136603	"SKI like proto-oncogene"	P12757	3	170357678-170396835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008472, HPA014233"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA008472: AB_1856933, HPA014233: "	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (2.94e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.34e-1)"	11.9	12.0	6.1	18.8	7.3	23.1	9.0	8.5	10.0	9.4	8.3	10.4	13.8	12.0	8.2	9.2	6.4	21.1	12.0	6.6	10.9	10.3	15.6	16.1	13.8	10.7	10.8	9.2	9.6	5.7	11.0	13.9	10.5	11.6	9.7	9.6	7.4	8.9	11.0	5.8	14.2	10.5	12.0	7.2	15.9	13.0	11.4	9.2	11.3	21.4	18.4	14.6	8.8	13.2	19.9	24.0	15.6	10.4	20.0	8.7	29.1	19.6	13.6	13.8	10.6	4.9	42.2	24.9	60.5	18.2	23.1	44.8	9.9	9.0	21.3	43.6	9.2	32.8	24.8	11.0	17.8	13.7	17.4	15.3	8.8	19.9	15.0	42.9	34.1	2.4	14.7	27.9	28.4	21.3	5.9	4.5	61.2	21.8	8.1	13.6	52.8	5.0	20.8	31.7	11.5	14.1	48.3	47.4	10.3	31.6	32.2	14.2	66.1	38.2	35.9	33.0	37.1	36.2	18.6	47.3	14.3	7.1	18.3	3.1	3.4	1.8	1.3	8.3	1.8	3.6	1.1	1.7	2.4	4.4	1.9	2.0	4.0	2.8	10.3	1.6	0.5	1.9	6.1	7.3	8.5	10.0	6.6	10.9	10.7	10.8	10.5	12.0	11.4	13.2	104.1	73.7	72.8	21.2	142.1	72.7	88.8	52.5	67.7	25.6	79.3	38.1	12.4	21.5	70.4	35.0	54.2	14.8	124.9	45.9	15.6	56.7	115.7	118.4	80.9	86.0	23.8	3.0	48.6	111.4	58.3	100.6	93.8	102.0	204.8	46.3	72.5	32.0	26.3	53.8	21.6	62.4	22.4	65.4	85.2	35.8	37.9	121.7	35.6	60.0	42.1	12.7	14.4	26.2	27.5	176.5	29.1	68.1	104.3	43.5	41.3	45.9	82.1	30.5	26.3	143.6	63.6	53.9	37.6	61.3	96.0	41.2	81.5	17.5	31.3	117.8
SLC2A3	GLUT3	ENSG00000059804	"Solute carrier family 2 member 3"	P11169	12	7919230-7936187	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 427.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 362.1;Endothelial cells: 356.2;Extravillous trophoblasts: 382.4;granulocytes: 485.1;Langerhans cells: 710.4;Macrophages: 305.2;T-cells: 328.9"	"Cancer enriched"	"Detected in all"	7	"testis cancer: 107.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 166.1;neutrophil: 223.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 223.4"	"Group enriched"	"Detected in many"	5	"BEWO: 1473.1;CACO-2: 1646.2;SuSa: 1119.9"									"CAB002763, HPA006539"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB002763: , HPA006539: AB_1078984"	"unprognostic (9.20e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.36e-8)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.91e-3)"	124.9	19.3	26.3	58.2	28.4	427.9	77.0	26.0	38.3	16.4	26.4	29.6	6.7	20.8	2.0	12.7	27.4	56.1	62.3	33.3	31.6	37.7	28.0	92.8	29.4	28.9	25.6	26.4	11.2	7.9	28.0	102.8	33.0	19.7	12.7	87.3	12.3	5.6	24.1	20.7	15.7	41.5	24.6	45.7	19.8	4.9	31.1	18.4	43.3	10.0	20.8	98.7	26.2	23.3	0.3	7.9	68.5	27.4	25.2	85.9	1473.1	24.7	26.7	23.9	55.9	1646.2	11.0	1.6	0.0	17.1	33.1	0.6	2.4	3.9	43.0	48.4	2.0	96.3	6.5	219.3	67.3	35.0	135.4	36.2	2.8	63.6	28.5	55.8	22.6	7.5	44.8	22.8	21.9	0.1	2.6	38.4	300.9	1.2	0.0	2.1	8.0	1.4	0.1	0.1	0.3	0.6	0.0	2.4	32.8	1119.9	0.0	4.9	23.1	29.7	15.6	57.4	2.5	0.2	68.8	5.2	86.9	15.9	16.6	166.1	19.3	29.7	25.3	2.3	20.2	7.4	16.9	19.5	10.0	7.0	10.8	14.8	223.4	15.6	1.0	0.8	24.9	17.4	26.3	28.4	26.0	38.3	33.3	31.6	28.9	25.6	33.0	24.6	31.1	23.3	362.1	144.2	98.8	5.5	301.0	129.5	3.5	1.7	8.6	33.0	5.1	7.6	21.0	7.2	26.8	3.7	62.6	69.6	112.1	0.2	0.0	0.2	3.1	5.0	84.3	356.2	1.2	13.7	24.4	0.0	382.4	188.9	12.2	4.3	485.1	6.5	96.4	2.4	113.4	5.0	20.8	0.3	0.0	76.4	710.4	3.1	10.2	305.2	183.2	34.7	43.4	28.5	41.2	6.6	5.0	0.7	1.3	7.9	93.2	5.3	0.1	1.4	10.3	70.2	118.3	21.5	187.1	2.4	1.2	4.9	82.0	111.4	328.9	41.7	0.1	4.0
SMNDC1	"SMNR, SPF30, TDRD16C"	ENSG00000119953	"Survival motor neuron domain containing 1"	O75940	10	110290730-110304938	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061214, HPA070666"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA061214: AB_2684451, HPA070666: "	"unprognostic (4.65e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.68e-3)"	"unprognostic (6.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-1)"	16.3	12.0	7.0	15.1	7.5	31.8	13.7	10.8	11.1	13.8	7.7	13.4	9.9	14.4	8.7	16.2	13.3	11.6	12.4	6.5	7.2	13.6	14.9	14.2	16.9	7.1	6.9	13.5	10.2	13.1	8.9	18.4	7.0	10.0	11.1	16.6	11.5	10.2	24.8	13.2	11.5	14.6	7.5	14.7	11.5	13.1	7.1	20.4	12.1	17.9	18.3	17.3	13.7	9.4	36.2	27.0	38.9	44.9	29.6	35.1	28.9	41.0	42.6	53.3	54.6	35.1	43.7	51.2	25.7	25.9	30.5	38.5	57.8	28.2	59.9	29.0	30.6	51.1	21.9	41.2	35.3	56.9	47.2	27.4	29.7	42.2	71.1	39.5	30.0	29.0	46.8	46.5	41.9	17.1	61.0	55.0	43.5	27.8	18.4	52.0	77.9	26.8	30.0	25.7	19.4	26.0	26.6	22.4	48.9	33.3	27.7	32.3	33.0	31.2	35.2	28.9	52.9	37.8	42.4	76.7	31.4	77.9	24.6	5.7	8.9	14.5	5.2	9.2	6.4	5.4	6.8	6.7	8.6	4.8	5.9	5.9	16.6	6.3	9.8	5.2	8.1	4.3	7.0	7.5	10.8	11.1	6.5	7.2	7.1	6.9	7.0	7.5	7.1	9.4	57.7	28.9	37.1	6.8	53.4	69.6	42.5	27.2	89.4	27.3	31.7	26.7	23.4	14.3	27.9	11.0	20.9	33.0	55.7	23.9	33.2	22.8	10.7	34.2	52.0	41.5	18.6	37.0	7.8	18.0	32.0	39.1	37.8	58.8	58.3	27.3	27.1	26.5	32.4	33.7	8.0	21.4	38.7	40.9	79.7	4.4	29.2	47.7	35.6	6.5	45.8	23.0	22.6	5.0	11.2	21.7	21.0	22.2	45.7	53.3	20.6	40.9	28.6	33.0	19.7	30.8	39.7	46.2	37.7	72.4	83.4	46.1	57.4	33.5	24.1	65.8
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 126.0;TIME: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	37.6	10.3	9.7	17.2	9.7	58.4	26.5	27.7	13.2	21.7	9.8	14.6	16.1	23.1	7.8	19.7	13.6	20.4	16.3	9.5	12.5	20.0	25.4	26.4	19.8	14.0	11.5	14.4	22.7	18.5	11.4	33.3	14.7	11.2	11.9	18.8	11.4	10.8	14.3	30.3	17.2	22.9	9.5	33.0	14.4	11.1	13.2	40.5	27.3	21.6	14.7	19.8	21.7	8.7	8.4	5.0	9.1	8.8	26.6	9.5	8.7	8.8	14.8	9.4	9.1	6.9	11.8	13.2	6.8	11.2	6.2	5.3	10.7	18.9	9.6	15.1	8.8	15.0	9.1	8.1	13.8	17.1	16.1	10.5	12.7	10.6	17.9	9.5	126.0	14.9	6.7	14.9	8.7	4.4	17.3	15.0	10.1	4.6	22.6	11.7	6.7	14.0	24.2	14.1	6.4	13.4	7.7	8.1	11.1	7.9	5.5	21.4	74.1	8.2	8.3	9.5	10.4	23.7	18.3	11.0	5.8	20.1	12.0	9.4	4.2	7.6	9.5	7.5	13.0	3.6	8.3	9.6	4.0	3.6	12.1	13.1	27.7	11.0	7.1	1.2	9.7	9.7	9.7	9.7	27.7	13.2	9.5	12.5	14.0	11.5	14.7	9.5	13.2	8.7	88.4	32.1	24.1	30.0	29.0	52.8	10.3	6.4	12.5	52.1	9.7	8.6	17.7	15.7	15.0	16.5	16.7	7.7	57.6	37.0	11.7	10.9	50.4	23.3	16.2	84.2	10.8	10.3	21.6	8.9	3.2	16.4	12.8	19.8	14.5	8.9	98.6	25.2	13.7	30.3	43.2	10.7	12.2	24.8	19.0	7.5	12.5	26.5	23.2	34.7	21.9	16.3	65.9	24.6	10.7	11.2	20.6	11.7	27.3	12.7	25.2	12.2	19.2	18.3	124.9	31.3	49.1	11.1	16.2	13.7	51.3	8.2	61.2	9.5	11.1	18.0
SP100		ENSG00000067066	"SP100 nuclear antigen"	P23497	2	230415942-230545606	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 189.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 255.0"					"Low region specificity"	"Detected in all"			"HPA016707, HPA017384"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear bodies"	Nucleoplasm	"HPA016707: AB_1857398, HPA017384: AB_1857399"	"unprognostic (8.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.25e-2)"	66.3	53.1	11.0	65.5	12.3	189.2	53.8	11.3	17.9	42.4	20.7	46.1	46.1	35.1	30.8	29.4	34.9	55.9	52.9	10.9	14.0	46.0	60.9	72.4	94.3	19.6	14.3	44.3	41.1	10.5	18.3	54.5	16.7	34.9	36.1	2.5	72.7	33.0	24.3	35.7	60.4	38.7	16.2	78.8	47.9	9.2	16.5	54.2	41.0	32.1	81.6	56.1	37.1	17.1	56.9	16.9	0.8	7.5	80.8	123.2	13.3	70.3	151.0	162.4	255.0	10.6	67.9	22.9	57.0	77.0	103.0	25.9	0.8	66.6	120.7	55.2	1.9	41.8	27.9	24.0	120.0	47.3	51.4	105.6	38.8	79.8	71.4	120.2	125.1	18.9	23.9	37.9	61.7	15.9	32.0	57.6	2.4	25.6	25.6	24.4	40.7	18.2	45.9	45.3	0.4	0.7	30.0	9.5	130.3	2.8	9.1	48.3	140.3	78.7	21.4	49.4	41.8	50.3	16.0	59.8	71.6	54.8	38.1	149.7	84.4	115.8	116.3	74.9	93.9	152.0	113.0	102.4	64.6	160.5	107.5	95.3	284.6	119.8	106.0	67.0	116.0	110.1	11.0	12.3	11.3	17.9	10.9	14.0	19.6	14.3	16.7	16.2	16.5	17.1	171.9	153.8	56.6	0.3	236.6	70.7	71.2	96.5	49.5	0.6	31.2	36.7	72.3	42.9	74.4	33.1	2.1	32.9	150.6	50.5	43.0	102.9	4.7	61.6	58.3	122.7	9.0	66.9	0.6	105.5	69.4	77.9	46.4	58.9	56.8	39.3	73.5	34.5	81.0	0.0	0.7	32.5	63.1	72.9	70.9	4.8	46.6	104.1	71.2	140.5	114.3	0.2	128.8	4.5	4.8	89.7	56.9	52.6	95.6	74.2	72.8	45.4	68.4	0.8	39.5	61.2	65.9	0.8	1.1	28.4	68.2	16.1	151.5	74.0	25.2	73.7
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378547	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 335.1;lung: 101.0;lymphoid tissue: 172.7"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 432.9;Kupffer cells: 411.9;Langerhans cells: 537.6;Macrophages: 453.3;monocytes: 357.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 179.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 179.7"	"Cell line enhanced"	"Detected in some"		"HEL: 90.1;HL-60: 159.7;HMC-1: 282.2;NB-4: 267.8;THP-1: 206.7;U-698: 85.3;U-937: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	36.5	19.7	12.0	107.3	13.1	335.1	17.7	14.3	19.4	7.9	15.8	15.6	21.5	7.3	2.1	9.1	19.1	21.3	13.5	11.7	16.4	10.6	15.6	101.0	65.0	31.2	20.9	5.2	7.8	3.1	7.6	28.0	24.7	10.3	10.2	1.0	14.6	6.1	5.0	13.8	29.3	21.9	19.8	172.7	17.0	3.7	26.2	15.7	8.8	8.3	32.0	29.9	7.6	30.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	72.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	0.0	159.7	282.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.7	0.0	0.0	0.2	267.8	0.2	0.0	0.0	48.7	0.2	47.5	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	206.7	0.3	0.0	0.5	0.5	0.1	0.1	0.3	85.3	0.3	117.5	0.1	14.1	19.2	179.7	0.0	27.4	0.0	3.9	0.0	0.0	16.4	2.4	0.0	0.0	83.8	0.0	34.7	0.9	0.0	7.3	12.0	13.1	14.3	19.4	11.7	16.4	31.2	20.9	24.7	19.8	26.2	30.3	2.1	3.2	1.1	10.4	72.6	10.5	0.5	0.0	1.2	1.3	2.1	5.0	2.9	4.3	0.6	5.5	0.0	2.3	6.3	0.5	19.6	0.1	7.5	0.1	0.3	5.5	4.2	39.7	3.1	0.4	3.1	2.6	1.1	0.3	33.7	0.2	7.9	3.2	432.9	0.0	3.3	0.3	0.0	411.9	537.6	27.5	1.8	453.3	10.6	36.5	357.5	7.0	8.2	3.5	1.5	0.0	0.1	0.0	21.8	0.4	0.2	2.3	0.7	1.7	13.1	1.5	1.4	5.1	9.3	0.8	9.9	4.2	4.8	1.1	0.4	0.5
SPOPL	BTBD33	ENSG00000144228	"Speckle type BTB/POZ protein like"	Q6IQ16	2	138501770-138573547	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034687	Uncertain		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA034687: AB_10670573"	"unprognostic (1.39e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.90e-2)"	"prognostic favorable (3.63e-4)"	"unprognostic (2.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.91e-3)"	7.9	5.9	6.1	9.7	8.1	14.2	12.7	6.7	8.0	6.6	4.8	8.3	7.9	8.5	3.6	6.2	6.6	7.3	5.4	5.5	6.2	8.8	9.4	7.6	11.3	7.6	9.1	10.3	5.6	7.3	4.3	6.8	7.9	9.4	8.9	9.8	11.5	8.1	4.6	8.5	8.4	7.4	7.6	11.2	9.3	3.7	7.1	4.9	8.5	8.0	9.7	8.0	6.3	9.1	13.3	4.0	7.2	7.0	5.8	9.7	13.8	9.6	7.2	5.9	7.0	14.8	10.6	14.2	9.0	8.3	5.3	5.1	9.5	8.4	12.4	11.1	7.7	9.0	9.2	23.2	6.0	10.0	12.1	6.4	12.3	11.7	10.8	12.0	9.6	3.3	3.0	19.2	10.1	12.9	1.0	9.4	6.5	9.3	6.9	5.0	12.6	8.1	9.3	18.7	8.4	10.3	14.7	13.8	7.3	8.5	7.6	10.9	9.6	9.5	8.1	12.0	14.7	27.6	21.6	10.3	15.9	9.2	8.8	0.4	1.6	2.8	0.3	1.5	0.3	1.1	0.2	0.3	2.2	1.1	0.1	0.2	5.7	0.4	1.3	0.9	0.4	0.6	6.1	8.1	6.7	8.0	5.5	6.2	7.6	9.1	7.9	7.6	7.1	9.1	16.9	12.8	13.6	25.8	25.9	55.6	11.4	7.9	13.6	9.9	38.8	13.8	13.2	15.7	20.6	3.7	4.2	6.4	15.0	20.3	7.9	10.1	1.7	11.9	10.3	12.4	19.2	5.0	55.3	13.3	7.3	12.3	17.3	11.8	8.8	12.5	8.9	13.8	8.9	18.5	67.2	19.8	18.3	31.5	37.7	2.8	17.1	33.2	12.4	48.7	27.5	9.2	9.2	63.8	54.1	21.1	12.6	15.8	11.8	19.5	11.0	16.4	16.1	16.6	6.6	18.8	18.5	10.0	18.8	10.3	44.8	6.2	10.8	4.9	12.0	21.3
STAT5A	"MGF, STAT5"	ENSG00000126561	"Signal transducer and activator of transcription 5A"	P42229	17	42287547-42311943	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Lactation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 78.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 101.0;HEL: 153.5;HMC-1: 85.2;K-562: 262.4;MOLT-4: 163.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB003860, HPA027873, HPA042128, HPA049883, HPA051156"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Cytosol"		"CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366"	"prognostic favorable (5.87e-4)"	"unprognostic (3.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	78.9	40.6	4.3	28.9	5.7	52.1	48.8	5.3	4.8	19.1	5.4	24.0	8.6	17.8	5.7	9.9	19.0	13.9	13.9	3.6	7.5	13.9	8.1	23.3	37.5	8.0	7.6	22.5	12.2	2.4	10.5	7.3	7.4	15.4	9.1	1.2	15.7	13.7	23.8	18.4	22.4	14.3	6.7	29.8	14.0	4.9	7.7	24.4	13.3	13.8	27.1	24.1	15.4	8.6	3.9	4.9	0.5	0.0	35.7	17.5	0.4	2.1	8.6	4.0	2.3	0.0	3.7	0.3	9.0	8.5	0.2	0.3	0.8	0.3	1.1	101.0	0.0	153.5	9.3	1.3	15.5	13.5	85.2	36.8	2.1	1.7	2.0	0.0	12.3	2.0	262.4	0.1	2.3	0.1	163.5	64.7	1.4	2.5	0.0	4.5	1.1	13.8	1.1	2.6	0.3	0.0	10.0	3.9	17.8	0.9	2.5	13.9	7.2	8.0	2.6	3.9	0.1	0.2	0.1	0.0	1.0	25.4	2.5	9.8	15.1	7.9	10.3	18.6	14.4	8.2	18.3	15.2	18.7	6.6	18.0	15.0	18.3	17.4	24.9	6.6	14.5	12.9	4.3	5.7	5.3	4.8	3.6	7.5	8.0	7.6	7.4	6.7	7.7	8.6	14.0	0.0	10.6	2.6	18.7	7.4	3.8	4.5	5.7	2.9	35.8	24.5	29.6	5.7	3.4	5.5	0.0	1.2	17.7	5.5	5.9	5.0	0.4	7.2	5.2	21.2	0.0	33.2	0.2	13.6	2.9	15.3	5.1	11.9	22.8	6.8	6.1	3.3	21.4	0.0	1.3	4.2	0.0	24.5	41.3	3.5	32.6	31.8	8.8	5.6	41.0	3.9	8.2	2.5	5.0	9.6	8.1	41.0	12.5	12.2	1.8	14.4	8.4	0.7	6.6	13.7	10.2	0.0	0.9	4.4	7.7	1.4	29.2	7.7	6.5	7.0
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042079-172188224	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5;lymphoid tissue: 45.2"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 107.7;Kupffer cells: 91.4;NK-cells: 171.0;T-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 143.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		16000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	14.9	5.7	3.1	37.1	3.6	76.5	11.4	18.4	5.6	4.5	3.5	8.5	8.4	4.9	1.7	5.6	4.7	13.2	7.6	3.1	4.0	5.9	6.2	18.4	44.1	6.2	4.4	2.5	7.2	3.1	4.1	17.2	5.8	4.4	6.9	1.2	4.7	3.5	5.0	14.2	16.0	7.8	5.4	45.2	11.1	14.0	6.4	20.6	5.3	5.5	25.0	14.9	5.2	7.0	22.2	20.2	12.7	18.8	14.7	18.1	31.5	28.4	24.0	20.2	18.9	10.6	28.6	26.8	14.6	35.6	42.3	25.4	5.7	35.1	13.5	35.0	9.3	32.1	8.2	6.1	20.2	32.7	36.4	17.4	7.5	27.4	23.1	7.5	18.3	10.4	3.0	36.2	14.7	35.7	23.5	73.4	5.0	11.3	16.1	38.2	9.9	17.7	8.2	27.6	8.3	10.2	16.4	22.5	77.9	15.6	8.2	68.7	24.8	22.3	11.3	15.8	15.5	30.2	48.4	17.1	29.4	49.8	143.3	16.7	26.5	23.4	36.5	46.3	26.9	10.0	19.3	26.3	22.5	8.1	11.0	20.0	48.9	16.9	71.8	7.1	26.7	44.0	3.1	3.6	18.4	5.6	3.1	4.0	6.2	4.4	5.8	5.4	6.4	7.0	35.8	3.2	11.2	1.6	40.5	6.6	8.4	7.2	5.7	4.3	3.3	3.7	3.8	5.7	6.1	1.8	6.2	4.1	107.7	11.8	1.9	4.5	2.5	3.5	4.6	23.9	12.0	11.8	8.5	6.2	27.2	9.3	20.9	7.1	28.4	3.6	18.2	2.3	36.3	47.1	7.9	19.9	2.0	91.4	43.8	3.2	2.8	61.3	8.8	32.8	49.8	2.1	171.0	10.1	14.4	10.7	11.8	1.5	42.8	11.7	6.5	2.0	6.1	2.2	13.1	5.1	10.2	5.3	7.8	2.6	4.1	5.1	81.4	11.4	5.3	10.7
STX11		ENSG00000135604	"Syntaxin 11"	O75558	6	144150517-144191939	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.1;bone marrow: 56.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 85.0;granulocytes: 90.3;Langerhans cells: 271.6;Macrophages: 158.0;monocytes: 85.5;Suprabasal keratinocytes: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	7	"basophil: 22.6;classical monocyte: 68.4;eosinophil: 43.5;intermediate monocyte: 81.1;myeloid DC: 25.4;neutrophil: 81.7;non-classical monocyte: 87.0"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.4;granulocytes: 81.7;monocytes: 87.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 17.2;Karpas-707: 10.1;RH-30: 6.9;TIME: 8.3;U-266/70: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007992	Approved					NA	NA		1100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA007992: AB_1857620"	"unprognostic (1.30e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.07e-1)"	25.1	4.4	0.6	5.8	0.6	56.5	14.5	0.6	1.1	1.9	0.7	2.8	1.0	1.4	0.3	5.1	2.6	2.1	7.3	0.7	0.8	3.6	3.1	21.3	5.5	1.0	0.7	0.9	1.1	0.6	2.1	2.4	0.9	1.3	0.9	0.2	2.1	0.3	2.5	8.2	3.3	1.9	0.8	14.1	2.0	1.1	0.9	1.8	7.5	0.9	3.5	4.0	3.2	1.1	0.4	0.1	0.1	3.9	0.2	0.3	0.6	0.4	0.3	0.4	0.7	0.1	0.4	0.1	0.4	0.6	0.7	0.6	0.0	0.1	0.2	17.2	0.6	3.0	0.6	0.1	1.0	0.9	0.5	0.0	0.0	0.2	0.1	0.2	4.3	0.8	0.1	10.1	0.5	0.2	0.4	0.9	0.0	0.0	0.3	0.1	6.9	0.6	0.0	1.9	0.2	0.1	1.2	0.1	1.7	0.3	0.1	3.8	8.3	0.2	1.0	0.4	0.3	11.6	4.6	0.1	0.2	2.1	0.4	22.6	68.4	43.5	6.0	81.1	3.8	1.4	2.7	5.1	25.4	2.4	1.0	3.0	81.7	3.2	87.0	2.7	8.3	43.9	0.6	0.6	0.6	1.1	0.7	0.8	1.0	0.7	0.9	0.8	0.9	1.1	41.9	54.5	10.7	0.0	16.6	85.0	11.3	6.3	3.4	0.0	11.1	4.6	4.5	4.3	6.6	1.8	0.0	0.9	38.1	0.1	0.0	6.4	0.4	3.7	0.7	23.7	3.5	6.1	0.1	2.6	5.7	11.2	0.5	5.0	90.3	0.2	8.2	1.4	30.1	0.0	0.1	0.4	2.0	73.7	271.6	1.2	0.6	158.0	44.4	2.8	85.5	0.0	21.6	0.0	0.1	6.1	3.3	0.0	63.1	14.4	0.0	0.1	10.7	0.1	0.0	46.6	9.7	3.0	3.8	11.2	154.6	28.0	36.6	3.2	0.6	33.3
TASL	"CXorf21, FLJ11577"	ENSG00000120280	"TLR adaptor interacting with endolysosomal SLC15A4"	Q9HAI6	X	30558809-30577766	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.5;lymphoid tissue: 10.9"	"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"THP-1: 166.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001185	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	1.8	1.8	0.6	10.9	0.6	19.5	2.1	0.7	1.0	1.1	1.1	3.5	4.7	0.6	0.4	1.6	0.8	3.9	0.6	0.7	0.6	1.1	2.4	4.7	10.5	1.3	1.1	0.3	0.3	0.7	0.3	2.9	1.3	1.0	3.4	0.2	1.0	0.6	0.1	0.7	3.0	2.2	0.9	9.8	3.6	0.3	1.5	5.8	0.6	0.4	10.2	4.1	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	13.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	21.5	0.0	0.0	0.0	20.5	0.0	21.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.0	0.0	0.0	0.0	0.0	0.1	15.0	1.6	7.5	0.0	23.9	0.0	8.6	21.9	24.1	1.6	19.8	0.3	23.0	2.0	1.1	25.3	23.6	1.8	1.3	30.6	7.1	44.4	45.9	3.4	8.0	0.6	0.6	0.7	1.0	0.7	0.6	1.3	1.1	1.3	0.9	1.5	2.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082096	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 254.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 556.4;Syncytiotrophoblasts: 502.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	38000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	44.6	28.7	21.6	63.4	18.3	254.5	20.2	18.5	32.3	31.3	15.7	77.2	35.9	23.8	11.1	36.0	25.9	24.9	31.0	21.9	19.0	26.4	27.8	78.0	23.0	24.2	19.9	93.9	15.9	44.8	13.1	103.2	26.3	13.2	55.6	47.3	15.7	13.4	76.2	21.8	32.1	31.5	20.8	15.5	21.4	21.6	25.3	22.0	20.1	68.7	28.1	68.5	17.4	20.7	175.3	155.0	69.8	142.1	151.7	87.3	438.7	242.5	183.7	168.1	276.3	384.6	156.6	178.5	446.3	91.0	363.5	261.8	243.3	81.1	204.2	860.4	82.4	677.4	120.2	179.2	119.4	561.8	130.4	99.1	78.6	144.5	129.0	47.8	56.9	95.6	287.3	164.1	132.8	161.7	185.8	116.8	214.9	228.6	314.0	97.3	103.9	214.1	148.3	435.3	159.3	65.9	234.4	613.9	55.2	115.9	595.0	115.8	72.5	198.4	159.7	175.3	369.7	46.3	387.8	276.7	232.3	149.2	122.3	0.0	1.6	2.2	2.2	7.3	1.4	5.1	2.4	1.5	3.5	3.1	2.1	1.7	0.2	1.9	13.2	7.1	6.4	2.1	21.6	18.3	18.5	32.3	21.9	19.0	24.2	19.9	26.3	20.8	25.3	20.7	25.4	44.8	32.1	43.1	46.6	60.3	37.2	33.6	21.1	53.1	37.1	34.9	103.0	41.5	38.8	20.2	148.0	122.5	53.2	156.6	0.0	49.4	3.5	35.3	20.3	23.6	56.1	556.4	24.7	41.8	25.3	32.4	77.5	56.1	23.4	40.2	8.6	93.2	73.4	13.5	28.3	67.8	22.4	37.1	77.6	5.3	11.5	161.7	17.8	44.0	49.4	22.0	9.2	11.6	8.2	52.0	50.8	8.6	42.1	25.6	48.3	13.1	32.1	44.4	26.3	36.3	29.3	23.8	18.2	51.3	35.8	502.7	42.6	16.6	103.5	23.7
TGFB1	"CED, DPD1, TGFB, TGFbeta"	ENSG00000105329	"Transforming growth factor beta 1"		19	41301587-41353922	"Human disease related genes, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 438.3;Extravillous trophoblasts: 452.1;Macrophages: 188.8;NK-cells: 223.5;T-cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000361, HPA073356"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	1290000		"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"	Cytosol	"CAB000361: AB_2201910, HPA073356: "	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (8.51e-3)"	"unprognostic (5.63e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.65e-3)"	"unprognostic (2.79e-2)"	"unprognostic (6.39e-2)"	"unprognostic (4.86e-3)"	39.8	28.6	10.8	39.7	10.7	82.9	25.4	11.8	9.4	53.2	9.5	31.0	14.4	45.9	7.4	52.2	27.7	18.1	35.8	9.5	15.5	35.8	14.7	63.4	34.0	24.5	14.9	17.4	14.3	11.5	18.0	32.1	17.6	31.6	8.4	0.6	21.2	19.8	8.1	29.3	37.8	21.8	18.4	88.9	20.1	8.1	19.4	16.7	20.2	8.3	25.7	44.1	45.3	17.7	57.7	87.6	3.4	0.3	41.7	35.3	10.0	81.9	64.4	25.2	15.4	40.4	30.1	57.0	88.6	110.5	26.8	30.1	17.8	54.6	11.1	76.6	17.9	199.0	18.0	50.4	47.7	54.9	119.6	45.0	17.5	50.5	32.7	138.7	135.2	21.1	108.0	116.8	27.9	42.1	43.1	79.6	9.4	12.0	52.7	44.4	13.1	85.4	46.8	20.3	0.3	6.5	23.9	0.1	15.1	32.5	1.9	36.3	170.3	96.4	77.2	20.7	91.2	74.4	31.7	36.3	90.3	106.4	16.4	1.1	0.8	3.9	0.7	1.2	0.6	0.2	0.3	0.4	0.5	0.3	0.2	0.3	2.4	0.3	0.8	0.9	0.3	0.9	10.8	10.7	11.8	9.4	9.5	15.5	24.5	14.9	17.6	18.4	19.4	17.7	55.0	0.0	0.0	3.3	120.6	44.4	36.5	64.8	38.7	0.2	14.4	9.7	2.3	4.3	17.2	16.5	0.0	5.4	438.3	1.4	0.0	12.8	1.0	5.7	18.2	63.1	0.0	28.0	1.6	17.1	452.1	34.3	14.3	5.0	64.9	20.0	71.4	2.7	141.2	0.0	2.1	1.4	22.4	136.1	158.6	1.8	12.2	188.8	23.2	30.0	105.8	0.3	223.5	0.0	0.6	45.1	16.4	18.0	156.5	32.9	0.4	9.0	9.7	0.7	39.5	13.9	78.6	3.1	8.0	40.3	18.9	55.7	221.9	4.1	0.8	31.1
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	"Transforming growth factor beta receptor 1"	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 128.4;Late spermatids: 101.7;Microglial cells: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 253.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144"	"unprognostic (2.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-2)"	15.9	9.9	9.8	18.2	9.3	33.7	15.4	13.2	8.9	19.4	11.8	18.8	11.7	20.6	8.8	15.0	8.5	21.7	8.2	6.8	11.3	22.6	14.8	16.3	13.8	18.4	14.5	13.0	8.3	8.5	7.6	48.8	20.0	17.1	13.4	4.7	8.3	16.8	8.7	6.2	9.3	33.0	18.0	16.5	18.4	18.3	17.5	11.2	11.2	13.2	13.6	22.5	8.4	27.9	13.7	19.5	115.5	36.1	26.2	19.3	17.4	44.1	47.8	40.7	44.9	19.9	9.3	29.7	13.4	34.6	32.1	30.4	39.6	34.1	54.0	77.1	12.3	43.9	20.7	17.8	43.2	27.2	102.8	40.2	35.4	62.8	29.5	25.2	7.4	10.9	62.4	12.1	55.4	20.3	4.0	31.0	24.7	12.2	11.5	11.0	253.1	12.5	9.9	3.8	31.1	36.2	34.3	150.2	46.4	47.3	28.1	36.6	13.6	29.8	25.5	129.3	27.3	12.1	13.4	20.0	62.5	45.9	26.2	16.2	2.4	9.5	7.8	1.6	6.7	1.6	3.3	5.8	2.0	1.2	3.2	6.2	4.9	4.3	2.0	1.4	2.4	2.2	9.8	9.3	13.2	8.9	6.8	11.3	18.4	14.5	20.0	18.0	17.5	27.9	13.5	6.4	8.8	18.9	18.9	23.6	7.4	19.9	44.3	8.0	18.9	11.7	7.6	4.3	12.8	60.7	0.0	23.0	37.3	5.0	0.0	18.8	128.4	6.4	22.7	17.6	9.6	7.4	14.2	31.2	6.7	36.0	9.2	9.3	29.9	19.5	6.4	12.7	49.4	0.0	8.6	7.3	8.2	32.4	52.5	101.7	9.6	39.7	35.6	116.2	24.3	3.1	35.0	45.8	21.1	33.8	4.2	13.5	11.9	18.4	3.6	13.8	5.0	2.0	32.9	21.8	20.9	11.0	12.7	25.6	16.2	19.4	25.4	7.6	8.3	11.5
THEMIS2	"C1orf38, ICB-1"	ENSG00000130775	"Thymocyte selection associated family member 2"	Q5TEJ8	1	27872543-27886685	"Predicted intracellular proteins"	"Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 215.5;lymphoid tissue: 126.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.5;Hofbauer cells: 62.6;Kupffer cells: 135.9;Langerhans cells: 59.9;Macrophages: 125.4;monocytes: 144.8;Plasma cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 403.3;eosinophil: 341.0;intermediate monocyte: 441.4;myeloid DC: 309.6;neutrophil: 498.1;non-classical monocyte: 454.6;plasmacytoid DC: 125.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 309.6;granulocytes: 498.1;monocytes: 454.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 135.9;U-266/70: 98.4;U-937: 62.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027513, HPA031096"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA027513: , HPA031096: AB_10599254"	"unprognostic (7.38e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.56e-3)"	"unprognostic (4.13e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.52e-3)"	30.7	10.6	10.8	72.8	13.1	215.5	12.7	13.6	14.4	7.2	12.3	14.7	10.1	5.7	3.9	8.0	10.2	23.6	6.6	11.2	16.6	9.2	19.1	45.8	47.9	22.2	14.3	3.3	5.4	2.7	4.9	18.8	19.1	5.4	10.1	0.9	11.1	3.9	3.4	4.5	28.2	15.5	15.4	126.0	12.2	22.4	17.8	16.0	11.0	4.5	29.9	26.9	6.4	24.6	9.1	0.3	3.4	0.5	11.4	15.6	1.5	1.9	20.0	28.7	40.2	1.3	2.4	12.8	1.2	6.6	15.9	1.3	5.2	1.2	4.6	1.7	1.2	18.0	0.4	2.3	22.3	23.0	27.8	7.9	0.3	14.8	0.1	1.5	11.1	1.0	24.7	135.9	2.1	6.1	0.9	20.1	11.8	0.3	1.8	4.1	12.8	23.2	8.6	0.3	0.2	5.0	0.1	0.8	26.2	2.1	0.3	20.2	6.9	1.7	0.2	5.6	0.3	98.4	6.1	0.8	32.3	62.1	0.5	41.7	403.3	341.0	71.9	441.4	66.1	41.5	53.1	60.2	309.6	21.8	45.6	48.2	498.1	61.9	454.6	125.2	56.4	380.7	10.8	13.1	13.6	14.4	11.2	16.6	22.2	14.3	19.1	15.4	17.8	24.6	2.2	3.2	20.0	0.3	42.6	3.2	1.1	2.7	0.6	0.4	1.0	0.6	0.7	2.8	8.7	0.0	0.0	0.8	87.5	0.3	0.0	0.9	2.3	4.5	1.8	6.8	10.7	6.1	6.2	8.3	1.3	1.8	1.1	6.4	13.3	7.1	3.6	1.3	62.6	0.0	0.7	0.2	36.7	135.9	59.9	5.2	0.6	125.4	17.8	6.5	144.8	0.1	54.6	0.5	14.7	8.7	0.0	0.4	57.3	3.0	0.0	0.4	3.2	0.2	0.0	21.9	2.1	1.8	2.9	0.1	1.1	2.5	21.2	3.0	0.8	5.0
TLR1	"CD281, KIAA0012, rsc786"	ENSG00000174125	"Toll like receptor 1"	Q15399	4	38790677-38856817	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3;lymphoid tissue: 26.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 15.4;Hofbauer cells: 14.9;Kupffer cells: 34.9;Macrophages: 32.7;Microglial cells: 29.0;monocytes: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 128.5"	"Group enriched"	"Detected in all"	6	"granulocytes: 128.5;monocytes: 42.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.3;HUVEC TERT2: 12.6;RPMI-8226: 14.4;U-698: 20.6;U-937: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (7.82e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.25e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.97e-2)"	8.8	4.1	1.9	26.9	2.1	34.3	7.3	2.3	1.8	4.6	2.8	4.9	6.5	6.0	2.1	3.3	6.0	9.6	2.3	1.8	2.4	4.4	8.8	10.8	16.2	4.9	3.2	10.2	5.1	1.6	1.0	10.0	5.2	3.5	6.8	1.4	9.0	3.7	0.5	1.8	6.2	9.8	3.9	24.9	6.4	1.3	4.1	8.1	1.6	3.4	19.7	8.0	1.1	6.7	0.2	2.0	0.1	0.0	0.3	1.5	0.0	0.0	0.5	0.1	1.1	0.2	5.4	11.3	1.1	0.0	5.3	0.3	0.1	1.4	0.3	1.3	0.5	1.4	0.5	0.0	0.1	2.1	0.6	0.4	0.3	0.5	0.0	0.4	12.6	0.2	1.6	3.3	1.7	0.0	0.5	4.6	0.0	0.0	0.0	7.7	0.1	14.4	1.3	0.0	0.0	1.5	0.0	0.1	0.5	0.1	0.1	2.7	3.3	1.1	0.5	0.1	0.7	1.2	0.2	20.6	2.8	7.7	0.3	0.1	22.0	8.3	3.0	30.8	2.3	6.5	3.2	2.5	13.8	5.6	3.1	1.8	128.5	5.6	42.7	4.5	1.3	9.0	1.9	2.1	2.3	1.8	1.8	2.4	4.9	3.2	5.2	3.9	4.1	6.7	1.0	0.0	1.5	1.0	15.4	0.3	0.6	3.0	1.8	0.3	2.9	1.1	0.2	0.0	4.4	1.8	0.0	0.1	8.6	0.6	1.9	5.5	0.0	6.1	0.7	2.6	0.0	0.8	0.7	4.4	0.2	3.1	2.0	4.7	3.8	0.1	0.4	2.5	14.9	0.0	1.6	0.4	2.0	34.9	14.6	0.2	0.0	32.7	0.0	29.0	19.2	1.9	6.2	3.5	2.2	2.0	0.3	2.6	2.1	1.1	0.6	1.1	7.8	0.2	0.0	3.9	0.5	0.1	0.3	0.8	0.6	0.1	6.1	2.6	1.4	1.4
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	26.8	11.8	4.3	51.7	4.4	69.9	12.5	4.6	7.5	7.9	7.6	4.6	3.9	3.3	11.8	5.4	8.2	16.3	6.1	4.0	5.3	5.1	11.3	39.9	8.8	9.5	5.9	2.5	8.8	3.4	4.0	11.4	7.9	4.7	3.3	1.5	17.2	12.3	1.7	3.5	4.9	11.7	7.1	35.9	5.2	1.9	7.4	3.6	3.4	3.7	15.4	23.6	4.0	10.1	7.1	0.1	0.3	0.0	1.0	2.9	0.0	0.0	0.5	0.5	0.8	3.3	0.4	0.0	0.8	0.0	0.0	6.4	0.6	0.4	0.3	0.1	0.1	0.2	0.0	0.8	0.1	11.6	0.9	12.5	12.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	11.4	0.7	0.0	2.7	0.3	0.0	0.0	13.3	16.3	0.0	0.3	0.7	0.1	3.3	0.4	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	11.3	1.7	48.4	199.6	1.8	0.3	178.9	0.5	0.4	1.1	0.3	121.3	1.2	1.3	0.2	457.8	5.3	121.5	1.1	0.2	76.2	4.3	4.4	4.6	7.5	4.0	5.3	9.5	5.9	7.9	7.1	7.4	10.1	1.7	6.4	77.3	0.7	1.1	1.1	1.2	18.4	1.2	0.0	9.7	2.2	1.3	2.8	19.5	3.7	0.0	0.2	0.6	0.2	0.0	5.0	0.3	1.6	0.5	2.6	0.0	3.6	0.1	3.8	0.2	1.9	2.6	4.9	3.8	0.5	1.4	1.8	17.4	0.0	0.5	0.3	0.0	117.2	35.7	1.3	0.6	101.8	1.8	33.7	68.4	0.4	1.0	1.0	0.1	3.1	0.0	0.4	1.4	3.4	1.5	1.0	7.5	0.3	13.1	0.6	5.1	0.2	1.0	1.9	1.1	0.1	2.3	0.5	0.5	2.0
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724735	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.6;Astrocytes: 50.9;Hepatic stellate cells: 62.8;Hofbauer cells: 38.2;Kupffer cells: 106.0;Macrophages: 64.5;monocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.8"	"Group enriched"	"Detected in many"	33	"dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 60.0;TIME: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	31.1	11.0	12.4	25.7	15.7	22.3	12.0	11.7	8.3	6.5	1.7	6.7	4.3	5.6	1.2	4.8	4.8	10.8	8.4	10.3	17.8	6.8	16.7	16.2	13.1	12.3	14.0	6.0	2.6	2.5	2.1	23.9	12.4	4.6	7.3	2.9	6.0	3.2	3.1	3.5	5.8	10.8	14.9	32.6	4.4	1.5	14.2	3.5	5.5	12.0	7.7	13.3	2.7	10.1	0.0	0.0	25.5	0.0	11.1	23.0	0.1	10.2	17.9	2.5	1.5	0.0	2.6	3.6	0.5	26.7	7.5	0.1	0.0	2.2	3.7	0.0	0.0	5.7	5.1	0.4	8.1	19.1	0.1	14.2	0.0	5.4	0.7	22.5	31.4	0.0	0.0	60.0	29.2	0.0	0.0	2.9	3.1	2.4	1.2	0.0	28.0	19.8	0.9	28.9	0.0	0.1	6.4	0.0	1.0	2.2	0.0	10.4	43.5	1.4	18.4	0.1	4.8	0.0	0.0	0.0	0.9	19.1	15.2	64.0	64.9	21.5	0.1	57.5	0.0	1.7	0.1	0.0	22.4	0.5	0.0	0.0	86.8	0.1	65.6	0.9	0.0	25.5	12.4	15.7	11.7	8.3	10.3	17.8	12.3	14.0	12.4	14.9	14.2	10.1	38.6	0.0	5.0	50.9	2.3	0.8	0.3	0.1	0.6	0.2	3.5	1.0	2.9	2.8	2.9	0.0	0.0	0.3	0.1	1.6	0.0	0.1	0.1	3.5	29.2	31.6	0.0	1.3	0.2	0.2	0.2	11.5	1.5	6.8	15.8	1.2	62.8	1.9	38.2	0.0	0.2	2.0	0.0	106.0	8.6	0.4	0.0	64.5	1.8	26.2	54.0	8.8	2.1	7.5	0.3	0.5	6.1	0.0	0.1	0.1	0.0	0.4	3.7	1.3	6.6	5.5	4.5	0.1	0.3	0.3	0.0	0.8	0.9	3.1	1.2	3.3
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575565-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.7;lymphoid tissue: 6.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 90.7;dendritic cells: 60.8;Langerhans cells: 72.7;Macrophages: 108.3;T-cells: 100.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 68.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 20.8;monocytes: 68.0;T-cells: 36.6"	"Group enriched"	"Detected in some"	8	"HDLM-2: 103.7;NB-4: 214.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB078469	Supported				"Secreted to blood"	NA	NA	10100		"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB078469: AB_908070"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-1)"	1.4	0.5	0.0	3.3	0.0	12.7	0.5	0.0	0.1	0.1	0.0	0.9	0.0	1.5	0.0	0.7	0.3	0.6	2.6	0.1	0.0	1.2	0.6	3.6	1.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	1.5	2.4	0.2	0.1	6.5	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.8	0.0	0.0	0.0	0.0	103.7	0.0	19.4	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	214.4	0.0	0.0	0.0	9.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	10.1	0.0	23.2	39.5	36.6	7.2	17.2	13.9	7.6	7.0	5.0	5.2	20.8	2.0	68.0	4.3	13.6	14.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	3.0	0.0	90.7	8.4	1.2	12.1	4.6	0.2	17.4	20.4	2.0	2.8	4.0	0.0	2.1	0.9	60.8	0.5	0.0	7.4	0.1	15.5	5.9	10.7	0.0	0.0	0.0	3.3	1.7	2.0	1.5	30.5	12.6	0.0	1.8	0.1	36.5	0.0	0.0	0.4	10.2	14.1	72.7	0.0	0.3	108.3	5.4	1.9	3.4	0.1	2.1	0.0	0.1	14.3	0.0	0.0	10.4	1.7	0.0	0.1	3.0	0.2	0.0	0.6	4.0	0.0	0.0	1.3	4.1	1.1	100.0	0.0	0.4	0.3
TNFRSF10C	"CD263, DcR1, LIT, TRAILR3, TRID"	ENSG00000173535	"TNF receptor superfamily member 10c"	O14798	8	23102921-23117445	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.0;lymphoid tissue: 23.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.9;Endothelial cells: 5.3;Gastric mucus-secreting cells: 13.7;granulocytes: 8.8;Proximal enterocytes: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 3195.8"	"Lineage enriched"	"Detected in many"	120	"granulocytes: 3195.8"	"Group enriched"	"Detected in many"	5	"BEWO: 108.8;HUVEC TERT2: 91.2"									CAB025635	Enhanced					NA	NA	14600000		"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB025635: "	"unprognostic (2.63e-1)"	"unprognostic (4.49e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.74e-3)"	"unprognostic (4.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.34e-3)"	"unprognostic (6.54e-2)"	8.3	1.8	1.2	23.8	1.0	21.0	1.0	0.9	2.4	4.1	1.7	2.8	2.0	1.1	0.7	2.2	4.7	12.7	1.6	0.7	1.0	2.6	2.6	7.5	1.6	1.6	1.2	0.5	2.5	1.8	1.1	8.3	1.6	1.8	3.0	0.1	1.1	1.5	0.5	0.4	2.4	3.1	1.4	18.4	2.6	0.8	1.6	2.9	3.6	7.2	1.3	6.9	0.4	1.3	0.7	3.6	1.3	3.4	0.0	0.7	108.8	4.4	0.0	0.3	0.4	0.0	4.1	0.2	1.4	3.9	0.3	0.6	0.2	0.4	0.2	4.4	1.1	0.4	1.1	1.2	11.2	0.5	2.0	12.1	0.8	2.0	0.8	1.6	91.2	0.2	0.0	0.0	0.8	3.2	0.0	2.6	4.2	0.2	0.1	0.2	0.1	0.0	19.4	0.4	0.0	0.2	0.2	0.2	1.0	9.7	14.7	0.6	18.0	1.0	2.3	3.3	0.3	3.4	1.3	0.0	4.9	0.9	1.7	57.8	26.7	511.0	0.1	14.4	0.3	1.4	0.5	0.1	6.0	0.4	0.6	0.3	3195.8	1.4	21.5	0.4	0.4	9.2	1.2	1.0	0.9	2.4	0.7	1.0	1.6	1.2	1.6	1.4	1.6	1.3	1.0	6.4	7.9	0.3	0.2	0.3	0.3	1.5	0.6	0.0	0.1	0.0	0.4	2.8	4.7	3.7	0.0	1.1	0.0	0.3	0.0	0.4	1.0	0.5	0.1	5.3	1.8	0.0	0.1	0.4	0.9	0.8	13.7	0.2	8.8	0.0	1.8	0.0	2.4	0.0	0.0	0.5	0.0	1.6	0.6	0.4	0.0	2.5	0.0	1.0	1.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	6.2	0.0	1.8	0.1	0.0	0.4	0.3	0.6	1.5	0.2	0.1	1.1	0.9	0.3	0.4	0.4
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12166991-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 68.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 268.7;Kupffer cells: 200.5;Langerhans cells: 288.0;Macrophages: 230.2;monocytes: 175.3;T-cells: 138.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 387.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.0;K-562: 45.7;THP-1: 51.8;U-87 MG: 30.8;U-937: 37.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	NA	NA	3230000	8100000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA004796: AB_1078436"	"unprognostic (4.45e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.82e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.10e-1)"	45.6	5.4	3.9	68.4	3.8	52.1	34.7	4.8	17.9	14.3	5.6	12.8	16.8	11.6	0.4	5.5	14.6	15.6	10.9	3.7	9.0	7.5	15.7	32.0	32.1	18.3	7.2	6.3	5.9	2.3	4.5	35.8	10.6	6.4	10.8	0.8	6.5	2.6	10.7	7.8	23.9	16.8	9.0	53.3	16.4	2.2	8.9	12.7	7.6	6.3	21.3	28.9	8.8	14.1	0.0	0.3	4.1	0.0	9.6	13.5	8.9	1.1	2.0	4.0	4.3	1.8	34.0	0.2	0.6	3.9	5.6	0.0	0.8	0.0	2.2	14.5	0.0	0.0	0.2	0.0	25.2	0.3	3.8	14.8	0.0	13.0	0.0	7.2	19.6	0.2	45.7	6.4	1.5	0.0	0.0	8.1	0.2	4.9	1.4	1.2	0.4	25.9	0.0	0.8	0.0	0.1	0.6	0.4	1.4	6.4	0.0	51.8	7.8	5.3	0.2	27.0	0.0	1.9	0.0	0.0	30.8	37.0	1.4	0.6	127.1	18.2	48.4	260.5	26.5	13.5	34.4	40.5	71.7	8.4	9.8	15.5	138.0	13.4	387.1	15.1	70.9	150.4	3.9	3.8	4.8	17.9	3.7	9.0	18.3	7.2	10.6	9.0	8.9	14.1	99.4	9.6	15.9	0.7	42.8	16.8	3.9	1.0	1.2	0.2	3.2	4.1	3.6	5.7	6.5	3.7	0.0	0.9	268.7	12.8	0.0	0.5	0.6	1.7	5.1	46.0	0.0	7.4	0.2	0.6	6.3	13.2	12.8	4.9	2.5	1.4	31.1	17.0	72.6	0.0	0.2	3.0	0.0	200.5	288.0	1.2	2.1	230.2	16.0	30.9	175.3	0.3	109.2	0.0	0.1	0.7	4.2	0.4	72.5	8.0	25.8	0.4	1.5	1.2	32.9	6.8	9.8	0.0	0.9	0.7	10.5	30.1	138.4	1.9	4.8	8.8
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028822-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 801.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	Yes		7600	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	37.9	36.7	17.4	49.9	18.6	74.9	27.9	21.8	25.1	26.9	25.3	36.9	42.6	27.9	34.4	36.7	22.4	37.2	19.1	18.0	18.9	39.0	47.5	40.0	59.9	18.5	18.4	24.3	28.6	26.7	22.4	50.2	18.1	31.8	37.3	25.5	26.7	24.2	21.3	26.5	42.6	23.9	18.7	38.5	36.5	18.9	18.8	58.9	37.6	20.2	60.6	42.7	28.8	19.2	105.2	71.7	131.4	108.2	52.2	61.8	129.8	92.6	81.0	105.0	94.8	190.5	127.6	296.4	96.4	48.5	112.3	98.9	159.1	147.2	153.0	64.9	81.6	378.6	54.9	139.0	135.4	165.1	124.0	69.8	76.4	102.4	166.8	94.0	111.5	98.1	167.8	98.7	120.9	233.2	235.3	119.7	106.3	104.1	131.6	197.7	123.1	157.7	121.4	95.2	108.6	75.4	145.4	88.3	95.0	94.2	98.6	146.4	109.9	84.7	71.3	78.8	100.9	62.7	75.6	338.3	113.7	91.1	82.0	12.6	9.9	16.8	6.6	10.3	8.3	10.5	7.3	7.0	9.5	10.1	7.7	6.9	19.1	6.3	13.2	18.8	9.0	5.4	17.4	18.6	21.8	25.1	18.0	18.9	18.5	18.4	18.1	18.7	18.8	19.2	116.9	118.6	201.5	66.0	117.6	245.9	338.0	90.3	153.7	98.2	90.5	75.7	49.7	78.6	170.3	99.3	60.5	192.1	137.1	194.1	74.3	94.4	10.0	151.3	167.4	115.1	91.8	486.5	86.9	65.8	175.4	121.4	84.1	259.2	78.6	119.1	67.1	131.7	99.2	72.3	77.4	126.9	69.2	101.2	109.1	12.8	59.7	151.6	72.9	74.9	95.4	88.0	78.2	87.4	90.7	119.2	169.8	69.6	234.1	162.3	94.1	136.2	68.3	87.0	85.5	135.5	130.8	116.8	54.6	129.4	214.2	801.5	111.5	123.7	117.8	237.7
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286682	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0;lung: 65.3;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 26.1;Hofbauer cells: 25.1;Kupffer cells: 35.5;Langerhans cells: 21.5;Late spermatids: 20.6;Macrophages: 104.2;monocytes: 19.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 8.5"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 615.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 615.1"	"Group enriched"	"Detected in some"	4	"SuSa: 6.2;U-87 MG: 24.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	20.4	1.4	0.4	44.1	0.4	96.0	1.2	0.4	8.5	0.8	2.3	0.9	0.4	2.2	0.0	1.5	3.9	9.9	3.8	0.4	0.6	1.1	6.9	65.3	0.4	0.9	0.7	0.5	3.9	1.1	2.4	7.7	1.9	0.7	0.3	0.6	1.2	0.5	0.5	0.2	1.0	8.4	0.6	11.1	0.8	0.3	2.6	3.1	0.7	2.6	1.3	12.6	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	1.6	0.0	0.1	82.7	2.3	0.0	20.7	0.1	0.6	0.1	0.0	32.8	1.5	0.2	0.0	615.1	0.2	10.1	0.7	0.0	32.5	0.4	0.4	0.4	8.5	0.4	0.6	0.9	0.7	1.9	0.6	2.6	0.9	0.0	6.4	26.1	0.0	1.8	0.4	0.4	5.4	0.0	0.0	0.1	0.1	0.3	2.8	12.4	0.0	0.0	0.4	0.3	0.1	0.0	0.3	12.1	0.3	1.8	3.8	0.0	0.0	0.0	0.2	1.1	2.5	1.1	0.1	6.3	0.0	0.7	0.5	25.1	0.0	0.0	0.0	2.0	35.5	21.5	20.6	0.0	104.2	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.2	0.0	0.3	13.3	0.1	0.0	0.8	2.8	0.0	0.1	0.0	0.1	14.6	2.0	0.0	0.0	0.1
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019429-59026654	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;lymphoid tissue: 4.3"	"Cell type enriched"	"Detected in some"	10	"Macrophages: 191.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"basophil: 63.5;neutrophil: 26.0"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 63.5"	"Cell line enriched"	"Detected in some"	19	"HEL: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004286, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		87000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.2	0.2	0.2	0.3	0.2	8.5	0.1	0.5	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.3	2.4	0.2	0.3	0.2	0.1	0.1	0.0	0.3	1.1	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.2	0.0	0.1	4.3	0.1	0.9	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	29.5	0.8	1.5	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.2	0.6	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.2	0.3	0.2	0.1	0.2	0.4	63.5	2.4	1.9	0.5	0.6	0.4	0.9	0.2	0.0	1.1	0.5	0.4	0.0	26.0	0.2	0.3	2.6	0.5	281.6	0.2	0.2	0.5	0.5	0.1	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.1	0.0	1.1	0.3	1.4	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.1	0.0	0.6	0.0	4.2	0.0	3.1	0.0	0.0	0.0	16.0	0.3	0.2	1.5	0.0	19.0	0.2	0.0	0.1	0.1	0.0	0.7	1.3	0.0	3.6	0.2	0.3	0.0	0.2	0.0	0.0	2.8	0.0	5.9	0.3	191.2	0.0	0.0	13.8	0.2	13.4	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.1	0.1	0.1
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"Transmembrane immune signaling adaptor TYROBP"	O43914	19	35904401-35908295	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 596.8;lymphoid tissue: 423.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3777.1;Kupffer cells: 3698.1;Langerhans cells: 1990.8;Macrophages: 2837.1;monocytes: 3371.2;NK-cells: 1772.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 6415.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"HMC-1: 678.1;THP-1: 390.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	126.3	76.1	55.8	234.3	54.3	596.8	59.1	58.6	116.8	44.3	61.4	62.0	70.6	25.9	15.0	28.1	43.7	105.0	39.7	53.0	66.4	34.4	85.5	261.5	161.0	81.7	64.0	18.3	24.7	22.0	27.0	124.7	74.8	31.7	49.8	3.9	38.3	26.7	10.6	21.5	78.8	68.0	74.1	423.3	43.1	15.0	74.0	52.5	21.9	31.6	36.6	131.7	21.5	114.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	56.7	0.0	0.0	0.5	33.2	678.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	49.1	0.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.9	0.0	390.6	0.0	0.0	0.3	0.8	0.1	0.4	0.1	1.0	0.1	10.8	0.1	974.2	4983.5	2573.9	468.0	3367.8	246.5	22.4	9.5	64.2	1912.0	8.4	11.7	51.2	6415.4	1664.1	3413.8	1653.1	9.5	5260.2	55.8	54.3	58.6	116.8	53.0	66.4	81.7	64.0	74.8	74.1	74.0	114.4	24.5	57.7	168.4	0.0	50.9	55.2	2.0	0.0	1.2	0.1	11.5	43.3	6.8	34.3	43.4	20.2	0.0	19.8	987.6	1.7	1.9	2.1	3.9	1.3	1.4	47.1	0.0	87.8	0.1	5.8	28.0	24.9	5.6	1.5	753.7	0.3	73.2	25.0	3777.1	0.0	0.1	0.2	0.0	3698.1	1990.8	11.6	9.3	2837.1	56.9	18.7	3371.2	0.6	1772.4	0.0	0.1	1.3	2.3	1.2	19.4	1.5	0.5	8.9	20.5	1.8	78.9	5.3	10.0	0.9	3.0	4.9	44.6	38.9	236.5	0.1	0.5	1.8
UGCG	GCS	ENSG00000148154	"UDP-glucose ceramide glucosyltransferase"	Q16739	9	111896814-111935369	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.9"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 294.5;Urothelial cells: 534.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	21	"plasmacytoid DC: 109.7"	"Lineage enriched"	"Detected in all"	21	"dendritic cells: 109.7"	"Cell line enhanced"	"Detected in all"		"LHCN-M2: 195.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024124	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA024124: AB_1858595"	"unprognostic (1.22e-2)"	"prognostic favorable (6.62e-4)"	"unprognostic (5.39e-2)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.53e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.77e-2)"	39.1	65.6	9.5	34.6	9.6	112.9	25.2	11.1	10.9	23.1	10.4	20.5	23.8	16.3	7.3	40.8	15.7	42.6	14.4	9.7	13.1	29.7	32.5	33.7	41.8	11.0	12.4	12.0	16.6	5.5	12.5	27.6	10.3	13.8	17.8	12.2	14.1	7.7	9.0	32.8	31.7	21.4	10.2	35.5	47.9	7.9	11.6	20.5	9.9	7.7	46.8	72.3	28.5	13.7	93.4	9.8	15.7	10.5	33.2	39.7	8.3	57.0	59.7	65.3	87.9	19.8	70.0	21.9	44.1	38.0	142.9	46.6	18.4	24.7	69.6	8.9	10.7	8.9	14.3	9.8	23.7	9.8	13.8	39.6	18.9	62.4	89.1	151.0	20.3	10.8	49.4	41.5	195.7	15.9	10.7	10.9	17.9	31.4	10.1	12.4	111.5	7.1	151.0	35.2	7.6	12.0	25.3	21.1	66.1	92.2	113.6	10.1	96.6	30.0	15.2	84.8	41.1	7.7	30.3	10.2	37.0	6.1	41.6	0.1	0.3	0.2	1.2	0.7	2.0	4.2	2.2	1.6	1.9	5.3	2.0	2.0	1.2	1.4	1.0	109.7	3.6	1.4	9.5	9.6	11.1	10.9	9.7	13.1	11.0	12.4	10.3	10.2	11.6	13.7	128.0	41.7	51.1	17.6	66.6	75.7	151.6	90.6	76.8	29.8	71.8	37.8	11.8	47.1	130.7	29.5	62.6	7.3	262.4	69.8	17.6	108.2	20.6	125.0	83.4	116.1	18.5	26.5	40.4	50.6	12.8	64.6	121.8	294.5	10.8	18.3	90.7	20.6	21.4	18.5	41.9	55.1	36.7	34.0	109.2	5.9	49.0	49.1	58.7	24.4	44.4	8.4	9.2	25.1	12.8	72.2	65.1	38.4	33.3	216.6	42.6	77.2	143.9	16.5	13.1	153.2	74.9	1.8	8.7	99.7	122.2	3.4	41.4	30.5	22.1	534.7
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 176.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 297.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333"	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	29.0	21.6	4.5	29.4	4.8	176.2	22.9	12.3	6.7	17.6	10.2	18.0	13.8	14.6	9.2	19.7	17.8	13.7	19.8	5.2	5.5	14.9	27.2	31.5	33.3	6.0	5.4	26.7	19.7	14.9	13.9	18.4	5.7	14.3	16.7	45.8	19.7	8.3	35.5	29.9	24.6	12.6	4.6	44.3	18.8	30.2	5.5	26.5	17.1	14.8	24.9	18.1	19.4	8.0	18.3	16.5	14.2	17.7	25.7	25.1	27.0	29.0	21.2	22.3	16.1	19.6	21.6	15.5	16.6	17.8	10.1	18.5	18.4	23.1	27.6	18.5	15.0	25.2	15.1	14.1	18.8	35.6	61.8	15.0	19.2	27.2	20.7	20.7	26.1	16.3	80.8	36.0	20.0	23.5	26.4	19.3	25.4	16.5	24.0	17.2	19.1	32.3	17.9	22.8	17.9	8.9	30.9	21.6	17.3	17.4	34.7	18.8	37.2	21.2	22.2	32.0	18.2	16.4	24.0	21.9	25.7	26.7	23.5	163.4	60.0	64.3	13.5	31.1	14.9	28.5	19.6	14.0	23.7	20.5	23.5	13.8	297.9	14.7	26.8	26.6	58.8	26.1	4.5	4.8	12.3	6.7	5.2	5.5	6.0	5.4	5.7	4.6	5.5	8.0	57.1	38.5	36.4	68.6	130.3	58.8	40.8	26.2	40.5	54.9	32.3	28.1	74.9	21.5	48.9	23.9	110.5	31.7	142.5	50.2	11.7	36.4	172.2	26.3	46.5	45.4	42.0	248.3	124.8	41.5	43.3	52.5	57.6	38.9	88.6	53.5	21.0	45.3	46.2	42.1	104.2	33.2	12.2	101.3	97.6	172.0	61.8	120.6	53.4	135.9	195.8	25.6	90.6	100.0	108.8	55.1	47.6	29.3	94.3	36.0	30.9	25.9	31.9	151.5	39.5	66.1	60.5	83.7	43.3	49.3	77.0	65.8	130.0	27.0	29.5	60.8
WDFY1	"FENS-1, KIAA1435, WDF1, ZFYVE17"	ENSG00000085449	"WD repeat and FYVE domain containing 1"	Q8IWB7	2	223855716-223945357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050603, HPA079597"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"		"HPA050603: AB_2681188, HPA079597: "	"unprognostic (2.49e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.55e-2)"	18.6	13.2	9.3	18.0	9.5	48.5	14.4	9.3	12.0	20.5	11.2	20.4	15.6	22.6	19.8	14.4	20.5	17.5	11.7	9.2	10.7	14.8	18.0	18.4	23.3	11.0	10.2	20.2	14.1	19.8	8.7	27.4	11.4	16.2	20.1	15.9	13.5	12.8	11.4	13.5	15.9	19.6	9.7	21.2	19.8	10.9	10.5	15.9	22.1	12.6	18.9	17.9	13.7	11.1	27.9	19.3	34.9	27.2	46.4	44.0	43.7	34.7	48.3	37.5	30.4	81.4	25.0	7.7	30.8	60.6	47.3	19.2	18.7	52.3	40.4	15.6	15.8	19.2	31.9	59.2	36.4	15.2	15.8	39.0	37.9	46.3	71.0	62.4	63.9	16.2	34.3	23.4	44.4	26.8	6.5	11.1	34.5	20.7	16.6	25.3	44.8	8.6	28.4	47.7	29.6	15.7	20.7	19.2	90.9	41.6	12.5	38.1	70.9	74.9	25.7	13.5	18.0	28.8	4.6	21.4	36.3	32.9	26.2	4.4	21.5	8.1	13.7	29.0	16.6	14.1	9.7	13.5	14.8	11.7	10.0	9.5	10.3	24.0	25.7	3.0	9.7	17.6	9.3	9.5	9.3	12.0	9.2	10.7	11.0	10.2	11.4	9.7	10.5	11.1	40.0	16.0	9.3	22.5	22.0	12.5	14.5	19.9	17.1	14.0	11.8	7.6	7.7	12.8	24.4	16.5	8.4	22.6	25.5	36.4	9.8	12.9	0.8	23.2	30.7	34.1	10.3	11.2	28.7	17.2	11.2	21.4	29.6	36.5	17.7	12.5	16.8	25.7	17.9	28.6	28.1	15.2	8.2	26.3	17.2	2.4	14.6	24.4	35.6	27.2	25.6	13.9	24.7	33.7	39.8	18.0	24.4	23.7	21.8	16.6	16.0	14.4	29.9	10.9	6.6	13.1	26.7	3.8	8.8	24.4	15.5	19.0	21.1	15.0	21.8	28.7
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385146-224437033	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028538, HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427"	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	33.7	28.3	21.9	32.1	21.3	88.9	26.7	20.0	22.0	28.9	27.5	28.9	21.2	26.5	20.8	52.1	22.7	27.1	28.0	23.4	22.8	23.7	35.4	35.1	33.8	21.5	22.0	24.3	24.4	26.4	20.6	35.6	20.2	26.1	25.4	31.5	28.7	25.0	57.1	40.9	26.5	28.6	18.8	38.2	26.7	37.4	22.1	36.0	26.0	45.0	33.2	32.6	31.5	21.9	49.7	28.0	54.6	29.7	76.8	74.6	47.6	58.4	86.4	51.7	48.0	39.0	46.8	51.9	74.4	86.3	21.7	40.6	40.2	47.2	76.1	55.3	53.6	36.2	31.5	31.0	74.7	40.3	68.6	70.8	58.4	55.0	52.1	72.6	80.8	31.7	52.7	51.4	62.4	24.8	42.4	34.7	65.7	41.5	32.0	42.6	66.1	44.2	55.1	48.3	29.5	56.0	64.8	94.9	74.9	55.5	117.5	67.0	88.7	47.7	28.7	41.5	71.3	66.8	33.6	35.2	53.3	26.1	66.8	2.1	1.0	2.1	1.4	1.4	0.8	0.8	0.8	1.0	0.9	0.6	0.7	1.0	4.8	1.5	2.4	1.0	1.1	0.8	21.9	21.3	20.0	22.0	23.4	22.8	21.5	22.0	20.2	18.8	22.1	21.9	32.6	105.8	54.2	55.2	34.4	111.4	29.6	30.9	43.3	24.6	54.1	30.5	49.2	40.0	48.2	35.0	31.3	30.4	54.3	34.8	5.9	22.2	243.3	60.6	35.2	44.2	35.4	53.7	63.4	23.8	15.7	37.9	26.5	71.0	48.1	34.1	41.4	44.2	53.4	38.7	61.3	44.4	40.7	133.4	96.4	102.1	37.0	74.5	46.2	67.5	45.7	16.3	32.0	63.3	70.0	34.2	26.2	28.2	33.0	49.0	19.2	22.8	55.4	24.2	19.7	35.2	41.4	37.1	25.8	63.9	122.3	68.3	45.1	37.9	25.0	63.7
ZNF267	HZF2	ENSG00000185947	"Zinc finger protein 267"	Q14586	16	31873807-31917357	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 131.1;Macrophages: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003866	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA003866: AB_1080698"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.60e-3)"	"unprognostic (8.64e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (2.34e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.21e-2)"	6.3	3.7	3.2	18.6	3.8	27.4	7.3	3.4	11.6	5.5	5.4	6.1	7.1	6.7	3.1	7.1	6.0	10.0	4.4	2.9	4.4	5.0	6.6	9.3	17.9	4.6	4.4	6.2	4.8	4.5	2.3	10.0	4.8	5.2	7.1	2.5	5.3	3.9	6.1	4.0	5.9	5.9	4.2	13.2	6.8	9.8	6.4	11.4	5.9	6.6	18.4	13.6	4.4	5.5	8.8	10.0	8.8	7.0	6.2	7.2	26.9	7.0	11.7	9.6	14.7	17.9	13.7	15.6	12.6	5.7	9.6	11.3	14.4	11.4	18.5	23.6	12.1	15.8	5.6	16.1	5.6	17.0	35.3	10.3	7.7	13.6	9.7	7.0	14.0	11.8	25.9	35.9	13.2	12.2	11.4	11.3	8.2	6.8	5.8	11.4	24.8	13.7	10.9	38.8	2.8	4.3	10.8	9.6	10.3	15.3	5.7	23.6	16.8	9.3	8.5	8.2	12.0	20.1	12.3	15.7	12.3	13.6	5.7	36.6	24.0	33.4	12.4	23.4	18.6	21.2	16.2	12.5	18.8	15.9	12.6	15.2	75.3	16.5	27.5	11.3	20.3	12.3	3.2	3.8	3.4	11.6	2.9	4.4	4.6	4.4	4.8	4.2	6.4	5.5	23.7	9.6	8.0	3.6	37.0	31.9	39.6	15.2	13.1	4.5	12.3	12.2	5.6	8.6	14.0	3.7	0.0	14.1	27.2	5.4	7.9	19.1	23.3	34.8	10.3	33.5	7.7	10.9	7.1	20.0	10.4	17.2	13.7	31.4	60.3	5.4	7.5	2.8	21.5	11.8	3.7	7.0	14.2	25.3	131.1	8.8	5.9	82.2	14.2	15.0	68.5	5.0	22.6	9.5	7.7	49.7	8.0	3.4	19.9	30.1	4.2	12.4	26.2	3.9	0.0	10.8	12.2	20.7	29.6	33.1	25.6	8.3	47.6	5.9	5.6	48.9
ZNFX1	"FLJ11277, KIAA1404"	ENSG00000124201	"Zinc finger NFX1-type containing 1"	Q9P2E3	20	49237946-49278426	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 132.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046629	Approved		Approved	Mitochondria		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"HPA046629: AB_2616451"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.71e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.86e-2)"	17.1	9.4	9.7	14.3	10.7	28.7	12.4	9.1	9.8	10.1	12.1	11.2	11.0	11.3	9.0	8.1	10.7	14.1	13.2	8.9	9.4	11.8	9.6	18.8	14.2	14.0	11.0	9.9	9.2	13.0	8.5	12.3	10.8	9.7	10.5	8.7	10.3	9.6	15.5	11.8	12.4	13.6	13.3	19.1	11.4	13.4	11.9	13.1	13.8	14.5	13.4	16.5	9.0	11.3	16.3	24.9	5.8	8.2	31.4	24.5	9.8	21.6	50.9	132.7	54.9	28.4	13.2	13.5	27.3	43.5	37.6	30.7	10.8	29.3	45.1	12.8	3.6	16.0	18.1	12.5	27.2	13.0	18.7	26.3	26.9	29.7	22.0	24.3	20.3	8.0	12.4	16.2	33.6	6.8	14.2	8.7	5.6	14.0	20.7	8.9	19.6	3.8	21.8	22.1	5.9	4.3	31.6	61.1	22.4	7.1	15.7	10.8	50.9	64.8	18.3	23.8	21.1	10.7	4.0	7.2	26.0	8.7	14.6	19.3	12.3	20.1	13.5	15.2	12.0	9.4	13.6	13.1	9.1	7.1	12.9	10.0	51.9	9.9	27.1	5.2	11.0	11.5	9.7	10.7	9.1	9.8	8.9	9.4	14.0	11.0	10.8	13.3	11.9	11.3	36.5	41.7	27.2	10.4	25.8	27.8	21.2	14.4	19.4	15.7	13.7	11.2	14.4	10.0	24.8	20.2	10.4	6.1	18.7	28.0	0.0	23.9	37.4	15.9	17.9	38.1	13.1	10.7	12.5	22.7	7.0	28.0	28.5	18.6	27.3	8.1	29.3	13.4	15.1	11.8	11.7	14.2	16.2	26.4	38.0	21.1	22.7	34.2	19.6	15.0	30.2	29.5	17.5	7.1	9.9	32.3	21.8	27.1	9.3	32.8	18.7	6.7	42.8	15.1	0.0	27.8	29.9	42.0	16.3	16.2	21.7	11.4	31.4	10.2	10.4	35.7